Sentence,class,file
Curr Mol  Med 2008; 8:384-92; PMID:18691065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Allergy Clin Immunol 2004; 113:227-34;  PMID:14767434; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Immunol 2012; 188:2622-9; PMID:22327070; http://dx.doi.org/10.4049/jimmu- nol.1101632 53.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Pathol 2002; 160:481-90;  PMID:11839568; http://dx.doi.org/10.1016/S0002- 9440(10)64867-5 54.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunol Res 2011; 50:87-96;  PMID:21442426; http://dx.doi.org/10.1007/s12026- 011-8205-2 55.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Curr Opin Immunol 1999; 11:420-6;  PMID:10448138; http://dx.doi.org/10.1016/S0952- 7915(99)80070-3 56.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature 2010; 464:1367-70; PMID:20200518; http://dx.doi.org/10.1038/nature08900 58.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Immunol 2012; 13:58-66; PMID:22138715;  http://dx.doi.org/10.1038/ni.2182 59.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature  1993; 362:245-8; PMID:8384701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med  1999; 189:1565-72; PMID:10330435; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 1998; 8:255- 64; PMID:9492006; http://dx.doi.org/10.1016/S1074-7613(00)80477-X 62.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature 2009; 461:788-92; PMID:19776740; http://dx.doi.org/10.1038/ nature0847635.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 2010; 32:852-62;  PMID:20620947; http://dx.doi.org/10.1016/j.immu- ni.2010.06.011 36.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Mol Immunol  2005; 42:295-303; PMID:15589317; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Int Immunol 2002; 14:1343-50; PMID:12407025; http://dx.doi.org/10.1093/intimm/ dxf094 39.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med 2011; 208:1523-31; PMID:21646394;  http://dx.doi.org/10.1084/jem.20101167 41.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Immunol 2011; 12:295-303;  PMID:21358638; http://dx.doi.org/10.1038/ni.2005 42.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Science  1997; 276:589-92; PMID:9110977; http://dx.doi.org/10.1126/science.276.5312.589 44.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Proc Natl Acad Sci U  S A 1998; 95:13823-8; PMID:9811885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Immunol 2011; 186:2571-83;  PMID:21242523; http://dx.doi.org/10.4049/jimmu- nol.1002567 47.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest 1999; 103:779-88;  PMID:10079098; http://dx.doi.org/10.1172/JCI5909,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
BMC Mol Biol 2006; 7:45;  PMID:17134490; http://dx.doi.org/10.1186/1471- 2199-7-45 105.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Proc Natl Acad Sci U S A  2004; 101:3880-5; PMID:15004274; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity  2003; 19:739-48; PMID:14614860; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunology 2009; 127:450-8; PMID:19604299; http://dx.doi.org/10.1111/j.1365-2567.2009.03114.x 110.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Immunol  2010; 11:527-34; PMID:20431622; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Immunol 2012; 188:968-75;  PMID:22180613; http://dx.doi.org/10.4049/jimmu- nol.1102840 112.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med 1988; 168:853-62; PMID:3049907;  http://dx.doi.org/10.1084/jem.168.3.853 113.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
T rends Cell Biol 2009; 19:514-22;  PMID:19733078; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Methods Mol Biol  2009; 531:225-52; PMID:19347321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Gene 2005; 353:98-106; PMID:15922518;  http://dx.doi.org/10.1016/j.gene.2005.04.004 116.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 2010; 33:699-712; PMID:21093321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature 1999; 400:378-82;  PMID:10432118; http://dx.doi.org/10.1038/2257291.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Clin Exp Immunol  1995; 101:436-41; PMID:7664490; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Pathol 2004; 164:1989- 2001; PMID:15161635; http://dx.doi.org/10.1016/S0002-9440(10)63759-5 93.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Pathol 2004; 57:477- 86; PMID:15113854; http://dx.doi.org/10.1136/ jcp.2003.012799 94.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Annu Rev Immunol  2010; 28:445-89; PMID:20192806; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Rev Immunol  2010; 10:225-35; PMID:20336151; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Crit Care Med 1998; 158:1863- 70; PMID:9847279; http://dx.doi.org/10.1164/ajrc- cm.158.6.9709123 97.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest 1995; 96:1303- 10; PMID:7657805; http://dx.doi.org/10.1172/ JCI118165 98.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cell Res 2006; 16:3- 10; PMID:16467870; http://dx.doi.org/10.1038/ sj.cr.7310002 99.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cell 1997; 89:587-96;  PMID:9160750; http://dx.doi.org/10.1016/S0092- 8674(00)80240-8 100.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 1998; 9:745-55;  PMID:9846495; http://dx.doi.org/10.1016/S1074- 7613(00)80671-8 101.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity  2000; 12:27-37; PMID:10661403; http://dx.doi.org/10.1016/S1074-7613(00)80156-9 102.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Eur J Immunol  2006; 36:1882-91; PMID:16810739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Allergy Clin Immunol 1998; 102:859-66;  PMID:9819306; http://dx.doi.org/10.1016/S0091- 6749(98)70029-6 78.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Allergy Clin Immunol 1999; 103:215-22;  PMID:9949310; http://dx.doi.org/10.1016/S0091-6749(99)70493-8 79.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Inflamm (Lond) 2012; 9:5; PMID:22401596;  http://dx.doi.org/10.1186/1476-9255-9-5 81.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Int Arch  Allergy Immunol 2003; 131:33-8; PMID:12759487;  http://dx.doi.org/10.1159/000070432 82.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunol Today 2000;  21:60-4; PMID:10652462; http://dx.doi.org/10.1016/ S0167-5699(99)01492-9 83.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Clin Exp Allergy 2001; 31:1509-14; PMID:11678849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Med Genet  2004; 41:535-9; PMID:15235025; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunol Rev  2011; 242:10-30; PMID:21682736; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Proc Natl Acad Sci U S A  2012; 109:16648-53; PMID:23011799; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
FEBS  J 2013; 280:2014-26; PMID:23461825; http://dx.doi.org/10.1111/febs.12225 88.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Lancet  2007; 370:1422-31; PMID:17950857; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
N Engl J Med 2011; 365:1088- 98; PMID:21812663; http://dx.doi.org/10.1056/ NEJMoa1106469 90.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol  Biol 1998; 18:60-5; PMID:9448046; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
"J Allergy Clin Immunol 2007; 119:529-41, quiz  542-3; PMID:17336608; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest 2006; 116:2183- 92; PMID:16841093; http://dx.doi.org/10.1172/ JCI24767 141.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Pharmacol Sci 2010; 114:239- 47; PMID:20948164; http://dx.doi.org/10.1254/ jphs.10R03CR 142.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol Biol 2009; 41:516- 24; PMID:19202006; http://dx.doi.org/10.1165/ rcmb.2008-0163OC 143.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest  2006; 116:309-21; PMID:16453019; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol Biol 2002; 27:536-41; PMID:12397012; http://dx.doi.org/10.1165/ rcmb.4682 132.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cell Commun Adhes 2010; 17:83-92;  PMID:21275604; http://dx.doi.org/10.3109/1541906 1.2010.551682 133.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Crit Care Med  2002; 165:1132-6; PMID:11956057; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Respir  Res 2006; 7:39; PMID:16551361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Science 1998; 282:2258- 61; PMID:9856949; http://dx.doi.org/10.1126/sci-ence.282.5397.2258119.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cell Metab  2007; 6:137-43; PMID:17681149; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 2012; 36:451-63; PMID:22425247;  http://dx.doi.org/10.1016/j.immuni.2011.12.020 121.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Immunol  2011; 12:631-8; PMID:21623379; http://dx.doi.org/10.1038/ni.2045 122.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Immunol 2012; 188:1503-13; PMID:22198948;  http://dx.doi.org/10.4049/jimmunol.1102832 123.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
"J Allergy Clin  Immunol 2012; 129:191-8, e1-4; PMID:22079492;  http://dx.doi.org/10.1016/j.jaci.2011.09.041 124.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 2012; 37:649-59; PMID:23063330; http://dx.doi.org/10.1016/j.immu- ni.2012.08.015 126.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Asthma 1985; 22:295-301; PMID:3908443; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Biochem Soc T rans 2009; 37:877-81; PMID:19614611; http://dx.doi.org/10.1042/ BST0370877,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
JAK-STAT 2013; 2:e25155; http://dx.doi.org/10.4161/jkst.25155Leukemia inhibitory factor (Li F) is a pleiotropic growth  factor that regulates several biological functions.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
"In IVF, it can be used as an in vitro supplement to the culture medium to enhance the quality of embryo at the stage of transfer into the uterus (United States Patent 5962321; Inventors: Gough, Nicholas Martin; Willson, Tracey Ann, Seamark, Robert Frederick [Beulah Park, AU], http://www.freepatentsonline.com/5962321.html).",Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Front  Biosci (Schol Ed) 2012; 4:1151-71; PMID:22202114;  http://dx.doi.org/10.2741/S323 2.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Dev Biol 2005; 280:260- 80; PMID:15882572; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Reprod  Dev 2012; 58:283-7; PMID:22790871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Hum Reprod Update  2005; 11:613-30; PMID:16006437; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Int J Biochem Cell Biol 2005; 37:2284- 96; PMID:16125646; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Semin Reprod  Med 2009; 27:62-79; PMID:19197806; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Bioessays 2001; 23:161-9;  PMID:11169589; http://dx.doi.org/10.1002/1521- 1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0 38.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Science  1992; 257:809-13; PMID:1496401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Nat Rev Cancer 2004; 4:97-105;  PMID:14964307; http://dx.doi.org/10.1038/nrc1275 42.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Oncogene 2004; 23:3550-60;  PMID:15116091; http://dx.doi.org/10.1038/ sj.onc.1207383 43.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Biol Chem 1997; 272:22389- 92; PMID:9278386; http://dx.doi.org/10.1074/ jbc.272.36.22389 44.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Biol  Chem 1999; 274:17209-18; PMID:10358079; http://dx.doi.org/10.1074/jbc.274.24.17209 45.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Cell 1993; 74:1135-45; PMID:8402883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biochem J 2000; 345:759-66;  PMID:10642538; http://dx.doi.org/10.1042/0264- 6021:3450759 49.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Stem Cells 1999; 17:138- 46; PMID:10342556; http://dx.doi.org/10.1002/ stem.170138 50.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Dev Dyn 1997; 208:190-8; PMID:9022056;  http://dx.doi.org/10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D 51.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Reprod Fertil 1994; 101:421- 6; PMID:7932378; http://dx.doi.org/10.1530/ jrf.0.1010421 25.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biol Reprod 1999; 60:355-64;  PMID:9916002; http://dx.doi.org/10.1095/biolre- prod60.2.355 27.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Immunol Rev 1995; 148:221-53;  PMID:8825289; http://dx.doi.org/10.1111/j.1600- 065X.1995.tb00100.x 30.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Mol Hum Reprod 1999; 5:581-6; PMID:10341007;  http://dx.doi.org/10.1093/molehr/5.6.581 33.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Eur J Obstet Gynecol Reprod Biol  2004; 112:69-73; PMID:14687743; http://dx.doi.org/10.1016/S0301-2115(03)00315-4 35.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Reprod Fertil Dev 2011; 23:714- 24; PMID:21635820; http://dx.doi.org/10.1071/ RD10315 36.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Fertil Steril 2012; 99:533- 42; PMID:23122949; http://dx.doi.org/10.1016/j.fertnstert.2012.10.00410.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Placenta 2005; 26(Suppl A):S21-30;  PMID:15837062; http://dx.doi.org/10.1016/j.placen- ta.2004.11.013 11.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Hum Reprod Update  2008; 14:335-44; PMID:18424427; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Int J Med Sci 2012; 9:447-52;  PMID:22859905; http://dx.doi.org/10.7150/ ijms.4593 13.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Eur J Contracept Reprod Health Care  2007; 12:212-9; PMID:17763259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Int Rev Immunol 1998;  16:397-426; PMID:9505197; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Stem Cells 2003; 21:5-14; PMID:12529546;  http://dx.doi.org/10.1634/stemcells.21-1-5 18.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Stem Cell Rev 2012; 8:1-15;  PMID:21537995; http://dx.doi.org/10.1007/s12015- 011-9261-7 19.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Hum Reprod  1997; 12:1233-9; PMID:9222008; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Fertil Steril 2003; 79(Suppl 1):808-14;  PMID:12620495; http://dx.doi.org/10.1016/S0015- 0282(02)04830-6 23.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Contraception 2006; 74:419-25;  PMID:17046385; http://dx.doi.org/10.1016/j.contra- ception.2006.05.070 82.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Reproduction 2006; 131:341- 9; PMID:16452727; http://dx.doi.org/10.1530/ rep.1.00956 83.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Placenta  2005; 26:548-55; PMID:15993704; http://dx.doi.org/10.1016/j.placenta.2004.08.012 84.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biol Reprod 2007; 76:203-10; PMID:17021346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Placenta 2005; 26(Suppl A):S37-41;  PMID:15837065; http://dx.doi.org/10.1016/j.placen- ta.2005.01.007 86.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Mol Reprod Dev 2008; 75:175- 83; PMID:17546632; http://dx.doi.org/10.1002/ mrd.20729 88.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
BJOG 2006; 113:152-8; PMID:16411991; http://dx.doi.org/10.1111/j.1471-0528.2005.00843.x 89.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biol Reprod 2012; 86:54;  PMID:22053093; http://dx.doi.org/10.1095/biolre- prod.111.094334 90.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Physiol  2005; 566:409-23; PMID:15890698; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Mol Cell Endocrinol 2011; 332:213- 20; PMID:21035520; http://dx.doi.org/10.1016/j.mce.2010.10.013 93.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Cell 1999; 98:617-27; PMID:10490101; http://dx.doi.org/10.1016/S0092- 8674(00)80049-566.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Oncogene 2001; 20:7925-34; PMID:11753675;  http://dx.doi.org/10.1038/sj.onc.1204990 67.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Int J Cancer  2006; 118:2943-7; PMID:16425286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Histopathology 2008; 53:139-46; PMID:18752497; http://dx.doi.org/10.1111/j.1365-2559.2008.03089.x 69.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Am J Reprod Immunol 2003; 50:316-21; PMID:14672334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Cancer Res 2009; 69:6823-30; PMID:19690134;  http://dx.doi.org/10.1158/0008-5472.CAN-09-1684 71.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Genes Dev 1998; 12:3872- 81; PMID:9869640; http://dx.doi.org/10.1101/ gad.12.24.3872 73.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Cell Mol Life Sci 1999; 55:1568- 77; PMID:10526574; http://dx.doi.org/10.1007/ s000180050396 74.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Nature  1997; 387:924-9; PMID:9202127; http://dx.doi.org/10.1038/43219 76.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Placenta 2006; 27:912-8;  PMID:16300827; http://dx.doi.org/10.1016/j.placen- ta.2005.10.003 77.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Eur J Obstet Gynecol  Reprod Biol 2002; 101:104-8; PMID:11858881;  http://dx.doi.org/10.1016/S0301-2115(01)00523-1 78.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Eur  J Obstet Gynecol Reprod Biol 2006; 126:206-11;  PMID:16386348; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Assist Reprod Genet 2003; 20:13-20; PMID:12645863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Cell 1995; 82:241-50;  PMID:7543024; http://dx.doi.org/10.1016/0092- 8674(95)90311-9 54.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Science 1997; 277:1630-5; PMID:9287210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Biol Chem  1996; 271:12121-4; PMID:8647800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biochem J  2002; 364:875-9; PMID:12049654; http://dx.doi.org/10.1042/BJ20020295 57.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Nucleic Acids  Res 1997; 25:2062-7; PMID:9153303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Proc Natl Acad Sci U S A 1998; 95:11107- 12; PMID:9736697; http://dx.doi.org/10.1073/ pnas.95.19.11107 59.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biochem J 1999; 341:691-6;  PMID:10417333; http://dx.doi.org/10.1042/0264-6021:3410691 60.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Biochem J 2000; 347:89-96; PMID:10727406;  http://dx.doi.org/10.1042/0264-6021:3470089 61.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Exp Cell Res 2009; 315:1724- 33; PMID:19331815; http://dx.doi.org/10.1016/j.yexcr.2009.01.026 63.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Biol Chem 1997; 272:24542-9; PMID:9305919; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Mol Cell Biol  2004; 24:407-19; PMID:14673173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Placenta  2008; 29:1024-8; PMID:18986700; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Hum Pathol 1995; 26:594-600;  PMID:7774887; http://dx.doi.org/10.1016/0046- 8177(95)90162-097.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Clin Endocrinol Metab 2002; 87:1094- 7; PMID:11889171; http://dx.doi.org/10.1210/ jc.87.3.1094 98.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Mol  Endocrinol 2005; 35:165-75; PMID:16087730;  http://dx.doi.org/10.1677/jme.1.0176794.,Non-OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
Proc Natl Acad Sci U S A 2001; 98:9324- 9; PMID:11481489; http://dx.doi.org/10.1073/ pnas.161271798 95.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
J Biol Chem 2006; 281:11444- 5; PMID:16517610; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/22/96/jkst-2-e25155.PMC3876431.pdf
JAK-STAT 2013; 2:e25763; http://dx.doi.org/10.4161/jkst.25763Cytokines play several roles in developing and/or reinforcing  premature cellular senescence of young cells.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Genes Dev 2010; 24:2463- 79; PMID:21078816; http://dx.doi.org/10.1101/ gad.1971610 2.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
PLoS Biol  2008; 6:2853-68; PMID:19053174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nat Rev Cancer 2009;  9:81-94; PMID:19132009; http://dx.doi.org/10.1038/ nrc2560 7.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene  1999; 18:3742-53; PMID:10391682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cytokine Growth Factor Rev 1997; 8:241-52;  PMID:9620640; http://dx.doi.org/10.1016/S1359- 6101(98)80005-1 10.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene 2000; 19:2548-56; PMID:10851053;  http://dx.doi.org/10.1038/sj.onc.1203551 11.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell Cycle  2012; 11:730-9; PMID:22374671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Exp Cell Res  1961; 25:585-621; PMID:13905658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nature 2003; 426:194-8; PMID:14608368;  http://dx.doi.org/10.1038/nature0211814.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Mol Cell 2007; 28:739-45; PMID:18082599; http://dx.doi.org/10.1016/j.mol- cel.2007.11.015 15.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 1997; 88:593-602; PMID:9054499;  http://dx.doi.org/10.1016/S0092-8674(00)81902-9 16.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nat Rev Mol Cell  Biol 2007; 8:715-22; PMID:17717516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nature 2005; 436:660-5; PMID:16079837; http://dx.doi.org/10.1038/nature03841 18.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nature 2005; 436:642; PMID:16079833; http://dx.doi.org/10.1038/436642a 19.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell Death  Differ 2006; 13:773-84; PMID:16410802; http://dx.doi.org/10.1038/sj.cdd.4401843 20.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
EMBO J  2011; 30:1536-48; PMID:21399611; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Mol Cell Biol  2004; 24:407-19; PMID:14673173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
FEBS  Lett 2001; 495:71-6; PMID:11322950; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene 2007; 26:7656-64; PMID:17563747;  http://dx.doi.org/10.1038/sj.onc.1210567 52.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cancer Cell  2009; 15:283-93; PMID:19345327; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Science 2009; 324:1713-6; PMID:19556508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Genes Cells  2012; 17:132-45; PMID:22233524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Immunity  2012; 36:239-50; PMID:22342841; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nat Struct Mol Biol 2013; 20:469-76; PMID:23454976; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene 2000; 19:2474-88; PMID:10851046; http://dx.doi.org/10.1038/ sj.onc.1203527 61.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Biochem J 2006; 395:1- 19; PMID:16526944; http://dx.doi.org/10.1042/ BJ20060086 63.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Mol Biol Cell 2007; 18:4543-52;  PMID:17804819; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Eur J Cell Biol  2011; 90:484-94; PMID:21145125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 1989; 58:573-81; PMID:2788034; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Science 1997; 277:1630-5; PMID:9287210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 1995; 82:241-50;  PMID:7543024; http://dx.doi.org/10.1016/0092- 8674(95)90311-9 39.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene 2001;  20:3464-74; PMID:11429693; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Curr Biol 2000; 10:47-50;  PMID:10660304; http://dx.doi.org/10.1016/S0960- 9822(99)00268-7 44.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Proc Natl Acad Sci U S A  2005; 102:4524-9; PMID:15764709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Genes Dev 2004; 18:381-6;  PMID:15004007; http://dx.doi.org/10.1101/ gad.1166904 46.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Int Immunol  2005; 17:1543-52; PMID:16219639; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Exp Hematol  2003; 31:398-405; PMID:12763138; http://dx.doi.org/10.1016/S0301-472X(03)00045-6 48.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
J Biol Chem 1999; 274:24392-400; PMID:10446219; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nat Cell Biol 2009; 11:973-9;  PMID:19597488; http://dx.doi.org/10.1038/ncb1909 22.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 2008; 133:1019- 31; PMID:18555778; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell  2008; 133:1006-18; PMID:18555777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
PLoS One 2010; 5:e9188; PMID:20169192; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Oncogene 2010; 29:273-84;  PMID:19802007; http://dx.doi.org/10.1038/ onc.2009.318 27.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell Cycle 2010; 9:3085-99; PMID:20699642;  http://dx.doi.org/10.4161/cc.9.15.12521 28.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
PLoS One 2012; 7:e36909;  PMID:22615843; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
J Biol Chem 2012; 287:26702- 14; PMID:22711534; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Hepatology 2012; 56:1150-9; PMID:22473749;  http://dx.doi.org/10.1002/hep.25744 33.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Expert Opin Ther Targets  2007; 11:613-24; PMID:17465721; http://dx.doi.org/10.1517/14728222.11.5.613 34.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Biochim Biophys Acta 2011; 1813:878-88; PMID:21296109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 2008; 132:363-74; PMID:18267069;  http://dx.doi.org/10.1016/j.cell.2007.12.032 82.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 2008; 134:657- 67; PMID:18724938; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Genes Dev 2007;  21:43-8; PMID:17210786; http://dx.doi.org/10.1101/ gad.1487307 85.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Annu Rev Med 2000; 51:245-70; PMID:10774463;  http://dx.doi.org/10.1146/annurev.med.51.1.245 87.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nature 2013; 499:97-101;  PMID:23803760; http://dx.doi.org/10.1038/ nature1234774.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Mech Ageing Dev 2009; 130:179- 88; PMID:19071156; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Nature 2013; 494:361- 5; PMID:23376950; http://dx.doi.org/10.1038/ nature11824 76.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
PLoS Biol 2010; 8:e1000476;  PMID:20838657; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
J Biol Chem 2000; 275:35942- 52; PMID:10962000; http://dx.doi.org/10.1074/jbc.M005832200 79.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Proc Natl Acad Sci U S A 2003; 100:13344- 9; PMID:14581617; http://dx.doi.org/10.1073/ pnas.2234026100 80.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Free Radic Biol Med 2008; 44:1817-32;  PMID:18329388; http://dx.doi.org/10.1016/j.freerad- biomed.2008.02.00164.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Methods 2012; 56:383- 8; PMID:22406489; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell 2010;  143:355-66; PMID:21029859; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cancer Lett 2012; 323:155-60;  PMID:22521547; http://dx.doi.org/10.1016/j.can- let.2012.04.003 67.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
J Immunol 2012; 189:1162-72; PMID:22753933;  http://dx.doi.org/10.4049/jimmunol.1102538 68.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell Cycle 2008; 7:3355-61;  PMID:18948731; http://dx.doi.org/10.4161/ cc.7.21.6919 69.,Non-OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Cell Cycle 2009; 8:1896-900; PMID:19478560;  http://dx.doi.org/10.4161/cc.8.12.8809 70.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Genes Dev  2013; 27:900-15; PMID:23599344; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
Mol Biol Cell 2006; 17:1583-92;  PMID:16436515; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/40/44/jkst-2-e25763.PMC3876432.pdf
JAK-STAT 2013; 2:e25764; http://dx.doi.org/10.4161/jkst.25764STAT3 and STAT5 (STAT3/5) proteins are crucial mediators  of cytokine- or growth factor-induced cell survival and proliferation.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Lett  2013; 336:167-73; PMID:23623921; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Res 2006; 66:9948-56;  PMID:17047057; http://dx.doi.org/10.1158/0008-5472.CAN-06-1092 21.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Lab Invest 2009; 89:717-25; PMID:19290007; http://dx.doi.org/10.1038/labin- vest.2009.11 22.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood  2007; 109:1678-86; PMID:17038539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Biochem  J 2005; 390:359-66; PMID:15833084; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood  2012; 119:3539-49; PMID:22144185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2007; 109:3906-14; PMID:17218386; http://dx.doi.org/10.1182/blood- 2006-07-036335 12.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2012; 119:3550-60;  PMID:22234689; http://dx.doi.org/10.1182/blood-2011-12-397554 14.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cell  1999; 98:295-303; PMID:10458605; http://dx.doi.org/10.1016/S0092-8674(00)81959-5 15.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Cell 2005; 7:87-99; PMID:15652752; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Oncogene  2002; 21:2000-8; PMID:11960372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Nat Rev Cancer 2004; 4:97-105; PMID:14964307; http://dx.doi.org/10.1038/nrc1275 3.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2003; 101:2940-54; PMID:12480704; http://dx.doi.org/10.1182/blood-2002-04-1204 4.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Nat Med 2005; 11:623-9; PMID:15895073; http://dx.doi.org/10.1038/nm1249 6.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2008; 112:2463-73; PMID:18579792; http://dx.doi.org/10.1182/blood- 2007-09-115477 7.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Genes Cancer 2012; 3:503-11; PMID:23264850;  http://dx.doi.org/10.1177/1947601912466555 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia 2011; 25:281- 9; PMID:21072051; http://dx.doi.org/10.1038/ leu.2010.263 54.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Free Radic Biol Med  2010; 49:516-27; PMID:20434540; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Science 2009; 323:793-7;  PMID:19131594; http://dx.doi.org/10.1126/sci- ence.1164551 56.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Cell Sci 2012; 125:2995- 3003; PMID:22393233; http://dx.doi.org/10.1242/ jcs.103093 57.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Proc Natl Acad Sci U S A 2003; 100:9342-7; PMID:12867595; http://dx.doi.org/10.1073/ pnas.1633516100 58.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2012; 120:2589- 99; PMID:22665934; http://dx.doi.org/10.1182/ blood-2012-01-404004 59.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Science  2009; 324:1713-6; PMID:19556508; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Biochim Biophys Acta  2011; 1807:534-42; PMID:20849810; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Mol Cancer Res 2008; 6:1099-105;  PMID:18644974; http://dx.doi.org/10.1158/1541- 7786.MCR-07-2177 63.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Cell Mol Med 2012; 16:1878-88;  PMID:22050790; http://dx.doi.org/10.1111/j.1582- 4934.2011.01483.x 65.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Biochem Pharmacol 2012; 83:1456- 64; PMID:22387047; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Neurosci 2009; 29:7003-14; PMID:19474327; http://dx.doi.org/10.1523/ JNEUROSCI.1110-09.200939.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Hepatol 2006; 45:271- 9; PMID:16595158; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Free Radic Biol Med  2012; 52:1101-10; PMID:22281400; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Biochem Biophys Res Commun 2004; 322:1005- 11; PMID:15336564; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Res 2010; 70:8222-32;  PMID:20807804; http://dx.doi.org/10.1158/0008-5472.CAN-10-0894 43.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cell Cycle  2010; 9:4294-6; PMID:20962592; http://dx.doi.org/10.4161/cc.9.21.13677 44.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Endocrinology 2009; 150:1122-31; PMID:18988672;  http://dx.doi.org/10.1210/en.2008-1241 45.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Immunol 2009; 183:2356-64;  PMID:19605693; http://dx.doi.org/10.4049/jimmu- nol.0901131 46.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Antioxid Redox Signal  2012; 16:1215-28; PMID:22316005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Lett 2008; 270:1-9;  PMID:18467025; http://dx.doi.org/10.1016/j.can- let.2008.03.036 48.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia 2013; In press; PMID:23558526;  http://dx.doi.org/10.1038/leu.2013.102 49.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Mol Biol Cell 2008; 19:2984- 94; PMID:18463161; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Mol Cell Biol  2002; 22:4189-201; PMID:12024032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia 2008; 22:1969-72; PMID:18401418; http://dx.doi.org/10.1038/ leu.2008.7824.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia  2010; 24:1397-405; PMID:20535152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Mol Cell Biol 2007; 27:3708-15; PMID:17353274;  http://dx.doi.org/10.1128/MCB.01838-06 26.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Science 1997; 276:1418-20; PMID:9162009; http://dx.doi.org/10.1126/sci- ence.276.5317.1418 27.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood  2011; 117:5816-26; PMID:21398578; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Antioxid Redox Signal 2009; 11:1107- 22; PMID:18999985; http://dx.doi.org/10.1089/ ars.2008.2308 29.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cell Signal 2006; 18:174- 82; PMID:15982852; http://dx.doi.org/10.1016/j.cell- sig.2005.04.002 31.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Antioxid Redox Signal 2005; 7:560-77;  PMID:15890001; http://dx.doi.org/10.1089/ ars.2005.7.560 33.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Free Radic Biol Med 2008; 45:329-35;  PMID:18466778; http://dx.doi.org/10.1016/j.freerad- biomed.2008.04.024 35.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Eur J Immunol 2012; 42:3202-11; PMID:22930452; http://dx.doi.org/10.1002/ eji.201242659 36.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
PLoS  One 2012; 7:e34050; PMID:22807997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Autophagy 2010; 6:1125- 38; PMID:20930550; http://dx.doi.org/10.4161/ auto.6.8.13547 38.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
J Neurochem 2005; 92:1521-30; PMID:15748169;  http://dx.doi.org/10.1111/j.1471-4159.2004.02990.x,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia  2012; 26:2390-7; PMID:22522791; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Front Biosci 2007; 12:2807-20;  PMID:17485261; http://dx.doi.org/10.2741/2274 78.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Mol Cell Biol  2008; 28:6668-80; PMID:18779318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Genes Dev 2007;  21:43-8; PMID:17210786; http://dx.doi.org/10.1101/ gad.1487307 73.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Leukemia 2009; 23:1432-40; PMID:19295548;  http://dx.doi.org/10.1038/leu.2009.49 74.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Hepatology 2012; 56:2375- 86; PMID:22711600; http://dx.doi.org/10.1002/ hep.25900 75.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Cancer Res 2013; 73:2052-8;  PMID:23400594; http://dx.doi.org/10.1158/0008- 5472.CAN-12-395567.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Biochem Biophys Res Commun 2010; 402:778- 83; PMID:21036145; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2011; 117:3320-30; PMID:21263150;  http://dx.doi.org/10.1182/blood-2010-08-303669 69.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2008; 111:2101-11; PMID:18042802;  http://dx.doi.org/10.1182/blood-2007-06-096297 70.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
Blood 2008; 111:3173-82; PMID:18192505;  http://dx.doi.org/10.1182/blood-2007-05-092510 71.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/jkst-2-e25764.PMC3876433.pdf
"JAK-STAT 2013; 2:e25256; http://dx.doi.org/10.4161/jkst.25256Telomerase, comprising a reverse transcriptase protein (T erT)  and an rNA template, plays a critical role during senescence  and carcinogenesis; however, the mechanisms by which  telomerase is regulated remain to be elucidated.",Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Nucleic Acids Res 2000; 28:669- 77; PMID:10637317; http://dx.doi.org/10.1093/ nar/28.3.669 2.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mol Cell Biol 2005; 25:8037-43;  PMID:16135795; http://dx.doi.org/10.1128/ MCB.25.18.8037-8043.2005 3.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Oncogene  2002; 21:4071-9; PMID:12037663; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Anticancer Agents Med Chem  2009; 9:1024-38; PMID:19663778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Gene  2012; 498:135-46; PMID:22381618; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Res 2005; 65:6516-20;  PMID:16061629; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0924 7.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Carcinogenesis 2007; 28:2282-90; PMID:17615260; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Science  1994; 264:270-3; PMID:8146661; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Theor Biol 1973; 41:181-90; PMID:4754905; http://dx.doi.org/10.1016/0022- 5193(73)90198-7 16.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell 1985; 43:405-13; PMID:3907856;  http://dx.doi.org/10.1016/0092-8674(85)90170-9 17.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell 1989; 59:521-9;  PMID:2805070; http://dx.doi.org/10.1016/0092- 8674(89)90035-4 18.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell 1997; 90:785-95; PMID:9288757; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Nat Genet 1998; 19:182-6;  PMID:9620778; http://dx.doi.org/10.1038/554 21.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Med Res  Rev 2012; 32:233-53; PMID:20549676; http://dx.doi.org/10.1002/med.20211 22.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Sci 2008; 99:1528-38; PMID:18754863;  http://dx.doi.org/10.1111/j.1349-7006.2008.00878.x23.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Nucleic Acids Res 2007; 35:1245- 56; PMID:17267411; http://dx.doi.org/10.1093/nar/ gkl1125 24.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Exp Cell  Res 2002; 274:25-34; PMID:11855854; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Neoplasia 2000; 2:426-32; PMID:11191109; http://dx.doi.org/10.1038/sj.neo.7900112 27.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Pathol 2011; 223:102-15; PMID:21125669; http://dx.doi.org/10.1002/ path.2806 29.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leukemia  2011; 25:1324-34; PMID:21502955; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
CNS  Neurosci Ther 2012; 18:722-8; PMID:22709411;  http://dx.doi.org/10.1111/j.1755-5949.2012.00349.x 31.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Biol Chem 1999; 274:13085- 90; PMID:10224060; http://dx.doi.org/10.1074/ jbc.274.19.13085 32.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Biol Chem 1998; 273:33436- 42; PMID:9837921; http://dx.doi.org/10.1074/ jbc.273.50.33436,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
FEBS Lett 2006; 580:6819-24;  PMID:17141225; http://dx.doi.org/10.1016/j.febs- let.2006.11.044 62.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2004; 104:2523-31;  PMID:15226182; http://dx.doi.org/10.1182/blood- 2003-12-4251 63.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Immunity  2012; 36:529-41; PMID:22520846; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Br J Haematol  2006; 134:366-84; PMID:16822289; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
JAK-STAT 2012; 1:55-64; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2008; 112:1402-12; PMID:18515659;  http://dx.doi.org/10.1182/blood-2008-01-134114 69.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mod Pathol 2009; 22:476-87;  PMID:19136931; http://dx.doi.org/10.1038/mod- pathol.2008.207 70.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
JAK-STAT 2012; 1:13-22;  http://dx.doi.org/10.4161/jkst.19316 71.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Biochem Biophys Res Commun  2004; 314:1080-5; PMID:14751243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J  Leukoc Biol 2008; 83:1240-8; PMID:18276798; http://dx.doi.org/10.1189/jlb.1207848 73.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Aging Cell  2012; 11:704-13; PMID:22621437; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leuk Res 2011; 35:416-8; PMID:21163530; http://dx.doi.org/10.1016/j.leu- kres.2010.11.002 48.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Lett 2009; 286:172-9;  PMID:19560862; http://dx.doi.org/10.1016/j.can-let.2009.05.028 49.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Lett 2012; 323:223-31; PMID:22554713;  http://dx.doi.org/10.1016/j.canlet.2012.04.022 51.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2012; 120:2438- 49; PMID:22875913; http://dx.doi.org/10.1182/ blood-2012-02-409110 52.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Clin Cancer Res 2009; 15:914-23; PMID:19188162;  http://dx.doi.org/10.1158/1078-0432.CCR-08-0792 53.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Cell Sci  2012; 125:2684-97; PMID:22366458; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Biol Chem  2001; 276:15571-4; PMID:11274138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Biochem J 2001; 355:459-64; PMID:11284734;  http://dx.doi.org/10.1042/0264-6021:3550459 59.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Br J Cancer  2006; 94:870-8; PMID:16508638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell Cycle  2007; 6:1496-501; PMID:17525530; http://dx.doi.org/10.4161/cc.6.12.430433.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
EMBO  J 2000; 19:2652-61; PMID:10835362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Res 2011; 71:266-76;  PMID:21071633; http://dx.doi.org/10.1158/0008-5472.CAN-10-1588 36.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood  2012; 120:3397-406; PMID:22898602; http://dx.doi.org/10.1182/blood-2012-05-378596 37.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Growth Factors 2008; 26:1-11; PMID:18365874;  http://dx.doi.org/10.1080/08977190802001389 38.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mol Cell Biol 2006; 26:230- 7; PMID:16354694; http://dx.doi.org/10.1128/ MCB.26.1.230-237.2006 39.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Virol  2008; 82:10175-87; PMID:18684838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Surg Res 2007; 143:415-21;  PMID:17662305; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J Biol Chem 2006;  281:25588-600; PMID:16785237; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Oncogene 2004; 23:4505- 15; PMID:15048073; http://dx.doi.org/10.1038/ sj.onc.1207582 43.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mol Cancer Ther 2012; 11:1112-21; PMID:22402124; http://dx.doi.org/10.1158/1535- 7163.MCT-11-0850 44.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Oncogene 2000; 19:2548-56; PMID:10851053;  http://dx.doi.org/10.1038/sj.onc.1203551 104.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2012; 119:2844-53; PMID:22323454;  http://dx.doi.org/10.1182/blood-2011-10-388538 105.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
DNA Cell Biol 2011; 30:71-8; PMID:21091189;  http://dx.doi.org/10.1089/dna.2010.1112 106.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell Signal 2008; 20:1489- 96; PMID:18502099; http://dx.doi.org/10.1016/j.cell-sig.2008.04.004 107.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell Death Dis 2012;  3:e436; PMID:23190608; http://dx.doi.org/10.1038/ cddis.2012.175 108.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Growth Factors 2008; 26:1-11; PMID:18365874;  http://dx.doi.org/10.1080/08977190802001389 109.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Int J Cancer 2009; 125:783- 90; PMID:19384955; http://dx.doi.org/10.1002/ijc.24335 111.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Sci  2008; 99:280-6; PMID:18201269; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
BMC Mol Biol 2009; 10:5-21; PMID:19187532;  http://dx.doi.org/10.1186/1471-2199-10-5 113.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mutat Res 1991; 256:271-82; PMID:1722017;  http://dx.doi.org/10.1016/0921-8734(91)90018-7 114.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell 1999; 97:419-22; PMID:10338204; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mol Cell 2008; 31:153-65; PMID:18657499;  http://dx.doi.org/10.1016/j.molcel.2008.06.01390.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Br J Haematol 1991; 79:428-37; PMID:1751370;  http://dx.doi.org/10.1111/j.1365-2141.1991.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leukemia 2008; 22:686-707; PMID:18337767; http://dx.doi.org/10.1038/ leu.2008.26 94.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Oncogene 2008; 27:2934-40;  PMID:18059341; http://dx.doi.org/10.1038/sj.onc.1210957 95.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Eur J Immunol 2003; 33:1372- 81; PMID:12731064; http://dx.doi.org/10.1002/ eji.200323761 96.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Mol Immunol  2007; 44:3416-26; PMID:17433443; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
J T ransl Med 2012; 10:116-27;  PMID:22676255; http://dx.doi.org/10.1186/1479- 5876-10-116 98.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2007; 109:1678-86; PMID:17038539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
PLoS  One 2012; 7:e31733; PMID:22347506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Blood 2012; 119:170-9;  PMID:22086413; http://dx.doi.org/10.1182/blood- 2011-07-370403 102.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell Signal 2006; 18:1212-8;  PMID:16380230; http://dx.doi.org/10.1016/j.cell- sig.2005.09.01076.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
N Engl J Med  2001; 344:1038-42; PMID:11287973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cancer Lett  2002; 178:187-97; PMID:11867204; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leuk  Lymphoma 2008; 49:1168-77; PMID:18569639; http://dx.doi.org/10.1080/10428190802043861 79.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cell Signal 2011; 23:1119- 27; PMID:21356308; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Curr  Opin Immunol 2012; 24:146-52; PMID:22342169;  http://dx.doi.org/10.1016/j.coi.2012.01.015 81.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Cytokine 2011; 56:133- 9; PMID:21824785; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leuk Res  2008; 32:1005-14; PMID:18192010; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leukemia  2012; 26:2176-85; PMID:22614177; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leuk Res 2011; 35:416-8; PMID:21163530; http://dx.doi.org/10.1016/j.leu- kres.2010.11.002 86.,OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Leukemia 2007; 21:2304-10; PMID:17713555;  http://dx.doi.org/10.1038/sj.leu.2404874 87.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
Eur J Haematol 2012; 89:288-93;  PMID:22725130; http://dx.doi.org/10.1111/j.1600- 0609.2012.01825.x 88.,Non-OADS,/arxiv_data1/oa_pdf/34/5e/jkst-2-e25256.PMC3876434.pdf
JAK-STAT 2013; 2:e25045; http://dx.doi.org/10.4161/jkst.25045SOCS3 is an inducible negative feedback inhibitor of cytokine  signaling.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Growth Factors 2012;  30:88-106; PMID:22339650; http://dx.doi.org/10.31 09/08977194.2012.660936 2.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nature 1997; 387:917-21;  PMID:9202125; http://dx.doi.org/10.1038/43206 4.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nature  1997; 387:921-4; PMID:9202126; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nature 1997; 387:924-9; PMID:9202127; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 1998;  95:114-9; PMID:9419338; http://dx.doi.org/10.1073/ pnas.95.1.1148.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Mol Cell 2006; 22:205-16; PMID:16630890;  http://dx.doi.org/10.1016/j.molcel.2006.03.024 9.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Genes Cells 1999; 4:339-51;  PMID:10421843; http://dx.doi.org/10.1046/j.1365- 2443.1999.00263.x,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Cell Signal  2009; 21:394-404; PMID:19056487; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Biochem Soc T rans  2012; 40:215-8; PMID:22260693; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
"J Leukoc Biol 2004; 76:237-44; PMID:15107455; http://dx.doi.org/10.1189/ jlb.0104041 41. van de Geijn GJ, Gits J, Aarts LH, Heijmans- Antonissen C, Touw IP .",OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 1999; 96:6964- 9; PMID:10359822; http://dx.doi.org/10.1073/ pnas.96.12.6964 43.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Biochem J  2005; 387:737-45; PMID:15554904; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Growth Factors 2007; 25:319-28; PMID:18236210;  http://dx.doi.org/10.1080/08977190701830151 46.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Mol  Endocrinol 2007; 21:2503-15; PMID:17609438;  http://dx.doi.org/10.1210/me.2006-0498 48.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2008; 283:6843-53; PMID:18195020; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Mol Cell 1998; 1:619-25;  PMID:9660946; http://dx.doi.org/10.1016/S1097- 2765(00)80062-3 51.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2004;  279:13746-54; PMID:14742442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Struct Mol Biol  2013; 20:469-76; PMID:23454976; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
FEBS J 2005; 272:6120-30;  PMID:16302975; http://dx.doi.org/10.1111/j.1742-4658.2005.05010.x 26.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
IUBMB Life 2012; 64:316-23; PMID:22362562; http://dx.doi.org/10.1002/iub.1011 27.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Mol Biol 2008; 381:928-40; PMID:18590740;  http://dx.doi.org/10.1016/j.jmb.2008.06.038 28.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Genes Dev 2004; 18:3055-65; PMID:15601820;  http://dx.doi.org/10.1101/gad.1252404 29.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Mol Biol  2009; 387:162-74; PMID:19385048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Am J Pathol  2004; 165:1499-508; PMID:15509521; http://dx.doi.org/10.1016/S0002-9440(10)63408-6 31.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Blood 2007; 109:1061-8; PMID:17008544;  http://dx.doi.org/10.1182/blood-2006-05-023556 32.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2007; 282:3418-22;  PMID:17138568; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
EMBO J 2003; 22:5036- 46; PMID:14517242; http://dx.doi.org/10.1093/ emboj/cdg503 35.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Immunity 2007; 27:811-23;  PMID:18031698; http://dx.doi.org/10.1016/j.immu-ni.2007.09.011 36.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
EMBO J 2007; 26:1782-93; PMID:17363902; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
T raffic  2009; 10:1168-79; PMID:19453968; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
EMBO J  1999; 18:1309-20; PMID:10064597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Structure 2006; 14:1285-92;  PMID:16905102; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Immunity  2012; 36:239-50; PMID:22342841; http://dx.doi.org/10.1016/j.immuni.2011.12.015 14.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Biochemistry  2002; 41:9229-36; PMID:12119038; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Mol Endocrinol 2005; 19:925-38; PMID:15604114; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Eur J Biochem 2002; 269:2516-26; PMID:12027890;  http://dx.doi.org/10.1046/j.1432-1033.2002.02916.x 19.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Biochem Biophys Res Commun 2003; 310:1188- 93; PMID:14559241; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 1999; 274:35553- 61; PMID:10585430; http://dx.doi.org/10.1074/ jbc.274.50.35553 21.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol  Chem 2000; 275:15985-91; PMID:10821852; http://dx.doi.org/10.1074/jbc.275.21.15985 22.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Immunol 2003; 4:551-6; PMID:12754507;  http://dx.doi.org/10.1038/ni938 23.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Immunity 2004; 20:153-65;  PMID:14975238; http://dx.doi.org/10.1016/S1074- 7613(04)00022-6 80.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Immunol Cell Biol 2012; 90:124-9; PMID:21519345;  http://dx.doi.org/10.1038/icb.2011.29 82.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Blood 2007; 110:1466-74; PMID:17510322; http://dx.doi.org/10.1182/blood- 2007-03-079178 83.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Invest Dermatol 2008; 128:1821- 9; PMID:18185532; http://dx.doi.org/10.1038/ sj.jid.5701224 84.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
EMBO  J 2006; 25:5805-15; PMID:17139252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Blood 2012; 120:2925-9;  PMID:22791286; http://dx.doi.org/10.1182/blood- 2012-04-422527 86.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Oncogene 2007; 26:4833-41; PMID:17297444;  http://dx.doi.org/10.1038/sj.onc.1210286 88.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Oncogene 2012; In  press; PMID:23178499; http://dx.doi.org/10.1038/ onc.2012.540 89.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Eur J Immunol 2007; 37:2082-9; PMID:17621372; http://dx.doi.org/10.1002/ eji.200737193 91.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Immunol  2009; 183:7047-53; PMID:19915050; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 2001; 98:9324- 9; PMID:11481489; http://dx.doi.org/10.1073/ pnas.161271798 66.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Cell 1999; 98:617-27;  PMID:10490101; http://dx.doi.org/10.1016/S0092- 8674(00)80049-5 67.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Circulation 2011; 124:2690- 701; PMID:22082679; http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.028498 69.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A  2005; 102:16333-8; PMID:16258063; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2006; 281:11444- 5; PMID:16517610; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Stem Cells 2006; 24:604-14; PMID:16123385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Oncogene 2004; 23:7150-60; PMID:15378075; http://dx.doi.org/10.1038/ sj.onc.1207930 73.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Immunol 2003; 4:540-5;  PMID:12754505; http://dx.doi.org/10.1038/ni931 74.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Immunol 2003; 4:546-50;  PMID:12754506; http://dx.doi.org/10.1038/ni932 75.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem  2004; 279:6905-10; PMID:14699146; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Cancer Lett 2011; 308:172-80; PMID:21624767;  http://dx.doi.org/10.1016/j.canlet.2011.04.024 78.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Oncogene 2006; 25:2520-30; PMID:16474852; http://dx.doi.org/10.1038/ sj.onc.120928152.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Clin Invest  2006; 116:1571-81; PMID:16710471; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Biochem J 2001; 353:109-16; PMID:11115404; http://dx.doi.org/10.1042/0264-6021:3530109 54.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Immunol  2011; 187:6318-26; PMID:22075701; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 2007; 104:20386- 91; PMID:18077349; http://dx.doi.org/10.1073/ pnas.0705957104 58.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Immunol  2009; 183:97-105; PMID:19535626; http://dx.doi.org/10.4049/jimmunol.0801986 59.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2003; 278:31972- 9; PMID:12783885; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 1999; 96:2071-6; PMID:10051596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Mol Cell Biol 2005; 25:9115- 26; PMID:16199887; http://dx.doi.org/10.1128/ MCB.25.20.9115-9126.2005 63.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Biol Chem 2006; 281:32953- 66; PMID:16956890; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Growth Factors 2009; 27:384-93; PMID:19919527;  http://dx.doi.org/10.3109/08977190903210954,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Proc Natl Acad Sci U S A 2013; 110:E697- 706; PMID:23386726; http://dx.doi.org/10.1073/ pnas.1218284110 113.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Neurosci  2012; 32:17097-107; PMID:23197703; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Diabetes 2004; 53:2232-41; PMID:15331532; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Med 2006; 12:829-34;  PMID:16783372; http://dx.doi.org/10.1038/nm1425 117.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Neuron 2009; 64:617-23;  PMID:20005819; http://dx.doi.org/10.1016/j.neu-ron.2009.11.021 120.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nature 2011; 480:372-5; PMID:22056987; http://dx.doi.org/10.1038/ nature10594102.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nature  1988; 332:83-5; PMID:3258060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Oncogene  2000; 19:2496-504; PMID:10851048; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Hematol  Oncol 2005; 23:91-3; PMID:16285006; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Haematologica  2013; 98:288-95; PMID:22929979; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Med 2004; 10:739-43; PMID:15208705; http://dx.doi.org/10.1038/nm1071 109.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Nat Med 2004; 10:734-8; PMID:15220914;  http://dx.doi.org/10.1038/nm1072 110.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Cell Metab 2006; 4:123-32; PMID:16890540;  http://dx.doi.org/10.1016/j.cmet.2006.06.010 111.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Endocrinology 2008; 149:5654- 61; PMID:18669597; http://dx.doi.org/10.1210/ en.2008-080593.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Exp Med  2003; 197:425-36; PMID:12591901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
J Exp Med 2006; 203:1021-31; PMID:16606674;  http://dx.doi.org/10.1084/jem.20052333 97.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Cell 2011; 144:601-13; PMID:21295337;  http://dx.doi.org/10.1016/j.cell.2011.01.011 98.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
T ransgenic  Res 2001; 10:545-53; PMID:11817542; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Eur J Immunol 1998; 28:2159-66; PMID:9692885; http://dx.doi.org/10.1002/ (SICI)1521-4141(199807)28:07<2159::AID- IMMU2159>3.0.CO;2-B 101.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
Arterioscler Thromb Vasc Biol  2013; 33:581-4; PMID:23329138; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/jkst-2-e25045.PMC3876435.pdf
JAK-STAT 2013; 2:e25434; http://dx.doi.org/10.4161/jkst.25434The retinal pigmented epithelium ( rPe) is a monolayer of  specialized epithelial cells located between the photoreceptors  of the retina and the choroidal blood supply.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Physiol Rev 2005; 85:845-81; PMID:15987797; http://dx.doi.org/10.1152/phys- rev.00021.2004 2.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Vision Res 2003; 43:2957- 8; PMID:14611932; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Ann N Y Acad Sci  1998; 857:1-12; PMID:9917828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Science 2002; 296:1653-5; PMID:12040185; http://dx.doi.org/10.1126/sci- ence.1071545 6.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
PLoS  One 2012; 7:e46892; PMID:23056515; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Oncogene 2000; 19:2607-11;  PMID:10851059; http://dx.doi.org/10.1038/sj.onc.1203478 8.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Mol  Cell Endocrinol 2013; In press; PMID:23541951;  http://dx.doi.org/10.1016/j.mce.2013.03.014 10.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
EMBO J 2010; 29:55- 67; PMID:19851287; http://dx.doi.org/10.1038/ emboj.2009.313 12.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Mol Immunol 2013; 54:122-31; PMID:23267850;  http://dx.doi.org/10.1016/j.molimm.2012.11.00513.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Exp Eye Res 2003; 76:421- 31; PMID:12634107; http://dx.doi.org/10.1016/ S0014-4835(03)00002-2 15.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Invest Ophthalmol Vis Sci 2004; 45:2407-12;  PMID:15223824; http://dx.doi.org/10.1167/iovs.04- 0003 16.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Ophthalmologica  2005; 219:214-21; PMID:16088240; http://dx.doi.org/10.1159/000085730 18.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Curr Mol Med 2002; 2:381-92; PMID:12108949;  http://dx.doi.org/10.2174/1566524023362456 21.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Exp Eye  Res 2002; 74:83-92; PMID:11878821; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Apoptosis 2008; 13:343-53;  PMID:18253836; http://dx.doi.org/10.1007/s10495- 008-0179-824.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Cell Immunol  2012; 273:79-84; PMID:22169226; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Curr Mol Med  2010; 10:802-23; PMID:21091424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
J Biol Chem  2009; 284:15173-83; PMID:19304658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
J Biol Chem 2011; 286:15543- 55; PMID:21383019; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
J  Biol Chem 2012; 287:24092-102; PMID:22645143; http://dx.doi.org/10.1074/jbc.M112.378240 29.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Proc Natl Acad Sci U S  A 1998; 95:3088-93; PMID:9501220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Nat Genet  1998; 20:344-51; PMID:9843205; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Stem Cells 1999; 17:138- 46; PMID:10342556; http://dx.doi.org/10.1002/ stem.170138 32.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Annu Rev Immunol 1997; 15:797- 819; PMID:9143707; http://dx.doi.org/10.1146/ annurev.immunol.15.1.797 33.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
PLoS  One 2011; 6:e23148; PMID:21912637; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Surv Ophthalmol 1998; 43:3-18; PMID:9716190;  http://dx.doi.org/10.1016/S0039-6257(98)00023-X 45.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Pathobiology 2010; 77:88-95; PMID:20332668;  http://dx.doi.org/10.1159/000278290 46.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Am J Pathol 2007; 170:2149-58; PMID:17525280;  http://dx.doi.org/10.2353/ajpath.2007.061018 41.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
PLoS  One 2012; 7:e47600; PMID:23094067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
J Cell Physiol 2009; 219:544- 52; PMID:19142872; http://dx.doi.org/10.1002/jcp.21698 43.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Free Radic Biol Med 2003; 35:1491-9; PMID:14642397; http://dx.doi.org/10.1016/j.freerad- biomed.2003.08.01835.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Exp Eye Res  2003; 76:397-403; PMID:12634104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Oncogene 2005; 24:5552- 60; PMID:16007214; http://dx.doi.org/10.1038/ sj.onc.1208719 39.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
Arch Ophthalmol 2005; 123:774-82; PMID:15955978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/50/jkst-2-e25434.PMC3876436.pdf
JAK-STAT 2013; 2:e26227; http://dx.doi.org/10.4161/jkst.26227The role of a non-canonical JAK-STAT pathway   in IFN therapy of poxvirus infection   and multiple sclerosis An example of Occam’s Broom?,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Proc R Soc Lond B Biol Sci 1957; 147:258- 67; http://dx.doi.org/10.1098/rspb.1957.0048 .,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Neurology 1984; 34:1273-9;  PMID:6384817 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Science 2002; 295:813-8;  PMID:11823631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Nat Rev Immunol 2006; 6:602-12; PMID:16868551 ;  http://dx.doi.org/10.1038/nri18857.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Cytokine Growth Factor Rev 2008; 19:383-94; PMID:18929502 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Proc Natl Acad Sci U S A 2011; 108:19689-94; PMID:22106296 ; http://dx.doi.org/10.1073/ pnas.1117347108 10.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Neuroimmunol 2013; 254:101- 9; PMID:23110939 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Interferon Cytokine Res 1996; 16:507-10; PMID:8836915 ;  http://dx.doi.org/10.1089/jir.1996.16.507 13.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Interferon Cytokine Res  2001; 21:399-408;  PMID:11440637 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Cell Sci 2003; 116:3089-98; PMID:12799413 ; http://dx.doi.org/10.1242/ jcs.00528,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Biol Chem 2010; 285:38720-9;  PMID:20937808 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Interferon Cytokine Res 2000; 20:565-76; PMID:10888113 ;  http://dx.doi.org/10.1089/10799900050044769 21.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Controlling nuclear JAKs and STATs  for specific gene activation by IFN γ. Biochem Biophys  Res Commun 2011; 410:648-53; PMID:21689637 ;  http://dx.doi.org/10.1016/j.bbrc.2011.06.047 23.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Virol 2005; 79:5632- 9; PMID :15827178 ; http://dx.doi.org/10.1128/ JVI.79.9.5632-5639.2005 24.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Nature 2007; 447:407-12; PMID:17522673 ; http://dx.doi.org/10.1038/ nature05915 25.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Epigenetics 2011; 6:516- 25; PMID:21266852 ; http://dx.doi.org/10.4161/ epi.6.4.14516 26.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Nature 2009; 461:819-22; PMID:19783980 ;  http://dx.doi.org/10.1038/nature0844827.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Biol Chem 2008; 283:5258-66;  PMID :18158285 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Biochem Biophys Res Commun 1994; 201:215- 21; PMID:8198577 ; http://dx.doi.org/10.1006/ bbrc.1994.1691 30.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Immunol 2010; 185:1103- 13; PMID:20543109 ; http://dx.doi.org/10.4049/ jimmunol.0902895 34.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Biochem J 2012; 443:329-38; PMID :22452815 ;  http://dx.doi.org/10.1042/BJ20112187 35.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
J Virol 2000; 74:11230- 9; PMID:11070021 ; http://dx.doi.org/10.1128/ JVI.74.23.11230-11239.2000 36.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Annu Rev Biochem 1998; 67:227-64; PMID:9759489 ;  http://dx.doi.org/10.1146/annurev.biochem.67.1.227 37.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Expert Rev Neurother 2005; 5:153-64; PMID :15853486 ;  http://dx.doi.org/10.1586/14737175.5.2.153 38.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Ther Adv  Neurol Disord 2012; 5:205-20; PMID:22783370 ;  http://dx.doi.org/10.1177/175628561245093639.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Arch Neurol 2005; 62:785-92;  PMID :15883267 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Proc Natl Acad Sci U S A  1995; 92:12270-4;  PMID:8618883 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Cell 2011; 146:621-32; PMID:21854986 ;  http://dx.doi.org/10.1016/j.cell.2011.06.048 43.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Mol Endocrinol 2010; 24:2088-98;  PMID:20484412 ; http://dx.doi.org/10.1210/ me.2010-0027 45.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Cell Biosci 2012;  2:13; http://dx.doi.org/10.1186/2045-3701-2-13 ;  PMID:22520625 46.,OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
Prog Brain Res  2010 ; 181:153-76 ;  PMID:20478437 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/02/jkst-2-e26227.PMC3876437.pdf
JAK-STAT 2013; 2:e25790; http://dx.doi.org/10.4161/jkst.25790STAT2 is an essential transcription factor in type i i FN mediated  anti-viral and anti-proliferative signaling.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2009; 284:27808- 15; PMID:19687011; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 1996; 271:4134- 7; PMID:8626752; http://dx.doi.org/10.1074/jbc.271.8.4134 34.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem  2013; 288:747-58; PMID:23139419; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Mol Biol Cell 2007; 18:2455-62; PMID:17442890;  http://dx.doi.org/10.1091/mbc.E06-09-0843 36.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J  Biol Chem 2004; 279:12379-85; PMID:14722125;  http://dx.doi.org/10.1074/jbc.M310787200 37.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem  2001; 276:16447-55; PMID:11150296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Cell Sci 2006; 119:1092- 104; PMID:16507591; http://dx.doi.org/10.1242/jcs.02822 39.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J  Biol Chem 2004; 279:39199-206; PMID:15175343;  http://dx.doi.org/10.1074/jbc.M400815200 40.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cell  2007; 131:93-105; PMID:17923090; http://dx.doi.org/10.1016/j.cell.2007.07.034 42.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2000; 275:2693-7; PMID:10644731; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nucleic Acids Res  1999; 27:4191-9; PMID:10518610; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Genes Dev 1988;  2:383-93; PMID:3371658; http://dx.doi.org/10.1101/ gad.2.4.383 19.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U S A 1990; 87:8761-5; PMID:2174163; http://dx.doi.org/10.1073/ pnas.87.22.8761 21.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cell  1992; 70:323-35; PMID:1638633; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science  1992; 257:809-13; PMID:1496401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U S A  1994; 91:4776-80; PMID:8197134; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science  1993; 261:1744-6; PMID:7690989; http://dx.doi.org/10.1126/science.7690989 25.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cell 1992; 70:313-22; PMID:1386289; http://dx.doi.org/10.1016/0092-8674(92)90105-L 27.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nature 1993; 366:129-35;  PMID:8232552; http://dx.doi.org/10.1038/366129a0 28.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nat Immunol 2000; 1:65-9;  PMID:10881177; http://dx.doi.org/10.1038/76932References 1.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science 1997; 277:1630-5; PMID:9287210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Oncogene 2000; 19:2619-27; PMID:10851061;  http://dx.doi.org/10.1038/sj.onc.1203525 3.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nat Rev Mol Cell Biol 2002; 3:651-62; PMID:12209125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Eur J Biochem 2004; 271:4606-12; PMID:15606747; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U  S A 1992; 89:7836-9; PMID:1502203; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nature 1996; 383:344-7; PMID:8848048; http://dx.doi.org/10.1038/383344a0 11.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nat Cell  Biol 2002; 4:140-7; PMID:11802163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Mol Cell Biol 2003; 23:620- 8; PMID:12509459; http://dx.doi.org/10.1128/ MCB.23.2.620-628.2003 14.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Cell Sci  2011; 124:892-9; PMID:21325029; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Immunity 2000; 13:795-804;  PMID:11163195; http://dx.doi.org/10.1016/S1074- 7613(00)00077-7,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Interferon Cytokine Res  2005; 25:553-63; PMID:16181056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Exp Med  2011; 208:1635-48; PMID:21727188; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science 2007; 315:1274-8;  PMID:17332413; http://dx.doi.org/10.1126/sci-ence.1136567 74.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 1996;  271:12408-13; PMID:8647845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 1996; 271:5790- 4; PMID:8621447; http://dx.doi.org/10.1074/ jbc.271.10.5790 76.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Interferon Cytokine Res 2001;  21:379-88; PMID:11440635; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
FEBS J 2006; 273:1569-81; PMID:16689942; http://dx.doi.org/10.1111/j.1742- 4658.2006.05176.x 78.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
PLoS Pathog 2011; 7:e1001297; PMID:21379341;  http://dx.doi.org/10.1371/journal.ppat.1001297 79.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cancer Immunol Immunother 2007; 56:1845-52;  PMID:17503042; http://dx.doi.org/10.1007/s00262- 007-0329-9 80.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Arch Biochem Biophys 2012; 518:79- 88; PMID:22198284; http://dx.doi.org/10.1016/j.abb.2011.12.006 82.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2008; 283:34029-36; PMID:18835816; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science 1997; 278:1630-2; PMID:9374464;  http://dx.doi.org/10.1126/science.278.5343.1630 84.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science 2009; 323:793-7;  PMID:19131594; http://dx.doi.org/10.1126/sci- ence.116455158.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
"Génin P , Morin P , Civas A. Impairment of interfer- on-induced IRF-7 gene expression due to inhibi-tion of ISGF3 formation by trichostatin A. J Virol  2003; 77:7113-9; PMID:12768031; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Proteomics 2011; 74:2786- 97; PMID:21839867; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cell 1995; 82:241-50;  PMID:7543024; http://dx.doi.org/10.1016/0092- 8674(95)90311-9 61.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Mol Endocrinol 2001; 15:2157-71; PMID:11731617;  http://dx.doi.org/10.1210/me.15.12.2157 64.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Science  1995; 267:1990-4; PMID:7701321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U S A  2011; 108:21170-5; PMID:22171011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Sci Signal 2009;  2:ra46; PMID:19690332; http://dx.doi.org/10.1126/scisignal.2000007 68.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Proteome Res 2013; 12:2414- 21; PMID:23312004; http://dx.doi.org/10.1021/ pr300825v 69.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Nucleic Acids Res 2012; 40(Database issue):D261-70; PMID:22135298; http://dx.doi.org/10.1093/nar/ gkr1122 70.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem  2000; 275:10247-55; PMID:10744710; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Cell  1998; 93:827-39; PMID:9630226; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
FEBS Lett 2012;  586:2597-605; PMID:22569091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem  1997; 272:26388-93; PMID:9334213; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2002; 277:1493- 9; PMID:11682488; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem  1999; 274:4045-52; PMID:9933596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2002; 277:9713-21; PMID:11786546;  http://dx.doi.org/10.1074/jbc.M111161200 53.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Oncogene  2004; 23:7076-86; PMID:15286706; http://dx.doi.org/10.1038/sj.onc.1207955 54.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Cell Physiol 2005; 204:567-73; PMID:15717316; http://dx.doi.org/10.1002/ jcp.20305 55.,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Eur J Biochem  1997; 247:298-305; PMID:9249040; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U S A 2013; 110:8656- 61; PMID:23653476; http://dx.doi.org/10.1073/ pnas.122165211087.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Biol Chem 2011; 286:20217- 27; PMID:21498520; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
Proc Natl Acad Sci U S A 2009;  106:9373-8; PMID:19478064; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
J Immunol 2011; 186:1685-93; PMID:21178011; http://dx.doi.org/10.4049/jimmu- nol.1001359,Non-OADS,/arxiv_data1/oa_pdf/8f/4a/jkst-2-e25790.PMC3876438.pdf
"Extracorporeal membrane oxygenation Warwick Butt1-3andGraeme MacLaren1,2,4* Addresses:1Paediatric Intensive Care Unit, Royal Children ’sHospital, 50Flemington Road, VIC3052, Australia;2Department ofPaediatrics, TheUniversity ofMelbourne, VIC3010, Australia;3Murdoch Children ’sResearch Institute, Clinical Sciences, 50Flemington Road, VIC3052, Australia;4Cardiothoracic Intensive Care Unit, National University Health System, 5Lower Kent Ridge Road, Singapore 119074 *Corresponding author: Graeme MacLaren (gmaclaren@iinet.net.au) F1000Prime Reports 2013, 5:55(doi:10.12703/P5-55) This isanopen-access article distributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/5/55 Abstract Extracorporeal membrane oxygenation (ECMO) isanadvanced form oflifesupport technology whereby venous blood isoxygenated outside ofthebody andreturned tothepatient.,Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
"Venoarterial ECMO in the groin vessels can be associated with cerebral hypoxemia if ventricular function recovers Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:55 http://f1000.com/prime/reports/m/5/55",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
"Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:55 http://f1000.com/prime/reports/m/5/55",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
"Another multinational trial of Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:55 http://f1000.com/prime/reports/m/5/55",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:55 http://f1000.com/prime/reports/m/5/55",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:55 http://f1000.com/prime/reports/m/5/55",Non-OADS,/arxiv_data1/oa_pdf/61/6a/medrep-05-55.PMC3876455.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 795–801International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  795OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5208 6Use of hormonal contraceptives to control   menstrual bleeding: attitudes and practice   of Brazilian gynecologists María Y Makuch1 Maria José D Osis1 Karla simonia de Pádua1,2 luis Bahamondes3 1center for research in reproductive   Health (ceMIcaMP), 2Prof Dr José  aristodemo Pinotti Women’s Hospital,   University of campinas, 3Department  of Obstetrics and gynaecology,   school of Medical sciences, University  of campinas, and national Institute  of Hormones and Women’s Health,   campinas, são Paulo, Brazil correspondence: María Y Makuch   center for research in reproductive  Health (ceMIcaMP), caixa Postal 6181,  campinas 13084-971, são Paulo, Brazil   Tel +55 19 3289 2856   Fax +55 19 3289 2440   email mmakuch@cemicamp.org.b rBackground:  The purpose of this study was to assess the attitudes and prescribing practices  of Brazilian obstetricians and gynecologists regarding use of contraceptive methods to interfere  with menstruation and/or induce amenorrhea.",Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
Available  from: http://www.tns-sofres.com/resultats-de-recherche-rapide?filtreS ecteur=32&filtreBesoin=none #.,Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
Available from: http://www.who.int/reproductivehealth/publications/ family_planning/9789241563888/en /.,Non-OADS,/arxiv_data1/oa_pdf/c5/97/ijwh-5-795.PMC3876489.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ijn-8-4577.PMC3876490.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4577–4591International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4577OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5158 8Variability in contrast agent uptake by different  but similar stem cell types ashwini Ketkar-atre1 T om struys1,2 stefaan J soenen3 Ivo lambrichts2 catherine M Verfaillie4 Marcel De cuyper5 Uwe himmelreich1 1Biomedical M rI/Mo saIc ,   Department of Imaging and Pathology,   Biomedical sciences group,   Katholieke Universiteit leuven,   leuven, Belgium; 2lab of histology,   Biomedical research Institute, hasselt  University, campus Diepenbeek,   agoralaan, Diepenbeek, Belgium;   3lab for general Biochemistry  and Physical Pharmacy, Faculty of  Pharmacy, ghent University, ghent,   Belgium; 4Interdepartmental stem  cell Institute, O&N IV, Katholieke  Universiteit leuven, leuven, Belgium;   5laboratory of BioNano colloids,   Interdisciplinary research centre,   Katholieke Universiteit leuven,   Kortrijk, Belgium correspondence: Uwe himmelreich   Biomedical MrI Unit/MosaIc, Katholieke   Universiteit leuven, O&N1, BUs 505,   herestraat 49, B-3000 leuven, Belgium   Tel +32 16 330 925   Fax +32 16 330 901   email u we.himmelreich@med.kuleuven.b eAbstract:  The need to track and evaluate the fate of transplanted cells is an important issue in  regenerative medicine.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ijn-8-4577.PMC3876490.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ijn-8-4577.PMC3876490.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/1c/ijn-8-4577.PMC3876490.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/ee/ndt-9-1847.PMC3876491.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1847–1851Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1847OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5489 3Olfactory functions are not associated with  autism severity in autism spectrum disorders iva Dudova Michal hrdlicka Department of child Psychiatry,   University hospital Motol, Prague,   czech republic correspondence: iva Dudova   Department of child Psychiatry, charles  University second Faculty of Medicine,  University hospital Motol, 84 V Uvalu,  Prague 15006, czech republic   Tel +420 224 433 458   Fax +420 224 433 420   email iva.dudova@lfmotol.cuni.c zBackground:  Changes in olfactory functions have been found in many neurodegenerative  and psychiatric disorders, including autism spectrum disorders (ASDs).",Non-OADS,/arxiv_data1/oa_pdf/32/ee/ndt-9-1847.PMC3876491.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/32/ee/ndt-9-1847.PMC3876491.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/ee/ndt-9-1847.PMC3876491.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/1f/tacg-6-113.PMC3876556.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2013:6 113–120The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  113Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S53615Proximal spinal muscular atrophy: current  orthopedic perspective Gerrit Haaker Albert Fujak Department of Orthopaedic Surgery,  Friedrich-Alexander-Universität  erlangen-Nürnberg, erlangen, Germany Correspondence: Albert Fujak   Department of Orthopaedic Surgery,  Friedrich-Alexander-Universität   erlangen-Nürnberg, Rathsberger Str 57,  D-91054 erlangen, Germany   Tel +49 9131 822 3935   Fax +49 9131 852 3565   email a.fujak@t-online.d eAbstract:  Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease of lower motor  neurons that is caused by a defective “survival motor neuron” (SMN) protein that is mainly  associated with proximal progressive muscle weakness and atrophy.",Non-OADS,/arxiv_data1/oa_pdf/f9/1f/tacg-6-113.PMC3876556.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/f9/1f/tacg-6-113.PMC3876556.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/1f/tacg-6-113.PMC3876556.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/c0/c2/SAJC-1-36.PMC3876596.pdf
Available from: http://globocan.iarc.fr/.,Non-OADS,/arxiv_data1/oa_pdf/c0/c2/SAJC-1-36.PMC3876596.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT00930033.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT00626509.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT0071 7587 .,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT0011321 7 .,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT01030783.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00631371.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01198158.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00719264.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00378703.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT009031 75.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00720941.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01064310.,Non-OADS,/arxiv_data1/oa_pdf/2f/b4/SAJC-1-30.PMC3876598.pdf
Available from: http://publications.cancerresearchuk.org/publicationformat/formatstats/statsworldwide20051.html.,Non-OADS,/arxiv_data1/oa_pdf/0f/37/SAJC-1-1.PMC3876600.pdf
Available from: http://www.prb.org.,Non-OADS,/arxiv_data1/oa_pdf/0f/37/SAJC-1-1.PMC3876600.pdf
Available from: http://www.icmr.nic.in/ncrp/report_pop_2001-04/05_Delhi%20Pages%20154-1 73.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0f/37/SAJC-1-1.PMC3876600.pdf
Available from: http://www.icmr.nic.in/ncrp/1999-00/PBCR%20Report%201999_00.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0f/37/SAJC-1-1.PMC3876600.pdf
Available from: http://www.indiancancersociety.org/cancer-resgistry/cancer-registry.htm.,Non-OADS,/arxiv_data1/oa_pdf/0f/37/SAJC-1-1.PMC3876600.pdf
Available  from: https://sites.google.com/site/nepalcensus.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from:  http://nhrc.org.np/reports/Non_Communicable_diseases.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://www.myrepublica.com/portal/index.php?action=news_details&news_id=16896.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from:  http://nationalcancerhospital.org/piyaprofile.aspx.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://www.ncrs.org.np/index.php?linkId=164.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://bhaktapurcancerhospital.org.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://nationalcancerhospital.org/Home.aspx.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://www.cancersocietynepal.org.np.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://nationalcancerhospital.org/aboutCcn.aspx.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://birhospital.awardspace.info.,Non-OADS,/arxiv_data1/oa_pdf/38/24/SAJC-1-5.PMC3876601.pdf
Available from: http://www.medicalphysics.org/apps/medicalphysics/MetcalfeCh12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/SAJC-1-27.PMC3876603.pdf
Available from: http://www.biotic.fr/en/pigment-range-permanent-makeup.html.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/SAJC-1-27.PMC3876603.pdf
Available from: http://www.freepatentsonline.com/WO2008074052.html.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/SAJC-1-27.PMC3876603.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01010061.,Non-OADS,/arxiv_data1/oa_pdf/99/3c/SAJC-1-84.PMC3876608.pdf
"ICON is organizing a conference alongwith SciGenome Labs and IIT – Madras on “Next-Generation  Sequencing and Bioinformatics for Genomics & Oncology” date: 3rd November 2012 venue:  IC & SR Auditorium, IC & SR Building,  Indian Institute of Technology - Madras,  Sardar Patel Road, Chennai 36 9 am to 6 pm International Speakers include Dr. Charlie Rudin, Johns Hopkins University, USA, Dr. Hanlee Ji, Stanford University, USA and  Dr. Steven Turner,  Pacific Biosciences, USA National Speakers include Dr Purvish Parikh, Dr Sudeep Gupta, Dr Raghu Digumarti, Dr T. Rajkumar, Dr Parag  Tamhankar, Dr Rajesh and Dr Sujatha For more information please visit: http://www.scigenomconferences.com/2012/default.phpNEWS",Non-OADS,/arxiv_data1/oa_pdf/e0/f1/SAJC-1-66.PMC3876612.pdf
Available f rom: http://www.canceratlasindia.org.,Non-OADS,/arxiv_data1/oa_pdf/e1/91/SAJC-2-31.PMC3876621.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/e1/91/SAJC-2-31.PMC3876621.pdf
Available from:  http://www.livestrong.org/pdfs/GlobalEconomicImpact.,Non-OADS,/arxiv_data1/oa_pdf/ea/38/SAJC-2-36.PMC3876622.pdf
Available from: http://www.indianjcancer.com/ preprintarticle.asp?id=104065 How to cite this article:  Shah A. Tackling the crisis of antibiotic  resistance.,Non-OADS,/arxiv_data1/oa_pdf/1f/8a/SAJC-2-3.PMC3876623.pdf
: Multinational oncology trials in India49  South Asian Journal of Cancer ♦ January‑ March  2013  ♦ Volume 2  ♦ Issue 1 http://www.business ‑standard.com/india/news/clinical ‑trials ‑ losingplot ‑in‑india/419660/.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available  from: http://www.ctmagnifier.org/2008/M2008_1_05.aspx.,OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://ctri.nic.in/Clinicaltrials/login.php.,OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.ecronacunova.com/pdf/ whitepapers/Whitepaper‑ CT%20in%20India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from:  http://www.mckinsey.com/locations/india/mckinseyonindia/ pdf/india_pharma_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from:  http://www.pwc.com/en_GX/gx/pharma ‑life‑sciences/pdf/ global ‑pharma ‑looks ‑to‑india ‑final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.guardian.co.uk/news/datablog/2012/ jun/30/healthcare ‑spending ‑world ‑country?intcmp=239.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.decisionview.com/sites/default/ files/analyst_report_pdfs/decisionview_enrollment_optimization_ report_mar2012.pdf.,OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://articles.economictimes.indiatimes.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://economictimes.indiatimes.com/news/ news ‑by‑industry/healthcare/biotech/healthcare/hit ‑by‑red‑ tape ‑clinical ‑trial‑companies ‑eye‑south ‑east‑asia‑for‑expansion/ articleshow/14077184.cms.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.touchbriefings.com/pdf/1 7/ pt031_r_4_bakhle%5B1%5D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.who.int/bulletin/ volumes/86/8/08‑010808/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://www.ijppsjournal.com/Vol2Suppl1/215R.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://m.indianexpress.com/news/10‑ die‑per‑ week ‑in‑drug ‑trials ‑in‑india/971834/.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from:  http://articles.timesofindia.indiatimes.com/2011‑ 06‑06/india/29624892_1_clinical ‑trials ‑drug ‑controller‑ general ‑ dcgi.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Available from: http://zeenews.india.com/news/nation/bonanza ‑ over‑5‑000‑ new‑ medical ‑seats ‑created_784825.html.,Non-OADS,/arxiv_data1/oa_pdf/43/aa/SAJC-2-44.PMC3876625.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a4/7f/SAJC-2-26.PMC3876628.pdf
"See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementTata Memorial Hospital’s annual Evidence Based Medicine Meeting Topics: Lung cancer, upper gastrointestinal cancers and multiple myeloma Dates:  1st to 3rd March 2013 Organizing Secretaries:  Thoracic/ GI: Dr. Vanita Noronha, Dr. K George     Multiple myeloma:  Dr. Hari Menon, Dr. Bhausaheb Bagal For further details, Contact:   Clinical Research Secretariat (CRS) at Tata Memorial Hospital: 022‑2417‑7000,   or Contact:  Dr. Vanita Noronha, Associate Professor, Department of Medical Oncology, Tata Memorial Hospital, Mumbai Phone (o)‑ +91 22‑24177000 ext 6313 Phone (c)‑  +91 9769328047 News 28th ICON Meeting, Mumbai Dates:   5th to 7th April 2013 Theme:  Controversy to Consensus For further details and registration please contact: Organizing Secretary:    Dr Sudeep Gupta, Professor of Medical Oncology, Convener, Gynecologic Oncology Working Group, Room No.",Non-OADS,/arxiv_data1/oa_pdf/a4/7f/SAJC-2-26.PMC3876628.pdf
Available from: http://path.upmc.edu/cases/ case167/dx.html.,OADS,/arxiv_data1/oa_pdf/69/94/SAJC-2-4a.PMC3876629.pdf
Available from: http://www.fda.rog/safety/medwatch/ safetyinformation/ucm218929.htm .,Non-OADS,/arxiv_data1/oa_pdf/2f/fb/SAJC-2-38.PMC3876638.pdf
Available from: http://www.fda.rog/safety/medwatch/ safetyinformation/ucm223728.htm .,Non-OADS,/arxiv_data1/oa_pdf/2f/fb/SAJC-2-38.PMC3876638.pdf
Available from: http://www.who.int/features/qa/15/en/ index.html.,OADS,/arxiv_data1/oa_pdf/94/6a/SAJC-2-18b.PMC3876641.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs297/ en/#content.,Non-OADS,/arxiv_data1/oa_pdf/94/6a/SAJC-2-18b.PMC3876641.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/0c/29/SAJC-2-105.PMC3876649.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/94/SAJC-2-102.PMC3876659.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/eb/94/SAJC-2-102.PMC3876659.pdf
Available from: http://www.mciindia.org/ RulesandRegulations/GraduateMedicalEducationRegulations1997 .,Non-OADS,/arxiv_data1/oa_pdf/f0/ba/SAJC-2-62.PMC3876660.pdf
"A S tudy Of Oral PF -023 41066, A c -Met /Hepatocyte Growth  Factor Tyrosine Kinase Inhibitor, In Patients With Advanced  Cancer, Available from: http://clinicaltrials.gov/ct2/show/NCT00585195.",Non-OADS,/arxiv_data1/oa_pdf/3d/ba/SAJC-2-91.PMC3876666.pdf
"Phase 3, Randomized, Open -Label Study Of The Efficacy And Safety Of  Crizotinib V ersus Pemetrexed/Cisplatin Or Pemetrexed/Carboplatin  In Previously Untreated Patients With Non -Squamous Carcinoma  Of The Lung Harboring A Translocation Or Inversion Event Involving  T he Anaplastic Lymphoma Kinase  (ALK)  Gene Locus;Available from:  http://clinicaltrials.gov/show/NCT01154140.",Non-OADS,/arxiv_data1/oa_pdf/3d/ba/SAJC-2-91.PMC3876666.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfdadocs/label/2011/202570s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/ba/SAJC-2-91.PMC3876666.pdf
"pathway using previously collected data sets (GSE10972, GSE4183, GSE8671, GSE10072, GSE4115 and GSE7670)14from the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/).",OADS,/arxiv_data1/oa_pdf/58/88/ncomms3667.PMC3876931.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/88/ncomms3667.PMC3876931.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ali, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/58/88/ncomms3667.PMC3876931.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3667 16 NATURE COMMUNICATIONS | 4:2667 | DOI: 10.1038/ncomms3667 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/58/88/ncomms3667.PMC3876931.pdf
Semiautomatic tracking with StarryNite [ 11]a n d AceTree [ 97]( a v a i l a b l ea t http://waterston.gs.washington.,Non-OADS,/arxiv_data1/oa_pdf/e1/36/12154_2013_Article_101.PMC3877407.pdf
"More recently, NucleiTracker4D (available at http://sourceforge.net/projects/ nucleitracker4d/ ) was used for the semiautomatic tracking of nuclei imaged by laser scanning confocal microscopy of Caenorhabditis elegans development [ 39].",OADS,/arxiv_data1/oa_pdf/e1/36/12154_2013_Article_101.PMC3877407.pdf
"The most remarkable work has been col- lected in the Ascidian Network for In Situ Expression and Embryological Data (ANISEED) database [ 133] and the 3D Virtual Embryo software for visualization and interaction [132], both available through http://aniseed-ibdm.univ-mrs. fr/virtual_embryo.php .",OADS,/arxiv_data1/oa_pdf/e1/36/12154_2013_Article_101.PMC3877407.pdf
"It wouldbe a major paradigm change in the field of developmental biology, as it uses new theoretical frameworks to revisit classi- cal embryology concepts.Table 2 Some online resources from the sea urchin community Resource Web site Sea urchin embryology tutorial, the web site is designed to providematerial for teaching developmental biology to undergraduates.http://worms.zoology.wisc.edu/ urchins/SUIntro.html Interactive tutorial developed by the Stanford University with support from the National Science Foundation.http://virtualurchin.stanford.edu/ microscope.htm Protocols to study the sea urchin development from the Stanford Universityhttp://www.stanford.edu/group/ Urchin/contents.html Protocols from the Swarthmore Collegehttp://www.swarthmore.edu/ NatSci/sgilber1/DB_lab/ Urchin/urchin_protocols.html The web site of E. Davidson's laboratory providing an updatedversion of the BioTapestryInteractive Network Viewer [ 79] for the GRN of the endomesoderm inStrongylocentrotus purpuratushttp://sugp.caltech.edu/endomes/J Chem Biol (2014) 7:17 –28 23",Non-OADS,/arxiv_data1/oa_pdf/e1/36/12154_2013_Article_101.PMC3877407.pdf
The hexadecimal values obtained in InkScape was then used in the free molecular viewing software YASARA 9.11.23 (http://www.yasara.org ) to color the amino acid residues of HCAII (PDB Code: 2cba [ 39] that had been labeled with AEDANS; the final image was rendered in POV-Ray 3.6 (http://www.povray.org ).,OADS,/arxiv_data1/oa_pdf/c4/e9/12154_2013_Article_106.PMC3877409.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Disrupting HSP90 and protein trafﬁcking in myeloma EJ Born et al 10 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/92/da/bcj201364a.PMC3877421.pdf
"Primers weredesigned using Primer-Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/, National Center for Biotechnology Information).",OADS,/arxiv_data1/oa_pdf/e4/a6/bcj201365a.PMC3877422.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Novel mutations in LGL leukemia EI Andersson et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/e4/a6/bcj201365a.PMC3877422.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/44/e3/bcj201366a.PMC3877423.pdf
( http://www.coi.gov.cn/ gongbao/nrhuanjing/nr2012/201304/t20130401_26413.html ).,Non-OADS,/arxiv_data1/oa_pdf/24/fb/11356_2013_Article_1885.PMC3877424.pdf
http://www.wmo.int/pages/ prog/arep/gaw/ghg/documents/GHGbulletin_7_en.pdf .,OADS,/arxiv_data1/oa_pdf/24/fb/11356_2013_Article_1885.PMC3877424.pdf
http://webbook.nist.gov/chemistry/ .,OADS,/arxiv_data1/oa_pdf/92/82/11356_2013_Article_1904.PMC3877427.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Hyperinsulinemia and VTA plasticity S Liu et al 4 Nutrition & Diabetes (2013) 1 – 4 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/95/22/nutd201338a.PMC3877429.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Ghrelin receptor and adipose inﬂammation XM a et al 9 &2013 Macmillan Publishers Limited Nutrition & Diabetes (2013) 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/03/0c/nutd201341a.PMC3877431.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/0e/eht278.PMC3877433.pdf
"(Accessed September 1, 2013, at http://www.medscape.",Non-OADS,/arxiv_data1/oa_pdf/58/ef/NAJMS-5-625.PMC3877434.pdf
"(Accessed September 1, 2013,  at http://www.bized.co.uk/timeweb/crunching/crunch_ relate_expl.htm) 14.",Non-OADS,/arxiv_data1/oa_pdf/58/ef/NAJMS-5-625.PMC3877434.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/58/ef/NAJMS-5-625.PMC3877434.pdf
"(Accessed Jun 5, 2012, at http://www.egmedicals.com/ pediatric2010/013005.pdf).",Non-OADS,/arxiv_data1/oa_pdf/e7/59/NAJMS-5-647.PMC3877438.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/e3/fa/NAJMS-5-653.PMC3877439.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/12/ab/NAJMS-5-666.PMC3877442.pdf
Available from:  http://www.npao.org.,Non-OADS,/arxiv_data1/oa_pdf/3f/ae/IJNMR-18-367.PMC3877458.pdf
Available from: http://www.portal.javanan.ir/ default.aspx [Last accessed on 2011 Nov].,OADS,/arxiv_data1/oa_pdf/a8/89/IJNMR-18-396.PMC3877463.pdf
Start a QR‑code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR‑code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/TI-20-195.PMC3877485.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/aa/4e/TI-20-195.PMC3877485.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/7e/bc/TI-20-208.PMC3877487.pdf
Available from:  http://www.oecd.org.,Non-OADS,/arxiv_data1/oa_pdf/55/70/TI-20-224.PMC3877490.pdf
"SUBJECTS AND METHODS Protein sequence retrieval The toxin protein sequences of C. fleckeri  were retrieved  from protein database of National Center for Biotechnology  Information  (NCBI, http://www.ncbi.nlm.nih.gov/ protein/) by GenBank accession no.",OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
Secondary structure prediction We used ExP ASy’s secondary structure prediction  server (http://web.expasy .org/protparam/)[12] to get an  idea about the secondary structure of the venom proteins.,OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
[13‑15] Solvent accessible regions and hydrophilicity  estimation Hydrophilicity of the proteins was estimated by using  ProtScale (http://web.expasy .org/protscale/) server of  ExP ASy .,OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
"For MHC class I peptide prediction,  we used Proteasomal cleavage/transporter of antigenic  peptides transporter/MHC class I combined prediction  server (http://tools.immuneepitope.org/processing/) and  for MHC class II peptide, we used MHC II‑binding  prediction  (http://tools.immuneepitope.org/mhcii).",OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
Allergenicity assessment In order to assay the degrees of allergenicity we operated  AllerHunter (http://tiger.dbs.nus.edu.sg/AllerHunter/ index.html).,OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
Available	 from:	http://www.marine‑medic.,OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
[Available 	 Online	at:	http://eprints.jcu.edu.au/5682/].,Non-OADS,/arxiv_data1/oa_pdf/aa/50/TI-20-235.PMC3877492.pdf
[24] The acceptable level for human and animal is total (AFT) <20 ppb with the level of (AFT M1) <0.5 ppb  for milk and its products;[20] http://www.uaex.edu.,Non-OADS,/arxiv_data1/oa_pdf/ed/02/TI-20-261.PMC3877494.pdf
Available from: http://www.foodstandards.gov.au.,Non-OADS,/arxiv_data1/oa_pdf/ed/02/TI-20-261.PMC3877494.pdf
Available from: http://www.fda.gov/ICECI/ ComplianceManuals/CompliancePolicyGuida.,OADS,/arxiv_data1/oa_pdf/ed/02/TI-20-261.PMC3877494.pdf
Available from: http://www.fao.org/ docrep/010/a1028s/a1028s00.htm.,Non-OADS,/arxiv_data1/oa_pdf/ed/02/TI-20-261.PMC3877494.pdf
http://www.sciencepub.net.,Non-OADS,/arxiv_data1/oa_pdf/ed/02/TI-20-261.PMC3877494.pdf
Available  from:  http://www.emedicine.medscape.com/article/.,Non-OADS,/arxiv_data1/oa_pdf/5b/bd/AJNS-8-157.PMC3877503.pdf
Available from: http://www.dow.com/ assets/attachments/business/process_chemicals/amberlite_and_duolite_ pharmaceutical_grade_resins/duolite_ap143‑1093/tds/doulite_ap143‑1093.,OADS,/arxiv_data1/oa_pdf/d9/51/IJPhS-75-523.PMC3877513.pdf
Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Quality/Q3C/Step4/Q3C_R5_Step4.pdf.,OADS,/arxiv_data1/oa_pdf/d9/51/IJPhS-75-523.PMC3877513.pdf
Available from: http://www.theartofformulation.com/Formulations_doc/unique_solutions.,Non-OADS,/arxiv_data1/oa_pdf/d9/51/IJPhS-75-523.PMC3877513.pdf
A vailable from: http://www.femalenetwork.com/girltalk/index.,Non-OADS,/arxiv_data1/oa_pdf/31/95/IJPhS-75-585.PMC3877521.pdf
Available from: http://pdf.usaid.gov/pdfdocs/PNACK016.,Non-OADS,/arxiv_data1/oa_pdf/31/95/IJPhS-75-585.PMC3877521.pdf
A vailable from: http://www.nlm.nih.gov/medlineplus/ency/article/001511.,Non-OADS,/arxiv_data1/oa_pdf/31/95/IJPhS-75-585.PMC3877521.pdf
A vailable from: http://dailymed.nlm.nih.gov/dailymed/archives/ fdaDrugInfo.cfm?archiveid=18356.,Non-OADS,/arxiv_data1/oa_pdf/31/95/IJPhS-75-585.PMC3877521.pdf
Available from: http://www.ipc.,Non-OADS,/arxiv_data1/oa_pdf/31/95/IJPhS-75-585.PMC3877521.pdf
"(Accessed April  30, 2013, at http://www.unaids.org/en/media/unaids/contenetassets/epidemiology/2012/gr2012/JC2434_ WorldAIDSday_results_en.pdf).",Non-OADS,/arxiv_data1/oa_pdf/e0/66/NAJMS-5-680.PMC3877529.pdf
"(Accessed January 31, 2012, at http://www.who.int/cardiovascular_diseases/guidelines/ POCKETGL.ENGLISH.AFR-D-E.rev1.pdf).",Non-OADS,/arxiv_data1/oa_pdf/e0/66/NAJMS-5-680.PMC3877529.pdf
"(Accessed January 2, 2010, at  http://www.who.int/entity/chp/steps/STEPS_Instrument_ v2.1.pdf).",OADS,/arxiv_data1/oa_pdf/e0/66/NAJMS-5-680.PMC3877529.pdf
"(Accessed January 10, 2010, at  http://www.who.int.mediacentre/factsheets/fs311/en/ index.html).",Non-OADS,/arxiv_data1/oa_pdf/e0/66/NAJMS-5-680.PMC3877529.pdf
"(Accessed  January 10, 2012, at http://www.bhsoc.org/blood_pressure_ list.stm/bp_monitors/automatic/stm) 36.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/NAJMS-5-680.PMC3877529.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/25/51/NAJMS-5-689.PMC3877530.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7b/a9/NAJMS-5-699.PMC3877531.pdf
"(Accessed December 29, 2012, at http://www.nacoonline.org).",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/NAJMS-5-707.PMC3877533.pdf
"(Accessed August 2, 2012 at http://www.nacoonline.org/Quick_Links/Publication/Blood_Safety_Lab_Services/).",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/NAJMS-5-707.PMC3877533.pdf
"(Accessed January 16, 2013, at http://dpd.cdc.gov/dpdx/Default.htm).",OADS,/arxiv_data1/oa_pdf/b8/9c/NAJMS-5-707.PMC3877533.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/NAJMS-5-707.PMC3877533.pdf
"(Accessed January 28, 2013, at http://www.wma.net/en/30publications/10policies/b3/index.html).",Non-OADS,/arxiv_data1/oa_pdf/af/4a/NAJMS-5-713.PMC3877534.pdf
"(Accessed July 21, 2013, at http://www.who.int/ictrp/network/trds/en).",OADS,/arxiv_data1/oa_pdf/af/4a/NAJMS-5-713.PMC3877534.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Stearoyl-CoA desaturase-1 is a key1 factor A Noto et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/29/73/cddis2013444a.PMC3877537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Caspase-2-mediated degradation of cytoskeleton proteins H Vakifahmetoglu-Norberg et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/5a/cddis2013463a.PMC3877538.pdf
Densitometric analysis was performed using ImageJ (US National Institutes of Health; http://rsb.info.nih.gov/nih-image/).,OADS,/arxiv_data1/oa_pdf/b0/66/cddis2013466a.PMC3877539.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ADAM17 is a survival factor for macrophage/microglia PM Vidal et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b0/66/cddis2013466a.PMC3877539.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Triptolide cytotoxicity in Leukemia stem-like cells Y Liu et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/99/60/cddis2013467a.PMC3877540.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Pin1 stabilizes p63 aproteins CL i et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cd/da/cddis2013468a.PMC3877541.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ROCK1/MLC in triptolide-induced apoptosis L Liu et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e5/56/cddis2013469a.PMC3877542.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Chk1 inhibition kills PIDDosome defective cells C Manzl et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/cddis2013470a.PMC3877543.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Cannabinoid-induced cell death by modulation of VDAC1 N Rimmerman et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ab/7b/cddis2013471a.PMC3877544.pdf
Details of the slide design and sequence selection are presented on the manufacturer’s website (http://www.microcribi.cribi.unipd.it/e-index.htm).,Non-OADS,/arxiv_data1/oa_pdf/d3/42/cddis2013472a.PMC3877545.pdf
"Normalised valueswere calculated for each spot, using the MIDAS software (TIGR Microarray DataAnalysis System), which is available at http://www.tigr.org.",OADS,/arxiv_data1/oa_pdf/d3/42/cddis2013472a.PMC3877545.pdf
"Differentially expressedgenes were detected with the SAM programme, which is available at http://www-stat.stanford.edu/ Btibs/SAM/index.html and were analysed through the IPA software.",OADS,/arxiv_data1/oa_pdf/d3/42/cddis2013472a.PMC3877545.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Satellite cell ageing S Fulle et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d3/42/cddis2013472a.PMC3877545.pdf
"Ingenuity Pathway Analysis (IPA7.0, Ingenuity System, http://www.ingenuity.com/) was used to establish physical and/or functional interactions among proteins found either upregulated or downregulated in AF-induced CD4 þT-cell subpopulations (T N,TCM,TTMand T EM).",OADS,/arxiv_data1/oa_pdf/cf/f1/cddis2013473a.PMC3877546.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)AF exerts a selective anti-memory effect B Chirullo et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cf/f1/cddis2013473a.PMC3877546.pdf
"To understand the functions of these potential IgG binding proteins, we carried out functional annotations with the Database for Annotation, Visualization and IntegratedDiscovery (DAVID, http://david.abcc.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/bc/94/cddis2013474a.PMC3877547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)IgG promotes tumor cell growth through ROS J Wang et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/bc/94/cddis2013474a.PMC3877547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Selenite promoted apoptosis in NB4 cells JJ An et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1b/52/cddis2013475a.PMC3877548.pdf
"The Ingenuity Pathway analysis (IPA, http://www.ingenui- ty.com/) was performed to identify the biological functions ofdifferentially expressed genes during cell passaging.",OADS,/arxiv_data1/oa_pdf/62/0c/cddis2013480a.PMC3877551.pdf
Gene interaction networks and signaling pathways were generated using IPA software (http://www.ingenuity.com/).,OADS,/arxiv_data1/oa_pdf/62/0c/cddis2013480a.PMC3877551.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Mutations and transformation of cultured hUC-MSCs Y Wang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/62/0c/cddis2013480a.PMC3877551.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Targeting FLIP in procaspase-8 overexpressing NSCLC JS Riley et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c4/4a/cddis2013481a.PMC3877552.pdf
"All primary antibodies used in this report are wellvalidated in our laboratory 25,57,58and they are included in the Neuroscience Information Framework (http://www.neuinfo.org) list of thoroughly characterizedantibodies (numbers 609566, 732011 and 839504, respectively).",OADS,/arxiv_data1/oa_pdf/71/7a/cddis2013482a.PMC3877553.pdf
"Heyman M, Gustafsson G, Kogner P. Childhood Cancer Incidence and Survival in Sweden 1984-2010 2013 (http://www.cceg.ki.se/documents/ChildhoodCancerIncidenceand SurvivalinSweden1984_2010.pdf).",OADS,/arxiv_data1/oa_pdf/71/7a/cddis2013482a.PMC3877553.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/LPS sensitized juvenile brains M Kalm et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/71/7a/cddis2013482a.PMC3877553.pdf
"26,27To identify the targets for miR-26a, we compared the lists of the ﬁrst 50 putative targets predicted by PicTar and MiRanda algorithms (http://pictar.mdc-berlin.de/ and http://www.microrna.org, respectively).",OADS,/arxiv_data1/oa_pdf/ba/06/cddis2013483a.PMC3877554.pdf
The miRNA target prediction and analysis was performed with the algorithms from TargetScan(http://www.targetscan.org/) PicTar (http://pictar.mdc-berlin.de/) and miRanda(http://www.microrna.org/).,OADS,/arxiv_data1/oa_pdf/ba/06/cddis2013483a.PMC3877554.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 L Lezina et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ba/06/cddis2013483a.PMC3877554.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Wentilactone A: a novel potential antitumor agent CL v et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e0/b0/cddis2013484a.PMC3877555.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/miR-9/MCPIP1 axis in PDGF-BB-mediated neurogenesis L Yang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/cddis2013486a.PMC3877557.pdf
Analysis of the western blots was doneusing the Image J software (National Institute of Mental Health; http://rsb.info.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/f6/11/cddis2013487a.PMC3877558.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)TRIM32-dependent transcription regulates neuronal differentiation A-L Hillje et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f6/11/cddis2013487a.PMC3877558.pdf
Genomic DNA was extracted from untreated cancer cell lines and DNA sequences within exons 2–11 of theTP53 gene were ampliﬁed by PCR according to a protocol of the International Agency for Research on Cancer (http://www-p53.iarc.fr/).,Non-OADS,/arxiv_data1/oa_pdf/f2/76/cddis2013488a.PMC3877559.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)17AAG treatment in HNC JL Roh et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f2/76/cddis2013488a.PMC3877559.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/HBHA induces apoptosis through induction of ER stress J-A Choi et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/29/9c/cddis2013489a.PMC3877560.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Beneﬁcial effect of PD-MSCs in Alzheimer’s disease H-M Yun et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fd/07/cddis2013490a.PMC3877561.pdf
"MiRNA targets were predicted by combinatorial utilization of three different web-based predictionalgorithms: TargetScan (http://www.targetscan.org/), miRanda (http://www.microrna.org) and RNA hybrid.",OADS,/arxiv_data1/oa_pdf/2f/98/cddis2013491a.PMC3877562.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MicroRNA mechanisms in neuroinﬂammation C Parisi et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2f/98/cddis2013491a.PMC3877562.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Strange attractors W Hou et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ae/47/cddis2013493a.PMC3877563.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/A20 as a key regulator for human adipogenesis A Dorronsoro et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/18/26/cddis2013494a.PMC3877564.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ae/66/cddis2013496a.PMC3877566.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PATZ1 in the p53 regulatory gene network T Valentino et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3c/3d/cddis2013500a.PMC3877567.pdf
"Amount of total oxidized proteins was determined usingthe OxyBlot Protein Oxidation Detection Kit (Merck Millipore, Darmstadt, Germany,www.merckmillipore.de) according to the manufacturer’s instructions.Bound secondary antibodies were detected using the chemiluminescent substrateECL (GE Healthcare Piscataway, NJ, USA, http://www.gelifesciences.com).Band intensities were quantiﬁed by NIH ImageJ software package(http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/0b/bb/cddis2013501a.PMC3877568.pdf
"52Delta2D (Decodon, Greifswald, Germany, http://www.decodon.com) was used for gel evaluation as earlier described.12,53 Protein spot of interest were excised from gels and subjected to in-gel trypticdigestion.",OADS,/arxiv_data1/oa_pdf/0b/bb/cddis2013501a.PMC3877568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Extrinsic aging affects MSC survival and function S Gei /C25leret al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0b/bb/cddis2013501a.PMC3877568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ERO1 a-dependent ER calcium release by PAC-1 M Seervi et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e9/99/cddis2013502a.PMC3877569.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/RLRs control the survival of MSCs K Yang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/72/6a/cddis2013504a.PMC3877571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Programmed cell death in Plasmodium falciparum D Engelbrecht and TL Coetzer 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3e/88/cddis2013505a.PMC3877572.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/mTOR and diabetes MV Blagosklonny 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3f/82/cddis2013506a.PMC3877573.pdf
The demonstration that respiration occurred in cells and not in the blood led scientists to search for a ‘‘re- /C2112013 Pagliarini and Rutter This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/32/7e/2615.PMC3877752.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommerc ial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/32/7e/2615.PMC3877752.pdf
[Keywords : biochemistry; mitochondria; proteomics] 3Corresponding authors E-mail rutter@biochem.utah.edu E-mail pagliarini@wisc.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.229724.113.,Non-OADS,/arxiv_data1/oa_pdf/32/7e/2615.PMC3877752.pdf
"/C2112013 Jonas and Izaurralde This article, published in Genes &Develop- ment , is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as describ ed at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/69/6e/2628.PMC3877753.pdf
[Keywords : DCP2; decapping; mRNA decay; SLiMs] 1Corresponding author E-mail elisa.izaurralde@tuebingen.mpg.de Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.227843.113.,OADS,/arxiv_data1/oa_pdf/69/6e/2628.PMC3877753.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/7d/57/2642.PMC3877754.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/7d/57/2642.PMC3877754.pdf
9Corresponding author E-mail bingwei@stanford.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.225169.113.,Non-OADS,/arxiv_data1/oa_pdf/7d/57/2642.PMC3877754.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/2648.PMC3877755.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.232710.113.,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/2648.PMC3877755.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/00/f4/2663.PMC3877756.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3Present address: Institut Curie/INSERM U934/CNRS UMR 3215, 26, rue d’Ulm, 75005 Paris, France.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/2663.PMC3877756.pdf
4Corresponding author E-mail danny.reinberg@nyumc.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.225888.113.,Non-OADS,/arxiv_data1/oa_pdf/00/f4/2663.PMC3877756.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2c/8f/2678.PMC3877757.pdf
6Corresponding author E-mail ruvkun@molbio.mgh.harvard.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.233254.113.,Non-OADS,/arxiv_data1/oa_pdf/2c/8f/2678.PMC3877757.pdf
Identification of dosage-sensitive genes within humanchromosome 21 and of their mechanisms of actionsconstitutes an important step in our understanding of /C2112013 Kurabayashi and Sanada This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/16/21/2708.PMC3877759.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.1Corresponding author E-mail kamon_sanada@gen.s.u-tokyo.ac.jp Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.226381.113.",Non-OADS,/arxiv_data1/oa_pdf/16/21/2708.PMC3877759.pdf
These three proteins are induced under different stress conditions: phosphate starvation for IraP (Bougdour This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/ by-nc/3.0/.Present addresses:173 Farrer Drive #09-02, Sommerville Park, Singapore 259280, Singapore;2National Institute of Allergy and Infectious Disease, Building 4, Room 109, Bethesda, MD 20892, USA;3Department of Chemistry, Box 210172, University of Cincinnati, Cincinnati, OH 45221, USA;4George Washington School of Medi cine and Health Sciences, 2300 I Street NW, Washington, DC 20037, USA;5UMR 5163, Laboratoire Adap- tation et Pathoge ´nie des Microorganismes, Centre National de la Recherche Scientifique, 38041 Grenoble, France.",Non-OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
6Corresponding author E-mail gottesms@helix.nih.gov Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.229617.113.,OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
using PYMOL (http://www.pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
Sequence alignment ofRssB E. coli and RssB P. aeruginosa was performed using the ClustalW2 program from the EMBL-EBI Web site (http://www.ebi.ac.uk/ Tools/msa/clustalw2) with default settings.,OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
( G) Crystal structure of the RssB N-terminal domain from E. coli .T h eR s s B E. coli N-terminal domain (PDB: 3EOD) was visualized using PYMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/54/9f/2722.PMC3877760.pdf
The database is available at http://dbtmee.hgc.jp.,OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by- nc/3.0/.4Corresponding authors E-mail kshirahi@iam.u-tokyo.ac.jpE-mail mohsugi@bio.c.u-tokyo.ac.jp Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.227926.113.",Non-OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
We prepared the refer-ence genome (mm9) and RefSeq annotation from the UCSCGenome Browser (http://genome.ucsc.edu) and downloaded the ncRNA annotation from fRNAdb (Kin et al.,OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
"regions, we used 20,414 TSSs provided by DBTSS (Database of Transcriptional Start Sites, http://dbtss.hgc.jp).",OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
"Using these potential reg- ulatory links from TFs to promoters, we analyzed the networkstatistics using Cytoscape 3.0 (http://www.cytoscape.org).",OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
"We also developed the database DBTMEE (Database of Transcriptome in Mouse EarlyEmbryos, http://dbtmee.hgc.jp).",OADS,/arxiv_data1/oa_pdf/d6/b8/2736.PMC3877761.pdf
"http://informahealthcare.com/jmf ISSN: 1476-7058 (print), 1476-4954 (electronic) J Matern Fetal Neonatal Med, 2014; 27(2): 149–154 !2014 Informa UK Ltd. DOI: 10.3109/14767058.2013.806896 ORIGINAL ARTICLE Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA 1cand spikes of high glucose values in the third trimester Peter Damm1, Henriette Mersebach2, Jacob Ra ˚stam2, Risto Kaaja3, Moshe Hod4, David R. McCance5, and Elisabeth R. Mathiesen1 1Departments of Endocrinology and Obstetrics, Center for Pregnant Women with Diabetes, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark,2Global Development, Novo Nordisk, Soeborg, Denmark,3Satakunta Central Hospital and Turku University, Pori, Finland,4Division of Maternal Fetal Medicine, Tel Aviv University, Petah-Tiqva, Israel, and5Metabolic Unit, Royal Victoria Hospital, Belfast, UK Abstract Objective : To analyse data from a randomised, controlled study of prandial insulin aspart versus human insulin, both with NPH insulin, in pregnant women with type 1 diabetes for potentialfactors predicting poor pregnancy outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/JMF-27-149.PMC3877859.pdf
"http://informahealthcare.com/ahb ISSN: 0301-4460 (print), 1464-5033 (electronic) Ann Hum Biol, 2014; 41(1): 76–83 !2014 Informa UK Ltd. DOI: 10.3109/03014460.2013.856472 RESEARCH PAPER A mixed effects model to estimate timing and intensity of pubertal growth from height and secondary sexual characteristics T. J. Cole1, H. Pan1, and G. E. Butler2 1MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, UK and2UCL Institute of Child Health and University College London Hospital, London, UK Abstract Aim: To estimate and compare pubertal growth timing and intensity in height, Tanner stage markers and testis volume.Subjects and methods : Data on height, genital stage, breast stage and pubic hair stage, testis volume and menarche in 103 boys and 74 girls from the Edinburgh Longitudinal Growth Study were analysed.",Non-OADS,/arxiv_data1/oa_pdf/ee/9b/AHB-41-76.PMC3877946.pdf
"149-155 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.149 plSSN: 1976-8257 eISSN: 2234-2753Open Access Structural Aspects of GPCR-G Protein Coupling Ka Y oung Chung School of Pharmacy, Sungkyunkwan University, Suwon, Korea (Received August 14, 2013; Revised September 10, 2013; Accepted September 17, 2013) G protein-coupled receptors (GPCRs) are membrane receptors; approximately 40% of drugs on the mar- ket target GPCRs.",Non-OADS,/arxiv_data1/oa_pdf/b7/42/toxicr-29-149.PMC3877993.pdf
"157-164 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.157 plSSN: 1976-8257 eISSN: 2234-2753Open Access Loss of Integrity: Impairment  of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke Jeong-Hyeon Kim1, Hyeong-Min Byun1, Eui-Cheol Chung1, Han-Y oung Chung2 and Ok-Nam Bae1,3 1College of Pharmacy, Hanyang University, Gyeonggi-do, Korea 2Department of Biotechnology and Bioinformatics, Korea University, Sejong City, Korea 3Institute of Pharmaceutical Science and Technology, Hanyang University, Gyeonggi-do, Korea (Received August 30, 2013; Revised September 17, 2013; Accepted September 23, 2013) Although stroke is one of the leading causes of death and disability worldwide, preventive or therapeutic options are still limited.",Non-OADS,/arxiv_data1/oa_pdf/ef/59/toxicr-29-157.PMC3877994.pdf
"165-172 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.165 plSSN: 1976-8257 eISSN: 2234-2753Open Access Recent Updates on Acetaminophen Hepatotoxicity: The Role of Nrf2 in Hepatoprotection Sang Il Gum and Min Kyung Cho Department of Pharmacology, College of Oriental  Medicine, Dongguk University, Kyungju, Korea (Received September 1, 2013; Revised September 25, 2013; Accepted September 26, 2013) Acetaminophen (APAP) known as para cetamol is the main ingredient in  Tylenol, which has analgesic and anti-pyretic properties.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/toxicr-29-165.PMC3877995.pdf
"173-179 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.173 plSSN: 1976-8257 eISSN: 2234-2753Open Access Gastrointestinal Tract Abnormalities Induced by Prenatal Valproic Acid  Exposure in Rat Offspring Ji-Woon Kim1, Chang Soon Choi1, Ki Chan Kim1, Jin Hee Park1, Hana Seung1, So Hyun Joo1, Sung Min Yang1, Chan Y oung Shin1,2 and Seung Hwa Park1,2 1Department of Neuroscience, School of Medicine and Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences, Konkuk University, Korea 2Institute of Functional Genomics, Konkuk University, Korea (Received September 9, 2013; Revised September 25, 2013; Accepted September 27, 2013) In-utero  exposure to valproic acid (VPA) has been known as a potent inducer of autism spectrum disorder (ASD), not only in humans, but also in animals.",Non-OADS,/arxiv_data1/oa_pdf/22/d3/toxicr-29-173.PMC3877996.pdf
"187-193 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.187 plSSN: 1976-8257 eISSN: 2234-2753Open Access Hepatotoxicity in Rats Treated with Dimethylformamide or Toluene or Both Ki-Woong Kim1 and Y ong Hyun Chung2 1Occupational Safety and Health Research Institute, KOSHA, Incheon Korea 2Occupational Safety and Health Research Institute, KOSHA, Daejeon Korea (Received July 30, 2013; Revised September 26, 2013; Accepted September 26, 2013) The effects of toluene in dimethylformamide (DMF )-induced hepatotoxicity were investigated with respect to the induction of cytochrome P-450 (CYP) and the activities of relate d enzymes.",Non-OADS,/arxiv_data1/oa_pdf/c2/91/toxicr-29-187.PMC3877998.pdf
"195-201 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.195 plSSN: 1976-8257 eISSN: 2234-2753Open Access Anti-inflammatory Effect of  Isaria sinclairii  Glycosaminoglycan in an Adjuvant-treated Arthritis Rat Model Mi Y oung Ahn1, Sang Duck Jee1, Jae Sam Hwang1, Eun Y oung Yun1, Kwang Seok Ahn2 and Y eong Shik Kim3 1Department of Agricultural Biology, National Academy of Agricultural Science, RDA, Suwon, Korea 2College of Oriental Medicine, Institute of Orient al Medicine, Kyunghee University, Seoul, Korea 3College of Pharmacy, Seoul National University, Seoul, Korea (Received August 6, 2013; Revised September 11, 2013; Accepted September 24, 2013) The anti-inflammatory effects of gl ycosaminoglycan (G AG) derived from Isaria sinclairii  (IS) and of IS extracts were investigated in a complete Freund’s adjuvant (CFA)-treated chronic arthritis rat model.Groups of rats were treated orally with 30 mg/kg one of the following: [1] saline control, extracts of [2] water-IS, [3] methanol-IS, [4] butano l-IS, [5] ethyl acetate -IS, or [6] Indomethacin ® as the positive con- trol for a period of two weeks.",Non-OADS,/arxiv_data1/oa_pdf/97/2e/toxicr-29-195.PMC3877999.pdf
"203-209 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.203 plSSN: 1976-8257 eISSN: 2234-2753Open Access Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of ε-Acetamidocaproic Acid in Rat Plasma Tae Hyun Kim1, Y ong Seok Choi2, Y oung Hee Choi3 and Y oon Gyoon Kim2,4 1Food Research Institute, Bioresources Regional Innovation Center, Soon Chun Hyang University, Asan, Korea 2College of Pharmacy, Dankook University, Cheonan, Korea 3College of Pharmacy, Dongkuk University, Seoul, Korea 4Life Science Pharmaceutical Research Center, Dankook University, Cheonan, Korea (Received August 14, 2013; Revised September 9, 2013; Accepted September 16, 2013) A simple and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was devel- oped and validated for the quantification of ε-acetamidocaproic acid (AACA), the primary metabolite of zinc acexamate (ZAC), in rat plasma by using normet anephrine as an internal standard.",Non-OADS,/arxiv_data1/oa_pdf/1e/4f/toxicr-29-203.PMC3878000.pdf
"AACA is classified as NSAID in PubChem Compound (http://pub-chem.ncbi.nlm.nih.gov), and was used to avoid pulmonaryfibrosis in patients treated with bleomycin (11).",Non-OADS,/arxiv_data1/oa_pdf/1e/4f/toxicr-29-203.PMC3878000.pdf
"211-215 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.211 plSSN: 1976-8257 eISSN: 2234-2753Open Access Investigation of Water Safety in Non-treated Drinking Water with Trace Toxic Metals Suw Y oung Ly1, Dae Hong Kim2 and Ga Eun Lee2 1Biosensor Research Institute, Seoul National Univ ersity of Science and Technology, Seoul, Korea 2Advanced Scientific Research Group in Asia  Pacific International School, Seoul, Korea (Received July 23, 2013; Revised September 4, 2013; Accepted September 4, 2013) The trace toxic metal copper was assayed using mercury immobilized on a carbon nanotube electrode (MCW), with a graphite counter and a reference elect rode.",Non-OADS,/arxiv_data1/oa_pdf/35/53/toxicr-29-211.PMC3878001.pdf
"217-219 (2013) http://dx.doi.org/10.5487/TR.2013.29.3.217 plSSN: 1976-8257 eISSN: 2234-2753Open Access Mutagenic Assessment of Olmesartan Cile xetil by Bacterial Mutation Assay Ji Won Kim1, Ilyoung Ahn2, Sung Ha Ryu3, Hong Ryeol Jeon4, Bong Sang Lee4 and Kyu-Bong Kim3 1Department of Pharmacology, CKD Research Institute, Yongin, Korea 2Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Osong, Korea 3College of Pharmacy, Dankook University, Cheonan, Korea 4CTC BIO Inc. Paltan, Hwaseong, Korea (Received September 26, 2013; Revised September 27, 2013; Accepted September 29, 2013) Hypertension is a serious health problem due to high frequency and concomitant other diseases including cardiovascular and renal dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/0c/77/toxicr-29-217.PMC3878002.pdf
http://dx.doi.org/10.1016/j.jad.2013.09.029 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/7b/32/main.PMC3878575.pdf
Published  by  Elsevier  B.V.   http://dx.doi.org/10.1016/j.ajp.2013.06.010Open access under CC BY-NC-SA license.,Non-OADS,/arxiv_data1/oa_pdf/e3/64/main.PMC3878642.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 15–24Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  15ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S5458 5experience with DPP-4 inhibitors   in the management of patients with   type 2 diabetes fasting during Ramadan Anja Schweizer1 Serge Halimi2,3 Sylvie Dejager4 1Novartis Pharma AG, Basel,  Switzerland; 2Department of  Diabetology, endocrinology and  Nutrition, University Hospital of  Grenoble, France; 3Joseph Fourier  University, Grenoble, France; 4Novartis  Pharma SAS,  Rueil-Malmaison, France Correspondence: Anja Schweizer   Novartis Pharma AG, Postfach,   CH-4002 Basel, Switzerland   Tel +41 61 324 3530   Fax +41 61 324 7105   email anja.schweizer@novartis.co mAbstract:  A large proportion of Muslim patients with type 2 diabetes mellitus (T2DM) elect  to fast during the holy month of Ramadan.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
"Available from: http://www.pewforum.or g.  Accessed August 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
Available from:  http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/vhrm-10-015.PMC3878957.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/f5/opth-8-137.PMC3878958.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 137–141Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  137ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5520 5Aphakia correction with retropupillary fixated  iris-claw lens (Artisan) – long-term results Maurice Schallenberg1,2 Dirk Dekowski1 Angela Hahn1 Thomas Laube1,3 Klaus-Peter Steuhl1 Daniel Meller1 1Department of Ophthalmology,   University Hospital Essen, University  of Duisburg-Essen, Essen, Germany;   2HELIOS Klinikum Wuppertal,   Wuppertal, Germany; 3Zentrum  für  Augenheilkunde PD Dr Laube,   Düsseldorf, Germany Correspondence: Maurice Schallenberg   HELIOS Klinikum Wuppertal,  Heusnerstrasse 40, 42283 Wuppertal,  Germany   Tel +49 202 896 3154   Fax +49 202 896 3110   Email maurice.schallenberg@helios- kliniken.d ePurpose:  To evaluate the technique, safety, and efficacy of the retropupillary implantation of  iris-claw intraocular lenses in a long-term follow-up study.",Non-OADS,/arxiv_data1/oa_pdf/12/f5/opth-8-137.PMC3878958.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/12/f5/opth-8-137.PMC3878958.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/f5/opth-8-137.PMC3878958.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 69–77OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  69Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5460 6Ocular side effects of biological agents in  oncology: what should the clinician be aware of?,Non-OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
"Available  from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06- 14_QuickReference_5x7.pd f. Accessed October 11, 2013.",OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/202570s000lbl.pd f. Accessed October 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/42/ott-7-069.PMC3878959.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/db/opth-8-127.PMC3878960.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 127–136Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  127Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S3804 1Number of times this article has been viewedAdvances in gene therapy technologies   to treat retinitis pigmentosa Hilda Petrs-Silva Rafael Linden institute of Biophysics, Federal  University of Rio de Janeiro,    Rio de Janeiro, Brazil Correspondence: Hilda Petrs-Silva   Laboratory of Neurogenesis, institute   of Biophysics, Prédio do CCS, Bloco G,   Sala G1-019, Federal University   of Rio de Janeiro, 373 Avenida Carlos   Chagas Filho, Cidade Universitária,   Rio de Janeiro 21941-902, Brazil   email hilda.ufl@gmail.co mAbstract:  Retinitis pigmentosa (RP) is a class of diseases that leads to progressive degenera - tion of the retina.",Non-OADS,/arxiv_data1/oa_pdf/18/db/opth-8-127.PMC3878960.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/db/opth-8-127.PMC3878960.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/db/opth-8-127.PMC3878960.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/cf/dddt-8-049.PMC3879015.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 49–65Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  49Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S676 2Development and use of sulodexide in vascular  diseases: implications for treatment Sergio Coccheri1 Ferdinando Mannello2 1Cardiovascular Medicine, University  of Bologna, Bologna, 2Department  of Biomolecular Sciences (Section  Clinical Biochemistry and Cell  Biology), University ‘Carlo Bo’,   Urbino, italyAbstract:  Sulodexide (SDX), a sulfated polysaccharide complex extracted from porcine  intestinal mucosa, is a blend of two glycosaminoglycan (GAG) entities, namely a fast-moving  heparin (HP) fraction and a dermatan sulfate (DS; 20%) component.",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/dddt-8-049.PMC3879015.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/dddt-8-049.PMC3879015.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/cf/dddt-8-049.PMC3879015.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/7f/ijn-9-043.PMC3879016.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 43–53International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  43OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5513 3Novel delivery system for T -oligo using   a nanocomplex formed with an alpha   helical peptide for melanoma therapy srijayaprakash B Uppada1,* T errianne erickson1 luke Wojdyla1 David N Moravec1 Ziyuan song2 Jianjun cheng2 Neelu Puri1,* 1Department of Biomedical sciences,   University of Illinois college of  Medicine at rockford, rockford,   2Department of Materials science and  engineering, University of Illinois at  Urbana-champaign, Urbana, Il, Usa *These authors contributed equally to  this work correspondence: Neelu Puri   University of Illinois college of   Medicine at rockford, Department   of Biomedical sciences, 1601 Parkview   avenue, rockford, Il 61107, Usa   Tel +1 815 395 5678   Fax +1 815 395 5666   email neelupur@uic.ed uAbstract:  Oligonucleotides homologous to 3 ′-telomere overhang (T -oligos) trigger inherent  telomere-based DNA damage responses mediated by p53 and/or ATM and induce senescence  or apoptosis in various cancerous cells.",Non-OADS,/arxiv_data1/oa_pdf/e5/7f/ijn-9-043.PMC3879016.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e5/7f/ijn-9-043.PMC3879016.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/7f/ijn-9-043.PMC3879016.pdf
"139Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL A comprehensive review of neuroanatomy of the   prostate Yong Hyun Park, Chang Wook Jeong, Sang Eun Lee Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea Although oncologic efficacy is the primary goal of radical prostatectomy, preserving potency and continence is also important, given  the indolent clinical course of most prostate cancers.",Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
"Keywords:  Prostatic neoplasms, Neurovascular bundle, Fascial anatomy, Penile erection, Urinary incontinenceProstate Int 2013;1(4):139-145 • http://dx.doi.org/10.12954/PI.13020Review Article Corresponding author:  Sang Eun Lee Department of Urology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea   E-mail: selee@snubh.org / Tel: +82-31-787-7343 / Fax: +82-31-787-4057 Submitted: 27 June 2013  / Accepted after revision: 5 August 2013INTRODUCTION Prostate cancer is the most common cancer among men, and  approximately 2.8 million men are estimated to have a history  of prostate cancer in the United States [1].",Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
Neuroanatomy of the prostate 140PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13020technique has inspired greater acceptance of the surgical ap - proach for prostate cancer therapy and came to be used glob - ally.,Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
4 / December 2013 141PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13020terior than previously described.,OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
Neuroanatomy of the prostate 142PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13020along the pelvic sidewall at the lateral aspect of the prostate  and bladder.,Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
"4 / December 2013 143PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13020artery, which could be either a prostatic or a capsular artery,  is located approximately 2–3 mm outside the capsule and can  be used as a visual cue to delineate the extension of the resec - tion of the NVBs.",Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
Neuroanatomy of the prostate 144PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13020antigen screening: importance of methods and context.,Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
4 / December 2013 145PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.130202011;108(6 Pt 2):984-92.,Non-OADS,/arxiv_data1/oa_pdf/a9/f3/pi-1-4-139-1.PMC3879050.pdf
"146Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Histopathological spectrum of 364 prostatic specimens  including immunohistochemistry with special reference  to grey zone lesions Monika Garg, Gurmeen Kaur, Vineeta Malhotra1, Ravish Garg2 Department of Pathology, MM Institute of Medical Sciences & Research, Mullana, India 1Department of Pathology, Dayanand Medical College &Hospital, Ludhiana, India 2MM Institute of Medical Sciences &Research, Mullana, India Purpose:  Prostatic lesions on routine staining sometimes cause a diagnostic dilemma, especially when malignant tissue is limited  and is mixed with benign prostatic glands or because of the presence of benign mimickers of carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
"Keywords:  Prostate, Malignancy, Immunohistochemistry, Alpha-methylacyl-CoA racemase, CytokeratinProstate Int 2013;1(4):146-151 • http://dx.doi.org/10.12954/PI.13026Original Article Corresponding author:  Monika Garg Department of Pathology, MM Institute of Medical Sciences & Research, Mullana, India   E-mail: monikakash7@yahoo.co.in / Tel: +91-94173-78514 / Fax: +91-1731-274375 Submitted: 21 September 2013  / Accepted after revision: 22 October 2013INTRODUCTION Benign prostatic hyperplasia (BPH) is a common urological  condition in men.",Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
"4 / December 2013 147PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13026cell marker high-molecular-weight-cytokeratin (HMWCK,  clone 34βE12) and the prostate biomarker alpha-methylacyl- CoA-racemase (AMACR), have been used as an adjunct to  morphology in these diagnostically challenging cases with  very high sensitivity and specificity.",Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
"Histopathological spectrum in prostatic specimens 148PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13026nuclear enlargement and hyperchromasia with prominent  nucleoli at places, and these cells were seen infiltrating the  stroma.",Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
4 / December 2013 149PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13026abscess formation was noted in 12.1% of cases.,Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
Histopathological spectrum in prostatic specimens 150PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13026benign cases studied.,Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
4 / December 2013 151PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13026CONFLICT OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/be/d4/pi-1-4-146-2.PMC3879051.pdf
"152Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Localization of higher grade tumor foci in potential   candidates for active surveillance who opt for radical  prostatectomy Sung Kyu Hong1,2, James A. Eastham2,3, Samson W. Fine4 1Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea 2Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA 3Department of Urology, Weill Medical College of Cornell University, New York, NY, USA 4Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Purpose:  To investigate actual intraprostatic location of higher graded tumor foci undetected via standard transrectal ultrasound- guided prostate biopsy amongst patients who would be clinically considered appropriate candidates for active surveillance (AS) but  underwent radical prostatectomy (RP).",Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
"Keywords:  Prostate, Prostatic neoplasms, Active surveillance, Prostate biopsy, Gleason scoreProstate Int 2013;1(4):152-157 • http://dx.doi.org/10.12954/PI.13029Original Article Corresponding author:  Sung Kyu Hong Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA   E-mail: skhong@snubh.org / Tel: +1-646-422-4338 / Fax: +1-212-988-0759 Submitted: 6 November 2013  / Accepted after revision: 3 December 2013INTRODUCTION Accurate identification of insignificant and/or low-risk pros - tate cancer (PCa) is crucial for the success of active surveil - lance (AS) in the current era of prostate specific antigen (PSA)  screening.",Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
4 / December 2013 153PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13029ty of novel focal therapies for unilateral PCa has been ques - tioned based upon apparent inaccuracy of prostate biopsy [7].,Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
Higher grade tumor foci missed by biopsy 154PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13029should include at least 10 to 12 cores [14].,Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
"4 / December 2013 155PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13029derwent RP , Washington et al.",OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
Higher grade tumor foci missed by biopsy 156PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13029ported.,Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
4 / December 2013 157PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13029cer.,Non-OADS,/arxiv_data1/oa_pdf/45/4c/pi-1-4-152-3.PMC3879052.pdf
"158Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Can microfocal prostate cancer be regarded as low-risk  prostate cancer?",Non-OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
"Keywords:  Prostate neoplasms, Biopsy, Low-risk prostate cancer, ProstatectomyProstate Int 2013;1(4):158-162 • http://dx.doi.org/10.12954/PI.13028Original Article Corresponding author:  Byung Ha Chung Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea   E-mail: chung646@yuhs.ac / Tel: +82-2-2019-3474 / Fax: +82-2-3462-8887 Submitted: 8 October 2013  / Accepted after revision: 26 November 2013INTRODUCTION Prostate specific antigen (PSA) screening for prostate cancer  has become widespread, the prostate biopsy technique has  evolved, and the detection of low-risk prostate cancer has  been increasing [1].",Non-OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
4 / December 2013 159PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13028radical prostatectomy (RP).,Non-OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
160PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13028(P= 0.01) (Table 1).,OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
"4 / December 2013 161PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13028Furthermore, extraprostatic extension was more likely to be  associated with positive surgical margins for anterior prostate  cancers than peripheral prostate cancers, suggesting that an - terior positive margins might be clinically significant, and at  greater risk of biochemical recurrence [14].",Non-OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
"162PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13028B, Eastham JA, et al.",OADS,/arxiv_data1/oa_pdf/20/79/pi-1-4-158-4.PMC3879053.pdf
"163Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Ten-core versus 16-core transrectal ultrasonography  guided prostate biopsy for detection of prostatic   carcinoma: a prospective comparative study in Indian  population V. Surya Prakash, G. Chandra Mohan, S. Venkata Krishnaiah, V. Vijaykumar, G. Ramesh Babu,   G. Vijaya Bhaskar Reddy, V. S. Mahaboob1 Department of Urology and Renal Transplantation, Narayana Medical College and Hospital, Nellore, India 1Advanced Research Centre, Narayana Medical College and Hospital, Nellore, India  Purpose:  To compare the cancer detection rate in patients with raised serum prostate-specific antigen (PSA) or abnormal digital rectal  examination (DRE) results between the 10-core and the 16-core biopsy techniques in an Indian population.",Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
"Keywords:  Prostate neoplasms, Prostate-specific antigen, Digital rectal examination, Transrectal ultrasonography, Prostate biopsyProstate Int 2013;1(4):163-168 • http://dx.doi.org/10.12954/PI.13025Original Article Corresponding author:  G. Chandra Mohan Department of Urology and Renal Transplantation, Narayana  Medical College and Hospital, Nellore-524003, Andhra Pradesh, India   Email: chandramohan_godala@yahoo.co.in / Tel: +918612317963 / Fax: +91-8612331763 Submitted: 29 August 2013  / Accepted after revision: 21 November 2013INTRODUCTION Prostate cancer has been the most common non cutaneous  malignancy in United States men since 1984 and now ac - counts for one-quarter of all such cancers (American Cancer  Society, 2008).",Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
Ten-core versus 16-core prostate biopsy  164PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13025transrectal ultrasonography (TRUS)-guided biopsy of the  prostate have led to increased detection of early-stage prostate  cancer and a decrease in mortality.,Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
"4 / December 2013 165PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13025(SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
Ten-core versus 16-core prostate biopsy  166PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13025the 95 patients.,Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
"Ten-core versus 16-core prostate biopsy  168PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13025veillance, Epidemiology, and End Results Registry analysis.",Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
Available from: http://seer.cancer.gov/archive/csr/1975_2005/.,Non-OADS,/arxiv_data1/oa_pdf/43/1d/pi-1-4-163-5.PMC3879054.pdf
"169Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Efficacy and safety of 120-W GreenLight   High-Performance System laser photo vaporization of  the prostate: 3-year results with specific considerations Yong Sun Choi, Woong Jin Bae, Su Jin Kim1, Kang Sup Kim, Hyuk Jin Cho, Sung-Hoo Hong, Ji Youl Lee,   Tae-Kon Hwang, Sae Woong Kim Department of Urology, The Catholic University of Korea School of Medicine, Seoul, Korea 1Urology, Health Promotion Center, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea Purpose:  High-Performance System (HPS) laser photo vaporization of the prostate (PVP) is a widely used procedure nowadays.",Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
"Keywords:  Lasers, Prostatic hyperplasia, Anticoagulants, 5-Alpha reductase inhibitors, Retention, Transurethral resection of prostateProstate Int 2013;1(4):169-176 • http://dx.doi.org/10.12954/PI.13030Original Article Corresponding author:  Sae Woong Kim Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea School of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea   E-mail: ksw1227@catholic.ac.kr / Tel: +82-2-2258-6226 / Fax: +82-2-2258-1080 Submitted: 12 November 2013  / Accepted after revision: 2 December 2013INTRODUCTION Benign prostatic hyperplasia (BPH) is a disease exhibiting one  of the fastest surging incidences because the elderly population  is rapidly growing [1].",Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
HPS laser PVP in specific considerations 170PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030implemented from medications regulating BPH symptoms  to medications reducing the size of the prostate to surgical  methods of removing the enlarged part of the prostate.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
4 / December 2013 171PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030agulant medication.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
HPS laser PVP in specific considerations 172PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030Fig.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
"4 / December 2013 173PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030about 8% of the patients during the first postoperative month,  the symptom disappeared after starting medication or ob - servation in most cases.",Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
"HPS laser PVP in specific considerations 174PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030 Along with the advancement of laser resection of the pros - tate, surgical cases that were considered inoperable or ex - tremely high-risk in the past have been attempted.",Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
4 / December 2013 175PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030preoperative and postoperative effects of laser resection of  the prostate on subjects including different unique cases.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
HPS laser PVP in specific considerations 176PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13030Long-Term Efficacy and Safety Study Group.,Non-OADS,/arxiv_data1/oa_pdf/17/ad/pi-1-4-169-6.PMC3879055.pdf
"177Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Anxiety level of early- and late-stage prostate cancer  patients Charles Johanes, Richard Arie Monoarfa, Raden Irawati Ismail1, Rainy Umbas Departments of Urology and 1Psychiatry, Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia, Jakarta, Indonesia  Purpose:  Anxiety can worsen prostate cancer patients’ decision making and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
"Keywords:  Prostatic neoplasms, Neoplasm staging, Anxiety disorders, Pain measurementProstate Int 2013;1(4):177-182 • http://dx.doi.org/10.12954/PI.13027Original Article Corresponding author:  Rainy Umbas Division of Urology Department of Surgery, Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia, Jl.",Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
"Anxiety level of early and late stage prostate cancer patients 178PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13027cancer, especially those receiving hormonal therapy [13].",Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
4 / December 2013 179PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13027PC score was analyzed by using the Spearman test.,OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
Anxiety level of early and late stage prostate cancer patients 180PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13027on the MAX-PC for referral to mental health services (psy - chiatry).,Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
Available  from: http://globocan.iarc.fr/.,Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
4 / December 2013 181PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1302719.,Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
Anxiety level of early and late stage prostate cancer patients 182PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13027Appendix.,Non-OADS,/arxiv_data1/oa_pdf/d9/59/pi-1-4-177-7.PMC3879056.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/57/thnov03p0802.PMC3879057.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/93/thnov03p0914.PMC3879107.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/03/72/thnov03p0916.PMC3879108.pdf
"Using the c -arm CT data, the distance between  the needle tips and each PFOB -TF-MSCs transplant a- tion’s center of mass (COM) as well as the shortest extent between injection COM and skin surface were  calculated using ImageJ (National Institutes of Health,  Bethesda, MD, http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/03/72/thnov03p0916.PMC3879108.pdf
"Tissue Barriers 2013; 1:e23815; http://dx.doi.org/10.4161/tisb.23815LI-cadherin belongs to the so called 7D-cadherins, exceptional  members of the cadherin superfamily which are characterized by seven extracellular cadherin repeats and a small cytosolic  domain.",Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Ann  N Y Acad Sci 2009; 1165:220-7; PMID:19538310;  http://dx.doi.org/10.1111/j.1749-6632.2009.04025.x.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dev Genes Evol 2012;  PMID:23179635; http://dx.doi.org/10.1007/s00427- 012-0422-8.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Front Biosci 1999; 4:D286- 98; PMID:10077541; http://dx.doi.org/10.2741/ Karam.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Annu Rev Physiol 1998; 60:105-19;  PMID:9558456; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Acta Physiol (Oxf)  2009; 195:171-86; PMID:18983444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Wiley Interdiscip Rev Dev Biol 2012; 1:479-99;  PMID:23066429; http://dx.doi.org/10.1002/wdev.32.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Control Release  2012; 160:431-9; PMID:22353618; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
World J Gastrointest Pathophysiol 2011; 2:123- 37; PMID:22184542; http://dx.doi.org/10.4291/wjgp.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Acta Physiol Scand 2002; 175:55-70;  PMID:11982505; http://dx.doi.org/10.1046/j.1365- 201X.2002.00967.x.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Annu Rev Physiol 1998; 60:143- 59; PMID:9558458; http://dx.doi.org/10.1146/ annurev.physiol.60.1.143.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J  Membr Biol 1986; 92:183-93; PMID:3761362; http://dx.doi.org/10.1007/BF01870707.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Annu Rev Physiol 2010; 72:463-93; PMID:20148685; http://dx.doi.org/10.1146/annurev- physiol-021909-135833.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol  1989; 108:1187-94; PMID:2647764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Curr Opin Cell Biol 2012;  PMID:23127608; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cell Adh Migr 2012; 6:365-73; PMID:22796940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Eur J Cell Biol 2002; 81:161-8; PMID:11998868; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Biol Aujourdhui  2012; 206:219-36; PMID:23171844; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Pathol 2012; 226:158- 71; PMID:21989576; http://dx.doi.org/10.1002/ path.3027.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Annu Rev Cell Dev Biol  2004; 20:811-38; PMID:15473861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Subcell Biochem 2012; 60:321-55;  PMID:22674078; http://dx.doi.org/10.1007/978-94-007-4186-7_14.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cold Spring Harb  Perspect Biol 2009; 1:a002899; PMID:20457565; http://dx.doi.org/10.1101/cshperspect.a002899.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000125; PMID:20182611; http://dx.doi.org/10.1101/cshper- spect.a000125.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Nat Rev Mol Cell Biol 2005; 6:622-34; PMID:16025097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol 2000; 148:399-404; PMID:10662767; http://dx.doi.org/10.1083/jcb.148.3.399.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Annu Rev Cell Dev Biol 1997; 13:119-46; PMID:9442870; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Curr Opin Cell Biol 1999; 11:540-8; PMID:10508657; http://dx.doi.org/10.1016/ S0955-0674(99)00025-3.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Curr Opin Cell Biol 1995; 7:619-27; PMID:8573335; http://dx.doi.org/10.1016/0955-0674(95)80102-2.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dev Biol 1996; 180:413-23; PMID:8954714; http://dx.doi.org/10.1006/ dbio.1996.0315.33.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Nature 1995; 374:327-37; PMID:7885471; http://dx.doi.org/10.1038/374327a0.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biochem 1996; 61:531-42; PMID:8806076;  http://dx.doi.org/10.1002/(SICI)1097- 4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P .,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol 1994; 125:1353- 69; PMID:8207063; http://dx.doi.org/10.1083/ jcb.125.6.1353.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Science 1994; 264:430-3; PMID:8153632;  http://dx.doi.org/10.1126/science.8153632.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Genomics 1998; 49:467-71; PMID:9615235; http://dx.doi.org/10.1006/ geno.1998.5281.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Hum Genet 1998; 103:96- 101; PMID:9737784; http://dx.doi.org/10.1007/ s004390050790.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Biol Chem  1995; 270:17594-601; PMID:7615566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Genomics 1998; 51:445- 51; PMID:9721215; http://dx.doi.org/10.1006/ geno.1998.5402.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dev Dyn 2001; 221:182-93;  PMID:11376485; http://dx.doi.org/10.1002/dvdy.1146.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Ann N Y Acad Sci  2000; 915:136-43; PMID:11193569; http://dx.doi.org/10.1111/j.1749-6632.2000.tb05236.x.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cell Mol Life Sci 2006; 63:1564-73; PMID:16791429; http://dx.doi.org/10.1007/ s00018-006-6014-x.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Exp Cell Res  2004; 294:345-55; PMID:15023525; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Eur Biophys J 2002; 31:532-8;  PMID:12451422; http://dx.doi.org/10.1007/s00249- 002-0248-9.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Sci 2003; 116:1001- 11; PMID:12584244; http://dx.doi.org/10.1242/ jcs.00322.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
EMBO J 2002; 21:2537- 46; PMID:12032067; http://dx.doi.org/10.1093/ emboj/21.11.2537.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Mol Biol  2008; 378:44-54; PMID:18342884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Mol Biol 2007; 370:220- 30; PMID:17512947; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol  1985; 100:327-32; PMID:3880756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol 1998; 142:837- 46; PMID:9700170; http://dx.doi.org/10.1083/jcb.142.3.837.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol 1996; 135:487-96; PMID:8896604; http://dx.doi.org/10.1083/ jcb.135.2.487.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
EMBO J 1999; 18:1738- 47; PMID:10202138; http://dx.doi.org/10.1093/ emboj/18.7.1738.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Biochemistry  2011; 50:2973-82; PMID:21366346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Theor Biol Med Model 2011; 8:18;  PMID:21663598; http://dx.doi.org/10.1186/1742- 4682-8-18.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Mol  Cell Neurosci 2008; 37:548-58; PMID:18201900; http://dx.doi.org/10.1016/j.mcn.2007.12.003.62.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Korean  J Gastroenterol 2012; 60:229-41; PMID:23089909;  http://dx.doi.org/10.4166/kjg.2012.60.4.229.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dig Dis Sci 2007; 52:536-42; PMID:17226075;  http://dx.doi.org/10.1007/s10620-006-9316-9.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Mod Pathol 2008; 21:1379-86;  PMID:18552820; http://dx.doi.org/10.1038/mod- pathol.2008.107.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Clin Oncol  (R Coll Radiol) 2008; 20:275-83; PMID:18353622; http://dx.doi.org/10.1016/j.clon.2008.01.013.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Hepatology 2009; 50:1453-63; PMID:19676131;  http://dx.doi.org/10.1002/hep.23143.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biochem  2010; 111:618-26; PMID:20568120; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cancer  Res Clin Oncol 2010; 136:1641-9; PMID:20204409;  http://dx.doi.org/10.1007/s00432-010-0822-y.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Mol Biol 2007; 370:220- 30; PMID:17512947; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cell Mol Life Sci 2012; 69:3851-62; PMID:22842778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Mol Biol  2008; 378:44-54; PMID:18342884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Ultramicroscopy 2000; 82:85-95;  PMID:10741656; http://dx.doi.org/10.1016/S0304- 3991(99)00154-0.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Proc Natl Acad Sci U S A 1996; 93:3477- 81; PMID:8622961; http://dx.doi.org/10.1073/ pnas.93.8.3477.47.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Biol Chem  1995; 270:17594-601; PMID:7615566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Mech Dev 2002; 115:15-26;  PMID:12049763; http://dx.doi.org/10.1016/S0925- 4773(02)00094-1.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
J Cell Biol 1997; 136:1109-21; PMID:9060475;  http://dx.doi.org/10.1083/jcb.136.5.1109.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Am J Pathol  1998; 153:333-9; PMID:9708792; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cancer Sci 2003;  94:575-81; PMID:12841864; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cancer Lett 2004; 212:253-9; PMID:15279905;  http://dx.doi.org/10.1016/j.canlet.2004.03.016.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dig Dis Sci 2008; 53:1811-7; PMID:17999183;  http://dx.doi.org/10.1007/s10620-007-0080-2.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Cancer  Sci 2003; 94:425-30; PMID:12824888; http://dx.doi.org/10.1111/j.1349-7006.2003.tb01459.x.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Virchows Arch  2010; 457:537-45; PMID:20844891; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
Dig Dis Sci 2012;  PMID:23053896; http://dx.doi.org/10.1007/s10620- 012-2425-8.,OADS,/arxiv_data1/oa_pdf/4f/ec/tisb-1-e23815.PMC3879124.pdf
"Tissue Barriers 2013; 1:e24221; http://dx.doi.org/10.4161/tisb.24221Correspondence to: Masahiko Itoh;   Email: mitoh@dokkyomed.ac.jpEpithelial cells form organized sheets  to protect underlying tissues and  maintain the physiological environment by the assembly of tight junctions (TJs) and adherens junctions (AJs), which mainly regulate paracellular molecular passage and selective cell-cell adhesion, respectively.",Non-OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Nat Rev Mol Cell Biol 2008;  9:887-901; http://dx.doi.org/10.1038/nrm2523;  PMID :18946477.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Biochim Biophys Acta 2008;  1778:660-9; PMID:17854762; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Front Biosci  2008; 13:6662-81; PMID:18508686; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Mol Biol Cell 2005; 16:2636- 50; http://dx.doi.org/10.1091/mbc.E05-01-0043;  PMID:15800060.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
PLoS One 2007; 2:e658; http://dx.doi.org/10.1371/journal.pone.0000658;  PMID:17668046.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Nat Rev Mol Cell Biol 2001; 2:285-93; http://dx.doi.org/10.1038/35067088;  PMID:11283726.7.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Cell 2006; 126:741-54; http://dx.doi.org/10.1016/j.cell.2006.06.043; PMID:16923393.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Mol Biol Cell 2008; 19:3801-11; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Biol Chem 2004; 279:44785-94;  PMID:15292177; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Cell 2012; 149:1084-97; PMID:22632972;  http://dx.doi.org/10.1016/j.cell.2012.04.021.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Dev Growth Differ 2012; 54:266-76; PMID:22524600; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Curr Biol  2003; 13:1129-33; PMID:12842012; http://dx.doi.org/10.1016/S0960-9822(03)00374-9.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Am  J Physiol Lung Cell Mol Physiol 2005; 288:L749- 60; PMID:15591411; http://dx.doi.org/10.1152/ ajplung.00361.2004.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Nat Cell Biol 2011; 13:159- 66; PMID:21258369; http://dx.doi.org/10.1038/ ncb2156.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Circ Res 2003; 93:848-56; PMID:14512443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Cell Biol 2011; 195:245- 61; PMID:22006950; http://dx.doi.org/10.1083/ jcb.201104118.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Biol Chem 1998;  273:29672-7; PMID:9792678; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Br J Pharmacol 2009; 158:41-9;  PMID:19226283; http://dx.doi.org/10.1111/j.1476- 5381.2009.00121.x.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Biol Chem 2002; 277:24855-8;  PMID:12023272; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Arterioscler Thromb Vasc Biol 2000; 20:E127-33; PMID:11116077; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Mol Biol Cell 2009; 20:3930-40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Proc Natl Acad Sci U S A 1995; 92:10629- 33; PMID:7479854; http://dx.doi.org/10.1073/ pnas.92.23.10629.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Cell Biol 1998; 142:101- 15; PMID:9660866; http://dx.doi.org/10.1083/ jcb.142.1.101.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Genes Dev 2002;  16:1032-54; http://dx.doi.org/10.1101/gad.978802;  PMID:12000787.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Gastroenterology 2001; 121:566-79; PMID:11522741; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Exp Cell Res 2000; 261:44-51; http://dx.doi.org/10.1006/ excr.2000.5046; PMID:11082274.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Ann N Y Acad Sci 2012; 1258:34-42;  PMID:22731713; http://dx.doi.org/10.1111/j.1749- 6632.2012.06526.x.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
J Cell Sci 2006;  119:2095-106; PMID:16638813; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
Dev Cell 2005; 8:777-86; PMID:15866167; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/54/tisb-1-e24221.PMC3879125.pdf
"Tissue Barriers 2013; 1:e24314; http://dx.doi.org/10.4161/tisb.24314Introduction The medicinal use of gold can be traced back through many  centuries, although historical proof for its efficacy is lacking.1  Today’s evidence supports the systemic use of gold salts in man for the treatment of inflammatory arthritis 2-5 but the practical  utility is decreased by the potential cytotoxic side effects.6 There  are reports of reduced pain and improved limb use in human and canine patients with arthropathies that receive gold beads implanted at acupuncture sites.",Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Clin Rheumatol 2008; 27:1363-9;  PMID:18500437; http://dx.doi.org/10.1007/s10067- 008-0918-9.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Vet Rec 2006; 158:722-6; PMID:16731702;  http://dx.doi.org/10.1136/vr.158.21.722.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Histochem Cell Biol  2002; 117:447-52; PMID:12029492; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Arthritis Rheum  2007; 56:544-54; PMID:17265489; http://dx.doi.org/10.1002/art.22401.4.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Ann Rheum Dis 2010; 69:964- 75; PMID:20444750; http://dx.doi.org/10.1136/ ard.2009.126532.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Ann Rheum Dis 1999; 58:281-7; PMID:10225812;  http://dx.doi.org/10.1136/ard.58.5.281.References 1.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Gold Bull 1982; 15:130- 40; PMID:11614517; http://dx.doi.org/10.1007/ BF03214618.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Clin Rheumatol 2005; 24:189-202;  PMID:15940552; http://dx.doi.org/10.1007/s10067- 004-0869-8.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Ann Rheum Dis 2001; 60:566-72; PMID:11350844;  http://dx.doi.org/10.1136/ard.60.6.566.tissue’s maximum and minimum width in each image and mea - surements were subsequently averaged to give an average maxi - mum and minimum width for each sample.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Langmuir 2005; 21:9303- 7; PMID:16171365; http://dx.doi.org/10.1021/ la050588t.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Mater Chem 2010;  20:6176-81; http://dx.doi.org/10.1039/c0jm01071e.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Eur J Pharm  Biopharm 2009; 72:370-7; PMID:18775492; http://dx.doi.org/10.1016/j.ejpb.2008.08.009.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Toxicol Appl Pharmacol 2009; 234:222- 35; PMID:18983864; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Arch Toxicol 2012; 86:1123-36;  PMID:22407301; http://dx.doi.org/10.1007/s00204- 012-0837-z.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Toxicology 2012; 299:99- 111; PMID:22634321; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Chemosphere 2009; 77:67-73;  PMID:19540550; http://dx.doi.org/10.1016/j.chemo- sphere.2009.05.015.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
FEBS J 2011; 278:1419-28; PMID:21362137; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Small 2013; 9:472-7; PMID:23112137; http://dx.doi.org/10.1002/smll.201201528.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Nano Lett 2004; 4:2479-81; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Histochem Cell Biol 2007; 128:1-6;  PMID:17549510; http://dx.doi.org/10.1007/s00418-007-0295-5.26.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Rheumatology (Oxford) 2002; 41:883- 91; PMID:12154205; http://dx.doi.org/10.1093/rheu- matology/41.8.883.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Clin Invest 1996; 97:769-76; PMID:8609234; http://dx.doi.org/10.1172/ JCI118476.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
T ransplantation 2002; 73:714-22; PMID:11907416;  http://dx.doi.org/10.1097/00007890-200203150- 00010.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Reprod Biol 2008; 8:57-68;  PMID:18432307; http://dx.doi.org/10.1016/S1642- 431X(12)60004-7.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Vet Surg 2001; 30:528-38; PMID:11704948;  http://dx.doi.org/10.1053/jvet.2001.28430.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Arthritis Res  2000; 2:356-60; PMID:11094448; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Best Pract Res Clin  Rheumatol 2010; 24:71-9; PMID:20129201; http://dx.doi.org/10.1016/j.berh.2009.08.011.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Am J Vet Res 2008; 69:1129-34; PMID:18764682;  http://dx.doi.org/10.2460/ajvr.69.9.1129.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Res Vet Sci 1992; 52:342-8; PMID:1620968; http://dx.doi.org/10.1016/0034- 5288(92)90035-Z.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Am J Vet  Res 2009; 70:848-61; PMID:19566470; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Physiol 2007; 578:291-9; PMID:17008373;  http://dx.doi.org/10.1113/jphysiol.2006.119446.11.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Eur J Pharm Biopharm 2009; 73:205- 18; PMID:19545624; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Pharm Sci 2008;  97:9-21; PMID:17721937; http://dx.doi.org/10.1002/ jps.21077.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Physiol Rev 2007; 87:545-64;  PMID:17429041; http://dx.doi.org/10.1152/phys- rev.00012.2006.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Biomed Opt  2012; 17:116015; PMID:23117810; http://dx.doi.org/10.1117/1.JBO.17.11.116015.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Res Vet Sci  2005; 78:189-92; PMID:15563928; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Vet  J 2009; 179:10-24; PMID:17911037; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Macromol Biosci 2006; 6:506-16; PMID:16921538; http://dx.doi.org/10.1002/ mabi.200600075.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Gene  1993; 129:285-9; PMID:8325511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Osteoarthritis  Cartilage 2012; 20:127-35; PMID:22179028; http://dx.doi.org/10.1016/j.joca.2011.12.002.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Toxicol Lett  2009; 191:96-102; PMID:19695318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
J Nanosci Nanotechnol 2006; 6:3261- 8; PMID:17048545; http://dx.doi.org/10.1166/ jnn.2006.482.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
BMC Neurosci 2012; 13:76;  PMID:22742423; http://dx.doi.org/10.1186/1471- 2202-13-76.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Equine Vet  J 2005; 37:75-80; PMID:15651739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Carbohydr Polym 2012; 90:1168-75;  PMID:22840054; http://dx.doi.org/10.1016/j.carb- pol.2012.06.071.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Osteoarthritis Cartilage 2012; 20:1583-90; PMID:22917743; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Colloids Surf  B Biointerfaces 2008; 66:274-80; PMID:18722754;  http://dx.doi.org/10.1016/j.colsurfb.2008.07.004.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Colloids Surf B Biointerfaces 2008; 65:1- 10; PMID:18499408; http://dx.doi.org/10.1016/j.col- surfb.2008.02.013.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Chem Soc Rev 2011; 40:1647- 71; PMID:21082078; http://dx.doi.org/10.1039/ c0cs00018c.56.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Biochem Pharmacol  1990; 39:1697-702; PMID:2160818; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Biochem Pharmacol 1998; 56:307- 12; PMID:9744567; http://dx.doi.org/10.1016/ S0006-2952(98)00031-8.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Ann Rheum Dis 1994; 53:315-22; PMID:8017985; http://dx.doi.org/10.1136/ ard.53.5.315.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
FEBS  Lett 1995; 361:89-96; PMID:7890047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Int Immunol  1999; 11:151-8; PMID:10069413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
Arthritis Rheum 2010; 62:1650- 9; PMID:20178133; http://dx.doi.org/10.1002/ art.27409.,Non-OADS,/arxiv_data1/oa_pdf/16/d8/tisb-1-e24314.PMC3879126.pdf
"Tissue Barriers 2013; 1:e24265;  http://dx.doi.org/10.4161/tisb.24265Last n ovember a group of principal investigators, postdoctoral  fellows and p hD students from around the world got together  in the city of Merida in Southeastern Mexico in a State of  the Art meeting on the “molecular structure and function of  the apical junctional complex in epithelial and endothelia.” They analyzed diverse tissue barriers including those in the gastrointestinal tract, the blood brain barrier and blood  neural and blood retinal barriers.",OADS,/arxiv_data1/oa_pdf/12/b7/tisb-1-e24265.PMC3879127.pdf
"OncoImmunology 2013; 2:e25912; http://dx.doi.org/10.4161/onci.25912Replenish the source within Rescuing tumor-infiltrating lymphocytes  by double checkpoint blockade Jaikumar Duraiswamy1, Gordon Freeman2, and George Coukos1,3,* 1Ovarian Cancer r esearch Center; Perelman s chool of Medicine; u niversity of Pennsylvania; Philadelphia, P a usa ; 2Department of Medical Oncology; Dana-Farber  Cancer Institute; Boston, M a usa ; 3Department of Oncology and Ludwig Center for Cancer r esearch; u niversity h ospital of Lausanne; Lausanne, s witzerland Keywords:  CTLA4, PD-1, regulatory T cells, tumor-infiltrating lymphocytes, vaccine we have recently reported that the PD-1 and CTL a4 signaling pathways are active in both effector and regulatory  T cells, causing profound immune dysfunctions in the tumor microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
N Engl J Med 2003;  348:203 -13; PMID:12529460 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Cancer Res 2013;  73:3591 -603; PMID:23633484 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Proc Natl Acad Sci U S A 2013;  110:E2480 -9; PMID:23610399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
J Exp Med 2009;  206:3015 -29; PMID:20008522 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Int Immunol 2009; 21:1065 -77;  PMID:19651643 ; http://dx.doi.org/10.1093/ intimm/dxp072 8.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Cancer Immunol Res 2013; 1:32-42; http://dx.doi.org/10.1158/2326 -6066.,Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
N Engl J Med  2013; 369:122 -33; http://dx.doi.org/10.1056/ NEJMoa1302369 ; PMID:23724867 10.,OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Oncogene 2003; 22:3188 -92; PMID:12789295 ;  http://dx.doi.org/10.1038/sj.onc.1206459,Non-OADS,/arxiv_data1/oa_pdf/a1/55/onci-2-e25912.PMC3879129.pdf
Tissue Barriers 2013; 1:e25502;   http://dx.doi.org/10.4161/tisb.25502The claudin family of integral membrane proteins was  identified as the major protein component of the tight  junctions in all vertebrates.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Bootstrap analysis of pfam00822 proteins using the MEGA  (Molecular Evolutionary Genetic Analysis) software program available at http://www.megasoftware.net.108 The phylogenetic tree resulting from  ClustalW2 analysis is shown.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
"Additional  unpublished results, particularly regarding clc-3 , can be found at http://wormbase.org.",Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol 1998; 141:1539- 50; PMID:9647647; http://dx.doi.org/10.1083/ jcb.141.7.1539 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol 1999; 147:185- 94; PMID:10508865; http://dx.doi.org/10.1083/ jcb.147.1.185 4.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol  2003; 161:653-60; PMID:12743111; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol 2002; 156:1099- 111; PMID:11889141; http://dx.doi.org/10.1083/ jcb.200110122 7.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell 2001; 104:165-72; PMID:11163249;  http://dx.doi.org/10.1016/S0092-8674(01)00200-8 8.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
FEBS Lett  2007; 581:3887-91; PMID:17651736; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Proc Natl Acad Sci U S A 2001; 98:10196- 201; PMID:11517306; http://dx.doi.org/10.1073/ pnas.171325898 10.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Biochim  Biophys Acta 2008; 1778:631-45; PMID:18036336;  http://dx.doi.org/10.1016/j.bbamem.2007.10.018.11.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Proc Natl Acad Sci U S A 1999; 96:511- 6; PMID:9892664; http://dx.doi.org/10.1073/ pnas.96.2.511 12.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell Mol Life  Sci 2006; 63:505-14; PMID:16456617; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Protein  Sci 2003; 12:218-27; PMID:12538885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Annu Rev Physiol 2006; 68:403- 29; PMID:16460278; http://dx.doi.org/10.1146/ annurev.physiol.68.040104.131404 17.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Am J Physiol Cell Physiol 2002; 283:C142-7;  PMID:12055082; http://dx.doi.org/10.1152/ajp - cell.00038.200222.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Am J Physiol Renal Physiol 2006; 291:F1288- 99; PMID:16804102; http://dx.doi.org/10.1152/ ajprenal.00138.2006 23.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Nature  2007; 446:801-5; PMID:17325668; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Virol 2008; 82:3555-60;  PMID:18234789; http://dx.doi.org/10.1128/ JVI.01977-07 25.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Virol 2007; 81:12465- 71; PMID:17804490; http://dx.doi.org/10.1128/ JVI.01457-07 26.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2002; 277:455-61; PMID:11689568;  http://dx.doi.org/10.1074/jbc.M109005200 27.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol  1999; 147:1351-63; PMID:10601346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Clin Endocrinol Metab 2006; 91:3076-9;  PMID:16705067; http://dx.doi.org/10.1210/jc.2006- 0200 29.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2005; 280:26233- 40; PMID:15905176; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2005; 280:42375- 82; PMID:16236711; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Development 2004; 131:2865- 74; PMID:15151982; http://dx.doi.org/10.1242/ dev.01146 67.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Curr Biol 2000; 10:1098-107;  PMID:10996790; http://dx.doi.org/10.1016/S0960- 9822(00)00695-3 68.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Nat Cell Biol  2000; 2:415-22; PMID:10878806; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol 2004; 268:448- 56; PMID:15063180; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol  1997; 181:121-43; PMID:9013925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol  1999; 212:101-23; PMID:10419689; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Development 2003; 130:5695-704; PMID:14522875;  http://dx.doi.org/10.1242/dev.00807 77.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol 1999; 209:111- 27; PMID:10208747; http://dx.doi.org/10.1006/ dbio.1999.924249.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Cell 2003; 5:611- 20; PMID:14536062; http://dx.doi.org/10.1016/ S1534-5807(03)00275-2 50.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol 2003; 161:979- 89; PMID:12782686; http://dx.doi.org/10.1083/ jcb.200212054 51.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Development  2007; 134:999-1009; PMID:17267446; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Genetics  2010; 185:831-9; PMID:20407131; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Sci 2006; 119:979-87; PMID:16525119;  http://dx.doi.org/10.1242/jcs.02898 54.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell 1996; 87:1059-68;  PMID:8978610; http://dx.doi.org/10.1016/S0092- 8674(00)81800-0 56.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev  Genet 1997; 20:111-8; PMID:9144922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol  2003; 161:991-1000; PMID:12782681; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Science  2002; 298:1955-9; PMID:12471248; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Cell Biol 2003; 162:15- 22; PMID:12847081; http://dx.doi.org/10.1083/ jcb.200212136 61.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol 2001; 230:29- 42; PMID:11161560; http://dx.doi.org/10.1006/ dbio.2000.0113 62.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Nat Cell Biol 2001; 3:983-91;  PMID:11715019; http://dx.doi.org/10.1038/ ncb1101-98332.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Membr Biol  2003; 194:59-76; PMID:14502443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2005; 280:19711- 20; PMID:15760900; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell  2005; 120:843-56; PMID:15797384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Dyn 2007; 236:596- 605; PMID:17195181; http://dx.doi.org/10.1002/ dvdy.21052 38.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
PLoS Genet  2012; 8:e1002510; PMID:22346764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
PLoS Biol 2008; 6:e239; PMID:18828675;  http://dx.doi.org/10.1371/journal.pbio.0060239 41.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Dev Biol  1994; 161:563-96; PMID:8314002; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Int Rev Cytol 1980; 63:97- 140; PMID:20795303; http://dx.doi.org/10.1016/ S0074-7696(08)61758-1 45.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Tissue Cell 1983; 15:27-37;  PMID:6857633; http://dx.doi.org/10.1016/0040- 8166(83)90031-9 48.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
EMBO  Rep 2002; 3:56-62; PMID:11751572; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Development  2012; 139:4191-201; PMID:23093425; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Mol Biol Evol 2007; 24:1596-9;  PMID:17488738; http://dx.doi.org/10.1093/molbev/ msm092 109.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Genome Biol 2005; 6:R17;  PMID:15693946; http://dx.doi.org/10.1186/gb-2005- 6-2-r17 110.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Proc Natl Acad Sci U S A 2008; 105:728- 33; PMID:18182484; http://dx.doi.org/10.1073/ pnas.0711018105 111.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
PLoS Pathog  2011; 7:e1001314; PMID:21408619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
PLoS One 2011; 6:e19937;  PMID:21611156; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
PLoS Genet 2009; 5:e1000537;  PMID:19557190; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
FEBS J  2005; 272:228-43; PMID:15634346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2008; 283:9177- 86; PMID:18258597; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Kidney Int  2008; 73:556-66; PMID:18033240; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Am J Physiol Cell Physiol 2011; 301:C1351-9;  PMID:21881001; http://dx.doi.org/10.1152/ajp - cell.00166.2011 95.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Mol Biol Cell  2007; 18:242-52; PMID:17093056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell 2004; 116:869-81;  PMID:15035988; http://dx.doi.org/10.1016/S0092- 8674(04)00251-X 97.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Cell 2003; 112:619-30;  PMID:12628183; http://dx.doi.org/10.1016/S0092- 8674(03)00113-2 98.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Development 2005; 132:3185- 95; PMID:15958510; http://dx.doi.org/10.1242/ dev.01900 99.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Mol Biol Cell 2012; 23:577-90; PMID:22190737;  http://dx.doi.org/10.1091/mbc.E11-09-0791 101.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Neuron 2006; 51:291- 302; PMID:16880124; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Genes Dev  2009; 23:345-58; PMID:19204119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Curr Biol  2003; 13:1042-6; PMID:12814550; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
BMC Med Genet 2004; 5:22; PMID:15345028;  http://dx.doi.org/10.1186/1471-2350-5-22 81.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
BMC Genomics 2001; 2:3;  PMID:11472633; http://dx.doi.org/10.1186/1471- 2164-2-3 82.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Kidney Int  1999; 56:1481-91; PMID:10504499; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Curr Opin Nephrol Hypertens 2005; 14:211-6;  PMID:15821412; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Biol Chem 2003; 278:19266- 71; PMID:12646566; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Am J Pathol 2003; 163:2337-46;  PMID:14633607; http://dx.doi.org/10.1016/S0002- 9440(10)63590-0 86.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Clin Invest  2006; 116:1346-59; PMID:16543952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Mol Cell Biol  2007; 27:8698-712; PMID:17923684; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
Kidney Int 2003; 64:404-13;  PMID:12846735; http://dx.doi.org/10.1046/j.1523- 1755.2003.00097.x 90.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
J Am Soc Nephrol 2004; 15:3006- 15; PMID:15579503; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/e1/87/tisb-1-e25502.PMC3879130.pdf
"Nat Med 2012; 18:1217-23; http://dx.doi.org/10.1038/nm.2843.Keywords:  zonula occludens, occludin,  phosphorylation, structure Submitted: 11/30/12Revised: 12/22/12Accepted: 01/04/13Citation: Bewley MC, Tash BR,  Tian F, Flanagan JM.",OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
"Tissue Barriers 2013; 1:e23496; http://dx.doi.org/10.4161/tisb.23496 *Correspondence to: John M. Flanagan;   Email jmf27@psu.eduTight junctions (TJs) are protein  complexes comprised of claudins,  which anchor them in the membrane and numerous cytosolic scaffolding proteins  including MAGI, MUPP1, cingulin and  members of the zonula occludens (ZO)  family.",OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biomed Biotechnol  2012; 2012:807356; PMID:22315516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Mol Cell Biol 2012; 32:242-50; PMID:22083955;  http://dx.doi.org/10.1128/MCB.06029-11.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Curr Opin Pharmacol 2009; 9:715-20; PMID:19632896; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Ann N Y Acad Sci  2009; 1165:62-8; PMID:19538289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Biochim Biophys Acta  2009; 1788:813-9; PMID:18706387; http://dx.doi.org/10.1016/j.bbamem.2008.07.017.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2002; 277:10201-8; PMID:11782481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Antioxid  Redox Signal 2011; 15:1195-219; PMID:21235353;  http://dx.doi.org/10.1089/ars.2010.3542.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Mol Biol 2005; 352:151-64; PMID:16081103;  http://dx.doi.org/10.1016/j.jmb.2005.07.017.10.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J  Proteome Res 2009; 8:808-17; PMID:19125584;  http://dx.doi.org/10.1021/pr7007913.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2009;  284:21036-46; PMID:19478092; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Proc Natl Acad Sci U S A 1993; 90:7834- 8; PMID:8395056; http://dx.doi.org/10.1073/ pnas.90.16.7834.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
EMBO J 2011; 30:4986-97; PMID:22117215; http://dx.doi.org/10.1038/emboj.2011.428.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Mol Biol Cell  2007; 18:721-31; PMID:17182847; http://dx.doi.org/10.1091/mbc.E06-08-0764.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2011; 286:43352-60; PMID:22030391; http://dx.doi.org/10.1074/jbc.M111.304089.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Ann N Y Acad Sci  2009; 1165:113-20; PMID:19538295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
EMBO J 2000; 19:5740-51; PMID:11060025; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Biochemistry 2009; 48:10014-9; PMID:19769408;  http://dx.doi.org/10.1021/bi901160f.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2011;  286:41776-85; PMID:21965656; http://dx.doi.org/10.1074/jbc.M111.272583.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2010; 285:13907-17;  PMID:20200156; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biol Chem 2005; 280:3747-56;  PMID:15548514; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Rev Esp Enferm Dig 2012; 104:255-63;  PMID:22662778; http://dx.doi.org/10.4321/S1130- 01082012000500006.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Virol 2011; 85:9811-23; PMID:21775443; http://dx.doi.org/10.1128/ JVI.00568-11.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Adv Otorhinolaryngol 2011; 72:153-6; PMID:21865717; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Cell Mol Life Sci 2006; 63:505-14; PMID:16456617;  http://dx.doi.org/10.1007/s00018-005-5472-x.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Cell Biol 2011; 193:565- 82; PMID:21536752; http://dx.doi.org/10.1083/ jcb.201010065.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Cell Sci 2012; 125:3545-56; PMID:22492786; http://dx.doi.org/10.1242/ jcs.100289.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Antioxid Redox Signal 2012; 16:649- 57; PMID:21967570; http://dx.doi.org/10.1089/ ars.2011.4313.24.,Non-OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
J Biomol NMR 2011; 49:85-98; PMID:21191805; http://dx.doi.org/10.1007/s10858- 010-9467-z.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Infect Genet  Evol 2012; 12:1235-45; PMID:22516225; http://dx.doi.org/10.1016/j.meegid.2012.04.001.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
Trends Microbiol 2012; 20:282- 90; PMID:22564250; http://dx.doi.org/10.1016/j.tim.2012.03.009.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
FEBS Lett  1996; 399:326-32; PMID:8985173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/cc/tisb-1-e23496.PMC3879131.pdf
"Tissue Barriers 2013; 1:e22639; http://dx.doi.org/10.4161/tisb.22639Introduction Multinucleation and cell hypertrophy are important cellular pro - cesses that generally arise from the fusion of mononucleated cells,  giving rise to an enlarged multinucleated cell called a syncytium.",Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Methods Mol Biol 2008; 475:149-61;  PMID:18979243; http://dx.doi.org/10.1007/978-1- 59745-250-2_9.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
J Exp Med 2005; 202:337- 40; PMID:16061722; http://dx.doi.org/10.1084/ jem.20051123.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Nat Rev Rheumatol 2011; 7:235-43; PMID:21386794;  http://dx.doi.org/10.1038/nrrheum.2011.23.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Adv Exp Med Biol 2011; 713:113-35; PMID:21432017; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Histopathology 1998; 32:225-31; PMID:9568507;  http://dx.doi.org/10.1046/j.1365-2559.1998.00378.x.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Am J  Gastroenterol 1999; 94:1678-81; PMID:10364044;  http://dx.doi.org/10.1111/j.1572-0241.1999.01162.x.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Cancer 2011; 117:4092- 9; PMID:21365635; http://dx.doi.org/10.1002/ cncr.26021.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
J Orthop  Sci 2004; 9:581-4; PMID:16228675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Nat Cell Biol 2011; 13:324- 30; PMID:21336303; http://dx.doi.org/10.1038/ ncb2174.13.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Science 1989; 244:1075-8; PMID:2543075; http://dx.doi.org/10.1126/science.2543075.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
FEBS Lett 2007; 581:2181-93;  PMID:17395182; http://dx.doi.org/10.1016/j.febs- let.2007.03.033.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Curr  Opin Microbiol 2009; 12:101-9; PMID:19144561; http://dx.doi.org/10.1016/j.mib.2008.11.006.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
FEMS Microbiol Rev 2011; 35:1100-25;  PMID:21517912; http://dx.doi.org/10.1111/j.1574-6976.2011.00271.x.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Cell 2007; 130:192; PMID:17632065;  http://dx.doi.org/10.1016/j.cell.2007.06.042.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Cell Microbiol 2004; 6:1097-111; PMID:15469437; http://dx.doi.org/10.1111/j.1462-5822.2004.00421.x.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
PLoS Pathog  2010; 6:e1000961; PMID:20585567; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
PLoS Pathog 2008; 4:e1000191;  PMID:18974829; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Cell Microbiol 2010; 12:1308-21;  PMID:20345487; http://dx.doi.org/10.1111/j.1462-5822.2010.01469.x.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
J Biol Chem 2005;  280:2998-3011; PMID:15533930; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Pharm  Res 1998; 15:726-33; PMID:9619781; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
Development 2011; 138:2347-57; PMID:21558381; http://dx.doi.org/10.1242/dev.055012.,OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
J  Clin Pathol 2008; 61:611-4; PMID:18037663; http://dx.doi.org/10.1136/jcp.2007.050849.,Non-OADS,/arxiv_data1/oa_pdf/6b/7c/tisb-1-e22639.PMC3879132.pdf
"Tissue Barriers 2013; 1:e24978;  http://dx.doi.org/10.4161/tisb.24978Intestines are organs that not only digest food and absorb  nutrients, but also provide a defense barrier against pathogens  and noxious agents ingested.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Invest Dermatol  2007; 127:2525-32; PMID:17934504; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Physiology (Bethesda)  2004; 19:331-8; PMID:15546850; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Ann N Y Acad Sci 2012; 1257:20-8; PMID:22671585;  http://dx.doi.org/10.1111/j.1749-6632.2012.06555.x 4.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Prog Biophys Mol Biol 2003;  81:1-44; PMID:12475568; http://dx.doi.org/10.1016/ S0079-6107(02)00037-8 5.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Scand  J Gastroenterol 2013; 48:58-69; PMID:23205909;  http://dx.doi.org/10.3109/00365521.2012.741616 6.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J  Gastroenterol 2011; 106:2165-73; PMID:22008894;  http://dx.doi.org/10.1038/ajg.2011.2577.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Mol Med 2011; 17:1323- 37; PMID:21915437; http://dx.doi.org/10.2119/mol - med.2011.00107 8.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Gastroenterol  Hepatol 2008; 23(Suppl 2):S146-50; PMID:19120888;  http://dx.doi.org/10.1111/j.1440-1746.2008.05405.x 9.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2012; 303:G32-41; PMID:22538402; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology  2012; 142:305-15; PMID:22044670; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Histochem Cytochem 2006; 54:933- 44; PMID:16651389; http://dx.doi.org/10.1369/ jhc.6A6944.2006 13.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Lab Invest 2003; 83:1045- 53; PMID:12861044; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Pathol 2012; 180:626-35; PMID:22155109;  http://dx.doi.org/10.1016/j.ajpath.2011.10.025,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
"Gastroenterology 2009;  137:2030-40, e5; PMID:19818778; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS  One 2010; 5:e15742; PMID:21203412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
"Gastroenterology 2012; 143:122, e15;  PMID:22446194; http://dx.doi.org/10.1053/j.gas - tro.2012.03.029 47.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Immunol 2011; 187:5255-67; PMID:21967897;  http://dx.doi.org/10.4049/jimmunol.1101186 49.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am  J Physiol Gastrointest Liver Physiol 2010; 298:G774- 83; PMID:20224006; http://dx.doi.org/10.1152/ ajpgi.00239.2009 51.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Proc Natl Acad Sci U S  A 2010; 107:4200-5; PMID:20142489; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Inflamm Bowel Dis 2012; 18:1303- 14; PMID:22081509; http://dx.doi.org/10.1002/ ibd.21930 54.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Exp Med  2007; 204:3067-76; PMID:18039951; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Mol Biosyst  2008; 4:1181-5; PMID:19396381; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Cell Physiol 2005; 203:15- 26; PMID:15389642; http://dx.doi.org/10.1002/ jcp.20189 32.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Dev Biol 2012; 371:136- 45; PMID:22819673; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2008; 295:G791-7; PMID:18719001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Renal Physiol  2012; 302:F943-56; PMID:21937605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
FEBS Lett 2011; 585:3113-9;  PMID:21907710; http://dx.doi.org/10.1016/j.febs - let.2011.08.045 36.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Ann N Y Acad Sci 2012; 1257:108-14;  PMID:22671596; http://dx.doi.org/10.1111/j.1749- 6632.2012.06522.x 37.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2010; 299:G1287-97; PMID:20884889; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology 2009; 137:1403-14;  PMID:19560465; http://dx.doi.org/10.1053/j.gas - tro.2009.06.049 40.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS  One 2011; 6:e16139; PMID:21305056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS One 2012; 7:e31686; PMID:22384056;  http://dx.doi.org/10.1371/journal.pone.0031686 42.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J  Physiol Gastrointest Liver Physiol 2011; 300:G586- 97; PMID:21212325; http://dx.doi.org/10.1152/ ajpgi.00041.201017.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Comp Physiol B 2010; 180:591-8;  PMID:20049600; http://dx.doi.org/10.1007/s00360- 009-0440-7 18.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Neurosci Lett 2007; 428:88-92; PMID:17964719;  http://dx.doi.org/10.1016/j.neulet.2007.09.059 19.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology 2001; 120:411-22; PMID:11159882;  http://dx.doi.org/10.1053/gast.2001.21736 20.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Vet Res  2011; 72:1046-51; PMID:21801061; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Biophys Res Commun 2009; 378:45-50;  PMID:19000657; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Mol Biol Cell  2008; 19:1912-21; PMID:18287530; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Mechanisms involved in vitamin D medi - ated intestinal calcium absorption and in non-classical  actions of vitamin D. J Steroid Biochem Mol Biol  2010; 121:183-7; PMID:20214989; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology 2008; 134:523-34;  PMID:18242218; http://dx.doi.org/10.1053/j.gas - tro.2007.11.040 25.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology  2011; 140:913-23; PMID:20727355; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Urol  2008; 179:1676-82; PMID:18343451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
FASEB J 2007; 21:3853-65; PMID:17622569;  http://dx.doi.org/10.1096/fj.07-8113com 28.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Biol Chem 2002; 277:21361- 70; PMID:11934881; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Scand Cardiovasc J 2011; 45:236-46;  PMID:21495910; http://dx.doi.org/10.3109/1401743 1.2011.572996 86.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Nephrol Dial T ransplant 2012; 27:2686-93;  PMID:22131233; http://dx.doi.org/10.1093/ndt/ gfr624 87.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Eur J Clin Invest 2012; 42:439-46;  PMID:22023490; http://dx.doi.org/10.1111/j.1365- 2362.2011.02609.x 88.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Toxicol In Vitro  2009; 23:1510-5; PMID:19540330; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Nutr Metab (Lond) 2010; 7:19; PMID:20222989;  http://dx.doi.org/10.1186/1743-7075-7-19 91.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Scand J Gastroenterol 2010; 45:191-9; PMID:20095884;  http://dx.doi.org/10.3109/00365520903406701 92.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Life Sci  2007; 80:1729-37; PMID:17383680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Shock 2009; 31:164-9;  PMID:18650780; http://dx.doi.org/10.1097/ SHK.0b013e31817fc310 95.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Pediatr Gastroenterol Nutr  2012; 54:463-70; PMID:22197938; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
World  J Gastroenterol 2012; 18:2180-7; PMID:22611310;  http://dx.doi.org/10.3748/wjg.v18.i18.2180 97.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Surgery 2002; 131:241- 4; PMID:11894026; http://dx.doi.org/10.1067/ msy.2002.116408 98.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Burn Care Rehabil  2005; 26:383-91; PMID:16151282; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Ann N Y Acad Sci 2009; 1165:294-300;  PMID:19538319; http://dx.doi.org/10.1111/j.1749- 6632.2009.04062.x 73.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Virchows Arch 2012; 460:261-70;  PMID:22297703; http://dx.doi.org/10.1007/s00428- 012-1195-1 74.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Dig Dis Sci 2011; 56:2802-9;  PMID:21748286; http://dx.doi.org/10.1007/s10620- 011-1688-9 75.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am  J Physiol Gastrointest Liver Physiol 2008; 294:G938- 47; PMID:18258792; http://dx.doi.org/10.1152/ ajpgi.00469.2007 76.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
FEBS J 2008; 275:411-20;  PMID:18167140; http://dx.doi.org/10.1111/j.1742- 4658.2007.06210.x 77.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS One 2011; 6:e27282; PMID:22073304;  http://dx.doi.org/10.1371/journal.pone.0027282 78.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Ann N Y Acad Sci 2009; 1165:301-7;  PMID:19538320; http://dx.doi.org/10.1111/j.1749- 6632.2009.04035.x 79.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
BMC Med 2011; 9:23; PMID:21392369;  http://dx.doi.org/10.1186/1741-7015-9-23 80.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Virchows Arch 2010; 456:245-50;  PMID:20143085; http://dx.doi.org/10.1007/s00428- 009-0879-7 81.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gut 2012; 61:220- 8; PMID:21865402; http://dx.doi.org/10.1136/ gutjnl-2011-300123 82.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Ann N Y Acad Sci  2012; 1258:43-51; PMID:22731714; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Med Hypotheses  2005; 64:547-52; PMID:15617864; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Scand J Gastroenterol 2011; 46:177-87;  PMID:21028948; http://dx.doi.org/10.3109/0036552 1.2010.52571657.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Pathol  2001; 159:2001-9; PMID:11733350; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Lab Invest 2005; 85:1139-62;  PMID:16007110; http://dx.doi.org/10.1038/labin - vest.3700316 59.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology 2002; 123:433- 43; PMID:12145796; http://dx.doi.org/10.1053/ gast.2002.34784 61.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Int J Colorectal Dis 2009; 24:1149-56;  PMID:19488769; http://dx.doi.org/10.1007/s00384- 009-0737-8 62.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Pathol  2010; 176:158-67; PMID:20008138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2009; 296:G1140-9; PMID:19221015; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Clin Gastroenterol 2010;  44:e14-9; PMID:19525861; http://dx.doi.org/10.1097/ MCG.0b013e31819f5652 66.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Biol Chem  2011; 286:31263-71; PMID:21771795; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Curr Opin Gastroenterol 2007; 23:379- 83; PMID:17545772; http://dx.doi.org/10.1097/ MOG.0b013e32816aa392 68.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Dig  Dis 2009; 27:450-4; PMID:19897959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Biol Chem  2010; 285:12037-46; PMID:20177070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2007; 293:G178-87; PMID:17615177; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gut 2007; 56:328- 35; PMID:16935925; http://dx.doi.org/10.1136/ gut.2006.100198 131.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Cell Microbiol 2002; 4:367-81; PMID:12067320;  http://dx.doi.org/10.1046/j.1462-5822.2002.00197.x 132.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Biophys Res Commun  2012; 428:321-6; PMID:23098909; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gut 2009; 58:1070-7; PMID:19036950; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gut 2009; 58:220- 7; PMID:18936106; http://dx.doi.org/10.1136/ gut.2008.150425 137.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Inflammation 2012; 35:308-15; PMID:21452036;  http://dx.doi.org/10.1007/s10753-011-9320-x 138.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Cell Physiol 2004; 287:C1412-7;  PMID:15229101; http://dx.doi.org/10.1152/ajp - cell.00007.2004 139.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS  One 2011; 6:e17472; PMID:21364771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Nutr 2010; 140:1956- 62; PMID:20861219; http://dx.doi.org/10.3945/ jn.110.123919 141.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Toxicol Appl Pharmacol  2010; 245:291-8; PMID:20362602; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Inflammation 2012; 35:23-32; PMID:21170673;  http://dx.doi.org/10.1007/s10753-010-9285-1 115.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Infect Immun  2010; 78:4958-64; PMID:20823198; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Infect Immun 2006; 74:6581- 9; PMID:17015453; http://dx.doi.org/10.1128/ IAI.00958-06 122.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS  One 2011; 6:e23858; PMID:21887334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Cell Microbiol 2011; 13:1683-702;  PMID:21790940; http://dx.doi.org/10.1111/j.1462- 5822.2011.01647.x 124.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Pathol 2011; 179:807- 18; PMID:21683675; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2009; 297:G940-9; PMID:20501441; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Gastrointest Liver Physiol  2008; 295:G1025-34; PMID:18787064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biol Chem 2009; 390:481-92; PMID:19335208;  http://dx.doi.org/10.1515/BC.2009.055 100.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Cell  Mol Med 2009; 13(9B):4061-76; PMID:19929946;  http://dx.doi.org/10.1111/j.1582-4934.2009.00975.x 101.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Int J Pharm 2012; 426:82- 9; PMID:22285474; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Eur J Pharm Sci 2011; 42:246- 52; PMID:21134443; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS One 2012; 7:e34946;  PMID:22529961; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochim Biophys Acta  2012; 1822:196-203; PMID:22001439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Virchows Arch 2006; 448:428-34; PMID:16328347;  http://dx.doi.org/10.1007/s00428-005-0120-2 107.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Renal Physiol  2010; 298:F24-34; PMID:19759267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Int J Colorectal  Dis 2009; 24:361-8; PMID:19184060; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Cancer Res  2008; 68:4258-68; PMID:18519685; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Br J Cancer 2010; 102:765- 73; PMID:20087348; http://dx.doi.org/10.1038/ sj.bjc.6605515 111.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS One 2008; 3:e3954; PMID:19088854;  http://dx.doi.org/10.1371/journal.pone.0003954 112.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Surgery 2007; 141:563- 9; PMID:17462455; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Nutr 2012; 142:2017- 24; PMID:23014495; http://dx.doi.org/10.3945/ jn.112.164947 168.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
PLoS  One 2012; 7:e42067; PMID:22848704; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Pediatr Surg 2012; 47:1135-42;  PMID:22703783; http://dx.doi.org/10.1016/j.jped - surg.2012.03.018 171.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
World J Gastroenterol 2011; 17:4960- 70; PMID:22174545; http://dx.doi.org/10.3748/wjg.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Regul Pept 2012; 178:95-101; PMID:22809889;  http://dx.doi.org/10.1016/j.regpep.2012.07.002 173.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Food  Chem Toxicol 2007; 45:1593-8; PMID:17399881;  http://dx.doi.org/10.1016/j.fct.2007.02.021 175.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Nutr 2011; 141:87-94; PMID:21068182;  http://dx.doi.org/10.3945/jn.110.125633 176.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Am J Physiol Cell Physiol  2010; 299:C1028-35; PMID:20739626; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Gastroenterology 2000; 118:1001- 11; PMID:10833473; http://dx.doi.org/10.1016/ S0016-5085(00)70351-9155.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Pharmacol 2006; 71:486-96;  PMID:16337152; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Nutr 2009; 139:710-4; PMID:19211824;  http://dx.doi.org/10.3945/jn.108.101485 157.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
MBio  2013; 4; PMID:23322640; http://dx.doi.org/10.1128/ mBio.00594-12 158.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Pharmacol 2010; 79:1437- 44; PMID:20096266; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Biophys Res Commun  2012; 423:229-33; PMID:22659740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Infect Immun 2008; 76:3793- 800; PMID:18505809; http://dx.doi.org/10.1128/ IAI.00460-08 161.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Biol Chem  1997; 272:26652-8; PMID:9334247; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Pharmacol  2008; 75:1639-48; PMID:18342294; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Pharmacol  2007; 73:824-30; PMID:17169334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biochem Biophys Res Commun  2011; 410:466-70; PMID:21672529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Surg  Res 2012; 173:341-7; PMID:21176921; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Pharmacol Exp Ther 2010; 335:92- 102; PMID:20592049; http://dx.doi.org/10.1124/ jpet.110.168237 144.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Cell Biochem Funct 2012; 30:320-7;  PMID:22281785; http://dx.doi.org/10.1002/cbf.2807 147.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Mol Cancer  Res 2007; 5:1147-57; PMID:18025260; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Cell Mol Life Sci  2007; 64:3139-47; PMID:17965834; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
J Surg  Res 2008; 144:1-7; PMID:17640674; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
FEBS Lett 2005; 579:4851-5; PMID:16099460;  http://dx.doi.org/10.1016/j.febslet.2005.07.066 152.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Biomaterials 2012; 33:1663-72; PMID:22116000;  http://dx.doi.org/10.1016/j.biomaterials.2011.11.010 154.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Arch Biochem Biophys  2004; 432:152-66; PMID:15542054; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/ab/tisb-1-e24978.PMC3879173.pdf
Tissue Barriers 2013; 1:e24240; http://dx.doi.org/10.4161/tisb.24240field.,Non-OADS,/arxiv_data1/oa_pdf/1a/00/tisb-1-e24240.PMC3879174.pdf
Tissue Barriers 2013; 1: e24965  http://dx.doi.org/10.4161/tisb.24965The intestinal epithelium constitutes the barrier between the  gut lumen and the rest of the body and a very actively renewing cell population.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Philos Trans R Soc  Lond B Biol Sci 1998; 353:821-30; PMID:9684279;  http://dx.doi.org/10.1098/rstb.1998.0246 2.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Theor Biol 1987; 127:381-91;  PMID:3328018; http://dx.doi.org/10.1016/S0022- 5193(87)80136-4 4.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Biochim Biophys Acta 2013; 1830:2410-26;  PMID:22922290; http://dx.doi.org/10.1016/j.bba- gen.2012.08.0065.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
PLoS One 2013; 8:e56951; PMID:23451116; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology  2008; 134:849-64; PMID:18325394; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
EMBO J  2012; 31:2685-96; PMID:22617424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J  Anat 1986; 177:43-53; PMID:3776888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Microsc Res Tech 2000; 51:179-90;  PMID:11054868; http://dx.doi.org/10.1002/1097- 0029(20001015)51:2<179::AID-JEMT9>3.0.CO;2-4 12.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Expert Rev Mol Med 2001; 3:1-18; PMID:14585148;  http://dx.doi.org/10.1017/S1462399401003623,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Top Dev Biol 2012; 101:55- 76; PMID:23140625; http://dx.doi.org/10.1016/ B978-0-12-394592-1.00003-X 47.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Cell Mol Med 2005;  9:11-24; PMID:15784161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Prolif 2009; 42:731-50; PMID:19788585;  http://dx.doi.org/10.1111/j.1365-2184.2009.00642.x 52.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature  1977; 269:518-21; PMID:909602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Science 2011; 334:1420- 4; PMID:22075725; http://dx.doi.org/10.1126/sci- ence.1213214 56.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Anat 1981; 160:51- 63; PMID:7211716; http://dx.doi.org/10.1002/ aja.1001600105 59.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature 2009; 459:262-5; PMID:19329995; http://dx.doi.org/10.1038/nature07935 60.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology 2012; 143:1266-76;  PMID:22841781; http://dx.doi.org/10.1053/j.gas- tro.2012.07.106 61.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology 1999;  116:7-14; PMID:9869596; http://dx.doi.org/10.1016/ S0016-5085(99)70222-2 62.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Mutat  Res 1995; 346:115-9; PMID:7533893; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature  2007; 449:1003-7; PMID:17934449; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Ann N Y Acad  Sci 2007; 1106:20-9; PMID:17360803; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell 2011; 145:851- 62; PMID:21663791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
BMC  Biol 2012; 10:19; PMID:22405133; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Exp Med 2011; 208:421- 8; PMID:21402747; http://dx.doi.org/10.1084/ jem.20110132 37.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell  2011; 144:92-105; PMID:21215372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell 2012; 148:112-25; PMID:22265406; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Stem Cell 2008; 2:22-31; PMID:18371418;  http://dx.doi.org/10.1016/j.stem.2007.12.012 40.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Rev Mol Cell Biol 2009; 10:207-17; PMID:19209183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cold Spring Harb Perspect Biol 2011; 3:a002642; PMID:21791699; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Opin Neurobiol 2010; 20:44-9; PMID:19896361; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Opin Genet Dev 2012; 22:354-60; PMID:22608824; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Cell 2011; 21:159- 71; PMID:21763616; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
PLoS One 2011; 6:e26898;  PMID:22125602; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology  1999; 116:208-10; PMID:9869619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Stem Cell 2012; 11:452-60; PMID:23040474;  http://dx.doi.org/10.1016/j.stem.2012.09.009 16.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Biol  2012; 362:194-218; PMID:22185794; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Cell Biol 2011; 192:767- 80; PMID:21383077; http://dx.doi.org/10.1083/jcb.201010127 20.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Dyn 2005; 233:1332- 6; PMID:15937933; http://dx.doi.org/10.1002/ dvdy.20446 21.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Rev Microbiol 2011; 9:356-68; PMID:21423246;  http://dx.doi.org/10.1038/nrmicro2546 22.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Anat  1974; 141:537-61; PMID:4440635; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dig Dis  Sci 2006; 51:718-23; PMID:16614994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Anat Rec 1985; 211:420-6; PMID:3993991;  http://dx.doi.org/10.1002/ar.1092110408 26.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat  Cell Biol 2012; 14:106-14; PMID:22119784; http://dx.doi.org/10.1038/ncb2384,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
"Gastroenterology 2012; 142:1195-205,  e6; PMID:22333952; http://dx.doi.org/10.1053/j.gas- tro.2012.02.006 93.",Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Physiol Gastrointest Liver Physiol  2012; 303:G443-52; PMID:22723265; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Int J Radiat Oncol Biol Phys 2012; 82:e521-8; PMID:22196132; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Anat 1983; 167:95- 117; PMID:6869312; http://dx.doi.org/10.1002/ aja.1001670109 96.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Electron Microsc Tech 1990; 16:2- 14; PMID:1698949; http://dx.doi.org/10.1002/ jemt.1060160103 98.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Anat 1971; 131:73- 99; PMID:4103773; http://dx.doi.org/10.1002/ aja.1001310105 99.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am  J Anat 1975; 144:39-56; PMID:170817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Biol 2010; 346:215- 23; PMID:20691176; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Stem Cell 2009; 4:427-39; PMID:19427292;  http://dx.doi.org/10.1016/j.stem.2009.04.014 103.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Biol Chem 2004;  279:47050-6; PMID:15345710; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Proc Natl Acad Sci U S  A 2011; 108:7820-5; PMID:21518866; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Biol 2006; 300:722-35;  PMID:17007831; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell 2012; 149:146- 58; PMID:22464327; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
PLoS One 2012; 7:e38965;  PMID:22745693; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Science 2010; 327:542- 5; PMID:20110496; http://dx.doi.org/10.1126/sci- ence.1180794 83.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Biol  Chem 1997; 272:23729-40; PMID:9295317; http://dx.doi.org/10.1074/jbc.272.38.23729 84.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature 2011; 469:415-8; PMID:21113151; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature 2008; 454:1132- 6; PMID:18641633; http://dx.doi.org/10.1038/ nature07173 86.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Proc Natl Acad Sci U S A  2012; 109:3932-7; PMID:22355124; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Biochem Biophys Res Commun 2005; 328:348- 52; PMID:15670790; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Biochim Biophys Acta  2013; 1830:2307-22; PMID:22917651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
"Gastroenterology 2012; 143:1518- 29, e7; PMID:22922422; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Commun 2010; 1:1-5; PMID:20975674; http://dx.doi.org/10.1038/ncomms1017 91.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dig Dis  Sci 1996; 41:88-104; PMID:8565772; http://dx.doi.org/10.1007/BF0220858963.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell 2002; 111:241-50;  PMID:12408868; http://dx.doi.org/10.1016/S0092- 8674(02)01014-0 64.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Genet 1998; 19:379-83; PMID:9697701;  http://dx.doi.org/10.1038/1270 65.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology 2007; 132:628- 32; PMID:17320548; http://dx.doi.org/10.1053/j.gas- tro.2006.08.039 66.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
EMBO J 2012; 31:3079- 91; PMID:22692129; http://dx.doi.org/10.1038/ emboj.2012.166 67.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Gastroenterology 2007; 133:1755-60;  PMID:18054544; http://dx.doi.org/10.1053/j.gas-tro.2007.10.029 68.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Genet 2008; 40:915-20;  PMID:18536716; http://dx.doi.org/10.1038/ng.165 69.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Proc Natl Acad Sci U S A 2008; 105:10420- 5; PMID:18650388; http://dx.doi.org/10.1073/ pnas.0804800105 71.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell  2010; 143:134-44; PMID:20887898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
"EMBO J 2011; 30:1104- 9; PMID:21297579; http://dx.doi.org/10.1038/emboj.2011.26 73. van der Flier LG, van Gijn ME, Hatzis P, Kujala P,  Haegebarth A, Stange DE, et al.",OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature  2013; 495:65-9; PMID:23446353; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
"Gastroenterology 2009; 136:2187-94,  e1; PMID:19324043; http://dx.doi.org/10.1053/j.gas- tro.2009.03.002.",Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Biol 2012; 22:R133-5;  PMID:22361152; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Genes Dev 2009; 23:2675- 99; PMID:19952104; http://dx.doi.org/10.1101/ gad.1850809 143.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Development  2010; 137:705-14; PMID:20147375; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Stem Cell 2012; 11:529- 40; PMID:23040479; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Stem Cell 2010; 6:175-81; PMID:20144789;  http://dx.doi.org/10.1016/j.stem.2009.12.007 146.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Commun 2011; 2:258; PMID:21448157; http://dx.doi.org/10.1038/ ncomms1260 147.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Development 2011; 138:543- 52; PMID:21205798; http://dx.doi.org/10.1242/ dev.053959 148.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Trends Cell Biol 2010; 20:346- 54; PMID:20359892; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Cell 2011; 20:163-76; PMID:21316585;  http://dx.doi.org/10.1016/j.devcel.2011.01.001 151.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Rev Genet 2007; 8:555-63;  PMID:17563758; http://dx.doi.org/10.1038/nrg2125 152.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Development  2012; 139:1806-20; PMID:22510986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Development 2011; 138:947-57; PMID:21303848; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Am  Soc Nephrol 2009; 20:2104-11; PMID:19762494;  http://dx.doi.org/10.1681/ASN.2008111173 125.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Cell 2011; 21:102-19;  PMID:21763612; http://dx.doi.org/10.1016/j.dev- cel.2011.06.012 126.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Opin Neurobiol 2010; 20:6- 13; PMID:20022236; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Science 2000; 287:1427-30;  PMID:10688781; http://dx.doi.org/10.1126/sci- ence.287.5457.1427 128.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Biol  2010; 345:49-63; PMID:20599897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Science 2010; 330:822-5; PMID:20929733;  http://dx.doi.org/10.1126/science.1196236 130.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature 2007; 446:185- 9; PMID:17330052; http://dx.doi.org/10.1038/ nature05574 131.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Cell  2010; 18:317-23; PMID:20159601; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Phys Rev  E Stat Nonlin Soft Matter Phys 2007; 76:021910;  PMID:17930068; http://dx.doi.org/10.1103/ PhysRevE.76.021910 133.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nature 2011; 470:353- 8; PMID:21331036; http://dx.doi.org/10.1038/ nature09793 134.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Exp Cell Res  2011; 317:2740-7; PMID:21745469; http://dx.doi.org/10.1016/j.yexcr.2011.06.012 135.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat  Cell Biol 2012; 14:131-9; PMID:22267085; http://dx.doi.org/10.1038/ncb2419 136.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Dev Cell 2009; 16:633- 47; PMID:19460341; http://dx.doi.org/10.1016/j.devcel.2009.03.010 137.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Science 2001; 294:2155-8; PMID:11739954; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Biophys J 1985; 48:85-91; PMID:4016212; http://dx.doi.org/10.1016/S0006-3495(85)83762-0 139.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Exp Cell Res 2011; 317:2719-24;  PMID:21787769; http://dx.doi.org/10.1016/j.yexcr.2011.07.010 140.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Colorectal Dis 2002; 4:76-89; PMID:12780627;  http://dx.doi.org/10.1046/j.1463-1318.2002.00336.x 109.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Pathol 1998; 185:246-55; PMID:9771477;  http://dx.doi.org/10.1002/(SICI)1096- 9896(199807)185:3<246::AID-PATH90>3.0.CO;2-8 110.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Cell Signal 2010; 22:717-27; PMID:20006983;  http://dx.doi.org/10.1016/j.cellsig.2009.11.021 111.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Cell Biol 2008; 180:1087-100; PMID:18347071;  http://dx.doi.org/10.1083/jcb.200710050 112.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Histochem Cytochem 2007; 55:1173- 80; PMID:17712178; http://dx.doi.org/10.1369/ jhc.7A7234.2007 114.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Cell Biol  1994; 126:1509-26; PMID:8089182; http://dx.doi.org/10.1083/jcb.126.6.1509 115.,Non-OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Nat Genet 2006; 38:21-3; PMID:16341222; http://dx.doi.org/10.1038/ng1701 116.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Biol 2005; 15:R758-9; PMID:16169474;  http://dx.doi.org/10.1016/j.cub.2005.08.053 117.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Opin Cell Biol  2011; 23:697-704; PMID:22000622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Biol 2011; 21:R599-609;  PMID:21820628; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Curr Opin Cell Biol 2009; 21:717- 23; PMID:19679459; http://dx.doi.org/10.1016/j.ceb.2009.07.001 120.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
J Cell Biol 2007; 178:1109- 20; PMID:17893240; http://dx.doi.org/10.1083/jcb.200703186 123.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
Am J Anat 1974; 141:461-79; PMID:4440632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/61/tisb-1-e24965.PMC3879175.pdf
"EMBO J 2011; 30:4157-70; PMID:21857650; http://dx.doi.org/10.1038/emboj.2011.304.Keywords:  leukocyte trafficking, diapedesis,  endothelial junctions, VE-cadherin, cell  adhesion Abbreviations:  For full list of abbreviations,  see page 5Submitted: 01/25/13; Accepted: 01/28/13Citation: Küppers V, Vestweber D, Schulte  D. Locking endothelial junctions blocks leukocyte extravasation, but not in all tissues  http://dx.doi.org/10.4161/tisb.23805; http:// dx.doi.org/10.4161/tisb.23805 *Correspondence to: Dietmar Vestweber;   Email: vestweb@mpi-muenster.mpg.deThe passage of leukocytes across the  blood vessel wall is a fundamen - tal event in the inflammatory response.",Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Am J Anat 1975; 143:59-92; PMID:1130298; http://dx.doi.org/10.1002/ aja.1001430104.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Exp Med 1998; 187:903-15; PMID:9500793; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Arch Histol Cytol 1999; 62:253-60; PMID:10495880; http://dx.doi.org/10.1679/ aohc.62.253.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Proc R Soc  Lond B Biol Sci 1964; 159:283-90; PMID:14114164;  http://dx.doi.org/10.1098/rspb.1964.0002.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Exp Med 1972; 136:568-88;  PMID:5050723; http://dx.doi.org/10.1084/jem.136.3.568.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Nat Immunol  2011; 12:761-9; PMID:21706006; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Pflugers Arch 2008; 456:71-81; PMID:18094992;  http://dx.doi.org/10.1007/s00424-007-0412-2.10.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Immunity  2007; 26:784-97; PMID:17570692; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Cell Biol 2004; 167:377-88; PMID:15504916; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Nat Cell Biol  2006; 8:113-23; PMID:16429128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Nat Cell Biol 2006; 8:156-62; PMID:16429129;  http://dx.doi.org/10.1038/ncb1355.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
EMBO J 2011; 30:4157- 70; PMID:21857650; http://dx.doi.org/10.1038/ emboj.2011.304.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Proc Natl Acad Sci U S A 1999; 96:9815-20; PMID:10449777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Cell Biol 1994; 127:235-45;  PMID:7929566; http://dx.doi.org/10.1083/ jcb.127.1.235.18.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Biol Chem  1998; 273:6166-70; PMID:9497337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Inflamm Res 1995; 44:169- 77; PMID:7545527; http://dx.doi.org/10.1007/ BF01782815.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Immunol Today 1995; 16:449-57;  PMID:7546210; http://dx.doi.org/10.1016/0167-5699(95)80023-9.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Immunity 2009; 30:731- 43; PMID:19427241; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Blood 2006; 107:4721- 7; PMID:16469869; http://dx.doi.org/10.1182/blood-2005-11-4683.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Cell Sci 2008; 121:29-37; PMID:18096689; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Cell Biol  2012; 196:641-52; PMID:22391038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Proc Natl Acad Sci U S A 2012; 109:8576- 81; PMID:22586082; http://dx.doi.org/10.1073/ pnas.1203906109.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Biol Chem 2012; 287:7728-37; PMID:22235119; http://dx.doi.org/10.1074/jbc.M111.297481.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Biol Chem 2009; 284:25602- 11; PMID:19633358; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Cardiovasc Res 2012; 93:130-40; PMID:21960684;  http://dx.doi.org/10.1093/cvr/cvr256.,Non-OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Mol Biol Cell 2012; 23:4212-25;  PMID:22956765; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Blood  2010; 115:3118-27; PMID:20167705; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Cell 2005; 123:903-15; PMID:16325583; http://dx.doi.org/10.1016/j.cell.2005.09.021.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
Proc Natl Acad Sci U S A 2008; 105:13-9; PMID:18093941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
J Biol Chem  2012; 287:7556-72; PMID:22194609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/88/tisb-1-e23805.PMC3879176.pdf
"Tissue Barriers 2013; 1:e23272; http://dx.doi.org/10.4161/tisb.23272Tissue barriers maintain homeostasis, protect underlying  tissues, are remodeled during organogenesis and injury and limit aberrant proliferation and dissemination.",Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 1993; 75:217-27; PMID:8402908;  http://dx.doi.org/10.1016/0092-8674(93)80064-L. 2.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell  1999; 97:551-2; PMID:10367884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 2010; 467:1118- 22; PMID:20877282; http://dx.doi.org/10.1038/ nature09468.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci 2009; 122:1723- 36; PMID:19461072; http://dx.doi.org/10.1242/jcs.030197.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 2010; 467:1123-7; PMID:20881961; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Science 2004; 305:862-5;  PMID:15297673; http://dx.doi.org/10.1126/sci- ence.1097545.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Proc Natl Acad Sci U S A 2009; 106:15610-5; PMID:19717441; http://dx.doi.org/10.1073/ pnas.0906923106.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
PLoS Biol 2011; 9:e1001134; PMID:21912513;  http://dx.doi.org/10.1371/journal.pbio.1001134.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 1997; 90:739-51; PMID:9288753; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 1999; 99:71-80;  PMID:10520995; http://dx.doi.org/10.1016/S0092- 8674(00)80063-X.13.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 1999; 99:59-69; PMID:10520994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat  Struct Mol Biol 2012; 19:1293-9; PMID:23104057; http://dx.doi.org/10.1038/nsmb.2416.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Science 2005; 307:265-8; PMID:15550623; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Neurosci  2008; 11:36-44; PMID:18059265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Neurosci 2008; 11:440-9; PMID:18327254;  http://dx.doi.org/10.1038/nn2064.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 2003; 113:285-99;  PMID:12732138; http://dx.doi.org/10.1016/S0092- 8674(03)00267-8.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Am J Physiol Cell Physiol  2004; 286:C1213-28; PMID:15151915; http://dx.doi.org/10.1152/ajpcell.00558.2003.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 2006; 126:741- 54; PMID:16923393; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci  2007; 120:1505-11; PMID:17452622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Curr Opin Cell  Biol 2001; 13:641-8; PMID:11544035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Development 2006; 133:1611-24; PMID:16613830;  http://dx.doi.org/10.1242/dev.02310.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Genes Cells 2001; 6:559- 71; PMID:11442635; http://dx.doi.org/10.1046/ j.1365-2443.2001.00441.x.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Proc Natl Acad Sci U S A 2004; 101:11432- 7; PMID:15273288; http://dx.doi.org/10.1073/ pnas.0403969101.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Biol Chem  2012; 287:37282-95; PMID:22955271; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Cell Biol  2010; 12:533-42; PMID:20453849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Curr Opin Cell Biol 2007; 19:508-14;  PMID:17935963; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci 2008; 121:358-68; PMID:18198190;  http://dx.doi.org/10.1242/jcs.017145.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Circ Res  2004; 95:892-901; PMID:15472119; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Ann N Y Acad Sci  2009; 1165:58-61; PMID:19538288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol  1993; 123:1777-88; PMID:8276896; http://dx.doi.org/10.1083/jcb.123.6.1777.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
T rends Biochem Sci 2002; 27:599-601; PMID:12468223; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell Death Dis 2012;  3:e273; PMID:22361748; http://dx.doi.org/10.1038/ cddis.2012.14.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci 2004; 117:19-29; PMID:14657270; http://dx.doi.org/10.1242/ jcs.00930.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol 2001; 154:491-7; PMID:11489913; http://dx.doi.org/10.1083/ jcb.200103047.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Development 2011; 138:4085-95; PMID:21831918;  http://dx.doi.org/10.1242/dev.066076.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Neuron 2011; 71:433-46;  PMID:21835341; http://dx.doi.org/10.1016/j.neu-ron.2011.06.041.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Science  2004; 303:1204-7; PMID:14976319; http://dx.doi.org/10.1126/science.1092121.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol 1999; 145:1077-88; PMID:10352023;  http://dx.doi.org/10.1083/jcb.145.5.1077.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Prog Neurobiol 2007; 82:57-79;  PMID:17537564; http://dx.doi.org/10.1016/j.pneu- robio.2007.02.011.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Med  2006; 12:1380-9; PMID:17099709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Angiogenesis  2009; 12:187-93; PMID:19266292; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Biochemistry (Mosc)  2001; 66:1174-86; PMID:11736639; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci 2005; 118:711- 21; PMID:15671061; http://dx.doi.org/10.1242/jcs.01665.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 1995; 374:327-37; PMID:7885471; http://dx.doi.org/10.1038/374327a0.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Proc Natl Acad Sci U S A 2009; 106:109-14; PMID:19114658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Biochem J  2000; 349:159-67; PMID:10861224; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
T rends Cell Biol 2004; 14:589- 93; PMID:15519846; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Cell Biol  2006; 8:1223-34; PMID:17060906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Physiol  2011; 226:3053-63; PMID:21302304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Cell Biol 2008; 10:923-34; PMID:18604199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Biol Cell 2011; 103:593-605; PMID:22054419;  http://dx.doi.org/10.1042/BC20110069.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature  2005; 436:193-200; PMID:16015319; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Immunol  2012; 188:4081-92; PMID:22442441; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Biol Chem 2007; 282:34888-95;  PMID:17855350; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Biol Chem  2007; 282:6899-905; PMID:17204469; http://dx.doi.org/10.1074/jbc.M609570200.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Mol Cell Biol  2010; 30:3086-98; PMID:20385769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
PLoS One  2012; 7:e33633; PMID:22448259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cancer Res 2008; 68:6922-31;  PMID:18757406; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5408.81.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Am J Dermatopathol 2009; 31:177- 81; PMID:19318806; http://dx.doi.org/10.1097/ DAD.0b013e318196672d.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cancer Res  2005; 65:8317-23; PMID:16166308; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
BMC Cancer 2009; 9:297;  PMID:19703316; http://dx.doi.org/10.1186/1471- 2407-9-297.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
PLoS One 2011; 6:e19396; PMID:21559368; http://dx.doi.org/10.1371/journal.pone.0019396.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Clin Invest 2010; 120:2684- 98; PMID:20664171; http://dx.doi.org/10.1172/ JCI42118.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
T rends Neurosci 2001; 24:719-25;  PMID:11718877; http://dx.doi.org/10.1016/S0166- 2236(00)02004-X.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cereb Blood Flow Metab 2012; 32:860- 73; PMID:22333621; http://dx.doi.org/10.1038/ jcbfm.2011.202.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol  2003; 161:653-60; PMID:12743111; http://dx.doi.org/10.1083/jcb.200302070.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol 1998; 141:397- 408; PMID:9548718; http://dx.doi.org/10.1083/ jcb.141.2.397.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Exp Med  2006; 203:2703-14; PMID:17116731; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell 1999; 98:147-57; PMID:10428027;  http://dx.doi.org/10.1016/S0092-8674(00)81010-7.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Blood 2005; 105:4337-44; PMID:15701713; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Genomics 1996;  32:39-48; PMID:8786119; http://dx.doi.org/10.1006/ geno.1996.0074.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Oncogene 2004; 23:5719-28; PMID:15208675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Am J Pathol 2000; 156:939-50;  PMID:10702410; http://dx.doi.org/10.1016/S0002- 9440(10)64962-0.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Neoplasia 2005;  7:180-9; PMID:15802023; http://dx.doi.org/10.1593/ neo.04481.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cancer Res  2004; 64:1008-15; PMID:14871832; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Biochem Biophys Res Commun  2010; 395:451-7; PMID:20331965; http://dx.doi.org/10.1016/j.bbrc.2010.03.124.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Biochem Biophys Res Commun  2010; 396:781-6; PMID:20382125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Biol 1993; 121:867-78; PMID:8491778;  http://dx.doi.org/10.1083/jcb.121.4.867.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nat Cell  Biol 2002; 4:720-4; PMID:12198496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 1989; 339:155-6;  PMID:2541345; http://dx.doi.org/10.1038/339155a0.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Mol Biol Cell  2012; 23:3873-81; PMID:22875994; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Hum Mol Genet 2011; 20:4759-74;  PMID:21903667; http://dx.doi.org/10.1093/hmg/ ddr403.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 2007; 446:680- 4; PMID:17377534; http://dx.doi.org/10.1038/ nature05652.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Immunol 2012; 189:3150-8;  PMID:22896629; http://dx.doi.org/10.4049/jimmu-nol.1201140.114.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Biol Chem 2007; 282:26294- 305; PMID:17569671; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Cell  Adh Migr 2011; 5:266-75; PMID:21610314; http://dx.doi.org/10.4161/cam.5.3.16294.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Exp Med 2007; 204:1083-93;  PMID:17485510; http://dx.doi.org/10.1084/ jem.20061273.109.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
PLoS  One 2012; 7:e42912; PMID:22936999; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
Nature 2003; 424:391-7; PMID:12879061;  http://dx.doi.org/10.1038/nature01784.,Non-OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
J Cell Sci 2012; 125:4137-46; PMID:22685328; http://dx.doi.org/10.1242/jcs.108282.,OADS,/arxiv_data1/oa_pdf/44/39/tisb-1-e23272.PMC3879177.pdf
"J Cell Biol 2012; 196:623-39; PMID:22371556; http://dx.doi.org/10.1083/jcb.201104143.Keywords:  tight junction, JAM-A,  aPKC, epithelial barrier, cell polarity,  PAR complex, cell-cell contact Submitted: 10/29/12Revised: 11/15/12Accepted: 11/21/12Citation: Ebnet K. JAM-A and aPKC:  A close pair during cell-cell contact maturation and tight junction formation in epithelial cells.",OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Tissue Barriers 2013; 1:e22993; http://dx.doi.org/10.4161/tisb.22993 Correspondence to: Klaus Ebnet;   Email: ebnetk@uni-muenster.deCell-cell adhesion plays a critical role  in the formation of barrier-forming  epithelia.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Nat Rev Mol Cell Biol  2001; 2:285-93; PMID:11283726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Nat Rev Mol Cell Biol 2003; 4:225- 36; PMID:12612641; http://dx.doi.org/10.1038/ nrm1055.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Histochem Cell Biol 2008; 130:1- 20; PMID:18365233; http://dx.doi.org/10.1007/ s00418-008-0418-7.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol 1998; 143:391-401; PMID:9786950;  http://dx.doi.org/10.1083/jcb.143.2.391.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Annu Rev Physiol  2006; 68:403-29; PMID:16460278; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Cell 2006; 126:741-54; PMID:16923393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Science  2002; 298:1955-9; PMID:12471248; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Annu Rev Genet 2001; 35:747-84;  PMID:11700298; http://dx.doi.org/10.1146/ annurev.genet.35.102401.091415.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Sci 2005; 118:2859-69; PMID:15976445; http://dx.doi.org/10.1242/ jcs.02412.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Mol Biol Cell  2004; 15:1981-90; PMID:14718565; http://dx.doi.org/10.1091/mbc.E03-08-0620.14.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol 2005; 168:705- 11; PMID:15738264; http://dx.doi.org/10.1083/ jcb.200408064.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Nat Cell Biol 2005; 7:262-9; PMID:15723052;  http://dx.doi.org/10.1038/ncb1226.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol  2001; 152:1183-96; PMID:11257119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Genes Cells 2001; 6:721-31;  PMID:11532031; http://dx.doi.org/10.1046/j.1365- 2443.2001.00453.x.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Biol Chem 2004; 279:41557-62 ; PMID :15292221; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Sci 2007; 120:2309-17; PMID:17606986;  http://dx.doi.org/10.1242/jcs.007443.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Cell 2003; 115:691-704; PMID:14675534; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Curr Biol 2004; 14:736- 41; PMID:15084291; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Curr Biol 2004; 14:1425-35; PMID:15324659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Cell 2010; 141:757- 74; PMID:20510924; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Dev Cell  2010; 18:52-63; PMID:20152177; http://dx.doi.org/10.1016/j.devcel.2009.12.008.25.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Front Biosci 2008; 13:6520-36; PMID:18508678;  http://dx.doi.org/10.2741/3172.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Sci 2002; 115:3565-73; PMID:12186943; http://dx.doi.org/10.1242/jcs.00032.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
EMBO J 2001; 20:3738- 48; PMID:11447115; http://dx.doi.org/10.1093/ emboj/20.14.3738.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
EMBO J 2001; 20:4391-8; PMID:11500366; http://dx.doi.org/10.1093/emboj/20.16.4391.,Non-OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol  2001; 154:491-7; PMID:11489913; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Genes Cells  2002; 7:1161-71; PMID:12390250; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
Cell  2010; 141:509-23; PMID:20434988; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol 2012; 196:623-39; PMID:22371556; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
J Cell Biol  2002; 158:967-78; PMID:12196510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/a9/tisb-1-e22993.PMC3879182.pdf
"J Exp Med 2011; 208:1721-35; PMID:21788407; http://dx.doi.org/10.1084/jem.20101920.Keywords:  docking structure, trans - migratory cup, Rap1, RhoG, vascular  permeability, leukocyte extravasation, actin, ICAM-1 Submitted: 01/29/13Revised: 02/01/13Accepted: 02/04/13Citation: Vestweber D, Zeuschner D,  Rottner K, Schnoor M. Cortactin regu - lates the activity of small GTPases and ICAM-1 clustering in endothelium: Implications for the formation of dock - ing structures.",OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Tissue Barriers 2013; 1:e23862; http://dx.doi.org/10.4161/tisb.23862 *Correspondence to: Dietmar Vestweber   and Michael Schnoor;  Email: vestweb@mpi-muenster.mpg.de  and mschnoor@cinvestav.mxCortactin is an actin-binding mol - ecule that regulates various cellular  processes requiring actin dynamics.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Exp Med  2011; 208:1721-35; PMID:21788407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Proc Natl Acad Sci U S A  1990; 87:3328-32; PMID:2110361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Nat Cell Biol  2001; 3:259-66; PMID:11231575; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Cell Biol  1993; 120:1417-26; PMID:7680654; http://dx.doi.org/10.1083/jcb.120.6.1417.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Curr Biol 2005; 15:1276-85; PMID:16051170; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Mol Biol Cell 2009; 20:3209-23; PMID:19458196;  http://dx.doi.org/10.1091/mbc.E08-12-1180.10.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Mol Biol Cell 2003; 14:3216-29; PMID:12925758; http://dx.doi.org/10.1091/ mbc.E02-11-0753.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Cell Adh Migr 2011; 5:187-98; PMID:21258212; http://dx.doi.org/10.4161/cam.5.2.14773.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Cell Motil  Cytoskeleton 2008; 65:687-707; PMID:18615630; http://dx.doi.org/10.1002/cm.20296.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Exp Cell Res 2010; 316:848-58; PMID:20004659; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Nat Cell Biol  2006; 8:113-23; PMID:16429128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Exp Med  2004; 200:1571-80; PMID:15611287; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Exp Med 1998; 187:903-15; PMID:9500793; http://dx.doi.org/10.1084/jem.187.6.903.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
PLoS One  2013; 8:e55202; PMID:23372835; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
"Microvasc Res 1988; 35:27-47; PMID:2830471;  http://dx.doi.org/10.1016/0026-2862(88)90048-9.20. van Rijssel J, Kroon J, Hoogenboezem M, van Alphen  FP, de Jong RJ, Kostadinova E, et al.",OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Mol Biol Cell 2012; 23:2831-44; PMID:22696684; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Cell Biol 2004; 167:377-88; PMID:15504916; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Biol Chem 2008; 283:31830-9; PMID:18809679; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Cell Biol 2007; 178:1279-93; PMID:17875742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Annu Rev Pathol 2011; 6:323- 44; PMID:21073340; http://dx.doi.org/10.1146/ annurev-pathol-011110-130224.15.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Genesis 2009; 47:638-46;  PMID:19621352; http://dx.doi.org/10.1002/ dvg.20544.,Non-OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
Circ Res  2006; 98:394-402; PMID:16385081; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
J Cell Biol 2002; 157:1233-45; PMID:12082081; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/ca/tisb-1-e23862.PMC3879184.pdf
"Gut 2012; 61:695-705; PMID:21813473; http://dx.doi.org/10.1136/gutjnl-2011-300012Keywords:  neuronal guidance molecule,  intestinal epithelial cells, leukocyte  migration, inflammatory bowel disease, apoptosis Abbreviations:  Adora2b, A2B adenosine  receptor; AOM, azoxymethane; cAMP,  cyclic adenosine monophosphate; CD, Crohn disease; DCC, deleted in colorec - tal cancer; DSS, dextran sulfate sodium; IBD, inflammatory bowel disease; Ntn-1, netrin-1; UC, ulcerative colitis; UNC, uncoordinated Submitted: 03/19/13Revised: 04/26/13Accepted: 05/06/13http://dx.doi.org/10.4161/tisb.24957 Citation: Aherne C, Collins C, Eltzschig H. Netrin-1  guides inflammatory cell migration to control mucosal immune responses during intestinal inflammation.",Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Tissue Barriers 2013; 1:e24957;  http://dx.doi.org/10.4161/tisb.24957*Correspondence to: Carol M. Aherne;  Email: carol.aherne@ucdenver.eduThe intestinal epithelium is a dynamic  barrier playing an active role in intes - tinal homeostasis and inflammation.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gastroenterology 2010; 139:2093-101; PMID:20600011; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Nat Rev Mol Cell Biol 2007; 8:296-306; PMID:17356579;  http://dx.doi.org/10.1038/nrm2142 31.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Inflamm Bowel Dis 2004; 10:778-88; PMID:15626897; http://dx.doi.org/10.1097/00054725-200411000-00013 33.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Leukoc Biol 2006; 80:1281-8;  PMID:16963624; http://dx.doi.org/10.1189/ jlb.0506346 34.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Int J Colorectal Dis 2008; 23:939-46;  PMID:18594843; http://dx.doi.org/10.1007/ s00384-008-0509-x 35.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
PLoS One 2009; 4:e6073; PMID:19562033; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Mucosal Immunol  2012; 5:354-66; PMID:22491176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Inflamm Allergy Drug Targets 2011; 10:39-46; PMID:21184649; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gastroenterology  2007; 133:1882-92; PMID:18054560; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Leukoc Biol 2008; 84:1213-21; PMID:18653784; http://dx.doi.org/10.1189/jlb.0408231 42.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gut 2012; 61:1154-62; PMID:22068168;  http://dx.doi.org/10.1136/gutjnl-2011-30082014.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Am J Respir Crit Care Med 2010; 181:815- 24; PMID:20075388; http://dx.doi.org/10.1164/ rccm.200905-0717OC 17.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
PLoS One 2011; 6:e14812; PMID:21625583; http://dx.doi.org/10.1371/journal.pone.0014812 18.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol 2011; 186:549-55;  PMID:21098235; http://dx.doi.org/10.4049/jimmu - nol.1002671 19.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
"Cold Spring Harb Perspect Biol 2011; 3:3; PMID:21123392;  http://dx.doi.org/10.1101/cshperspect.a001727 20. van Gils JM, Derby MC, Fernandes LR,  Ramkhelawon B, Ray TD, Rayner KJ, et al.",OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Nat Immunol 2012; 13:136- 43; PMID:22231519; http://dx.doi.org/10.1038/ ni.2205 21.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Dev Biol  2003; 258:364-84; PMID:12798294; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Dev Neurobiol 2011; 71:362-73; PMID:21485011;  http://dx.doi.org/10.1002/dneu.20869 24.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Neuroinflammation 2010; 7:37; PMID:20615234; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Ann N Y Acad Sci 2006;  1072:288-99; PMID:17057208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Oncol Rep  2010; 24:869-74; PMID:20811666; http://dx.doi.org/10.3892/or.2010.869References 1.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Curr Opin Gastroenterol  2012; 28:301-9; PMID:22573190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gastroenterology 2011; 140:1748-55;  PMID:21530741; http://dx.doi.org/10.1053/j.gas - tro.2011.01.056 4.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4607-14; PMID:20826446; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Curr Allergy Asthma Rep 2004; 4:83- 9; PMID:14680627; http://dx.doi.org/10.1007/ s11882-004-0048-7 6.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gastroenterology 2011; 141:1821-31; PMID:22027263; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol  2011; 186:4367-74; PMID:21357264; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gastroenterology 2009; 136:607- 18; PMID:19105964; http://dx.doi.org/10.1053/j.gastro.2008.10.037 9.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
IFN- γ attenuates  hypoxia-inducible factor (HIF) activity in intesti - nal epithelial cells through transcriptional repres - sion of HIF-1 β. J Immunol 2011; 186:1790-8;  PMID:21199896; http://dx.doi.org/10.4049/jimmu - nol.1001442 12.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Gut  2012; 61:695-705; PMID:21813473; http://dx.doi.org/10.1136/gutjnl-2011-300012 13.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Nat  Immunol 2009; 10:195-202; PMID:19122655;  http://dx.doi.org/10.1038/ni.1683,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Anesthesiology  2012; 116:1245-57; PMID:22531331; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol 2010; 185:3750-8; PMID:20693423;  http://dx.doi.org/10.4049/jimmunol.1000435 54.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Nature 2000; 407:747-50; PMID:11048721; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Biochim  Biophys Acta 2011; 1808:1329-39; PMID:20546702;  http://dx.doi.org/10.1016/j.bbamem.2010.05.01648.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
PLoS  Med 2008; 5:e137; PMID:18578565; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol  2009; 182:3965-8; PMID:19299692; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol 2009; 182:4957-64;  PMID:19342675; http://dx.doi.org/10.4049/jimmu - nol.0801324 51.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Adv Exp Med Biol  2007; 621:17-31; PMID:18269208; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Blood 2008; 111:2024-35; PMID:18056839; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
PLoS One  2012; 7:e32416; PMID:22389701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
J Immunol  2012; 189:4566-73; PMID:23028059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/32/tisb-1-e24957.PMC3879190.pdf
Tissue Barriers 2013; 1:e24783; http://dx.doi.org/10.4161/tisb.24783;  http://dx.doi.org/10.4161/tisb.24518epithelial tissues form a selective barrier that separates the  external environment from the internal tissue milieu.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375 2.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Rev Mol Cell Biol  2001; 2:285-93; PMID:11283726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Med Electron Microsc 2003; 36:147-56;  PMID:14505058; http://dx.doi.org/10.1007/s00795- 003-0219-y4.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Physiol Cell Physiol  2004; 286:C1213-28; PMID:15151915; http://dx.doi.org/10.1152/ajpcell.00558.2003 5.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol 2005; 171:939-45; PMID:16365161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J  Cell Sci 2008; 121:3677-82; PMID:18987354; http://dx.doi.org/10.1242/jcs.0238877.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Invest Dermatol  2007; 127:2525-32; PMID:17934504; http://dx.doi.org/10.1038/sj.jid.5700865 8.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Rev Mol Cell Biol  2010; 11:502-14; PMID:20571587; http://dx.doi.org/10.1038/nrm2927 9.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Science 2004; 303:1483- 7; PMID:15001769; http://dx.doi.org/10.1126/sci-ence.1094291,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Res 2007; 67:2030-9;  PMID:17332331; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2808 42.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Exp Cell Res 2011; 317:838-48; PMID:21211535;  http://dx.doi.org/10.1016/j.yexcr.2010.12.025 43.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2012; 287:10115-20; PMID:22337879;  http://dx.doi.org/10.1074/jbc.C111.333419 45.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Proc Natl Acad Sci U S  A 1998; 95:14979-84; PMID:9844001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Neurochem  2012; 120:741-51; PMID:22118475; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Biochem Biophys Res Commun 2002; 299:472-8; PMID:12445825; http://dx.doi.org/10.1016/S0006-291X(02)02681-5 49.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2005; 280:19543-50; PMID:15784625; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Pathol  2010; 177:2921-37; PMID:21075858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem  2011; 286:9127-35; PMID:21163944; http://dx.doi.org/10.1074/jbc.M110.191361 52.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol 2009; 185:1243- 58; PMID:19546243; http://dx.doi.org/10.1083/ jcb.200809044 53.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Med  2000; 6:1275-7; PMID:11062541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Front Biosci 2012; 17:1948- 64; PMID:22201848; http://dx.doi.org/10.2741/4031 27.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
EMBO J  2002; 21:1948-56; PMID:11953314; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Clin Exp Allergy  2000; 30:685-98; PMID:10792361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Microbiol 2000;  2:11-7; PMID:11207559; http://dx.doi.org/10.1046/ j.1462-5822.2000.00025.x 32.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Infect Dis  2011; 204:1283-92; PMID:21917902; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Respirology 2007; 12:834-42; PMID:17986111;  http://dx.doi.org/10.1111/j.1440-1843.2007.01175.x 34.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Eur  Respir J 2010; 36:1016-26; PMID:20351035; http://dx.doi.org/10.1183/09031936.00125809 35.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Blood  2009; 113:4799-809; PMID:19258599; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Sci  2003; 94:655-67; PMID:12901789; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Sci 2012; 125:2547-52; PMID:22833291;  http://dx.doi.org/10.1242/jcs.066654 38.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Adh  Migr 2012; 6:365-73; PMID:22796940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Curr Opin Genet Dev 2006; 16:51-9;  PMID:16377174; http://dx.doi.org/10.1016/j.gde.2005.12.007 11.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Dermatol Sci 2007; 45:7-21; PMID:17141479;  http://dx.doi.org/10.1016/j.jdermsci.2006.10.006 12.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Int Rev Cytol  2007; 264:65-163; PMID:17964922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Invest Dermatol 2007; 127:2499- 515; PMID:17934502; http://dx.doi.org/10.1038/ sj.jid.5701015 14.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Cell Biol 2002; 4:E101- 8; PMID:11944044; http://dx.doi.org/10.1038/ ncb0402-e101 16.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell 1991; 67:869-77;  PMID:1720352; http://dx.doi.org/10.1016/0092- 8674(91)90360-B 17.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Invest Dermatol 1993; 100:685- 91; PMID:8491991; http://dx.doi.org/10.1111/1523- 1747.ep12472348 18.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Bioessays  2005; 27:356-65; PMID:15770686; http://dx.doi.org/10.1002/bies.20203 21.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Mol Biol Cell 2005; 16:5040- 52; PMID:16055505; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Mol Biol Cell 2010; 21:152- 64; PMID:19889837; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem  2003; 278:1372-9; PMID:12393869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Subcell Biochem  2012; 60:197-222; PMID:22674073; http://dx.doi.org/10.1007/978-94-007-4186-7_9 25.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Curr Opin  Cell Biol 2001; 13:534-40; PMID:11544020; http://dx.doi.org/10.1016/S0955-0674(00)00248-9,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Oncogene 1999; 18:7080-90; PMID:10597309; http://dx.doi.org/10.1038/ sj.onc.1203191 85.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biochem  2008; 103:598-606; PMID:17559062; http://dx.doi.org/10.1002/jcb.21431 86.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Adh Migr  2011; 5:306-14; PMID:21715983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Oncogene 2012; 31:1636-48; PMID:21841821; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
PLoS One  2008; 3:e4080; PMID:19114997; http://dx.doi.org/10.1371/journal.pone.0004080 91.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem  2008; 283:12691-700; PMID:18356166; http://dx.doi.org/10.1074/jbc.M708887200 92.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
FASEB J 2011; 25:4174-83; PMID:21852538;  http://dx.doi.org/10.1096/fj.11-185926 93.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Cell Biol 2009; 11:162-71;  PMID:19136966; http://dx.doi.org/10.1038/ncb1824 94.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Neurochem 2001; 76:1421-30;  PMID:11238727; http://dx.doi.org/10.1046/j.1471- 4159.2001.00140.x 95.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Mol Endocrinol 2005; 19:2564-78; PMID:15928314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol 2006; 174:593- 604; PMID:16893970; http://dx.doi.org/10.1083/ jcb.20060208069.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Sci 2004; 117:5509-19; PMID:15494377;  http://dx.doi.org/10.1242/jcs.01425 70.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Pathol 2008; 172:905-15; PMID:18349130;  http://dx.doi.org/10.2353/ajpath.2008.070698 71.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Res 2011; 71:7080-90; PMID:21990319;  http://dx.doi.org/10.1158/0008-5472.CAN-11-2009 72.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Int J Cell Biol 2012;  2012:676731; PMID:22505933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J  Cell Biol 1997; 139:1861-72; PMID:9412478; http://dx.doi.org/10.1083/jcb.139.7.1861 74.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol 2005; 171:663- 73; PMID:16301332; http://dx.doi.org/10.1083/ jcb.200505098 75.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Oncogene  2013; PMID:23318419; http://dx.doi.org/10.1038/ onc.2012.563 76.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2008; 283:18393-401;  PMID:18434311; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2004; 279:43061-9; PMID:15292248; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2001; 276:4972- 80; PMID:11076937; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Prostate  2005; 63:259-68; PMID:15538719; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2011; 286:2750-61; PMID:21084306;  http://dx.doi.org/10.1074/jbc.M110.171504 83.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Host Microbe 2009; 5:47-58;  PMID:19154987; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Genes Dev 2004; 18:2354-8;  PMID:15466487; http://dx.doi.org/10.1101/ gad.1232104 56.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Biochem  J 2012; 447:61-70; PMID:22783993; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Annu Rev Cell Dev Biol  2001; 17:463-516; PMID:11687497; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Semin Cancer Biol 2010; 20:161- 8; PMID:20470890; http://dx.doi.org/10.1016/j.sem- cancer.2010.05.002 61.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biochem 1987; 34:187- 202; PMID:3611200; http://dx.doi.org/10.1002/ jcb.240340305 62.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Biol Chem  2002; 383:159-65; PMID:11928810; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer 2007; 109:1811- 20; PMID:17354228; http://dx.doi.org/10.1002/cncr.22606 64.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Ophthalmol 2001; 85:147-53; PMID:11159476;  http://dx.doi.org/10.1136/bjo.85.2.147 66.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Pathol  2005; 166:61-71; PMID:15632000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biol  1997; 136:399-409; PMID:9015310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Exp Cell Res  2010; 316:353-65; PMID:19854171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Clin Endocrinol Metab  2004; 89:5145-55; PMID:15472219; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Endocrinology  2007; 148:218-31; PMID:17038551; http://dx.doi.org/10.1210/en.2006-1120 128.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Res 2010; 70:2095-104; PMID:20160036;  http://dx.doi.org/10.1158/0008-5472.CAN-09-4155 129.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Pathol  2003; 162:1831-43; PMID:12759241; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Eur Surg  Res 2007; 39:208-15; PMID:17396032; http://dx.doi.org/10.1159/000101452 132.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biochem  2011; 112:2508-17; PMID:21557297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
PLoS One 2008; 3:e2153; PMID:18478055;  http://dx.doi.org/10.1371/journal.pone.0002153 134.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Invest  Dermatol 2008; 128:1737-46; PMID:18200054;  http://dx.doi.org/10.1038/sj.jid.5701242 135.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Exp Cell Res 2009; 315:3500-8; PMID:19665015; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Nat Cell Biol  2011; 13:1100-7; PMID:21804545; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
T ransl Res 2007; 149:211- 22; PMID:17383595; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Chest 2010; 138:1173-9;  PMID:20495107; http://dx.doi.org/10.1378/chest.10-0157 114.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Gynecol Oncol  2008; 108:361-9; PMID:18073130; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Cancer 2005; 92:2018- 23; PMID:15870707; http://dx.doi.org/10.1038/ sj.bjc.6602599 117.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Skin  Pharmacol Physiol 2006; 19:65-70; PMID:16685144;  http://dx.doi.org/10.1159/000091972 118.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Cancer 1998; 77:1857-63; PMID:9667659; http://dx.doi.org/10.1038/bjc.1998.309 120.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Arthritis Rheum 2013; 65:247-57;  PMID:23001478; http://dx.doi.org/10.1002/ art.37712 122.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Blood  2011; 117:5112-22; PMID:21403126; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J  Dermatol Sci 2010; 59:184-91; PMID:20728315;  http://dx.doi.org/10.1016/j.jdermsci.2010.07.010 124.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Biosci Rep  2013; 33:e00030; PMID:23409978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Res 2007; 67:3094-105; PMID:17409416;  http://dx.doi.org/10.1158/0008-5472.CAN-06-3259 98.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Anaesth 1996; 76:629- 31; PMID:8688260; http://dx.doi.org/10.1093/ bja/76.5.629 99.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Cancer  1994; 69:580-5; PMID:8123491; http://dx.doi.org/10.1038/bjc.1994.106 100.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
HPB Surg 2009; 2009:397375; PMID:19421334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Cell Biochem  2009; 107:272-83; PMID:19306293; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Eur J Cancer  2006; 42:728-34; PMID:16524717; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Dis Esophagus  2011; 24:49-55; PMID:20807231; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Int J Cancer 2006; 119:2895- 900; PMID:16998833; http://dx.doi.org/10.1002/ ijc.22219 106.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Cancer  1996; 74:579-84; PMID:8761373; http://dx.doi.org/10.1038/bjc.1996.404 107.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Br J Cancer  1999; 80:273-8; PMID:10390008; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Clin Exp Metastasis 2004;  21:75-8; PMID:15065605; http://dx.doi.org/10.1023/ B:CLIN.0000017204.38807.22 109.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Gut 2001; 48:808- 11; PMID:11358900; http://dx.doi.org/10.1136/gut.48.6.808,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2001; 276:41175- 81; PMID:11500511; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Am J Physiol Renal Physiol  2006; 290:F43-51; PMID:16077081; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Commun Adhes 2012; 19:11- 6; PMID:22401168; http://dx.doi.org/10.3109/15419 061.2012.665969 149.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cell Death Differ  1999; 6:377-86; PMID:10381631; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2002; 277:49976-81; PMID:12376527; http://dx.doi.org/10.1074/jbc.M210179200142.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
"Lundström A, Egelrud T. Evidence that cell shed-ding from plantar stratum corneum in vitro involves  endogenous proteolysis of the desmosomal protein  desmoglein I. J Invest Dermatol 1990; 94:216-20;  PMID:1688905; http://dx.doi.org/10.1111/1523- 1747.ep12874531 143.",OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Mol Biol Cell 2009; 20:328- 37; PMID:18987342; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem 2007; 282:8325-31; PMID:17227756; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
BMC Cancer 2008; 8:373; PMID:19091121; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Cancer Res 2007; 67:8198-206;  PMID:17804733; http://dx.doi.org/10.1158/0008- 5472.CAN-07-0607 139.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Gastroenterology  2005; 129:1251-67; PMID:16230078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Genes Dev  2006; 20:543-56; PMID:16481467; http://dx.doi.org/10.1101/gad.1407406 141.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
J Biol Chem  2006; 281:3614-24; PMID:16286477; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/5f/tisb-1-e24783.PMC3879235.pdf
Tissue Barriers 2013; 1:e24180;  http://dx.doi.org/10.4161/tisb.24180Destabilization of cell-cell contacts involved in the  maintenance of endothelial barrier function can lead to increased endothelial permeability.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Am J Respir Cell Mol Biol 2007; 37:699- 705; PMID:17630321; http://dx.doi.org/10.1165/ rcmb.2006-0429OC.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Appl Physiol  2006; 101:1710-9; PMID:16902064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
T rends Cardiovasc Med  2007; 17:55-9; PMID:17292047; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Rev Mol Cell Biol 2009; 10:63- 73; PMID:19197333; http://dx.doi.org/10.1038/ nrm2597.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Circulation 2005; 111:643- 9; PMID:15668343; http://dx.doi.org/10.1161/01.CIR.0000154548.16191.2F .,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Intern Med 2006; 259:381-92; PMID:16594906; http://dx.doi.org/10.1111/j.1365-2796.2006.01624.x.8.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Microvasc  Res 2012; 83:71-81; PMID:21741394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Clin Pract  Cardiovasc Med 2009; 6:16-26; PMID:19029993;  http://dx.doi.org/10.1038/ncpcardio1397.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Vasc  Res 1997; 34:208-11; PMID:9226302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
EMBO J 2001; 20:4639-47; PMID:11532928; http://dx.doi.org/10.1093/emboj/20.17.4639.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Rev Mol Cell  Biol 2009; 10:53-62; PMID:19197332; http://dx.doi.org/10.1038/nrm2596.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Circ  Res 2006; 98:176-85; PMID:16456110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
EMBO J  2002; 21:6791-800; PMID:12486000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Vasc  Res 2005; 42:77-89; PMID:15637443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Am J Physiol Heart Circ Physiol 2012; 302:H2220- 9; PMID:22447948; http://dx.doi.org/10.1152/ajp- heart.00975.2011.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Am J Physiol Heart Circ Physiol 2007; 292:H3190- 7; PMID:17308001; http://dx.doi.org/10.1152/ajp- heart.01177.2006.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Proc Natl Acad Sci U S A  2010; 107:9944-9; PMID:20463286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Sci 2010; 123:1385-8; PMID:20410370;  http://dx.doi.org/10.1242/jcs.066183.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nature  2010; 468:580-4; PMID:21107430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Ann Biomed  Eng 2012; 40:568-77; PMID:22016325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Int Rev Cytol  2006; 248:261-98; PMID:16487793; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Fluids Barriers CNS 2012; 9:23;  PMID:23140302; http://dx.doi.org/10.1186/2045- 8118-9-23.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
T rends Cardiovasc Med 2004; 14:143- 51; PMID:15177265; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Proc Natl Acad Sci  USA 2009; 106:70107015; http://dx.doi.org/10.1073/ pnas.0811253106.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Surg Res  2002; 102:13-21; PMID:11792146; http://dx.doi.org/10.1006/jsre.2001.6295.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Arterioscler Thromb Vasc Biol 2006; 26:62- 8; PMID:16269664; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Cardiovasc Res 2010; 87:320-30;  PMID:20543206; http://dx.doi.org/10.1093/cvr/ cvq146.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Curr Top Dev  Biol 2009; 89:33-54; PMID:19737641; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Curr Opin Cell Biol 2010; 22:583- 8; PMID:20728328; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2004; 167:1183-94; PMID:15596540;  http://dx.doi.org/10.1083/jcb.200403043.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 2006; 281:2901-10; PMID:16253998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2010; 189:1107- 15; PMID:20584916; http://dx.doi.org/10.1083/ jcb.201001149.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Proc Natl Acad Sci U S A  2011; 108:4708-13; PMID:21383129; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Biol Cell 2006; 98:721- 30; PMID:16895521; http://dx.doi.org/10.1042/ BC20060039.38.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Bioessays 2011; 33:732- 6; PMID:21826690; http://dx.doi.org/10.1002/ bies.201100064.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Science  2009; 323:638-41; PMID:19179532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biomech 2007; 40:2096-106;  PMID:17544431; http://dx.doi.org/10.1016/j.jbio- mech.2007.04.006.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Science 2007; 315:111-5;  PMID:17204653; http://dx.doi.org/10.1126/sci-ence.1135085.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2007; 179:1043-57; PMID:18056416;  http://dx.doi.org/10.1083/jcb.200703036.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Proc Natl Acad Sci U S A  2010; 107:9944-9; PMID:20463286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Phys Biol 2008; 5:016005;  PMID:18379019; http://dx.doi.org/10.1088/1478- 3975/5/1/016005.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Rev Mol Cell Biol 2004; 5:261-70;  PMID:15071551; http://dx.doi.org/10.1038/ nrm1357.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Exp Cell Res 1999; 252:13-9; PMID:10502395;  http://dx.doi.org/10.1006/excr.1999.4601.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 1998; 273:29786- 93; PMID:9792693; http://dx.doi.org/10.1074/ jbc.273.45.29786.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Cell 1992; 70:293-301; PMID:1638632; http://dx.doi.org/10.1016/0092-8674(92)90103-J.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Cell 2005; 123:903-15; PMID:16325583;  http://dx.doi.org/10.1016/j.cell.2005.09.021.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
EMBO J 2011; 30:4157- 70; PMID:21857650; http://dx.doi.org/10.1038/ emboj.2011.304.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2011;  195:543-52; PMID:22084304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Cell Biol  2010; 12:533-42; PMID:20453849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem  2002; 277:18868-74; PMID:11907041; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Cell Biol 2004;  6:21-30; PMID:14647292; http://dx.doi.org/10.1038/ ncb1075.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Mol Cell 2000; 5:533-43; PMID:10882138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Mol Biol Cell  2005; 16:4531-42; PMID:16030252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2010; 189:1075- 7; PMID:20584914; http://dx.doi.org/10.1083/ jcb.201005151.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Biol Cell  2007; 99:489-502; PMID:17696879; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol  2003; 160:399-407; PMID:12566430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Mol Cancer 2008; 7:71; PMID:18796137; http://dx.doi.org/10.1186/1476- 4598-7-71.,Non-OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Mol Cell Biol 2007; 27:8190- 204; PMID:17875928; http://dx.doi.org/10.1128/ MCB.00661-07.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 2012; 287:7556-72; PMID:22194609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol  2011; 194:643-56; PMID:21844208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
T rends Cell Biol  2006; 16:453-60; PMID:16893648; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem  2006; 281:7228-36; PMID:16407299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Proc Natl Acad Sci U S A 2012; 109:8576- 81; PMID:22586082; http://dx.doi.org/10.1073/ pnas.1203906109.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 2012; 287:7728-37; PMID:22235119; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol  2012; 196:641-52; PMID:22391038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Biol 2012; 196:115- 30; PMID:22232703; http://dx.doi.org/10.1083/ jcb.201103116.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Microvasc Res 2009; 77:304-13; PMID:19323978; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
T rends Cell Biol 2004; 14:111-4; PMID:15055199; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Annu Rev Biomed Eng 2007; 9:121-67;  PMID:17373886; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nature 2005; 437:426- 31; PMID:16163360; http://dx.doi.org/10.1038/ nature03952.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Cell Sci 2008; 121:29- 37; PMID:18096689; http://dx.doi.org/10.1242/jcs.022681.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 2010; 285:7045- 55; PMID:20048167; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
J Biol Chem 2005; 280:31906- 12; PMID:16027153; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
Nat Rev Mol Cell Biol  2010; 11:502-14; PMID:20571587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/40/tisb-1-e24180.PMC3879236.pdf
- Korean J Orthod 2013;43:160-167 http://dx.doi.org/10.4041/kjod.2013.43.6.261261www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/25/8e/kjod-43-261.PMC3879281.pdf
"262 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2013.43.6.261This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.Therefore, it would not be meaningful to calibrate the  difference between the horizontal plane at natural head  position and the FH plane.",Non-OADS,/arxiv_data1/oa_pdf/25/8e/kjod-43-261.PMC3879281.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.263",Non-OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
"Ha et al • SSRO and condylar remodeling www.e-kjo.org 264 http://dx.doi.org/10.4041/kjod.2013.43.6.263 INTRODUCTION   Among orthognathic surgery procedures that can  induce condylar position changes, sagittal split ramus  osteotomy (SSRO) is one of the most frequently per - formed.",Non-OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
"Ha et al • SSRO and condylar remodeling www.e-kjo.org 265 http://dx.doi.org/10.4041/kjod.2013.43.6.263 width and height on the coronal plane, and height and  depth on the sagittal plane; the measurements were  obtained according to the method reported by Hop - penreijs et al.3 (Figure 1).",OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
Ha et al • SSRO and condylar remodeling www.e-kjo.org 266 http://dx.doi.org/10.4041/kjod.2013.43.6.263 RESULTS   The mean amount of mandibular set-back was 6.8  ± 2.2 mm.,OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
"Ha et al • SSRO and condylar remodeling www.e-kjo.org 267 http://dx.doi.org/10.4041/kjod.2013.43.6.263   Several lateral cephalography studies have reported  condylar remodeling and resorption in the antero - su perior aspects of the condyles after orthognathic  surgery.3,14-16 The results of the present study were con- sistent with those findings: the condylar heights on the  sagittal and coronal planes reduced after surgery ( p <  0.05; Table 2) and the anterior and superior areas on  the sagittal plane showed prominent bone resorption  (p < 0.05; Table 3).",Non-OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
Ha et al • SSRO and condylar remodeling www.e-kjo.org 268 http://dx.doi.org/10.4041/kjod.2013.43.6.263 These differences in the distribution of the regions  show ing prominent changes may have resulted from dif- ferences in the sample size rather than differences in the  type of orthognathic surgery.,Non-OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
"Ha et al • SSRO and condylar remodeling www.e-kjo.org 269 http://dx.doi.org/10.4041/kjod.2013.43.6.263 functional loading and their adaptive capacity probably  is smaller than in patients with deep bites.21,22 Patients  presenting with predispositional factors relating to con- dy lar adaptive capacities, therefore, should be informed  about the possibility of condylar resorption and its  possible effects on stability.",Non-OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
Ha et al • SSRO and condylar remodeling www.e-kjo.org 270 http://dx.doi.org/10.4041/kjod.2013.43.6.263 resonance imaging study.,OADS,/arxiv_data1/oa_pdf/7d/e1/kjod-43-263.PMC3879282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.271",Non-OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
Kim et al • Root lengths measured by CBCT www.e-kjo.org 272 http://dx.doi.org/10.4041/kjod.2013.43.6.271 INTRODUCTION   Inflammatory root resorption is an unavoidable patho- logic consequence of orthodontic tooth move  ment.1-3  The incidence of root resorption is reportedly 1 - 86%  in nonorthodontically treated patients and 19 - 93% in  orthodontically treated patients.4 Evalua  tion of the  severity of root resorption requires the establishment of  reference data on the normal root length.,Non-OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
"Kim et al • Root lengths measured by CBCT www.e-kjo.org 273 http://dx.doi.org/10.4041/kjod.2013.43.6.271 s scan time, 0.292-mm isometric voxel size, and 12-bit  grayscale.",OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
Kim et al • Root lengths measured by CBCT www.e-kjo.org 274 http://dx.doi.org/10.4041/kjod.2013.43.6.271 ment CBCT images of 31 male and 31 female patients  with malocclusions.,OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
"Kim et al • Root lengths measured by CBCT www.e-kjo.org 275 http://dx.doi.org/10.4041/kjod.2013.43.6.271 of the incisors, canines, and premolars were divided  according to gender, the assumption of normal distribu- tion was rejected.",Non-OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
Kim et al • Root lengths measured by CBCT www.e-kjo.org 276 http://dx.doi.org/10.4041/kjod.2013.43.6.271 and female subjects.,OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
Kim et al • Root lengths measured by CBCT www.e-kjo.org 277 http://dx.doi.org/10.4041/kjod.2013.43.6.271 the root apex.,OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
Kim et al • Root lengths measured by CBCT www.e-kjo.org 278 http://dx.doi.org/10.4041/kjod.2013.43.6.271 21:468-73.,OADS,/arxiv_data1/oa_pdf/f2/e3/kjod-43-271.PMC3879283.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.279",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
"Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 280 http://dx.doi.org/10.4041/kjod.2013.43.6.279 INTRODUCTION   The contour of the lower face, including the lips and  soft-tissue chin, is thought to be closely related to the  underlying dentoalveolar structure.",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 281 http://dx.doi.org/10.4041/kjod.2013.43.6.279 mine the possible discriminants for each group.,OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
"Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 282 http://dx.doi.org/10.4041/kjod.2013.43.6.279 of ODI, U1-NPog, overjet, and U1-upper lip, respectively  (Table 4).",OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 283 http://dx.doi.org/10.4041/kjod.2013.43.6.279 the two child nodes.,Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
"Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 284 http://dx.doi.org/10.4041/kjod.2013.43.6.279 the dependent variables (e.g., no-strain or strain group)  in a stratified manner, with the earlier division or node  (higher in the tree) demonstrating a greater effect.",OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
"Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 285 http://dx.doi.org/10.4041/kjod.2013.43.6.279 with Class II division 1 and Class I malocclusions,  implying that the maxillary incisors tend to supra-erupt  in Class II division 1 malocclusion.2 Hayashida et al.19 reported that the most influential factor for the vertical  position of the lower lip is the varying position of the  tip of the maxillary incisor.",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 286 http://dx.doi.org/10.4041/kjod.2013.43.6.279 tension in the mentalis.,Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
Yu et al • Soft-tissue chin strain during lip closure www.e-kjo.org 287 http://dx.doi.org/10.4041/kjod.2013.43.6.279 division 1 malocclusion with incompetent lips and  normal occlusion.,Non-OADS,/arxiv_data1/oa_pdf/4d/a0/kjod-43-279.PMC3879284.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.288",Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
"Lee et al • Korean and Vietnamese arch forms www.e-kjo.org 289 http://dx.doi.org/10.4041/kjod.2013.43.6.288 INTRODUCTION   Nowadays, clinicians tend to apply lighter forces during  orthodontic treatment by means of self-ligating brackets  and small superelastic archwires.",Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
"Lee et al • Korean and Vietnamese arch forms www.e-kjo.org 290 http://dx.doi.org/10.4041/kjod.2013.43.6.288 dis tance between the first molar FA points; intercanine  depth, the shortest distance from the line connecting the  canine FA points to the origin; and intermolar depth,  the shortest distance from the line connecting the first  molar FA points to the origin.",Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
Lee et al • Korean and Vietnamese arch forms www.e-kjo.org 291 http://dx.doi.org/10.4041/kjod.2013.43.6.288 0.161).,Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
Lee et al • Korean and Vietnamese arch forms www.e-kjo.org 292 http://dx.doi.org/10.4041/kjod.2013.43.6.288 arches of the Korean group showed significantly less  intermolar depth (Table 3).,OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
Lee et al • Korean and Vietnamese arch forms www.e-kjo.org 293 http://dx.doi.org/10.4041/kjod.2013.43.6.288 9.,Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
Ava il able from: http://www.mospa.go.kr/gpms/ns/ mogaha/user/userlayout/bulletin/userBtView.ac - tion?userBtBean.bbsSeq=1022589&userBtBean.,Non-OADS,/arxiv_data1/oa_pdf/60/d3/kjod-43-288.PMC3879285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.294",Non-OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
Kunii et al • IL-6 in severe root resorption www.e-kjo.org 295 http://dx.doi.org/10.4041/kjod.2013.43.6.294 INTRODUCTION   Orthodontic tooth movement is achieved by repeated  bone resorption on the pressure side and bone  formation on the tension side.,Non-OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
"Kunii et al • IL-6 in severe root resorption www.e-kjo.org 296 http://dx.doi.org/10.4041/kjod.2013.43.6.294 measured with a Periotron 8000 meter (Oraflow Inc.,  Amityville, NY, USA).",OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
"Kunii et al • IL-6 in severe root resorption www.e-kjo.org 297 http://dx.doi.org/10.4041/kjod.2013.43.6.294 in the present experiment.12 Control cells were covered  with thin glass plates without lead weights, which  produced a CF of 0.032 g/cm2.",OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
Kunii et al • IL-6 in severe root resorption www.e-kjo.org 298 http://dx.doi.org/10.4041/kjod.2013.43.6.294 the control group (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
Kunii et al • IL-6 in severe root resorption www.e-kjo.org 299 http://dx.doi.org/10.4041/kjod.2013.43.6.294 deeper periodontal tissues; these agents induce cellular  proliferation and differentiation and promote wound  healing and tissue remodeling.15 Dudic et al.16 reported  that the GCF composition changes during orthodontic  tooth movement.,OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
Kunii et al • IL-6 in severe root resorption www.e-kjo.org 300 http://dx.doi.org/10.4041/kjod.2013.43.6.294 mature osteoclasts.,OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
"Kunii et al • IL-6 in severe root resorption www.e-kjo.org 301 http://dx.doi.org/10.4041/kjod.2013.43.6.294 N, Nakamura I, et al.",OADS,/arxiv_data1/oa_pdf/57/50/kjod-43-294.PMC3879286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Case Report pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.6.302",Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 303 http://dx.doi.org/10.4041/kjod.2013.43.6.302 INTRODUCTION   Closing old edentulous spaces in the mandibular  posterior region is a major challenge.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 304 http://dx.doi.org/10.4041/kjod.2013.43.6.302 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 305 http://dx.doi.org/10.4041/kjod.2013.43.6.302 TREATMENT ALTERNATIVES   The following treatment options were considered for  mandibular space closure:   1.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
"Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 306 http://dx.doi.org/10.4041/kjod.2013.43.6.302 of such teeth,8 and increased risk of failure.",Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 307 http://dx.doi.org/10.4041/kjod.2013.43.6.302 most of the space between the second molars and the  premolars was closed without the added anchorage of  miniscrew implants.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 308 http://dx.doi.org/10.4041/kjod.2013.43.6.302 duced by Köle9 in 1959.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
"Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 309 http://dx.doi.org/10.4041/kjod.2013.43.6.302 between cortical bone walls increase stability and  decrease bone loss in alveolar ridge splitting.18 In the  present case, two cylindrical bone blocks were used to  stabilize the alveolar ridges in their expanded positions,  for autogenous bone grafting and achieving stable  buccal cortical bone.",Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
Ozer et al • Alveolar expansion-assisted space closure in the mandibular posterior region www.e-kjo.org 310 http://dx.doi.org/10.4041/kjod.2013.43.6.302 Restorative Dent 2010;30:487-93.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/kjod-43-302.PMC3879287.pdf
"183 Lab Anim Res 2013: 29(4), 183-189 http://dx.doi.org/10.5625/lar.2013.29.4.183 Is sheep lumbar spine a suitable alternative model for human  spinal researches?",Non-OADS,/arxiv_data1/oa_pdf/fa/c2/lar-29-183.PMC3879336.pdf
"Briefly, ImageJ (version 1.47) was downloaded from http://rsbweb.nih.gov/ij/download.html as well as V olumest (http://lepo.it.da.ut.ee/~markkom/volumest/download/) (accession date: 01/04/2013) plug and added to ImageJsoftware.",OADS,/arxiv_data1/oa_pdf/fa/c2/lar-29-183.PMC3879336.pdf
"190 Lab Anim Res 2013: 29(4), 190-195 http://dx.doi.org/10.5625/lar.2013.29.4.190 Walnut extract exhibits anti-fatigue action via improvement of exercise tolerance in mice Dae-Ik Kim1, Kil-Soo Kim2* 1Daegu Technopark Oriental Medicine Industry Support Center, Daegu, Korea 2College of Veterinary Medicine, Kyungpook National University, Daegu, Korea This study was conducted to investigate the anti-fatigue effect of walnut extract (WE) on forced swimming capacity in mice.",Non-OADS,/arxiv_data1/oa_pdf/27/ec/lar-29-190.PMC3879337.pdf
"196 Lab Anim Res 2013: 29(4), 196-203 http://dx.doi.org/10.5625/lar.2013.29.4.196 Bone regeneration of mouse critical-sized calvarial defects with  human mesenchymal stem cells in scaffold Jin-Young Im1,2#, Woo-Kie Min3#, Changkook You4, Hyun-Ok Kim5, Hee-Kyung Jin1,6, Jae-sung Bae1,2* 1Stem Cell Neuroplasticity Research Group, Kyungpook National University, Daegu, Korea 2Department of Physiology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, Korea 3Department of Orthopaedic Surgery, Kyungpook National University Hospital, Daegu, Korea 4Ossgen, Gyeongbuk Technopark, Gyeongbuk, Korea 5Department of Laboratory Medicine, Yonsei Cell Therapy Center, Yonsei University College of Medicine, Seoul, Korea 6Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu, Korea Combination of tissue engineering and cell therapy represents a promising approach for bone regeneration.",Non-OADS,/arxiv_data1/oa_pdf/f5/c2/lar-29-196.PMC3879338.pdf
"204 Lab Anim Res 2013: 29(4), 204-211 http://dx.doi.org/10.5625/lar.2013.29.4.204 Protective effect of diallyl di sulfide on cyclophosphamide-induced  testicular toxicity in rats Sung-Hwan Kim#, In-Chul Lee#, Hyung-Seon Baek, Changjong Moon, Sung-Ho Kim, Jong-Choon Kim* College of Veterinary Medicine, Chonnam National University, Gwangju, Korea This study investigated the protective effects of diallyl disulfide (DADS) against cyclophosphamide (CP)- induced testicular toxicity in male rats.",Non-OADS,/arxiv_data1/oa_pdf/bd/bd/lar-29-204.PMC3879339.pdf
"212 Lab Anim Res 2013: 29(4), 212-220 http://dx.doi.org/10.5625/lar.2013.29.4.212 Precautionary effects of Red Liriope platyphylla on NGF secretion  and A β42 deposition under the preclinical stage of Alzheimer's disease in Tg2576 mice Sun-Il Choi#, Jun Go#, Ji-Eun Kim, Young-Ju Lee, Moon-Hwa Kwak, Young-Jin Jung, Dae-Youn Hwang* Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University, Miryang, Korea Red Liriope platyphylla (RLP) has been manufactured from Liriope platyphylla (L. platyphylla, LP) roots using steaming process and investigated as a curative agent for treatment of diabetes, obesity and neurodegenerative disorders.",Non-OADS,/arxiv_data1/oa_pdf/a1/8f/lar-29-212.PMC3879340.pdf
"221 Lab Anim Res 2013: 29(4), 221-225 http://dx.doi.org/10.5625/lar.2013.29.4.221 Nattokinase improves blood fl ow by inhibiting platelet aggregation and thrombus formation Ja-Young Jang1#, Tae-Su Kim2#, Jingmei Cai1, Jihyun Kim1, Youngeun Kim1, Kyungha Shin1, Kwang Sei Kim1,  Sung Kyeong Park3, Sung-Pyo Lee2, Ehn-Kyoung Choi1, Man Hee Rhee4*, Yun-Bae Kim1* 1College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea 2Misuba RTech Co., Ltd., Asan, Korea 3Daejeon Health Sciences College, Daejeon, Korea 4College of Veterinary Medicine, Kyungpook National University, Daegu, Korea The effects of nattokinase on the in vitro  platelet aggregation and in vivo  thrombosis were investigated in comparison with aspirin.",Non-OADS,/arxiv_data1/oa_pdf/00/40/lar-29-221.PMC3879341.pdf
"226 Lab Anim Res 2013: 29(4), 226-228 http://dx.doi.org/10.5625/lar.2013.29.4.226 Single coronary artery originat ing from the right aortic sinus  without a left anterior descending and circumflex artery in  conventional swine Kyung-Seob Lim1,2,3, Myung-Ho Jeong1,2,3,4*, Jong-Eun Park2,4, In-Ho Bae1,2, Dae-Sung Park2,3, Jong-Min Kim2,3,  Jung-Ha Kim2,3, Doo-Sun Sim2,3, Keun-Ho Park2,3, Young-Joon Hong2,3, Youngkeun Ahn2,3 1Korea Cardiovascular Stent Research Institute, Gwangju, Korea 2Heart Research Center Nominated by Korea Ministry of Health and Welfare 3Cardiovascular Research Center, Chonnam National University Hospital, Gwangju, Korea 4Regeneromics Research Center, Chonnam National University, Gwangju, Korea Single coronary artery is a rare coronary artery anomaly.",Non-OADS,/arxiv_data1/oa_pdf/fa/00/lar-29-226.PMC3879342.pdf
http://dx.doi.org/10.1016/j.fob.2013.12.002,OADS,/arxiv_data1/oa_pdf/f9/af/main.PMC3879403.pdf
"33, 4971–4984  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f9/af/main.PMC3879403.pdf
"GOslim termswere obtained from TAIR ( ftp://ftp.arabidopsis.org/home/tair/ Ontologies/Gene_Ontolo gy/ATH_GO_GOSLIM.txt ,d a t e d9 July 2013 [last accessed October 8, 2013]), excluding termsunsupported by experimental o r computational analysis, that is, evidence codes ND, NR, and NAS.",OADS,/arxiv_data1/oa_pdf/85/50/mst166.PMC3879440.pdf
1993 ) to the genome sequence ( ftp://ftp.ncbi.,OADS,/arxiv_data1/oa_pdf/85/50/mst166.PMC3879440.pdf
Supplementary Material Supplementary tables S1–S8 and ﬁgures S1–S5 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/85/50/mst166.PMC3879440.pdf
"The source code of the simulation pro-grams presented here is available at http://veda.cs.uiuc.edu/ evolsimul (last accessed October 11, 2013).",Non-OADS,/arxiv_data1/oa_pdf/42/32/mst170.PMC3879441.pdf
"We then searched these segments for biases in the intersite spacingbetween adjacent pairs of CAD binding sites using the iTFsprogram ( http://veda.cs.uiuc.edu/iTFs , last accessed October 11, 2013; [ Kazemian et al.",OADS,/arxiv_data1/oa_pdf/42/32/mst170.PMC3879441.pdf
Available from: http://www.leventhal.ch/software/ .,Non-OADS,/arxiv_data1/oa_pdf/e6/09/mst172.PMC3879443.pdf
"2011 ), available from http://hmmer.janelia.org/software (last accessed February 17, 2013), was used to interrogate the Joint Genome Institute(JGI) A. queenslandica genome database ( www.metazome.",OADS,/arxiv_data1/oa_pdf/15/7a/mst174.PMC3879445.pdf
"net/amphimedon , last accessed April 20, 2013) for DEATH (PF00531), NACHT (PF05729), and LRR (PF12799) domainsusing Pfam HMMs available from http://pfam.sanger.ac.uk/ (last accessed February 17, 2013).",Non-OADS,/arxiv_data1/oa_pdf/15/7a/mst174.PMC3879445.pdf
"sanger.ac.uk/search , last accessed March 4, 2013), Hmmer (http://hmmer.janelia.org/search , last accessed February 17, 2013), and InterProScan v1.05 plug-in for GeneiousProv6.1.5 created by Biomatters (available from: http://www.",OADS,/arxiv_data1/oa_pdf/15/7a/mst174.PMC3879445.pdf
"As independent conﬁrmation of these determinations, the genomic sequences spanningthese concatenated models were submitted to theAugustus web server ( http://bioinf.uni-greifswald.de/ augustus , last accessed June 8, 2013) to predict the gene structure and coding sequence.",OADS,/arxiv_data1/oa_pdf/15/7a/mst174.PMC3879445.pdf
"Phylogenetic trees were drawn using FigTree v1.4.0 ( http://tree.bio.ed.ac.uk/software/ﬁgtree/ ,l a s t accessed May 16, 2013).",OADS,/arxiv_data1/oa_pdf/15/7a/mst174.PMC3879445.pdf
"Analysis of SNPs Data sets of SNPs and their alle le frequency in YRI, CEU, and JPTCHB populations were downloaded from the 1000Genome Pilot Project ( The 1000 Genomes Project Consortium 2010 :ftp://ftp-trace.ncbi.nih.gov/1000genomes/ ftp/pilot_data/paper_data_sets/a_map_of_human_variation/ , last accessed October 24, 2013).",OADS,/arxiv_data1/oa_pdf/1f/84/mst185.PMC3879449.pdf
"To polarize SNPs, we usedinformation about the ancestral allele included in VCF ﬁles,which derives from the four-way EPO alignments (for moredetails, see ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/pilot_ data/technical/reference/ancestral_alignments/README , last accessed October 24, 2013).",Non-OADS,/arxiv_data1/oa_pdf/1f/84/mst185.PMC3879449.pdf
Supplementary Material Supplementary text and ﬁgures S1–S11 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/1f/84/mst185.PMC3879449.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/1f/84/mst185.PMC3879449.pdf
Supplementary Material Supplementary ﬁgures S1–S8 and table S1 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/44/78/mst189.PMC3879451.pdf
"Transcriptom e assemblies of 71 species were obtained from the Deep Metazoan Phylogeny database (http://www.deep-phylogeny.org/ , last accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
"F or submission, we excluded contigs shorter than 200 bp, according to the submissionguidelines; the full transcriptome assemblies are available at http://zfmk.de/bioinform atics/Full_Transcriptome_ Assemblies.zip (last accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
"2 - r c( Meyer and Misof 2010 ; http://mare.zfmk.de , last accessed November 4, 2013), apply- ing taxon weighting -t 1.5.",Non-OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
"2002 ;http://www.tree-puzzle.de , last accessed November 4, 2013), applying the BLOSUM62 substitutionmatrix ( Henikoff S and Henikoff JG 1992 )a st h eB L O S U M 6 2 substitution matrix is implemented in the software MARE(Meyer and Misof, 2010 ;http://mare.zfmk.de , last accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
"Data sets are deposited at Dryad: http://doi.org/ 10.5061/dryad.mk8p7 (last accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
"They acknowledge the Cologne High Efﬁcient Operating Platform f or Science (CHEOPS, HPC clus- ter at the RRZK, University of Cologne, Cologne, Germany;available from: http://rrzk.uni-koeln.de/cheops.html )f o rt h eopportunity to perform analyses.",OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
",t h eG e r m a nS c i e n c eF o u n d a t i o n (DFG): priority program SPP 1174 “Deep MetazoanPhylogeny” ( http://www.deep-phylogeny.org ), and by institu- tional funding of the Heidelberg Institute for Theoretical Studies.",Non-OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
Available from: http://www.zfmk.utilities.de .,OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
Available from: http://mare.zfmk.de (current version).,Non-OADS,/arxiv_data1/oa_pdf/1e/2c/mst196.PMC3879454.pdf
All alignments used for tree reconstruct ions of putative venom proteins are available at: http://www.reumont.net/ vReumont_etal2013_MBE_FirstVenomou sCrustacean_TreeAlignments.zip .,OADS,/arxiv_data1/oa_pdf/9d/35/mst199.PMC3879455.pdf
"Segmentation and rendering of single structures was accomplished with Reconstruct ( Fiala 2005 ) and Blender ( http://www.blender.org , last accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/9d/35/mst199.PMC3879455.pdf
Phylogenetic analyses were performed with the as- sistance of SBCS Informatics ( http://informatics.sbcs.qmul.ac.,OADS,/arxiv_data1/oa_pdf/9d/35/mst199.PMC3879455.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/f8/ijbsv10p0001.PMC3879586.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/9d/ijbsv10p0015.PMC3879587.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a4/c5/ijbsv10p0025.PMC3879588.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/8f/ijbsv10p0033.PMC3879589.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/a9/ijbsv10p0043.PMC3879590.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b0/43/ijbsv10p0053.PMC3879591.pdf
"Until 10 October  2013, 291 complete holometabolous insect mt g e- nomes have been sequenced and lodged in GenBank (http://www.ncbi.nlm.nih.gov), representing 9 or- ders.",OADS,/arxiv_data1/oa_pdf/b0/43/ijbsv10p0053.PMC3879591.pdf
RNA  alignment was conducted by G -blocks Server  (http://molevol.cmima.csic.e s/castresana/Gblocks_s erver.html) by more stringent selection.,OADS,/arxiv_data1/oa_pdf/b0/43/ijbsv10p0053.PMC3879591.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c9/f4/ijbsv10p0073.PMC3879593.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/13/ijbsv10p0080.PMC3879594.pdf
"85 –23,  revised 1985; http://grants1.nih.gov/grants/olaw/   references/phspol.htm), as well as with specific n a- tional laws where applicable.",Non-OADS,/arxiv_data1/oa_pdf/ee/13/ijbsv10p0080.PMC3879594.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/b8/ijbsv10p0090.PMC3879595.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/c0/ijbsv10p0103.PMC3879596.pdf
http://www.who.int/mediacentre/factsheets/fs104/en/index.html    2.,Non-OADS,/arxiv_data1/oa_pdf/14/c0/ijbsv10p0103.PMC3879596.pdf
"[Internet] World Health Organization,  Global Tuberculosis Report 2013.  http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf   3.",Non-OADS,/arxiv_data1/oa_pdf/14/c0/ijbsv10p0103.PMC3879596.pdf
"Based on data supplied by the International Union  of Basic and Clinical Pharmacology Committee on recep-Review Biomol  Ther 21(6), 411-422 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology www.biomolther.org   *Corresponding Author E-mail: imds@pusan.ac.kr Tel: +82-51-510-2817, Fax: +82-51-513-6754Received  Oct 4, 2013  Revised  Oct 30, 2013  Accepted  Nov 4, 2013http://dx.doi.org/10.4062/biomolther.2013.080 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"412Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080tor nomenclature and drug classi ﬁ cation (NC-IUPHAR), 354  GPCRs are now recognized as non-chemosensory GPCRs (Sharman et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"414Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080(DiLuigi et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"416Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080In this context, Yamashita et al.",OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"418Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080were carefully undertaken (Park et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"420Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080canonical pathways.",OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"422Biomol  Ther  21(6), 411-422 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.080J.",OADS,/arxiv_data1/oa_pdf/c9/bb/ooomb4-21-411.PMC3879912.pdf
"Secondary or tertiary struc-Review Biomol  Ther 21(6), 423-434 (2013) *Corresponding Author E-mail: jonghoe@dankook.ac.kr Tel: +82-31-8005-3194, Fax: +82-31-8021-7201Received  Oct 16, 2013  Revised  Nov 5, 2013  Accepted  Nov 5, 2013http://dx.doi.org/10.4062/biomolther.2013.085 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"424Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085tures of aptamers allow target binding and determine target  speci ﬁ city and af ﬁ nity (Ellington and Szostak, 1990; Tuerk  and Gold, 1990; Schneider et al., 1995; Mosing et al., 2005;  Chen et al., 2009).",OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"426Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085 Fig.",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"428Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085tion of ribose is a nuclease attack site.",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"430Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085of gelonin, a ribosomal toxin (Chu et al., 2006a).",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"432Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085Hamula, C. L., Le, X. C. and Li, X. F. (2011) DNA aptamers binding  to multiple prevalent M-types of Streptococcus pyogenes.",Non-OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"434Biomol  Ther  21(6), 423-434 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.085Xu, W. and Lu, Y.",OADS,/arxiv_data1/oa_pdf/5d/d3/ooomb4-21-423.PMC3879913.pdf
"The activation of NF- κB by  extracellular stimuli follows the rapid phosphorylation, ubiqui-tination, and proteolytic degradation of I κBα, which leads to  the nuclear translocation and phosphorylation of NF- κB, and Original Article Biomol  Ther 21(6), 435-441 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: hwchang@yu .ac.kr (Chang HW), jkson@yu.ac.kr (Son JK) Tel: +82-53-810-2811 ( Chang HW), +82-53-810-2817 (Son JK) Fax: +82-53-810-4654 ( Chang HW), +82-53-810-4654 (Son JK) The fi  rst two authors contributed equally to this work.Received  Sep 2, 2013  Revised  Oct 28, 2013  Accepted  Oct 31, 2013 http://dx.doi.org/10.4062/biomolther.2013.068 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/5f/ooomb4-21-435.PMC3879914.pdf
"436Biomol  Ther  21(6), 435-441 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.068binding of NF- κB to a speci ﬁ c sequence in the promoter region  of its target genes, triggers its transcriptional activation (Amit and Ben-neriah, 2003; Takada et al., 2003; Xu et al., 2005).",Non-OADS,/arxiv_data1/oa_pdf/7a/5f/ooomb4-21-435.PMC3879914.pdf
"438Biomol  Ther  21(6), 435-441 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.068RESUL TS Eff ect of emodin on the productions of pro-infl  ammatory  cytokines  Pro-in ﬂ ammatory cytokines, such as, IL-6 and TNF- α, are  produced by macrophages and mast cells, and play important roles in various in ﬂ ammatory responses (Guha and Mack- man, 2001).",Non-OADS,/arxiv_data1/oa_pdf/7a/5f/ooomb4-21-435.PMC3879914.pdf
"440Biomol  Ther  21(6), 435-441 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.068NF-κB pathway.",Non-OADS,/arxiv_data1/oa_pdf/7a/5f/ooomb4-21-435.PMC3879914.pdf
"Indeed, many previous studies on the correlation between an-tioxidants and aging support this notion (Harrington and Har-ley, 1988; Adachi and Ishii, 2000; Wu et al., 2002; Ishii et al.,  2004).Original Article Biomol  Ther 21(6), 442-446 (2013) *Corresponding Author E-mail: dkkim@woosuk.ac.kr Tel: +82-63-290-1574, Fax: +82-63-290-1812The fi  rst two authors contributed equally to this work.Received  Sep 12, 2013  Revised  Nov 1, 2013  Accepted  Nov 4, 2013http://dx.doi.org/10.4062/biomolther.2013.073 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/ee/ooomb4-21-442.PMC3879915.pdf
"444Biomol  Ther  21(6), 442-446 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.073RESUL TS PGG extends lifespan of C. elegans  in normal conditions To determine the lifespan extension properties of PGG,  lifespan assays were performed with wild-type N2 worms.",OADS,/arxiv_data1/oa_pdf/2d/ee/ooomb4-21-442.PMC3879915.pdf
"446Biomol  Ther  21(6), 442-446 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.073of electron transport system, but induction of damage of the  mitochondrial membrane (Adachi et al., 1989).Taken together,  we can possibly estimate that the PGG’s inhibitory effects on the mitochondrial respiration may be also responsible for the enhanced resistance and prolonged lifespan by PGG treat-ment in C. elegans .",Non-OADS,/arxiv_data1/oa_pdf/2d/ee/ooomb4-21-442.PMC3879915.pdf
"The Original Article Biomol  Ther 21(6), 447-453 (2013) *Corresponding Author E-mail: youngjoe@catholic.ac.kr Tel: +82-2-2258-7484, Fax: +82-2-593-2522Received  May 13, 2013  Revised  May 28, 2013  Accepted  May 30, 2013http://dx.doi.org/10.4062/biomolther.2013.041 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/d5/ooomb4-21-447.PMC3879916.pdf
"448Biomol  Ther  21(6), 447-453 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.041inhibitory activity of MAG and other myelin-associated inhibi- tors appears to require the Rho/ROCK pathway (Lehmann et  al., 1999; Vinson et al., 2001).",Non-OADS,/arxiv_data1/oa_pdf/27/d5/ooomb4-21-447.PMC3879916.pdf
Quantifi  cation of branch length Images obtained from neuronal induction experiments were  analyzed using the ImageJ (http://rsb.info.nih.gov/ij/) program to determine the lengths of cellular processes.,OADS,/arxiv_data1/oa_pdf/27/d5/ooomb4-21-447.PMC3879916.pdf
"450Biomol  Ther  21(6), 447-453 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.041Thus, we tested whether pretreatment with CSPGs dose-de- pendently inhibits the morphological changes of WJ-MSCs into neuron-like cells in EGM2 in the presence of Y27632.",Non-OADS,/arxiv_data1/oa_pdf/27/d5/ooomb4-21-447.PMC3879916.pdf
"452Biomol  Ther  21(6), 447-453 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.041we presume that a ROCK inhibitor may be used ef ﬁ ciently in  cell therapy since it can block the inhibitory effect of most neu-rite outgrowth inhibitors exposed in injured tissue.",Non-OADS,/arxiv_data1/oa_pdf/27/d5/ooomb4-21-447.PMC3879916.pdf
"iNOS is found in astrocytes, microglia, and macrophages where it is a major source of reactive oxygen species (ROS) generation Original Article Biomol  Ther 21(6), 454-461 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology www.biomolther.org   Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: solar93@cbu.ac.kr (Kim YB), ssj66@gwnu.ac.kr (Joo SS) Tel: +82-43-261-3358 (Kim YB),  +82-33-640-2856 (Joo SS)Fax: +82-43-271-3246 (Kim YB), +82-33-640-2856 (Joo SS)The fi  rst two authors contributed equally to this work.Received  Sep 2, 2013  Revised  Oct 4, 2013  Accepted  Oct 18, 2013 http://dx.doi.org/10.4062/biomolther.2013.067 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/76/ooomb4-21-454.PMC3879917.pdf
"456Biomol  Ther  21(6), 454-461 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.067in place by ligature, and the incision was sutured.",Non-OADS,/arxiv_data1/oa_pdf/59/76/ooomb4-21-454.PMC3879917.pdf
"458Biomol  Ther  21(6), 454-461 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.067Spontaneous locomotor activity was evaluated using a vid- eo tracking system (Smart v2.5; Panlab Technology), connect-ed to a CCTV monitor.",OADS,/arxiv_data1/oa_pdf/59/76/ooomb4-21-454.PMC3879917.pdf
"460Biomol  Ther  21(6), 454-461 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.067expression were downregulated by WRPE-BF, suggesting its  pivotal role for anti-in ﬂ ammatory activity.",Non-OADS,/arxiv_data1/oa_pdf/59/76/ooomb4-21-454.PMC3879917.pdf
"Additionally, our studies revealed that EUE has Original Article Biomol  Ther 21(6), 462-469 (2013) *Corresponding Author E-mail: jang@skku.edu Tel: +82-31-290-7780, Fax: +82-31-292-8800Received  Sep 13, 2013  Revised  Oct 30, 2013  Accepted  Nov 5, 2013http://dx.doi.org/10.4062/biomolther.2013.074 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/ooomb4-21-462.PMC3879918.pdf
"464Biomol  Ther  21(6), 462-469 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.074for 10 s and then removed from the pool.",OADS,/arxiv_data1/oa_pdf/52/9a/ooomb4-21-462.PMC3879918.pdf
"466Biomol  Ther  21(6), 462-469 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.074RESUL TS  Eff ects of EUE on the spontaneous alternation behavior  Y-maze test Scopolamine signi ﬁ cantly decreased the spontaneous al- ternation behavior compared with the control group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/52/9a/ooomb4-21-462.PMC3879918.pdf
"468Biomol  Ther  21(6), 462-469 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.074In order to elucidate the underlying mechanism of action  of EUE, we assessed the effect of EUE on scopolamine-in-duced TBARS activity.",OADS,/arxiv_data1/oa_pdf/52/9a/ooomb4-21-462.PMC3879918.pdf
"In this study, we attempted to identify parameters responding to Original Article Biomol  Ther 21(6), 470-475 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: sunnyk im@gachon.ac.kr (Kim SY), ypjang@khu.ac.kr (Jang YP) Tel: +82-32-899-6411 (Kim SY), +82-2-961-9421 (Jang YP)Fax: +82-32-899-6591 (Kim SY), +82-2-966-3885 (Jang YP)Received  Sep 9, 2013  Revised  Oct 21, 2013  Accepted  Oct 24, 2013 http://dx.doi.org/10.4062/biomolther.2013.071 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/09/ooomb4-21-470.PMC3879919.pdf
"472Biomol  Ther  21(6), 470-475 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.071DART-MS measurement of skin tissue sample Direct analysis was carried out with intact tissue, with each  sample placed between the inlet of MS analyzer and the DART ion source.",OADS,/arxiv_data1/oa_pdf/ec/09/ooomb4-21-470.PMC3879919.pdf
"474Biomol  Ther  21(6), 470-475 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.071skin, especially the stratum corneum (SC) which consists of  ceramides cholesterol and fatty acids (Lampe et al., 1983, Kim  et al., 2010a).",Non-OADS,/arxiv_data1/oa_pdf/ec/09/ooomb4-21-470.PMC3879919.pdf
"Here we developed a sensitive, simultaneous and fast quan- ti tation method for the determination of serotonin, dopamine  and norepinephrine in plasma using UPLC/MSMS (ultra-per-formance tandem mass spectrometry) and examined the im-pact of high fat diet (HFD)-induced obesity on the plasma lev-els of monoamine neurotransmitters in male C57BL/6 mice to Original Article Biomol  Ther 21(6), 476-480 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: sjbae@ewha.ac.kr (Bae SJ), kmlim@ewha.ac.kr (Lim KM) Tel: +82-2-3277-3056 (Bae SJ), +82-2-3277-3055 (Lim KM)Fax: +82-2-3277-3760 (Bae SJ), +82-2-3277-3760 (Lim KM)Received  Aug 28, 2013  Revised  Sep 19, 2013  Accepted  Oct 10, 2013 http://dx.doi.org/10.4062/biomolther.2013.063 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/58/ooomb4-21-476.PMC3879920.pdf
"478Biomol  Ther  21(6), 476-480 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.063serotonin, dopamine, norepinephrine in hypothalamic-pitui ta- ry-adrenal axis activity is deeply involved in mood disorders (Lanni et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/db/58/ooomb4-21-476.PMC3879920.pdf
"480Biomol  Ther  21(6), 476-480 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.063neurotransmitters can be used to assess obesity-associated  mood changes.",Non-OADS,/arxiv_data1/oa_pdf/db/58/ooomb4-21-476.PMC3879920.pdf
"Cytoskeletal reorganization is dependent on Original Article Biomol  Ther 21(6), 481-486 (2013) *Corresponding Author E-mail: eunyimoon@sejong.ac.kr Tel: +82-2-3408-3768, Fax: +82-2-466-8768The fi  rst two authors contributed equally to this work.Received  Sep 26, 2013  Revised  Nov 1, 2013  Accepted  Nov 11, 2013http://dx.doi.org/10.4062/biomolther.2013.076 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/46/ooomb4-21-481.PMC3879921.pdf
"482Biomol  Ther  21(6), 481-486 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.076small GTPases, including Rac1, Cdc42, and Rap1 (Takai et  al., 1995; Takai et al., 2001; Bailey et al., 2009), which is also  important in macrophage migration (A ﬂ aki et al., 2011).",OADS,/arxiv_data1/oa_pdf/61/46/ooomb4-21-481.PMC3879921.pdf
"484Biomol  Ther  21(6), 481-486 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.076Macrophage motility decreased by CM was reversed by the  treatment with dexamethasone To examine whether macrophage motility is regulated by  inﬂ ammatory responses, the effect of dexamethasone (Dex),  a famous anti-in ﬂ ammatory agent, was measured in CM- treated IC-21 cells.",Non-OADS,/arxiv_data1/oa_pdf/61/46/ooomb4-21-481.PMC3879921.pdf
"486Biomol  Ther  21(6), 481-486 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.076Takai, Y., Sasaki, T. and Matozaki, T. (2001) Small GTP-binding pro- teins.",OADS,/arxiv_data1/oa_pdf/61/46/ooomb4-21-481.PMC3879921.pdf
"Three consecutive Original Article Biomol  Ther 21(6), 487-492 (2013) *Corresponding Author E-mail: donghak@konkuk.ac.kr  Tel: +82-2-450-3366, Fax: +82-2-3436-5432Received  Oct 21, 2013  Revised  Nov 8, 2013  Accepted  Nov 13, 2013http://dx.doi.org/10.4062/biomolther.2013.086 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/a3/ooomb4-21-487.PMC3879922.pdf
"488Biomol  Ther  21(6), 487-492 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.086rounds of random mutagenesis and screening yielded a highly  improved CYP1A2 mutant with a >10-fold increase in the bio-activation of aromatic amine based on the genotoxicity assay and a 12-fold enhanced catalytic ef ﬁ ciency in steady-state  analysis (Kim and Guengerich, 2004b).",OADS,/arxiv_data1/oa_pdf/e3/a3/ooomb4-21-487.PMC3879922.pdf
"490Biomol  Ther  21(6), 487-492 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.086in the range of 4.3-15 μM (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e3/a3/ooomb4-21-487.PMC3879922.pdf
"492Biomol  Ther  21(6), 487-492 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.086synthase is associated with essential hypertension.",Non-OADS,/arxiv_data1/oa_pdf/e3/a3/ooomb4-21-487.PMC3879922.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/87/evt175.PMC3879964.pdf
Supplementary Material Supplementary tables S1 andﬁgures S1–S3 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/d1/87/evt175.PMC3879964.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/e6/evt178.PMC3879967.pdf
"All data were analyzed with the R statistical softwarepackage ( http://cran.r-project.org , last accessed December 2, 2013) using the nonparametric Wilcoxon rank-sum test (analternative to the Student’s t-test for small samples; Hollander and Wolfe 1973 ).",OADS,/arxiv_data1/oa_pdf/52/e6/evt178.PMC3879967.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/52/e6/evt178.PMC3879967.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/a6/evt179.PMC3879968.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/32/a6/evt179.PMC3879968.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/fa/evt186.PMC3879974.pdf
"aFull specimen information is available on the arctos database: http://arctos.database.museum/SpecimenSearch.cfm , last accessed November 28, 2013. bTotal reads ¼unﬁltered reads.",OADS,/arxiv_data1/oa_pdf/55/fa/evt186.PMC3879974.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/5b/evt188.PMC3879976.pdf
"The resultant plasmids were puriﬁed by Wizard Plus SV Minipreps DNA Puriﬁcation Systems (Promega) and sequenced using T7 (5 0T AATACGACTCACTATAGGG30)a n dS p 6( 50GATTTAGGTGACA CTATAGAATAC30) primers by the Genomics Unit at the Parque Cientı ´ﬁ c od eM a d r i d( http://www.fpcm.es/ ,l a s t accessed December 2, 2013).",OADS,/arxiv_data1/oa_pdf/fc/5b/evt188.PMC3879976.pdf
Relative abundance of each splice variant was measured as the result of the gel intensity for each single band using ImageJ software ( http://rsb.info.nih.,OADS,/arxiv_data1/oa_pdf/fc/5b/evt188.PMC3879976.pdf
"Bioinformatics General Analysis Sequence data were annotated using the BioEdit software (http://www.mbio.ncsu.edu/BioEdit/bioedit.html , last accessedDecember 2, 2013) and aligned to Tv1-RAGE mRNA (cDNA) and to genomic RAGE DNA in each species using EBI PairwiseAlignment ( http://www.ebi.ac.uk/Tools/psa/ , last accessed December 2, 2013) to obtain the exonic composition of each isoform and to compare it to the canonical one.",OADS,/arxiv_data1/oa_pdf/fc/5b/evt188.PMC3879976.pdf
"Pfam ( http://pfam.sanger.ac.uk/ ,l a s t accessed December 2, 2013) was used for general domain prediction and SignalP4.0 Server ( http://www.cbs.dtu.dk/ser- vices/SignalP/ , last accessed December 2, 2013) for signal pep- tide prediction.",OADS,/arxiv_data1/oa_pdf/fc/5b/evt188.PMC3879976.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/23/evt196.PMC3879982.pdf
"To diagnose the origin of each miRNA family during plantevolution in those most curated sequenced species (fromPhytozome 9.0.1, http://www.phytozome.net/ , last accessed December 6, 2013), we mapped miRNA family presence/ab- sence onto the green plant tree (illustrated in ﬁg.",OADS,/arxiv_data1/oa_pdf/a3/23/evt196.PMC3879982.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/ef/evt201.PMC3879985.pdf
"Trees, align- ments, orthology, and paralogy predictions can be found in phylomeDB ( http://phylomedb.org , last accessed December 20, 2013) with the PhyID code 181.",Non-OADS,/arxiv_data1/oa_pdf/90/ef/evt201.PMC3879985.pdf
Supplementary Material Supplementary ﬁgures S1–S8 andtables S1–9 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/90/ef/evt201.PMC3879985.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/dd/evt202.PMC3879986.pdf
"Substructures, repeats, and motifs were searched with ap- propriate applications within t he online tool Oligonucleotids repeats ﬁnder, developed by Bazin, Kosarev, and Babenko(http://wwwmgs.bionet.nsc.ru/mgs/programs/oligorep/InpFo rm.htm , last accessed December 20, 2013).",OADS,/arxiv_data1/oa_pdf/86/dd/evt202.PMC3879986.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/6b/evt205.PMC3879987.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713000998ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/52/8a/S0033291713000998a.PMC3880065.pdf
Using WFU PickAtlas (http://www.nitrc.org/ projects/wfu_pickatlas/) we created a mask that in- cluded the six chosen ROIs and comprised a total of11700 voxels.,Non-OADS,/arxiv_data1/oa_pdf/52/8a/S0033291713000998a.PMC3880065.pdf
"Future multi-centre work in this area would bene ﬁt from the subcharacterization of UHR individuals withdifferent clinical and cognitive pro ﬁles, the recruitment of participants at the same stage of neurodevelop- ment and the use of a standardized image acquisitionsequence.Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291713000998.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/S0033291713000998a.PMC3880065.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713001074ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c8/5f/S0033291713001074a.PMC3880066.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713001013ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3d/10/S0033291713001013a.PMC3880067.pdf
"Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291713001013.Acknowledgments This work was partially supported by the European College of Neuropsychopharmacology, NetworksInitiative, Neuroimaging Network, which had no further role in the study design, in the collection, analysis and interpretation of data, in the writing ofthe manuscript, and in the decision to submit it for publication.",Non-OADS,/arxiv_data1/oa_pdf/3d/10/S0033291713001013a.PMC3880067.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/43/hyt156.PMC3880145.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/be/hyt182.PMC3880146.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/e7/ntt127.PMC3880232.pdf
Retrieved from http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/53/e7/ntt127.PMC3880232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Total genomic alteration as measured by SNP array in MDS T Cluzeau et al 4 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/37/05/bcj201352a.PMC3880435.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Rapid-onset high-penetrance plasmacytoma mouse model YH u et al 11 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/0a/7d/bcj201353a.PMC3880436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/ba/df/bcj201354a.PMC3880437.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/bcj201355a.PMC3880438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Phospho-STAT5 in juvenile myelomonocytic leukemia D Hasegawa et al 6 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/b7/90/bcj201356a.PMC3880439.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Decreasing mortality of ATLL D Chihara et al 3 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/c3/31/bcj201357a.PMC3880440.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bendamustine triple regimen in multiple myeloma M Ofﬁdani et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/bb/84/bcj201358a.PMC3880441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/ed/db/bcj201359a.PMC3880442.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 3 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/c6/7a/bcj201360a.PMC3880443.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)FDG-PET in mouse model of human myeloma K Duncan et al 12 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/27/25/bcj201361a.PMC3880444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Effects of KIR ligand incompatibility on CBT J Tanaka et al 10 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/97/0c/bcj201362a.PMC3880445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)STAT inhibitor OPB-31121 F Hayakawa et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/f5/8a/bcj201363a.PMC3880446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Serotonin and Kv channels in the mesenteric artery DJ Sung et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/48/b3/emm2013116a.PMC3880459.pdf
"Available from http://stemcells.nih.gov/info/2001report/pages/ chapter10.aspx 3 Goldring, CE, Duffy, PA, Benvenisty, N, Andres, PW, Ben-David, U, Eakins, Ret al.",OADS,/arxiv_data1/oa_pdf/f0/dc/emm2013133a.PMC3880460.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Effect of ASK1 on NSC after inﬂammatory condition JS o n g et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/22/29/emm2013134a.PMC3880461.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/LPS recognition by TLR4 BS Park and J-O Lee 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/b3/97/emm201397a.PMC3880462.pdf
July 2011. http://www.info.pmda.go.jp/shinyaku/P201100119/ 80012600_22300AMX00592_A100_1.pdf .,OADS,/arxiv_data1/oa_pdf/33/71/40261_2013_Article_146.PMC3880470.pdf
June 2012. http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&ApplNo=202611&DrugName=MYRBETRIQ&ActiveIngred= MIRABEGRON&SponsorApplicant=APGDI&ProductMktStatus =1&goto=Search.Label_ApprovalHistory .,OADS,/arxiv_data1/oa_pdf/33/71/40261_2013_Article_146.PMC3880470.pdf
"Adopted by the 18th WMA General assembly and amended by 48th WMA General Assembly, Somerset West, South Africa,October 1996. http://www.wma.net/en/30publications/10policies/ b3/.",Non-OADS,/arxiv_data1/oa_pdf/33/71/40261_2013_Article_146.PMC3880470.pdf
http://www.ich.,Non-OADS,/arxiv_data1/oa_pdf/33/71/40261_2013_Article_146.PMC3880470.pdf
"MIDAs can be accessed freely through a user-friendly web-interface at http://www.ncbi.nlm.nih.gov/CBBresearch/Yu/midas/index.html Key words: Isotopic Distribution, Accurate mass, Mass spectrometry, Proteomics Received: 26 April 2013/Revised: 31 July 2013/Accepted: 2 August 2013/Published online: 20 November 2013 Introduction Most biomolecules are composed of hydrogen, carbon, nitrogen, oxygen, and sulphur.",OADS,/arxiv_data1/oa_pdf/37/f5/13361_2013_Article_733.PMC3880471.pdf
The program of JFC was downloaded from http://bioinformatica.cigb.edu.cu/ isotopica/centermass.html .,OADS,/arxiv_data1/oa_pdf/37/f5/13361_2013_Article_733.PMC3880471.pdf
The BRAIN code was downloaded from http://www.bioconductor.org/ packages/release/bioc/html/ BRAIN.html .,OADS,/arxiv_data1/oa_pdf/37/f5/13361_2013_Article_733.PMC3880471.pdf
"MIDAs Web Interface MIDAs web interface http://www.ncbi.nlm.nih.gov/CBBresearch/ Yu/midas/index.html is user-friendly, but at the same time offers considerable flexibility.",OADS,/arxiv_data1/oa_pdf/37/f5/13361_2013_Article_733.PMC3880471.pdf
"To make these algorithms widely accessible, we have made them available through a user-friendly web-interface athttp://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/37/f5/13361_2013_Article_733.PMC3880471.pdf
ha−1(http://www.chinapesticide.gov.cn/ service/aspx/B3X.aspx?aiid=GRHEX ).,OADS,/arxiv_data1/oa_pdf/7b/e5/11356_2013_Article_2036.PMC3880475.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/76/c2/aps2013131a.PMC3880477.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/db/3c/aps2013142a.PMC3880479.pdf
The questionnaire is available on the web site of the IOF ( http://www.iofbonehealth.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"UN (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2010) World Population Prospects: The 2010 Revision, http://esa.un.org/unpd/ wpp/index.htm Accessed 16th December 2011 3.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"Data retreived in November, 2011; http://epp.eurostat.ec.europa.eu 3.",OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"UN (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2010) WorldPopulation Prospects: The 2010 Revision, http://esa.un.org/unpd/ wpp/index.htm Accessed 16th December 2012 5.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Accessed http://www.shef.ac.uk/ FRAX/pdfs/WHO_Technical_Report.pdf 2.,OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"UN (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2010) World Population Prospects: The 2010 Revision, http://esa.un.org/unpd/ wpp/index.htm Accessed 16th December 2012 1h Population projections Domain Burden of disease —background information Background and aims Secular changes in life expectancy and birth rate are likely to increase the number of elderly individuals in the EU member states and thereby increase the need for resourceallocation for diseases as sociated with ageing.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"United Nations (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population Prospects: http://esa.un.org/unpd/wpp/unpp/ panel_indicators.htm , accessed May2012;1i Fracture projections Domain Burden of disease —scorecard element Background and aims As noted, the number of men and women aged 50 years or more is set to increase with time in the EU.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"United Nations (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population Prospects: http://esa.un.org/unpd/wpp/unpp/ panel_indicators.htm , accessed May2012.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"FRAX is a computer-based algorithm ( http://www.shef.ac.uk/FRAX ) that calculates the 10-year probability of a major fracture (hip, clinical spine, humerus or wrist fracture) and the 10- year probability of hip fracture.",OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Accessible at: http://www.schattauer.de/en/ magazine/subject-areas/journa ls-a-z/osteology/contents/ archive/issue/special (Accessed May 2012) 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Access at http://www.shef.ac.uk/ FRAX/pdfs/WHO_Technical_Report.pdf 6.,OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"National Institute for Clinical Excellence (2008) Technology Appraisal (TA) 160: Alendronate, etidronate, risedronate, raloxi- fene and strontium ranelate for the primary prevention of osteoporotic fragility fractu res in postmenopausal women (amended) http://www.nice.org.uk/nicemedia/live/11746/47176/ 47176.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"National Institute for Clinical Excellence (2008) Technology Appraisal (TA) 161: Alendronate, etidronate, risedronate, raloxi-fene, strontium ranelate and teriparatide for the secondaryprevention of osteoporotic fragility fractures in postmenopausal women http://www.nice.org.uk/ni cemedia/live/11748/42508/ 42508.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Accessible at: http://www.schattauer.de/en/ magazine/subject-areas/journals-a-z/osteology/contents/archive/is- sue/special (Accessed May 2012) 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Available at http://www.nhfd.co.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
[On-line] Available at http://www.sqg.de/downloads/QIDB/2011/AQUA_ 17n1_Indikatoren_2011.pdf (Accessed on 29 June 2012).,OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Access at http://www.shef.ac.uk/ FRAX/pdfs/WHO_Technical_Report.pdf 3.,OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
"UN (2010) Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat (2010) World Population Prospects: The 2010 Revision, http://esa.un.org/unpd/ wpp/index.htm Accessed 16th December 2011 2.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/11657_2013_Article_144.PMC3880480.pdf
Available at: http://www.unicef.org/nutrition/index_24850.html .,Non-OADS,/arxiv_data1/oa_pdf/29/66/10995_2013_Article_1265.PMC3880483.pdf
"http://www.lead.org.au/fs/shootingranges.pdf Rosas SB, Andres JA, Rovera M, Correa NS (2006) Phosphate- solubilizing Pseudomonas putida can influence the rhizobia- legume symbiosis.",Non-OADS,/arxiv_data1/oa_pdf/f2/d7/11356_2013_Article_1968.PMC3880484.pdf
"Available at: http://www.shef.ac.uk/FRAX/ pdfs/WHO_Technical_Report.pdf 6.Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, III, Khaltaev N (2008) A reference standard for the description ofosteoporosis.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data accessed November, 2011. http://esa.un.or g/unpd/wpp/unpp/ p2k0data.asp 75. Cooper C, Campion G, Melton LJ, III (1992) Hip fractures in the elderly: a world-wide projection.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
Available at: http://www.iofbonehealth.org/ osteoporosis-europe an-unionten-years-progress-and-ongoing- challenges 10. International Osteoporosis Foundation (IOF) (2013) Osteoporo- sis Advisory Panel.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
INAMI-RIZIV Institut nationale d ’assurance maladie invalidité (2011) Accessed June 2011. http://www.inami.fgov.be/insurer/fr/ rate/pdf/last/doctors/rx20110601fr.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
The Social Insurance Institution of Finland (2011) Accessed July 2011. http://kela.fi/ 16.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retrieved in November, 2011. http://esa.un.org/unpd/wpp/ unpp/p2k0data.asp 2.Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, III, Khaltaev N (2008) A reference standard for the description ofosteoporosis.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retreived in November, 2011. http://epp.eurostat.ec.europa.eu , 54.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retrieved November, 2011. http://epp.eurostat.ec.europa.eu , 33.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
INAMI-RIZIV Institut national d ’assurance maladie-invalidité (2011) Accessed June 2011. http://www.inami.fgov.be/insurer/fr/ rate/pdf/last/doctors/rx20110601fr.pdf 58.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
Ministry of Health Bulgaria (2011) http://www.mh.government.bg/ Articles.aspx?lang=bg-BG&p ageid=383&categoryid=3999 .,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
Estonian Medicine Information (Raviminfo) (2011) Accessed Au- gust 2012. http://www.raviminfo.ee/otsing.php 66.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
http://kela.fi/ 67.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Health Payment Center in Latvia (VNC) (2011) communication with Toms Noviks August, 2011. http://www.vnc.gov.lv/ 80.",Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
http://www.sg.min-saude.pt/ 89.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
http://www.infarmed.pt/ 90.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Casa National de Asigurari de Sanatate (2011) Accessed August, 2011. http://www.cnas.ro/medicamente/lista-medicamentelor-2011 92.",Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
British National Formulary (2011) http://www.bnf.org/bnf/ 96.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retrieved in November, 2011. http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspPage 91 of 115, 136 Arch Osteoporos (2013) 8:136",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retrieved in November, 2011. http://epp.eurostat.ec.europa.eu , 3.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
http://www.inami.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
Ministry of Health Bulgaria (2011) http://www.mh.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
Danish Medicines Agency (2011) http://www.medicinpriser.dk Accessed July 2011.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
The Social Insurance Institution of Finland (2011) http://kela.fi/ Accessed July 2011 11.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
National Authority of Medicines and Health Products Portugal (2011) http://www.infarmed.pt/ Accessed July 2012 20.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Casa National de Asigurari de Sanatate (2011) http://www.cnas.ro/ medicamente/lista-medicamentelor-2011 Accessed August, 2011 21.",Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
British National Formulary (2011) http://www.bnf.org/bnf/ 24.,Non-OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
"Data retrieved in November, 2011. http://esa.un.org/unpd/wpp/unpp/ p2k0data.asp 40.",OADS,/arxiv_data1/oa_pdf/9c/30/11657_2013_Article_136.PMC3880487.pdf
http://europa.eu.int/comm/food/fs/sc/scf/ index_en.html .,Non-OADS,/arxiv_data1/oa_pdf/1d/87/11356_2013_Article_2022.PMC3880489.pdf
A country specificFRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/p2k0data.asp 13.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed June: http://www.inami.fgov.be/insurer/fr/rate/ pdf/last/doctors/rx20110601fr.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Page 19 of 218, 137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed January 2013. http://censusresults.nsi.bg/Census/Reports/ 2/2/R1.aspx 2.,OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 3.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Available at http://www.iofbonehealth.org/eastern-european-central-asian-audit 10.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspTable 19 Number of men and women eligible for treatment, treated and treatment gap in 2010 Number potentially treated (1000 s )Number eligible for treatment (1000 s )Difference (1000 s )Treatment gap(%) Men 2 92 90 98 Women 13 240 227 95Arch Osteoporos (2013) 8:137 Page 27 of 218, 137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspTable 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Cyprus assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 5 0 – 7 44 04 54 85 2 75+ 44 47 54 59All 84 92 102 112 Men 5 0 – 7 42 42 73 03 4 75+ 22 24 26 32A l l 4 65 15 76 6 Women and Men 5 0 – 7 46 47 27 98 6 75+ 66 71 81 91All 130 142 169 177137, Page 34 of 218 Arch Osteoporos (2013) 8:137",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk(http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data re-trieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.asp137, Page 42 of 218 Arch Osteoporos (2013) 8:137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"A country specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).Epidemiology of fracture in Denmark Data on hip fracture incidence are available for Denmark [5], based on admission statistics from the Danish Na-tional Board of Health.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data re-trieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.asp 13.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed January 2013 http://pxweb.tai.ee/esf/pxweb2008/Database_en/ Morbidity/databasetree.asp 5.,OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed Au- gust: http://www.raviminfo.ee/otsing.php 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in No-vember, 2011: http://esa.un.org/unpd /wpp/unpp/p2k0data.asp137, Page 58 of 218 Arch Osteoporos (2013) 8:137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
http://www.kaypahoito.fi/web/kh/suositukset/naytaartikkeli/ …/ ccs00092 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed July: http://kela.fi/ 13.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.asp137, Page 66 of 218 Arch Osteoporos (2013) 8:137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in France assuming the uptake of treatment remains unchanged 0100'000200'000300'000400'000500'000600'000700'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed January 2013 http://www.egms.de/static/en/meetings/gmds2012/ 12gmds165.shtml 6.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data ret- rieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Germany assuming the uptake of treatment remains unchanged 050'000100'000150'000200'000250'000300'000350'000400'000450'000500'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Acountry specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data ret- reived in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Greece assuming the uptake of treatment remains unchanged Table 19 Number of men and women eligible for treatment, treated and treatment gap in 2010 Number potentially treated (1000 s )Number eligible for treatment (1000 s )Difference (1000 s )Treatment gap(%) Men 50 40 −10 −25 Women 333 482 149 310200'000400'000600'000800'0001'000'0001'200'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000/year Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk (http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 137, Page 106 of 218",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data re- trieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Italy assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 2,932 3,003 3,142 3,232 75+ 8,173 8,751 9,235 9,835 All 11,104 11,753 12,377 13,067 Men 50–74 1,812 1,873 2,003 2,121 75+ 2,886 3,164 3,488 3,955 All 4,698 5,036 5,492 6,076 Women and Men 50–74 4,744 4,875 5,146 5,353 75+ 11,058 11,915 12,723 13,790 All 15,803 16,790 17,869 19,143 0100'000200'000300'000400'000500'000600'000700'000800'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed Jan 2013 http://www.vmnvd.gov.lv/lv/420-k liniskas-vadlinijas/klinisko- vadliniju-datu-baze/registretas-2012gada 4.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Health Payment Center in Latvia (VNC) (2011) communication with Toms Noviks August, 2011. http://www.vnc.gov.lv/ 10.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in No- vember, 2011: http://esa.un.org/unpd/w pp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Table 19 Number of men and women eligible for treatment, treated and treatment gap in 2010 Number potentially treated (1000 s )Number eligible for treatment (1000 s )Difference (1000 s )Treatment gap(%) Men 2 24 22 93 Women 12 80 68 85137, Page 122 of 218",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is a lso available for the assess- ment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data re- trieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspArch Osteoporos (2013) 8:137 137, Page 130 of 218",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed Jan 2013 http://www.conseil- scientifique.lu/index.php?id=84 4.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in No- vember, 2011: http://esa.un.org/unpd/wpp/unpp/p2k0data.asp 11.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in No- vember, 2011: http://esa.un.org/unpd/w pp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Page 145 of 218, 137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Malta assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 5 0 – 7 41 21 21 41 4 75+ 17 18 19 23A l l 2 93 03 33 7 Men 50–74 7 8 9 9 75+ 5 6 7 9A l l 1 21 41 61 8 Women and Men 5 0 – 7 41 92 02 32 3 75+ 22 24 26 32 A l l 4 14 44 95 5",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
country specific FRAX model is a lso available for the assess- ment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data ret- rieved in November, 2011: http://esa.un.org/ unpd/wpp/unpp/ p2k0data.aspPage 153 of 218, 137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in the Netherlands assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 547 590 637 659 75+ 1,250 1,315 1,400 1,539 All 1,796 1,905 2,036 2,198 Men 50–74 410 444 483 509 75+ 480 529 614 756 All 890 973 1,097 1,265 Women and Men 50–74 957 1,033 1,119 1,168 75+ 1,730 1,844 2,014 2,296 All 2,686 2,877 3,133 3,463 0100'000200'000300'000400'000500'000600'000700'000800'000900'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data ret- rieved in November, 2011: http://esa.un.org/ unpd/wpp/unpp/ p2k0data.aspPage 161 of 218, 137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Poland assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 364 380 422 453 75+ 669 722 756 825 All 1,033 1,102 1,178 1,278 Men 50–74 344 366 397 420 75+ 207 221 230 259 All 551 586 627 679 Women and Men 50–74 708 746 819 873 75+ 876 943 986 1,084 All 1,584 1,689 1,805 1,957 0100'000200'000300'000400'000500'000600'000700'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is a lso available for the assess- ment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Communi- cation with Lina Freitas: http://www.sg.min-saude.pt/ 9.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Accessed July: http://www.infarmed.pt/ 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data ret- rieved in November, 2011: http://esa.un.org/ unpd/wpp/unpp/ p2k0data.aspPage 169 of 218, 137 Table 19 Number of men and women eligible for treatment, treated and treatment gap in 2010 Number potentially treated (1000 s )Number eligible for treatment (1000 s )Difference (1000 s )Treatment gap(%) Men 40 53 13 24 Women 269 425 156 37Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Portugal assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50– Men 50– Women and Men 50–74 205 211 221 230 75+ 622 666 712 763 All 828 878 933 992 74 123 128 138 149 75+ 206 225 247 279 All 330 354 385 428 74 329 340 360 378 75+ 829 892 959 1,042 All 1,157 1,231 1,318 1,420 0200'000400'000600'000800'0001'000'0001'200'0001'400'0001'600'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Accessed August, 2011: http://www.cnas.ro/medicamente/lista-medicamentelor-2011 9.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspPage 177 of 218, 137 Arch Osteoporos (2013) 8:137",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.asp 12.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.euPage 193 of 218, 137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Slovenia assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 5 0 – 7 44 54 75 15 4 75+ 105 117 125 137 All 150 165 176 191 Men 5 0 – 7 44 24 44 85 2 75+ 33 37 43 53 All 74 82 91 105 Women and Men 50–74 87 92 99 105 75+ 137 155 169 190 All 224 246 267 296 0200'000400'000600'000800'0001'000'0001'200'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 137, Page 194 of 218",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is a lso available for the assess- ment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://esa.un.org/unpd/ wpp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Spain assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 942 1,007 1,095 1,175 75+ 3,407 3,667 3,905 4,188 All 4,349 4,674 5,000 5,363 Men 50–74 572 614 683 763 75+ 1,191 1,313 1,460 1,665 All 1,764 1,927 2,142 2,428 Women and Men 50–74 1,514 1,621 1,778 1,938 75+ 4,599 4,980 5,365 5,853 All 6,113 6,601 7,143 7,791 0100'000200'000300'000400'000500'000600'000700'000800'000900'0001'000'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assessment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in No- vember, 2011: http://esa.un.org/unpd/w pp/unpp/p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost ( €000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in Sweden assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 746 802 821 815 75+ 1,964 2,027 2,149 2,360 All 2,709 2,829 2,970 3,175 Men 50–74 614 655 672 677 75+ 828 866 987 1,178 All 1,442 1,521 1,659 1,856 Women and Men 50–74 1,360 1,457 1,493 1,492 75+ 2,792 2,892 3,136 3,538 All 4,152 4,349 4,629 5,031 0100'000200'000300'000400'000500'000600'000700'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
A country specific FRAX model is also available for the assess- ment of fracture risk ( http://www.shef.ac.uk/FRAX/ ).Incidence data for hip and forearm fractures were retrieved from Singer et al.,OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data retrieved in November, 2011: http://epp.eurostat.ec.europa.eu 2.",OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
http://www.bnf.org/bnf/ 10.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
"Data re- trieved in November, 2011: http://esa.un.org/unpd/wpp/unpp/ p2k0data.aspArch Osteoporos (2013) 8:137 Table 18 Present and future cost (£ 000,000) of fracture (direct cost and cost of QALYs) by age and calendar year in men and women in the UK assuming the uptake of treatment remains unchanged 2010 2015 2020 2025 Women 50–74 2,025 2,157 2,818 2,333 75+ 5,459 5,680 7,345 6,484 All 7,484 7,837 10,163 8,817 Men 50–74 1,752 1,860 2,438 2,046 75+ 2,233 2,402 3,275 3,087 All 3,985 4,262 5,713 5,133 Women and Men 50–74 3,777 4,017 5,255 4,380 75+ 7,691 8,082 10,620 9,571 All 11,468 12,099 15,876 13,951 0200'000400'000600'000800'0001'000'0001'200'000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011alendronate denosumab etidronate ibandronate PTH raloxifene risedronate strontium ranelate teriparatide zoledronic acidDDDs/100,000 person-years Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/11657_2013_Article_137.PMC3880492.pdf
Available at: http://www.who.int/childgrowth/en/.,Non-OADS,/arxiv_data1/oa_pdf/d7/c2/petr0018-0103.PMC3880615.pdf
"ORIGINAL ARTICLE  165  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Comparative Study of Aerobic Performance Between Football and Judo Groups                  in Prepubertal Boys                                                          Moez Triki *1ABCDG , PhD ; Haithem Rebai 1ACEG , PhD ; Mohammed Shamssain 2ACEG , MD ; Kaouthar Masmoudi 3BG , PhD ;  Nicole Fellmann 4,5CEG , PhD; Hela Zouari 1 BEG , PhD ; Nouri Zouari 3BG , MD; Zouhair Tabka 1ACDEG , MD Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Triki M, et al    166  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              VO 2max  does not increase with training before the peak  of puberty  [10-16] .",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Aerobic Performance Between Football and Judo   167  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   (Seca, Hultafors, Sweden)  and body mass was  measured to the nearest 0.1 kilogram with a standard  scale (Avery Berkel model HL 120; Avery Weigh- Tronix Inc., Fairmont, MN, USA).",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Triki M, et al    168  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              Table 2: Ventilatory threshold and maximal physiological responses of the three groups   Parameter  Football (n=32)  Mean (SD)  Judo (n=32)  Mean (SD)  Controls (n=32)  Mean (SD)  P. Value  Power [VT] (W) 44.84 (14.08) 42.84 (12.89) 44.25 (12.95) 0.8  VO 2   [VT] (l/min/Kg)  28.15 (6.18)  26.21 (8.06)  29.98 (8.25)  0.1  RER [VT] 0.90 (0.08) 0.89 (0.10) 0.83 (0.05) 0.0003  VE [VT] (l/mn)  26.88 (6.54)  26.53 (7.27)  26.72 (7.27)  1  HR [VT] (bpm) 127.53 (11.01) 129.88 (15.66) 138.31 (15.35) 0.007  Power  max  (W)  114.06 (22.34)  115.22 (24.23)  98.59 (17.67)  0.003  Vo 2   max   (l/min/Kg) 53.86 (7.28) 52.45 (7.86) 53.25 (7.48) 0.8  RER max   1.07 (0.12)  1.12 (0.16)  0.99 (0.09)  0.0002  VE max (l/mn) 62.86 (14.38) 74.61 (19.99) 62.92 (11.33) 0.003  HR max , bpm  186.55 (8.57)  188.19 (11.70)  187.56 (10.42)  0.2  SD: Standard Deviation; VT: Ventilatory Threshold; VO 2 : Oxygen Consumption; RER: Respiratory Exchange Ratio; VE: Minute  Ventilation; HR: Heart Rate   RESULTS  Table 1 shows the physical and lung function  measurements in the three groups.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Aerobic Performance Between Football and Judo   169  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Table 4: Pearson correlation values (r) between  anthropometric variables and aerobic performance parameters   Variable  Football  Judo  Controls  VO 2 max vs. LM 0.51* 0.38* 0.39*  VO 2 max vs. FM  -0.36*  -0.36*  -0.53*  Pmax vs. LM 0.11 0.36* 0.62*  VO 2 [VT] vs. LM  -0.07  -0.30  0.07  P[VT] vs. LM 0.36* 0.13 0.42*  VE[VT] vs. VO 2  [VT]   0.65*  0.86*  0.75*  VE[VT] vs. P[VT] 0.75* 0.66* 0.60*  VE[VT] vs. HR[VT]  0.42*  0.54*  0.50*                           * P<0.05; VO2: Oxygen Consumption; VE: Minute Ventilation; VT: Ventilatory Threshold; HR: Heart Rate    significant relationship between P[VT] and LM and  mainly with VE to VO 2  [VT], P[VT] and HR[VT] in  all groups.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Triki M, et al    170  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              practice of football or judo in prepubertal boys; they  are similar to the control group.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Aerobic Performance Between Football and Judo   171  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   program and showed an increase in mass related to  peak VO 2  of 13.7% for the experimental group of  prepubertal boys (n = 16).",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Triki M, et al    172  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              the control group compared to the footballers and  judokas.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Aerobic Performance Between Football and Judo   173  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   [3] Cordain L, Tucker A, Moon D, et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"    Triki M, et al    174  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              [34] Romijn JA, Coyle EF, Sidosis LS, et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/89/ASJSM-4-165.PMC3880659.pdf
"ORIGINAL ARTICLE  175  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Narita Target Heart Rate Equation Underestimates the Predicted Adequate Exercise                  Level in Sedentary Young Boys                                                          Marefat Siahkouhian *ACDEG , PhD; Davar Khodadadi BDG Authors’ Affiliation:   Department of Physical Education & Sport  Sciences, University of Mohaghegh  Ardabili, Ardabil, Iran   Authors’ Contribution     A.",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"    Siahkouhian M and Khodadadi D    176  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              skiers  [4] .",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"    Narita Equation & Training Intensity  177  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3), Sep 2013    selected to gradually progress in increments from  moderate to maximal intensity.",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"    Siahkouhian M and Khodadadi D    178  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              Table 2: GXT Peak values for Vco2, Vo2, heart rate, time to exhaustion and phase of exhaustion  Variables  Mean (SD)  Vco2 (l/min) 6.24 (9.81)  Vo2 (l/min)  2.77 (0.39)  (Vco2/Vo2 ratio) (%) 1.32 (0.06)  Heart Rate (b/min)   97.36 (7.48)  Time to Exhaustion (min) 14.17 (1.59)  Phase of Exhaustion (No)  5.19 (0.59)  SD: Standard Deviation  and Narita target heart rate equation are shown in Table  3.",OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"    Narita Equation & Training Intensity  179  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3), Sep 2013     Figure 1:  RER curve during the GXT protocol in the subjects  basis of what is called the 'AT' and even more  confusion concerning the noninvasive determination of  the AT via gas exchange parameters during exercise  [23,24] .",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"    Siahkouhian M and Khodadadi D    180  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                REFERENCES  [1] Bodner ME, Rhodes EC.",Non-OADS,/arxiv_data1/oa_pdf/a4/e9/ASJSM-4-175.PMC3880660.pdf
"ORIGINAL ARTICLE  181  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   The Effects of Ingestion of Sugarcane Juice and Commercial Sports Drinks on Cycling  Performance of Athletes in Comparison to Plain Water                             Kommi Kalpana *1ADEG ; Priti Rishi Lal 2AEG ; Doddipalli Lakshmi Kusuma 1AEG ;   Gulshan Lal Khanna 3AEG   Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Kalpana K, et al    182  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              been shown to be effective hydration drinks.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Effects of Sugarcane Juice on Cycling Performance of Athletes  183  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013     Table 1: Nutrient composition of sports drink and sugarcane juice  Nutrients  Sports drink(25mg)  Sugarcane Juice (100g)  Energy (k.cal) 91 39  Carbohydrate (g)  25  9.1  Vitamin A (IU) 500  188   Vitamin B1 (mcg)  -  12   Vitamin B12 * (mcg) 2 -  Vitamin –C* (mg)  60  -  Vitamin –D3* (IU) 400 -  Vitamin –E* (mg)  10  -  Calcium Pancothenate* (mg) 10 -  Potassium (mg)  100  360   Sodium (mg) 100 20   Calcium (mg)  200  74  Phosphorus (mg) 150 22  Iron (mg)  -  0.1  Zinc* (mg) 1.25 -  Magnesium* (mg)  75  -  Manganese*  (mcg) 100 -  Selenium*  (mcg)  20  -                                     * Not measured in ScJ  water, which was given during exercise and the 9%  solution, in the form of pure sugarcane juice was given  after exercise.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Kalpana K, et al    184  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                  Fig.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Effects of Sugarcane Juice on Cycling Performance of Athletes  185  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Table 2: Total exercise time and peak blood lactate concentration of athletes with select liquid drinks   Parameter  Liquid Supplements  Total Exercise Time (min)  (Mean ± Standard Error)  ANOVA value  Total exercise time Plain Water 62.0 (5.29)  F= 0.07 NS  Sports Drink 64.3 (5.63)  Sugarcane Juice 63.4 (5.54)  Peak Blood Lactate  Concentration  Water  12.0 (0.66)  F= 0.01 NS   Sports Drink  12.0 (0.57)  Sugarcane Juice  12.1 (0.68)                        NS: Not significant   exercise, the mean hemoglobin and hematocrit level  was increased with increase in exercise time ( P<0.05)   and decreased during recovery ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Kalpana K, et al    186  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              Table 3: Pre and post exercise changes in body weight and sweat loss of subjects in the trials with select liquid drinks   Hydration Indicators  Mean ± Standard Error  ANOVA Value  Plain Water  Sports drink  Sugarcane juice  Pre exercise body weight (kg) 63.7(1.52) 64.0(1.48) 63.7(1.52) F=0.01 NS   Post exercise body weight (kg)  63.5(1.56  63.7(1.49)  63.5(1.54)  F= 0.00 NS   Change in body weight (%) 0.4(0.07) 0.5(0.08) 0.4(0.07) F= 0.15 NS   Sweat loss (ml)  797.6(58.83)  799.6(100.82)  759.6(102.77)  F=0.04 N S       NS: Not significant  difference between three trials viz; SpD, ScJ and PW,  but the mean values showed that the subjects  performed exercise for a longer time with SpD and ScJ  than PW.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Effects of Sugarcane Juice on Cycling Performance of Athletes  187  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Table 5: Kruskals wallis test results for gastro intestinal tolerance of the subjects during exercise and recovery with select liquid drinks   Gastrointestinal  tolerance  Trial  Exercise Time (min) (Mean Ranks)  Recovery  20  40  60  80  Thirst  Plain Water  16.5  16.0  11.5  7.5  22.0  Sport Drink  27.0  16.0  14.5  6.0  20.5  Sugarcane juice  25.5  22.3  16.5  6.0  26.5  Chi- square Value   9.09*  9.57 NS   4.10   NS   2.00   NS   2.63   NS   Sweetness Plain Water 9.0 9.0 5.5 3.0 8.2  Sport Drink 26.9 21.5 17.8 9.0 29.3  Sugarcane juice 33.1 27.5 19.2 10.0 31.4  Chi- square Value 31.9* 24.9* 21.9* 11.0* 30.9*  Stomach Upset  Plain Water  23.0  18.0  13.5  5.0  22.5  Sport Drink  23.0  18.0  15.0  6.5  24.0  Sugarcane juice  23.0  18.0  13.5  8.0  22.5  Chi- square Value  0.00 NS   0.00   NS   2.00   NS   2.44   NS   2.00   NS   Fullness Plain Water 19.5 15.5 10.5 3.0 18.5  Sport Drink 22.5 18.9 15.7 7.5 21.4  Sugarcane juice 27.0 22.0 17.5 9.0 29.0  Chi- square Value 6.28* 3.98 NS  6.32* 8.17* 10.72*  Nausea  Plain Water  23.0  18.5  15.5  6.50  23.0  Sport Drink  23.0  18.5  15.5  6.50  23.0  Sugarcane juice  23.0  18.5  15.5  6.50  23.0  Chi- square Value  0.00   NS   0.00   NS   0.00   NS   0.00   NS   0.00   NS       * Significant at P<0.05; NS : Not significant  water or by sports drink or sugarcane juice.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Kalpana K, et al    188  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              composition of sugarcane juice.",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"    Effects of Sugarcane Juice on Cycling Performance of Athletes  189  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   [18] Gisolfi CV, Duchman M. Guidelines for optimal replacement beverages for different athletic events .",Non-OADS,/arxiv_data1/oa_pdf/6e/35/ASJSM-4-181.PMC3880661.pdf
"ORIGINAL ARTICLE  190  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Attributes of Dental Trauma in a School Population with Active Sports Involvement                                         Anand Prabhu *ABCDEFG , MDS; Arun Prasad Rao ABCDEG , MDS; Mohan Govindarajan ACDEG , MDS;                      Venugopal Reddy ACDEG , MDS; Ramalingam Krishnakumar ACDEG , MDS; Sugumaran Kaliyamoorthy ACDEG , MDS Authors’ Affiliation:   Department of Pedodontics and Preventive  dentistry, Rajah Muthiah Dental College  and Hospital, Annamalai University,  Annamalainagar, Tamilnadu.",Non-OADS,/arxiv_data1/oa_pdf/bf/34/ASJSM-4-190.PMC3880662.pdf
"    Dental Injuries in Children in Active Sports Involvement  191  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   obstacle course, horse riding facilities and swimming  pool facilities.",Non-OADS,/arxiv_data1/oa_pdf/bf/34/ASJSM-4-190.PMC3880662.pdf
"    Prabhu A, et al    192  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              Table 2:  Toothwise distribution of trauma and trauma scores in children with active sports involvement Trauma score  1  2  3  4  5  6  Total (N%)  Maxillary right central incisor 41 21 1 1 1 1 66 (39.8)  Maxillary right lateral incisor  16  17  0  0  0  0  33 (19.9)  Maxillary left central incisor 20 21 1 0 0 0 42 (25.3)  Maxillary left lateral incisor  6  4  0  1  0  0  11 (6.6)  Other teeth 8 4 2 0 0 0 14 (8.4)  Total injured teeth  91(51.8)  67(40.4)  4(2.4)  2(1.2)  1(0.6)  1(0.6)  166 (100)               Chi square value = 24.30; P. value= 0.2    maxillary left central incisors.",Non-OADS,/arxiv_data1/oa_pdf/bf/34/ASJSM-4-190.PMC3880662.pdf
"    Dental Injuries in Children in Active Sports Involvement  193  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013        Table 5:  Trauma distribution by Lip coverage and Overjet  Anatomic risk factor  Trauma  Total  Yes  No  Lip coverage Adequate  36 303 339 (76%)  Inadequate  70 37 107(24%)  Total 106 (23.8%) 340 (76.2%) 446 (100%)  Overjet   <3.5 mm  18  222  240 (53.8%)  3.5 to 5.5 mm  54  98  152 (34.1%)  >5.5 mm  34  20  54 (12.1%)  Total   106 (23.8%)  340 (76.2%)  446 (100%)                                 Chi-square value = 134.80; P. value <0.001; Gamma value = -0.78       Sport was the leading cause of injury as reported in  an earlier study  [4]  and the second most common cause  was of unknown origin in accordance with Rai and  Munshi  [5] .",Non-OADS,/arxiv_data1/oa_pdf/bf/34/ASJSM-4-190.PMC3880662.pdf
"    Prabhu A, et al    194  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                REFERENCES  [1] Traebert J, Peres MA, Blank V, et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/34/ASJSM-4-190.PMC3880662.pdf
"ORIGINAL ARTICLE  195  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Altered Peak Knee Valgus during Jump-Landing among Various Directions                                       in Basketball and Volleyball Athletes                                                   Komsak Sinsurin 1ABCDEFG , PT; Roongtiwa Vachalathiti *1ACDEG , PhD, PT;                                      Wattana Jalayondeja 1ACDEG , PhD, PT; Weerawat Limroongreungrat 2ACDEG , PhD, PT Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"    Sinsurin K, et al    196  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              tasks in the air requiring the athlete to jump and land in  multi-directions.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"    Knee Valgus Angle during Jump-Landing  197  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013       Fig.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"    Sinsurin K, et al    198  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                Fig.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"    Knee Valgus Angle during Jump-Landing  199  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   could induce more knee valgus loading than occurred  in the other directions and increase the risk of knee  injury.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"    Sinsurin K, et al    200  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              [14] Coventry E, O'Connor KM, Hart BA, et al.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ASJSM-4-195.PMC3880663.pdf
"ORIGINAL ARTICLE  201  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Martial Arts Training Attenuates Arterial Stiffness in Middle Aged Adults  Peter C. Douris *1 , EdD; Teresa Ingenito 1ABCDEG , MSc; Barbara Piccirillo 2ABCDEG , MSc; Meredith Herbst 1ABCDEG , DPT;  John Petrizzo 1ABCDEG , DPT; Vincen Cherian 1ABCDEG , DPT; Christopher McCutchan 1ABCDEG , DPT;                                       Caitlin Burke 1ABCDEG , DPT; George Stamatinos 1ABCDEG , DPT; Min-Kyung Jung 3CDG , PhD  Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Douris PC, et al    202  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              within the vascular walls?",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Martial Arts Training Attenuates Arterial Stiffness  203  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   with an average experience of approximately twenty  years in SBD.",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Douris PC, et al    204  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              test, subjects were assessed for passive hamstring  length.",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Martial Arts Training Attenuates Arterial Stiffness  205  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Table 2: Comparison of results between the soo bahk do and sedentary subjects  Parameter  Soo Bahk Do (n=10)  Mean (SEM)  Sedentary (n=10)  Mean (SEM)  Observed  Power  P. value  Pulse Wave Velocity (m/s)  7.60 (0.85)  18.15 (3.07)  0.88  0.004  Trunk (cm) 48.05 (3.18) 30.65 (3.49) 0.94 0.002  Hamstring (d)  78.10 (2.64)  65.20 (2.56)  0.91  0.003    normal aging have been shown to be directly related  with increasing arterial stiffness starting in middle- aged persons  [2,4] .",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Douris PC, et al    206  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              associated with aging result in decreased compliance  and flexibility of the connective tissue found within the  musculotendinous unit [28] .",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"    Martial Arts Training Attenuates Arterial Stiffness  207  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013     REFERENCES  [1] Kingwell BA, Gatzka, CD.",Non-OADS,/arxiv_data1/oa_pdf/5e/15/ASJSM-4-201.PMC3880664.pdf
"ORIGINAL ARTICLE  208  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Changes of Serum Retinol Binding Protein 4 Levels Following 8 Weeks                                      Moderate Aerobic Exercise                                                    Narges Ahmadi 1ABG ; Mehrzad Moghadasi* 2ACDG , PhD; Reza Nuri 3ADG , PhD Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/db/08/ASJSM-4-208.PMC3880665.pdf
"    Changes of Serum RBP4 Following 8 Weeks Aerobic Exercise  209  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   METHODS AND SUBJECTS  Subjects:  Twenty female karate athletics (24.3 ± 4.8 years; mean  ± SD) participated in this study.",Non-OADS,/arxiv_data1/oa_pdf/db/08/ASJSM-4-208.PMC3880665.pdf
"    Ahmadi N, et al    210  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                 Table 1: Anthropometric and metabolic characteristics (mean ± SD) of the subjects before and after training  Parameter  Control (Mean±SD)  Training (Mean±SD)  Pre-training  Post-training  Pre-training  Post-training  Body mass (Kg)  57.8 (8.4)  57.9 (8.4)  55.1 (9.1)  57.4 (9.1)* †   Body mass index (Kg/m 2 ) 21.4 (3.0) 21.4 (3.0) 21.3 (2.8) 22.2 (2.6)* †   Body fat (%)  17.3 (5.0)  17.8 (5.2)  18.6 (3.3)  19.0 (3.0)  Waist to hip ratio 0.74 (0.05) 0.75 (0.05) 0.73 (0.04) 0.70 (0.03)  VO 2max  (ml.Kg - 1 .min - 1 )  47.7 (3.5)  47.9 (3.4)  47.5 (3.8)  48.2 (2.8)        *:   P<0.05 for between-group differences; †:   P<0.05, pre-training vs. post-training values; SD: Standard Deviation  The relationships between variables in the training  groups were determined using Spearman correlation  test.",Non-OADS,/arxiv_data1/oa_pdf/db/08/ASJSM-4-208.PMC3880665.pdf
"    Changes of Serum RBP4 Following 8 Weeks Aerobic Exercise  211  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013     levels and body composition parameters including  body mass, BMI and WHR in female athletes.",Non-OADS,/arxiv_data1/oa_pdf/db/08/ASJSM-4-208.PMC3880665.pdf
"    Ahmadi N, et al    212  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              [3] Quadro L, Blaner WS, Salchow DJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/db/08/ASJSM-4-208.PMC3880665.pdf
"ORIGINAL  ARTICLE  213  Publi shed by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)              Asian J Sports Med; Vol 4 (No 3),  Sep 2013 Physio logical Responses of General vs.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Zouhal H, et al    214  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              success relationship by demonstrating a significant  difference between top team and lower team in  Norwegian 1 st  division championship.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Football and Endurance Exercises  215  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3), Sep 2013   aerobic exercises: 15s/15s at 120% of maximal aerobic  speed (MAS) and an integrated exercise on the HTE in  highly trained soccer players.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Zouhal H, et al    216  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                   Fig.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Football and Endurance Exercises  217  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3), Sep 2013      Table 1: Physiological parameters determined at rest and during the maximal graded exercise testing (n=7)  HR: heart rate.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Zouhal H, et al    218  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                                            Fig.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Football and Endurance Exercises  219  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3), Sep 2013       first two sets of the exercises.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"    Zouhal H, et al    220  Asian J Sports Med; Vol 4 (No 3), Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                REFERENCES  [1] Bangsbo J.",Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
Available at: http://www.sportsci.org/resource/stats/index.html.,Non-OADS,/arxiv_data1/oa_pdf/33/05/ASJSM-4-213.PMC3880666.pdf
"ORIGINAL ARTICLE  221  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Comparison of Dynamic Balance in Collegiate Field Hockey and Football Players Using  Star Excursion Balance Test                                                          Rashi Bhat ABCDG ; Jamal Ali Moiz *ACDEG , MPT Authors’ Affiliation:   Centre for Physiotherapy and  Rehabilitation Sciences, Jamia Millia  Islamia, New Delhi, India   Authors’ Contribution     A.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Bhat R and Moiz JA    222  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              to be a predictive measure of lower extremity injury in  high school basketball players.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Dynamic Balance in Collegiate Field Hockey and Football Players  223  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   and visual demonstration of the testing procedure was  given to each participant.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Bhat R and Moiz JA    224  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                Table 1: Demographic Characteristics of Subjects  Variable  Field Hockey (n=15)  Mean (SD)  Football (n=15)  Mean (SD)  P. value  Age (years)  21.20 (1.61) 20.93 (1.71) 0.7  Weight (Kg)  62.76 (7.18)  65.66 (7.61)  0.3  Height (meters) 1.68 (0.07) 1.73 (0.06) 0.07  Body Mass Index (kg/m 2 )  22.05 (1.37)  21.83 (1.57)  0.7  Right Limb Length (cm) 88.50 (3.90) 92.37 (4.80) 0.02  Left Limb Length (cm)  88.76 (4.09)  92.63 (4.80)  0.02                             SD: Standard Deviation  was evaluated using independent t-test and statistical  significance was assumed at P<0.05.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Dynamic Balance in Collegiate Field Hockey and Football Players  225  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Table 3: Comparison of total normalized reach distances of right and left leg in between the games  Limb  Field hockey  Mean (SD)  Football  Mean (SD)  t *  P. value  Right  770.87 (19.77) 764.92 (26.19) 0.702 0.5  Left  778.45 (27.39)  773.15 (22.14)  0.583  0.6                             * Independent t-test; SD: Standard Deviation   dynamic balance as compared to football players.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Bhat R and Moiz JA    226  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              similar static and dynamic balance as compared to  gymnasts and superior dynamic balance than basketball  players.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Dynamic Balance in Collegiate Field Hockey and Football Players  227  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013        Thorpe and Ebersole  [5]  found that posterior reach  direction of SEBT is correlated with hip extensor  strength in football players.",OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Bhat R and Moiz JA    228  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                REFERENCES  [1] Winter DA, Patla AE, Frank JS.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"    Dynamic Balance in Collegiate Field Hockey and Football Players  229  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   [33] Hart JM, Garrison JC, Kerrigan DC, et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/f9/ASJSM-4-221.PMC3880667.pdf
"SHORT COMMUNICATION   230  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   Relationship between Aerobic Capacity and Yo-Yo IR1 Performance in Brazilian  Professional Futsal Players                           Daniel A. Boullosa* 1ABCDG , PhD; Lais Tonello 2CDG ,   BPhEd; Isabela Ramos 2BG , MSc;                                                 Alessandro de Oliveira Silva 2DG , MSc; Herbert G. Simoes 2CEFG , PhD; Fabio Y. Nakamura 2ACEG , PhD Authors’ Affiliation:   1.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/ASJSM-4-230.PMC3880668.pdf
"    Aerobic correlates of Yo-Yo IR1 in Professional Futsal  231  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013   performance in this test has been reported to be related  to HIA during matches, VO 2 max, and selected  physiological responses during high-intensity  intermittent exercise  [5,6] .",Non-OADS,/arxiv_data1/oa_pdf/db/1b/ASJSM-4-230.PMC3880668.pdf
"    Boullosa DA, et al    232  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                  Table 1:  Players’ characteristics and physiological responses (n=15)  Parameters  Mean (SD)  Age (yrs)  25.9 (5.1)  Body Mass (kg)  74.37 (6.02)  Height (m) 1.77 (0.04)  Yo-Yo Intermittent Recovery Test level 1 (m)  1,226 (282)  Maximum heart rate recorded during the Yo-Yo test (bpm) 184 (15)  Maximum lactate after the Yo-Yo test (mmol∙L - 1 )  8.17 (1.63)  Maximum aerobic speed recorded during the ramp test (km∙h - 1 )   17.69 (1.88)  Maximum heart rate recorded during the Ramp test (bpm)  184 (5)  VO 2 max   (ml∙kg - 1 ∙min - 1 ) 57.25 (6.35)  VO 2 max (ml∙kg - 0.75 ∙min - 1 )  76.34 (8.46)  SD: Standard Deviation; VO 2 max: Maximum oxygen consumption in normal and mass adjusted values    DISCUSSION  Surprisingly S peak  significantly correlated with Yo-Yo  IR1 performance while VO 2 max did not.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/ASJSM-4-230.PMC3880668.pdf
"    Aerobic correlates of Yo-Yo IR1 in Professional Futsal  233  Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                                     Asian J Sports Med; Vol 4 (No 3),  Sep 2013     than the reported from other studies with elite team  sport athletes  [5,6]  and similar to the observed results in  semi- elite soccer referees; for example  [13] .",Non-OADS,/arxiv_data1/oa_pdf/db/1b/ASJSM-4-230.PMC3880668.pdf
"    Boullosa DA, et al    234  Asian J Sports Med; Vol 4 (No 3),  Sep 2013               Published by:  Tehran University of Medical Sciences  (http://asjsm.tums.ac.ir)                              REFERENCES  [1] Barbero-Alvarez JC, D'Ottavio S, Vera JG, et al.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/ASJSM-4-230.PMC3880668.pdf
The size of  each “wear” vector was therefore equivalent to the “wear”  measurement error.StatsDirect software (http://www.statsdirect.com) was  used for statistical calculations.,OADS,/arxiv_data1/oa_pdf/72/1b/10.5301_hipint.5000038.PMC3880854.pdf
Available at http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ rvfmap.htm (accessed May 2013).,OADS,/arxiv_data1/oa_pdf/18/cd/emi201381a.PMC3880870.pdf
Available at http://www.niaid.nih.gov/ topics/biodefenserelated/biodefense/pages/cata.aspx (accessed September 2013).,OADS,/arxiv_data1/oa_pdf/18/cd/emi201381a.PMC3880870.pdf
Available at http://www.nihbrp.com/ Citations/completed/HumanHealthEcologyTeam/riftvalley/ RVFV_Working_Group_Report%202004.pdf (accessed September 2013).,Non-OADS,/arxiv_data1/oa_pdf/18/cd/emi201381a.PMC3880870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Risk of RVFV introduction and establishment in the US and EU AI Rolin et al 8 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/18/cd/emi201381a.PMC3880870.pdf
The amounts of p24gagand Pr55gagin the Western blot were quantified using ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/e3/a6/emi201383a.PMC3880871.pdf
The signal strength of protease was quantified by ImageJ (http://rsb.info.nih.go v/ij/) and the values below the gel image represent the mean of three independent experiments.,OADS,/arxiv_data1/oa_pdf/e3/a6/emi201383a.PMC3880871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information for this article can be found on Emerging Microbes and Infections’ website (http://www.nature.com/EMI/)Slow progression of CRF07_BC PH Lin et al 9 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/e3/a6/emi201383a.PMC3880871.pdf
Available at http://www.health.qld.gov.au/dengue/documents/dengue-mgt- plan.pdf (accessed 16 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
Available at http://www.oesr.qld.gov.au/products/profiles/pop-housing-profiles-lga/ pop-housing-profile-townsville.pdf (accessed 15 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
Available at http://www.oesr.qld.gov.au/products/profiles/pop-housing-profiles-lga/ pop-housing-profile-cairns.pdf (accessed 15 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
Available at http://www.bom.gov.au/climate/averages/tables/cw_031011.shtml and http://www.bom.gov.au/climate/averages/tables/cw_032040.shtml (accessed 18Aprial 2013).,OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
Available at http://cran.r-project.org/web/packages/rpart/index.html (accessed 24 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Imported dengue, weather and autochthonous dengue XD Huang et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/f3/c9/emi201385a.PMC3880872.pdf
We included other swine-associated zoonotic diseases by reviewing lists compiled by the World Organization for Animal Health (www.oie.int)and the Merck Veterinary Manual (http://www.merckmanuals.com).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://faostat3.fao.org/faostat-gateway/go/to/home/E (accessed 26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.cdc.gov/h1n1flu/yearinreview/yir5.htm (Accessed 12 October 2012).,OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ebola/ ebolatable.htm (accessed 11 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://wwwn.cdc.gov/foodborneoutbreaks/ Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.merckvetmanual.com/mvm/index.jsp?cfile 5htm/bc/52400.htm (assessed 3 July 2012).,OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.merckmanuals.com/vet/respiratory_system/respiratory_diseases_of_pigs/ swine_influenza.html?qt 5influenza&alt 5sh (accessed 26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.who.int/immunization_ monitoring/diseases/tetanus/en/index.html (accessed 15 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
"Available at: http://www.nytimes.com/2009/05/01/ health/01egypt.html?_r 50 (accessed April 30, 2009).",Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.cfsph.iastate.edu/DiseaseInfo/notes/ Nipah.pdf (accessed 22 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.gpo.gov/fdsys/pkg/CHRG-111hhrg54577/ html/CHRG-111hhrg54577.htm (accessed on 26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: http://www.oie.int/en/for-the-media/press-releases/detail/article/the-oie-advocates-implementing-international-standards-for-humane-killing-of-animals-for- disease-pre/ (accessed11 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
Available at: https://www.avma.org/KB/Resources/ Reports/Documents/onehealth_final.pdf (accessed 21 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information for this article can be found on Emerging Microbes & Infections’ website (http://www.nature.com/emi/)Global review of swine zoonoses SU Khan et al 11 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/73/37/emi201387a.PMC3880873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Receptor binding and transmission of H5N1 virus H Zhao et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/89/c7/emi201389a.PMC3880874.pdf
Topological map of virus spread constructed with a force-directed graphWe designed a tool to determine all possible connections between cities using public open source code from Tim Dwyer and ThomasJakobsen (http://bl.ocks.org/mbostock/4062045#index.html).,OADS,/arxiv_data1/oa_pdf/1b/07/emi201391a.PMC3880875.pdf
Available at http://www.shagri.gov.cn/xwkd/news/ 201304/t20130409_1340203.htm (accessed 1 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/1b/07/emi201391a.PMC3880875.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Supplementary Information for this article can be found on Emerging Microbes & Infections ’ website (http://www.nature.com/EMI/)Spread of H7N9 by online knowledge analysis C Chen et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/1b/07/emi201391a.PMC3880875.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Cancer Research UK, Bowel cancer incidence statistics.",Non-OADS,/arxiv_data1/oa_pdf/c8/0c/flgastro-2013-100329.PMC3880905.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bjorkman DJ, Popp JW Jr.",Non-OADS,/arxiv_data1/oa_pdf/b1/aa/flgastro-2013-100334.PMC3880906.pdf
"2008 [cited 5 September 2010];http://www.thejag.org.uk/Forms/tabid/72/Default.aspx 13 Reznick R, Regehr G, MacRae H, et al.",OADS,/arxiv_data1/oa_pdf/b1/aa/flgastro-2013-100334.PMC3880906.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: R.G.M.,Non-OADS,/arxiv_data1/oa_pdf/5b/b8/srep03574.PMC3880958.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3574 | DOI: 10.1038/srep03574 7",Non-OADS,/arxiv_data1/oa_pdf/5b/b8/srep03574.PMC3880958.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/c2/srep03572.PMC3880959.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3572 | DOI: 10.1038/srep03572 7",Non-OADS,/arxiv_data1/oa_pdf/2d/c2/srep03572.PMC3880959.pdf
"Each cell linewas seeded in triplicate in its specific culture medium at an initial concentration of 2.5 310 5cells/flask (25 cm2), and cell growth was monitored after 24, 48, 72 and 96 h. Data from individual growth curves was used to calculate growth rate and doublingtime (t d) with http://www.doubling-time.com/compute.php.",OADS,/arxiv_data1/oa_pdf/33/29/srep03576.PMC3880960.pdf
Unsupervised feature selection .Antenna imaging movies were processed in a KNIME (www.knime.org) workflow using the ImageBee plugin 54for insect neuroimage data (http://tech.knime.org/community/image-processing).,OADS,/arxiv_data1/oa_pdf/33/29/srep03576.PMC3880960.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/29/srep03576.PMC3880960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3576 | DOI: 10.1038/srep03576 9",Non-OADS,/arxiv_data1/oa_pdf/33/29/srep03576.PMC3880960.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/58/srep03577.PMC3880961.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3577 | DOI: 10.1038/srep03577 8",Non-OADS,/arxiv_data1/oa_pdf/d3/58/srep03577.PMC3880961.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9b/ec/srep03579.PMC3880962.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3579 | DOI: 10.1038/srep03579 4",Non-OADS,/arxiv_data1/oa_pdf/9b/ec/srep03579.PMC3880962.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/48/srep03570.PMC3880963.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3570 | DOI: 10.1038/srep03570 5",Non-OADS,/arxiv_data1/oa_pdf/c9/48/srep03570.PMC3880963.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3571 | DOI: 10.1038/srep03571 8",Non-OADS,/arxiv_data1/oa_pdf/ba/d7/srep03571.PMC3880964.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4b/73/srep03564.PMC3880965.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3564 | DOI: 10.1038/srep03564 7",Non-OADS,/arxiv_data1/oa_pdf/4b/73/srep03564.PMC3880965.pdf
"11       http://www.medsci.org  1  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 1-6. doi: 10.7150/ ijms.6663   Research Paper   Influence of Endodontic Treatment on Systemic  Oxidative Stress  Francesco Inchingolo1,*,, Massimo Marrelli 2,4,*, Susanna Annibali6, Maria Paola Cristalli6, Gianna Dipal- ma2, Alessio Danilo Inchingolo7, Antonio Palladino7, Angelo Michele Inchingolo5, Marco Gargari8,*, Marco  Tatullo 2,3,4,*   1.",Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
"11       http://www.medsci.org  2  Introduction  Reactive chemical species (RCS) are highly rea c- tive molecules, atoms, or ions that are the intermed i- ates of physiological reactions involved in controlling  important vital processes.",Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
"11     http://www.medsci.org  3  Materials and Methods   Study Participants  The authors recruited 2 groups of patients from   private studies and dental clinics: these patients were  recruited randomly, were informed regarding the study and they have signed an informed consent .",Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
11     http://www.medsci.org  4  with values of 261 ± 10 for the d -ROMs test and 2227 ±  55 for the BAP test.,Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
"11     http://www.medsci.org  5  Discussion   Systemic oxidative stress has been correlated  with several pathological or physiopathological con- ditions such as type 2 diabetes mellitus, aging, card i- ovascular diseases, cancer, pulmonary diseases, and  hepatopathies.",Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
11     http://www.medsci.org  6  baseline compared t o endodontically -treated  groups22.,Non-OADS,/arxiv_data1/oa_pdf/c0/65/ijmsv11p0001.PMC3880985.pdf
"1 1      http://www.medsci.org  7  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 7-16. doi: 10.7150/ ijms.6851  Research Paper   17β-Estradiol Inhibits M esenchymal Stem C ells-Induced  Human AGS G astric Cancer Cell M obility via Suppre s- sion of CCL5-  Src/Cas/Paxillin Signaling P athway   Chao -Hung Kuo1,2,3, Chung -Jung Liu1,2, Chien- Yu Lu1,3, Huang -Ming Hu1, Fu-Chen Kuo4, Yu-Sen Liou1,  Yuan -Chieh Yang5, Ming -Chia Hsieh6,7, Oscar K. Lee8,9, Deng -Chyang Wu1,2,3,10 , Sophie S.W.",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
"1 1      http://www.medsci.org  8  Introduction  Gastric cancer  is one of the most common can- cers [1, 2]  and the secondary leading cause of ca n- cer-related mortality  worldwide [2].",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
"11     http://www.medsci.org  9  60-mm culture dishes  in RPMI -1640 medium  supplemented with 100μg/ml penicillin, 100μg/ml  streptomycin, 2 mM glutamine, 1 mM HEPS buffer, and 10% fetal bovine serum (all from Life Technol o- gies, Carlsbad, CA , USA).",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
"11     http://www.medsci.org  10  R&D Systems (Minneapolis, MN, USA) according to  the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
11     http://www.medsci.org  11        Fig.,Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
1 1      http://www.medsci.org  12    Fig.,Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
"11     http://www.medsci.org  13   To further investigate the molecular mechanism  underlying the E2  inhibitory effect on CCL -5-induced  AGS cell migration, we treated AGS cells with CCL -5  (1ng/ml) for 3 hours and measured the phosphoryl a- tion/activation of cell mobility -related proteins by  immunoblotting assay.",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
11     http://www.medsci.org  14    Fig.,Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
"11     http://www.medsci.org  15  adhesion protein and pa xillin cytoskeletal protein,  which regulate cell migration in invasive cells during  cancer metastasis [16-18].",Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
11     http://www.medsci.org  16  26.,Non-OADS,/arxiv_data1/oa_pdf/44/40/ijmsv11p0007.PMC3880986.pdf
1 1      http://www.medsci.org  17  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 17-23 .,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
11     http://www.medsci.org  18  mechanism of r etinal neovascularization  diseases and  provide potential molecular therapies .,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
"11     http://www.medsci.org  19  Carlsbad, California, USA) with SYBR green ready  mix (Applied Biosystem) and SDS 2.1 software (Ap- plied Biosystems).",OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
1 1      http://www.medsci.org  20    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
11     http://www.medsci.org  21  miR- 126-inhibitors increased VEGF and MMP -9 ex- pression in hypoxia -induced RF/6A cells (Figure 6).,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
11     http://www.medsci.org  22      Fig 6.,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
11     http://www.medsci.org  23  Supplementary Material   Fig.S1-Fig.S2.,Non-OADS,/arxiv_data1/oa_pdf/95/93/ijmsv11p0017.PMC3880987.pdf
1 1      http://www.medsci.org  24  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 24-33 .,Non-OADS,/arxiv_data1/oa_pdf/e3/c8/ijmsv11p0024.PMC3880988.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/c8/ijmsv11p0024.PMC3880988.pdf
11       http://www.medsci.org  34  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 34-43 .,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
11     http://www.medsci.org  35  to be €9569 (€8658 - 92% direct costs) .,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"11       http://www.medsci.org  36  Settings and Participants   A prospective, randomized, comparative study  was conducted from June 2010 to January 2013 in S i- lesia, Poland.",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"11       http://www.medsci.org  37  In total, 117 patients with unilateral venous leg  ulcers were included to this study.",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"11     http://www.medsci.org  38  ardized in use of Kikuhime (Advancis Medical, UK)  manometer (45 –50 mmHg for superficial reflux and  50–55 mmHg for superficial with deep venous reflux).",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"11     http://www.medsci.org  39  patients and E (Unna boots) – 20%, 6/30 patients (see  Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
11     http://www.medsci.org  40  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
11     http://www.medsci.org  41    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"11     http://www.medsci.org  42  The four layer bandage was associated with signif i- cantly shorter time to healing: hazard ratio (95% con- fidence interval) from multifactorial model bas ed on  five trials was 1.31 (1.09 to 1.58), P=0.005.",Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
11     http://www.medsci.org  43  14.,Non-OADS,/arxiv_data1/oa_pdf/9b/6e/ijmsv11p0034.PMC3880989.pdf
"1 1      http://www.medsci.org  44  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 44-51. doi: 10.7150/ ijms.7463   Research Paper   Amelioration of Radiation -induced Skin Injury by  HIV-TAT-Mediated Protein Transduction  of RP-1 from  Rana pleurade   Shuyu Zhang1,†,, Wenjie Wang2,†, Ying Peng3, Qing Gu1, Judong Luo1, Jundong Zhou4, Jinchang Wu4,  Yinglong Hou5, Jianping Cao1   1.",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
11     http://www.medsci.org  45  variable degrees of skin reactions can occur  (3).,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
"11     http://www.medsci.org  46  Grand Island, NY).",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
"11     http://www.medsci.org  47  The effect of TAT -RP1 on anti -superoxide  anion ability  of HaCaT cells   To evaluate the anti -superoxide anion capability   of TAT- RP1 on cultured human skin  cells, we treated  the HaCaT cells with  RP-1 or TAT -RP1 for 4 h and  measured total anti-supero xide anion ability  of cells.",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
11     http://www.medsci.org  48    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
11     http://www.medsci.org  49  not only be transduced into cultured  skin cells but  also penetrate the rat skin.,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
11     http://www.medsci.org  50    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
"11     http://www.medsci.org  51  of skin penetration lie in the stratum corneum, which  blocks the penetration of extraneous molecules as a self-protection barrier (33,34) .",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ijmsv11p0044.PMC3880990.pdf
11       http://www.medsci.org  52  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 52-59 .,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11     http://www.medsci.org  53  latory peritoneal dialysis (7).,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
"11     http://www.medsci.org  54  Statistical analysis  The statistical analysi s was performed using the  SPSS v. 16.0 software package (IBM, Armonk, NY ,  USA ).",OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11     http://www.medsci.org  55  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11     http://www.medsci.org  56  ated according to the degree of baseline proteinuria.,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11       http://www.medsci.org  57    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11     http://www.medsci.org  58  in patients with proteinuria 0.3 -3 g/day or proteinuria  > 3 g/day.,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
11     http://www.medsci.org  59  21.,Non-OADS,/arxiv_data1/oa_pdf/e4/54/ijmsv11p0052.PMC3880991.pdf
1 1      http://www.medsci.org  60  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 60-64 .,Non-OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
11     http://www.medsci.org  61  mediates cap -independent translation initiation and is  important for HAV replication  [4-6].,Non-OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
"11     http://www.medsci.org  62  jected to emulsion PCR, and enriched DNA beads  were loaded onto a  picotiter plate and pyrosequenced  with a Roche/454 GS Junior sequencer using Titan i- um chemistry (454 Life Sciences Corp., Branford, CT, USA)  [18].",OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
11     http://www.medsci.org  63  (450G/A) were observed.,OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
11     http://www.medsci.org  64  The effect  of mutations in 5 ’UTR  of HAV on the  severity of the disease is a long story that has never  been clearly proven.,Non-OADS,/arxiv_data1/oa_pdf/0f/18/ijmsv11p0060.PMC3880992.pdf
1 1      http://www.medsci.org  65  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 65-79 .,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
"11     http://www.medsci.org  66  pacity in response to loss of mass from injury or pa r- tial hepatectomy (1, 14) .",Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  67  U/ml penicillin and 100 µg/ml streptomycin.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  68  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
1 1      http://www.medsci.org  69  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  70  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
"11     http://www.medsci.org  71  when this similarity was represented as a percentage  of th e probe sets/genes in the primary hepatocytes  that were also expressed in the HPCs, the similarity  reached 88.9% (3427/3857).",OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  72    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  73  Table  5.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  74    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
1 1      http://www.medsci.org  75  Immunocyto/histochemistry expression  analysis   Immunocytochemical characterization of cu l- tured HPCs (Fig.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  76    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  77    Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
"11     http://www.medsci.org  78  up-regulated more than 20 -fold in HPCs were d e- tected, including the progenitor marker CD90 , four  genes related to hepatocyte metabolism ( CYBRD1 ,  BCAT1 , TIMP2  and PAM ) and two cytokine genes  (EGF , PDGFD ).",Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11     http://www.medsci.org  79  poly(epsilon -caprolactone) nanofiber scaffolds.,Non-OADS,/arxiv_data1/oa_pdf/2d/0d/ijmsv11p0065.PMC3880993.pdf
11       http://www.medsci.org  80  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 80-86 .,Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11       http://www.medsci.org  81  Introduction  Cervical cancer is the second most common type  of cancer in women worldwide [1] and the fourth  most common female malignancy in Korea [2, 3] .",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11     http://www.medsci.org  82  calculations were performed using SAS version 8.0  (SAS institute Inc., Cary, NC, USA).",OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11       http://www.medsci.org  83  Among 87 cases of ASCUS, 23 (26.4%) cases were  ≥CIN2 and 10 (11.5%) cases were ≥CIN3.",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11       http://www.medsci.org  84  Discussion   Our immunocytochemistry study showed that  the expression of the HPV L1 capsid protein was  higher in LSIL than ASCUS, HSIL, and cancer.",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11       http://www.medsci.org  85  In this study, we wanted to explore the rate of  HPV L1 expression in ASCUS cytology.",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"11     http://www.medsci.org  86  knowledge, this is the first study to examine the i m- munocytochemistry of HPV L1 according to  HPV16 -positive cytology, as well as the association  between cervical cytology and histopathology a c- cording to the multiplicity of HPV16 infections.",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/ijmsv11p0080.PMC3880994.pdf
"1 1      http://www.medsci.org  87  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 87-96. doi: 10.7150/ ijms.7651   Research Paper   Microgravity  Inhibits Resting  T Cell Immunity i n an  Exposure Time- Dependent Manner   Haiying Luo, Chongzhen Wang, Meifu Feng, Yong Zhao   State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China    Corresponding author : Dr. Yong Zhao, Transplantation Biology Research Division, State Key Laboratory of Biomembrane and Me m- brane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beichen West Road 1 -5, Chaoyang District, Beijing, China 100101.",Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
"11     http://www.medsci.org  88  performed during spaceflight compared to a 1g  in-flight centrifuge control or in a rotating clinostat or  a rot ating -wall vessel (RWV) bioreactor on the  ground, under conditions similar to the effects occu r- ring in microgravity 10,12.",Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
"11     http://www.medsci.org  89  with 2.5 μg/ml Con A for 24h, 48h and 72h or PMA  and Ionomycin for 6h at 37°C and 5% CO 2 as d e- scribed previously 7,14.",Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
"11     http://www.medsci.org  90  were dividing at the 48h -activation point, while the  dividing proportions of CD4+ (12%) and CD8+ (10%) T  cells in the MMg group were significantly decreased  and only half in CD4+ cells and two- thirds in CD8+  cells of those in the static control group (P<0.01, Fig.",Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
11     http://www.medsci.org  91    Figure 2 The proliferation of T cell subsets in response to ConA after 16h -MMg pre -exposure.,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
11     http://www.medsci.org  92  PMA plus Ionomycin after 16h MMg pre- exposure.,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
11     http://www.medsci.org  93    Figure 4 The cytokine production of T cell subsets and the IL -2 effect on their proliferatio n in response to ConA after MMg  pre-exposure.,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
1 1      http://www.medsci.org  94    Figure 5 The apoptosis and CD95 expression  of MMg pre -exposed T cell subsets in response to ConA were c hanged .,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
"11     http://www.medsci.org  95  We proposed that the low level expression of the  activation markers was, at least in part, responsible  for the reduction of the cell proliferation during T cell  activation after MMg pre -exposure since these activ a- tion markers participate in cell proliferation and co r- relate with the degree of immune activation 30.",Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
11     http://www.medsci.org  96  dicating that the increased susceptibility of T cells to  activation -linked apoptosis after MMg pre- exposure  might be a result of low expression of CD71 38.,Non-OADS,/arxiv_data1/oa_pdf/6f/ef/ijmsv11p0087.PMC3880995.pdf
"1 1      http://www.medsci.org  97  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 97-105. doi: 10.7150/ ijms.6964   Research Paper   Histology, Glycosaminoglycan Level and Cartilage  Stiffness in Monoiodoacetate -Induced Osteoarthritis :  Comparative Analysis with Anterior Cruciate Ligament  Transection in Rat Model and Human Osteoarthritis  Sangeetha  Vasudevaraj Naveen1, Raja Elina Ahmad3, Wong Jia Hui1, Abdulrazzaq Mahmod Suhaeb1,  Malliga Raman Murali, Rukmanikanthan Shanmugam1 and Tunku Kamarul1,2   1.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
11     http://www.medsci.org  98  This has led to considerable research efforts being  directed in the recent years to improve the under- standing of this disease process.,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
"11     http://www.medsci.org  99  very thin cartilage, exposed bone, visible osteophytes  and change in ca rtilage colour from the shiny white  usually seen in normal cartilage to a yellowish co l- oured tissue.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
11     http://www.medsci.org  100  and the average value of the data was subsequently  used in the statistical analysis.,OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
"1 1      http://www.medsci.org  101  Biochemical Analysis   Fig 3A and 3B represents the GAG/total protein  of tibia and femur for MIA and ACLT groups, respe c- tively.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
"11     http://www.medsci.org  102    Figure 4:  Cartilage stiffness of normal, MIA and ACLT rats (A) and human tissues (B) showed significantly lower cartilage stiffness sco res.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
11     http://www.medsci.org  103  (20-22).,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
11     http://www.medsci.org  104  have a protective effect against shearing and loading  mechanical forces.,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
"11     http://www.medsci.org  105  tion, analysis and interpretation of data; the writing of  the manuscript; the decision to submit the manuscript  for publication.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ijmsv11p0097.PMC3880996.pdf
"1 1      http://www.medsci.org  106  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(1): 106-115. doi: 10.7150/ ijms.7264   Research Paper   Increased Expression o f Macrophage Migration  Inhibitory Factor and DJ -1 contribute to Cell Invasion  and Metastasis of Nasopharyngeal Carcinoma   Xiao -juan PEI 1, Tong -tong WU 1, Bin LI 2, Xiao -ying TIAN 3, Zhi LI 2, Qing -xu YANG 1  1.",Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  107  only 50 -60% because of the frequency of distant m e- tastasis and local recurrence [ 3-4].,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
"11     http://www.medsci.org  108  Paraffin tissue microarray construction   In this study, the paraf fin tissue microarray co n- struction was conducted by previous description [32].",OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
"11     http://www.medsci.org  109  Bio., 1:1000 dilution), Akt (Abcam , 1:500 dilution),  pAkt (Abcam, 1:500 dilution)  or Actin  antibody  (Abcam, Cambridge, MA ) at 4 ℃ overnight.",Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  110  expression level reached significance for overall su r- vival  (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  111    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  112  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
"11     http://www.medsci.org  113  urement of  MIF in tumor cells of NPC is able to be a  valuable  clinical parameter  to directly predict the  prognosis of NPC patients, because  it exhibits  closely  correlation to lymph node status and clinical stage.",Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  114  through their own specific pathways.,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
11     http://www.medsci.org  115  36.,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/ijmsv11p0106.PMC3880997.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)AAV-encoded CBD3 for neuropathic pain G Fischer et al 51 &2014 Macmillan Publishers Limited Gene Therapy (2014) 44 – 51",Non-OADS,/arxiv_data1/oa_pdf/3d/8e/gt201356a.PMC3881029.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Proteidic delivery technology in the chinchilla WQ i et al 18 Gene Therapy (2014) 10 – 18 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/2a/af/gt201349a.PMC3881030.pdf
"For the ApoB functional interactions, online database resource search tool for the retrieval of interacting genes (STRING) was used, which allowedannotation of functional interactions of ApoB protein in cell (http://string-db.org/).",OADS,/arxiv_data1/oa_pdf/62/06/gt201358a.PMC3881031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)shRNA and miRNA against ApoB induce different liver changes P Maczuga et al 70 Gene Therapy (2014) 60 – 70 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/62/06/gt201358a.PMC3881031.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/cc/ceg-7-001.PMC3881092.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 1–6Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  1OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S5341 0Treatment of relapsing Clostridium difficile    infection using fecal microbiota transplantation rahul Pathak1 hill ambrose Enuh1 anish Patel1 Prasanna Wickremesinghe2 1Department of internal Medicine,  new York Medical College, internal  Medicine Program at richmond  University Medical Center, staten  island, nY, Usa; 2Department of  Gastrointestinal Medicine, n ew Y ork  Medical College, internal Medicine  Program at richmond University  Medical Center, staten island, nY, Usa Correspondence: Prasanna  Wickremesinghe   new York Medical College, internal  Medicine Program at richmond  University Medical Center, Department  of Gastrointestinal Medicine, 355 Bard  avenue, staten island, nY, Usa, 10310   Tel +1 718 818 2419   Email pcwickpc@aol.co mBackground:  Clostridium difficile  infection (CDI) has become a global concern over the  last decade.",Non-OADS,/arxiv_data1/oa_pdf/2c/cc/ceg-7-001.PMC3881092.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/2c/cc/ceg-7-001.PMC3881092.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/cc/ceg-7-001.PMC3881092.pdf
Available from http://highroadsolution.com/ file_upload_2/files/fda =response=letter=to=fmt=inquiry.pdf.,OADS,/arxiv_data1/oa_pdf/2c/cc/ceg-7-001.PMC3881092.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/f0/thnov03p0927.PMC3881094.pdf
This is an open- access article distributed under the terms  of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/07/8e/thnov03p0930.PMC3881095.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/73/thnov03p0943.PMC3881096.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/65/thnov03p0953.PMC3881097.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b4/6b/thnov03p0964.PMC3881098.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/29/thnov03p0986.PMC3881099.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a6/52/thnov03p1004.PMC3881100.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/29/thnov03p1012.PMC3881101.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/42/TOMINFOJ-7-34.PMC3881102.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/CPEMH-9-251.PMC3881103.pdf
OncoImmunology 2013; 2:e26382; http://dx.doi.org/10.4161/onci.26382,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Adv Cancer Res  1997; 71:209-40;  PMID:9111867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Semin Cancer Biol  2005 ; 15:423-35; PMID:16043359 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nature  2007 ; 446:153- 8; PMID:17344846 ; http://dx.doi.org/10.1038/ nature05610 4.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Proc Natl Acad Sci U S A  2005 ; 102:2408 -13; PMID:15695337 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Aging Cell  2008 ; 7:667-80; PMID:18652575 ;  http://dx.doi.org/10.1111/j.1474-9726.2008.00416.x 6.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nature  2009 ; 458:719-24; PMID:19360079 ;  http://dx.doi.org/10.1038/nature07943 7.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Cancer Res 2012 ; 72:1081 -91;  PMID:22237626 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3722 8.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
"Nature  2012 ; 482:400- 4; PMID:22318521 ; http://dx.doi.org/10.1038/ nature10755 9. van der Bruggen P, Stroobant  V, Vigneron  N, Van  den Eynde  B. Peptide database: T cell-defined  tumor antigens.",OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nat Med   2006 ; 12:198-206; PMID:16444264 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Immunol Rev  2002 ; 190:86- 94; PMID:12493008 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Annu Rev Immunol 2007 ; 25:267- 96; PMID:17134371 ; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141609 15.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nat Rev Cancer 2012 ;  12:252-64; PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Proc Natl Acad Sci U S A  1999 ; 96:2233 -8; PMID:10051624 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Springer Semin Immunopathol  2005 ; 27:19- 35; PMID :15965711 ; http://dx.doi.org/10.1007/ s00281-004-0192-0 18.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Annu Rev Immunol 2002 ; 20:395- 425; PMID:11861608 ; http://dx.doi.org/10.1146/ annurev.immunol.20.100301.064801 20.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nat Rev Rheumatol  2012 ; 8:195-202; PMID:22293756 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Mol Pharmacol  2009 ; 75:1262 -79; PMID:19297520 ;  http://dx.doi.org/10.1124/mol.109.055624 23.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Proc Natl Acad Sci U S A 2005 ;  102:5120 -5; PMID:15793000 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Cell 2005 ; 120:437-47; PMID:15734677 ;  http://dx.doi.org/10.1016/j.cell.2005.01.027 26.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nature   2011 ; 479:232-6; PMID:22048312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
J Invest Dermatol  1990 ;  94:94-100; PMID:2295840 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
Nat Cell Biol 2008 ; 10:1241 - 7; PMID:18978832 ; http://dx.doi.org/10.1038/ ncb1108-1241 30.,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
PLoS Comput Biol  2007 ;  3:e53; PMID:17367205 ; http://dx.doi.org/10.1371/ journal.pcbi.0030053,Non-OADS,/arxiv_data1/oa_pdf/4f/25/onci-2-e26382.PMC3881104.pdf
"OncoImmunology 2013; 2:e25997; http://dx.doi.org/10.4161/onci.25997The TLR7 agonist imiquimod as an adjuvant   for radiotherapy-elicited in situ vaccination  against breast cancer sandra Demaria1,2,3,*, Claire Vanpouille-Box1,3, silvia C. Formenti2,3, and s ylvia a dams3,4 1Department of Pathology; New y ork u niversity s chool of Medicine; New y ork, N y usa ;   2Department of r adiation Oncology; New y ork u niversity s chool of Medicine; New y ork, N y usa ; 3Nyu Cancer Institute; New y ork, N y usa ;   4Departmet of Medicine; New y ork u niversity s chool of Medicine; New y ork, N y usa Keywords:  abscopal effect, breast cancer, cutaneous metastases, cyclophosphamide, immunological adjuvant,  radiotherapy, synergy, T cells, Toll-like receptor 7, tumor rejection Abbreviations : DC, dendritic cell; ICAM1, intercellular adhesion molecule 1; IL-10, interleukin-10; TLR, Toll-like receptor.",Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
Clin  Cancer Res 2012; 18:6748-57;  PMID:22767669 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1149 .,Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
J Natl Cancer Inst 2013; 105:256-65;  PMID:23291374 ;  http://dx.doi.org/10.1093/jnci/djs629 .,Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
Immunol Rev 2007; 220:47-59;  PMID:17979839 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
Clin Cancer Res  2012; 18:6668-78;  PMID:23048078 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
J Immunol  2010; 184:5360-7;  PMID:20308630 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/fc/onci-2-e25997.PMC3881106.pdf
"OncoImmunology 2013; 2:e26618; http://dx.doi.org/10.4161/onci.26618Preventing surgery-induced NK cell dysfunction  and cancer metastases with influenza vaccination Lee- hwa Tai1, Jiqing Zhang1,2,3, and r ebecca C a uer1,4,5,* 1Centre for Innovative Cancer r esearch; Ottawa h ospital r esearch Institute; Ottawa, Canada; 2Department of Cellular and Molecular Medicine;   university of Ottawa; Ottawa, Canada; 3Department of Neurosurgery; The s econd h ospital of s handong u niversity; s handong, China;   4Department of s urgery; u niversity of Ottawa; Ottawa, Canada; 5Department of Biochemistry, Microbiology, and Immunology; u niversity of Ottawa; Ottawa, Canada Keywords:  cancer metastases, influenza vaccine, immunosuppression, natural killer cells, surgical stress Abbreviations: IFN α, interferon α ; IFNγ, interferon γ ; NK, natural killer; PBMC, peripheral blood mononuclear cell surgical resection is the mainstay of treatment for solid tumors, but the postoperative period is uniquely inclined to  the formation of metastases, largely due to the suppression of natural killer (NK) cells.",Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Lancet Oncol 2003; 4:760-8; PMID:14662433 ; http://dx.doi.org/10.1016/ S1470-2045(03)01282-8 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Cancer Res 2013; 73:97-107;  PMID:23090117 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-19935.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Langenbecks Arch Surg 2004; 389:475-84; PMID :15173946 ;  http://dx.doi.org/10.1007/s00423-004-0472-0 6.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Ann Surg Oncol 2003; 10:972-92; PMID:14527919 ; http://dx.doi.org/10.1245/ ASO.2003.02.007 7.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Int J Cancer 1999; 80:880-8; PMID:10074922 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(19990315)80:6<880::AID-IJC14>3.0.CO;2-Y 8.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
Clin Cancer Res 2013; 19:5104-15;  PMID:23881927 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0246 10.,Non-OADS,/arxiv_data1/oa_pdf/ab/a5/onci-2-e26618.PMC3881108.pdf
"OncoImmunology 2013; 2:e26527;  http://dx.doi.org/10.4161/onci.26527Retargeting NK-92 cells by means   of CD19- and CD20-specific chimeric antigen  receptors compares favorably with antibody- dependent cellular cytotoxicity Laurent Boissel1, Monica Betancur-Boissel1, Weiquan Lu1,2, Daniela s Krause3,   richard a  Van etten1,2, Winfried s Wels4, and h ans Klingemann1,2,* 1Molecular Oncology r esearch Institute; Tufts Medical c enter; Boston, M a Usa; 2Division of h ematology/Oncology; Tufts Medical c enter; Boston, M a Usa;   3center for r egenerative Medicine and c ancer c enter; Massachusetts General h ospital; Boston, M a Usa;   4chemotherapeutisches Forschungsinstitut Georg- speyer- haus; Frankfurt am Main, Germany Keywords:  CAR, lentiviral vector, lymphoid malignancies, NK cells, NK-92 Abbreviations: ADCC, antibody-dependent cell-mediated cytotoxicity; ALL, acute lymphoblastic leukemia;   CAR, chimeric antigen receptor; CLL, chronic lymphocytic leukemia; Fc γRIII, Fc receptor, IgG, low affinity III;   GvHD, graft- versus -host disease; Luc, luciferase; NHL, non-Hodgkin lymphoma; NK, natural killer;   NKR, natural killer resistant; NSG, NOD scid  gamma.",Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Blood 2012; 120:4256-62;  PMID:23007405 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
N Engl J Med 2011; 365:725-33; PMID:21830940 ; http://dx.doi.org/10.1056/ NEJMoa1103849 5.,OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Expert Opin Biol Ther 2011; 11:855-73;  PMID:21463133 ; http://dx.doi.org/10.1517/147125 98.2011.573476 6.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cytotherapy 2010; 12:969-70;  PMID:21073262 ;  http://dx.doi.org/10.3109/14653249.2010.536216 7.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Leuk Lymphoma 2012;  53:958-65;  PMID:22023526 ; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cytotherapy 2003; 5:259-72;  PMID:12850795 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cytotherapy  2008; 10:625-32;  PMID:18836917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
J Hematother  Stem Cell Res 2001; 10:535-44; PMID:11522236 ;  http://dx.doi.org/10.1089/15258160152509145 13.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cancer Immunol Immunother 2008; 57:411- 23; PMID:17717662 ; http://dx.doi.org/10.1007/ s00262-007-0383-3 16.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
J Cell Mol Med  2012; 16:569-81;  PMID :21595822 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cancer Immunol  Immunother 2012; 61:1451-61;  PMID:22310931 ;  http://dx.doi.org/10.1007/s00262-012-1212-x 18.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cancer Gene Ther  2012; 19:84-100;  PMID:21979579 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
J Biomed Biotechnol 2011; 2011:379123; http://dx.doi.org/10.1155/2011/379123 ;  PMID:21660134 20.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Leuk Lymphoma  2009; 50:1361-8;  PMID:19562616 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Blood 2002; 99:754-8; PMID:11806974 ;  http://dx.doi.org/10.1182/blood.V99.3.754 22.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Nat Rev Cancer 2008; 8:299-308;  PMID:18354418 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
J Cancer 2011; 2:443-57; PMID:21850212 ;  http://dx.doi.org/10.7150/jca.2.443 26.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Curr Opin Hematol 1999;  6:394-9;  PMID:10546793 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Cancer Biol Ther 2009; 8:2211-20; PMID:19923897 ; http://dx.doi.org/10.4161/ cbt.8.23.10455 28.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Transfusion 2013; 53:404-10; PMID:22670662 ;  http://dx.doi.org/10.1111/j.1537-2995.2012.03724.x 29.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
"Transfusion 2013; 53:412- 8, quiz 411; PMID:22738379 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Blood 2012; 119:5758-68; PMID:22544698 ; http://dx.doi.org/10.1182/ blood-2012-03-415364 32.,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Leuk Res 1999; 23:255-61;  PMID:10071078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
Nat Med 2003; 9:959-63;  PMID:12796774 ; http://dx.doi.org/10.1038/nm886,Non-OADS,/arxiv_data1/oa_pdf/93/32/onci-2-e26527.PMC3881109.pdf
"http://dx.doi.org/10.1016/j.redox.2013.12.003Abbreviations: GSH, reduced glutathione; GSSG, oxidized glutathione; ROS, reactive oxygen species; SAXS, small angle X-rays scattering; 20SPT, 20S proteasome co re particle; 26SPT, 26S proteasome; TEM, transmission electron microscopy ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/a9/85/main.PMC3881202.pdf
"http://dx.doi.org/10.1016/j.redox.2013.11.005Abbreviations: DFO, deferrioxamine or Desferals; EPR, electron paramagnetic resonance; IR, ionizing radiation; LIP, labile iron pool; PBS, phosphate-bufferedsaline ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ec/9f/main.PMC3881203.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.101 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:101-107  101Review Article www.cmj.ac.k r Mitochondrial Dynamics in the Heart as a Novel Therapeutic Target  for Cardioprotection Seung Joon Hwang and Weon Kim * Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine , Seoul, Korea Traditionally, mitochondria have been regarded  solely as energy generators for cells;  however, accumulating data have demonstr ated that these complex organelles play  a variety of roles within the cardiomyocyte that extend beyond this classic function.",Non-OADS,/arxiv_data1/oa_pdf/0a/f9/cmj-49-101.PMC3881204.pdf
"Key Words:  Mitochondrial dynamics; Myocardial re perfusion injury; Myocytes, cardiac This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 November, 2013 revised 23 November, 2013 accepted 25 November, 2013 Corresponding Author: Weon Kim Division of Cardiology, Department of Internal Medicine, Kyung Hee  University Hospital, Kyung Hee  University School of Medicine, 1, Hoegi-dong, Dongdaemoon-gu,  Seoul 130-702, Korea TEL: +82-2-958-8170 FAX: +82-2-958-8160  E-mail: mylovekw@hanmail.net INTRODUCTION 　Mitochondria are typically regarded as energy gen- erators, but the latest data demonstrate other divergent functions such as oxygen free radical production, control of cell ion homeostasis, and regulation of cell apoptosis and necrosis.",Non-OADS,/arxiv_data1/oa_pdf/0a/f9/cmj-49-101.PMC3881204.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.108 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:108-112  108Original Article-Nephrology and urology www.cmj.ac.k r Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed  Kidney of Rats with Unilateral Ureteral Obstruction Seong Kwon Ma, Soo Yeon Joo1, Chang Seong Kim, Joon Seok Choi, Eun Hui Bae, JongUn Lee1  and Soo Wan Kim * Departments of Internal Medicine and 1Physiology, Chonnam National University Medical School, Gwangju, Korea The present study aimed to investigate chan ges in the mammalian target of rapamycin  (mTOR) signaling pathway in the obstructed kidney of rats with unilateral ureteral  obstruction (UUO).",Non-OADS,/arxiv_data1/oa_pdf/cd/57/cmj-49-108.PMC3881205.pdf
"Key Words:  mTOR protein, rat; Ureteral Ob struction; Fibrosis; Apoptosis  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 October, 2013 revised 4 November, 2013 accepted 5 November, 2013 Corresponding Author: Soo Wan Kim Department of Internal Medicine,  Chonnam National University Medical School, 42 Jebong-ro, Dong-gu,  Gwangju 501-757, Korea TEL: +82-62-220-6271FAX: +82-62-225-8578 E-mail: skimw@chonnam.ac.kr INTRODUCTION 　Interstitial fibrosis and tubu lar atrophy of the kidney is  the final common pathogenesis of chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/cd/57/cmj-49-108.PMC3881205.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.113 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:113-117  113Original Article-Neuroscience www.cmj.ac.k r Factors Related to Catheter-Induced Hemorrhage after Brain  Parenchymal Catheterization Jong Hyun Mun, Kyu Yong Cho *, Byung Chan Lim, Jun Seob Lim and Rae Seop Lee Department of Neurosurgery, Kwangju Christian Hospital, Gwangju, Korea This article aimed to investigate the incidenc e rate and possible risk factors for cathe- ter-induced hemorrhage (CIH) after brain parenchymal catheterization.",Non-OADS,/arxiv_data1/oa_pdf/06/ba/cmj-49-113.PMC3881206.pdf
"Key Words:  Drainage; Cerebral Hemorrhag e; Brain; Catheterization This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 October, 2013 revised 24 November, 2013 accepted 26 November, 2013 Corresponding Author: Kyu Yong Cho Department of Neurosurgery, Kwangju Christian Hospital, 37 Yangnim-ro,  Nam-gu, Gwangju 503-715, Korea TEL: +82-62-650-5133 FAX: +82-62-650-5116 E-mail: damianus1@naver.com INTRODUCTION 　Brain puncture by catheter is  thought to be the most com- monly used procedure in the neurosurgical field.",Non-OADS,/arxiv_data1/oa_pdf/06/ba/cmj-49-113.PMC3881206.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.118 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:118-124  118Original Article-Circul ation and hemodynamics www.cmj.ac.k r Effect of Atorvastatin-Eluting Stents in a Rabbit Iliac Artery  Restenosis Model Kyung Seob Lim1,2,3, Myung Ho Jeong1,2,3,*, In Ho Bae1,2,3, Jun-Kyu Park1,2, Dae Sung Park2,3,  Jong Min Kim2,3, Jung Ha Kim2,3, Dong Lyun Cho1,3, Doo Sun Sim1,2,3, Keun-Ho Park1,2,3,  Young Joon Hong1,2,3 and Youngkeun Ahn1,2,3 1Korea Cardiovascular Stent Institute of Chonnam National University, 2Cardiovascular Research Center, Chonnam National University  Hospital, 3Regeneromics Research Center, Chonnam National University, Gwangju, Korea Statins have pleiotropic effects, which includ e the inhibition of neointima hyperplasia,  the inhibition of vascular inflammation, and platelet inhibition.",Non-OADS,/arxiv_data1/oa_pdf/cc/a5/cmj-49-118.PMC3881207.pdf
"Key Words:  Drug-eluting Stents; Coronary Restenosis; Hydroxymethylglutaryl-CoA  Reductase Inhibitors; Inflammation This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 September, 2013 revised 31 October, 2013 accepted 1 November, 2013 Corresponding Author: Myung Ho Jeong Professor, Director of Korea Cardio-vascular Stent Research Institute Dire- ctor of Heart Research Center Nomi- nated by Korea Ministry of Health and welfare, Director of Department of  Education and Research, Chonnam  National University Hospital, 42 Jebong- ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6243 FAX: +82-62-228-7174E-mail: myungho@chollian.net  mhjeong@chonnam.ac.kr INTRODUCTION 　Over recent decades, drug-e luting stents (DES) have  emerged as the preferred treatment for coronary artery dis-ease, and the use of DES has increased significantly.",Non-OADS,/arxiv_data1/oa_pdf/cc/a5/cmj-49-118.PMC3881207.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.125 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:125-128  125Case Report www.cmj.ac.k r Parathyroid Cyst Presenting as Acute Pancreatitis: Report of a Case Mi-Young Kim, Cho-Yun Chung, Jong-Sun Kim, Dae-Seong Myung, Sung-Bum Cho,  Chang-Hwan Park, Young Kim1 and Young-Eun Joo* Departments of Internal Medicine and 1Pathology, Chonnam National University Medical School, Gwangju, Korea We report the first case of hypercalcemia-induced acute pancreatitis caused by a func- tioning parathyroid cyst in a 67-year-old ma n. Laboratory investigation revealed in- creased serum amylase and lipase, increase d serum ionized calcium and parathyroid  hormone (PTH) levels, and decreased serum phosphate, indicating pancreatitis and  primary hyperparathyroidism (PHPT).",Non-OADS,/arxiv_data1/oa_pdf/c1/6e/cmj-49-125.PMC3881208.pdf
"Key Words:  Pancreatitis; Hyperparathyroidism, Primary; Cysts This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 March, 2013 revised 24 May, 2013 accepted 7 June, 2013 Corresponding Author: Young-Eun JooDepartment of Internal Medicine, Chonnam National University Medical  School, 42, Jebong-ro, Dong-gu,  Gwangju 501-757, KoreaTEL: +82-62-220-6296 FAX: +82-62-225-8578 E-mail: yejoo@chonnam.ac.kr INTRODUCTION 　Pancreatitis is pathologically  defined as the histologic  presence of inflammation within the parenchyma of the pancreas.",Non-OADS,/arxiv_data1/oa_pdf/c1/6e/cmj-49-125.PMC3881208.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.129 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:129-132  129Case Report www.cmj.ac.k r Percutaneous Treatment of an Injured Coronary Stent Using the  Looping Wire Technique Lae-Young Jung and Sang-Rok Lee * Division of Cardiology, Department of Internal Medici ne, Chonbuk National University Hospital, Jeonju, Korea  Drug-eluting stent implantation is an effective treatment for coronary artery disease,  yet unexpected serious complications du ring stent implantation are possible.",Non-OADS,/arxiv_data1/oa_pdf/96/86/cmj-49-129.PMC3881209.pdf
"Key Words:  Drug-eluting Stents; Complication; Angioplasty  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 January, 2013 revised 5 February, 2013 accepted 14 February, 2013 Corresponding Author: Sang-Rok LeeDivision of Cardiology, Department of  Internal Medicine, Chonbuk National University Hospital, Chonbuk National  University Medical School, Research  Institute of Clinical Medicine, Chonbuk National University, 42 Wonjam-5-gil,  Deokjin-gu, Jeonju 561-712, Korea Tel: +82-63-250-2418 FAX: +82-63-250-1680 E-mail: medorche@jbnu.ac.kr INTRODUCTION 　Drug-eluting stent (DES) implantation is an effective  treatment for coronary artery disease, yet adverse events are possible owing to unexpe cted serious complications  during DES implantation.",Non-OADS,/arxiv_data1/oa_pdf/96/86/cmj-49-129.PMC3881209.pdf
"http://dx.doi.org/10.4068/cmj.2013.49.3.133 ⒸChonnam Medical Journal, 2013 Chonnam Med J 2013;49:133-135  133Case Report www.cmj.ac.k r A Case of Gastric Cancer Manifesting as a Solitary Brain Metastasis  in the Cerebellopontine Angle That Mimicked Acoustic Neuroma Ho Yeon Joo, Myoung Hun Chae, Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee,  Chul Soo Kim and Young Hoon Park * Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea At the time of diagnosis, about 20% of patien ts with gastric cancer have stage IV disease  involving the liver, lung, and bone.",Non-OADS,/arxiv_data1/oa_pdf/4f/0f/cmj-49-133.PMC3881210.pdf
"Key Words:  Stomach Neoplasms; Brain; Neuroma, Acoustic This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 July, 2013 revised 1 September, 2013 accepted 22 September, 2013 Corresponding Author: Young Hoon ParkDepartment of Internal Medicine, Inha  University School of Medicine, 7-206, Shinheung-dong 3-ga, Jung-gu,  Incheon 400-711, Korea TEL: +82-32-890-2580FAX: +82-32-890-3764 E-mail: carrox2yh@naver.com INTRODUCTION 　Gastric cancer is one of the most common cancers in  Korea, and at the time of diagnosis, approximately 20% of gastric cancer patients have stage IV disease that com-monly involves the liver, lung, and bone.",Non-OADS,/arxiv_data1/oa_pdf/4f/0f/cmj-49-133.PMC3881210.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/9b/jcav05p0001.PMC3881216.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/82/04/jcav05p0003.PMC3881217.pdf
http://cancer.gov/csr/1975_2010/   2.,Non-OADS,/arxiv_data1/oa_pdf/82/04/jcav05p0003.PMC3881217.pdf
http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/82/04/jcav05p0003.PMC3881217.pdf
[Internet] http://www.nice.org.uk/CG058  5.,Non-OADS,/arxiv_data1/oa_pdf/82/04/jcav05p0003.PMC3881217.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/de/e6/jcav05p0025.PMC3881218.pdf
This is an open- access article distributed under the ter ms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/62/jcav05p0044.PMC3881220.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/73/jcav05p0058.PMC3881221.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/b y-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/96/jcav05p0069.PMC3881222.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/27/thnov04p0001.PMC3881223.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7e/50/thnov04p0012.PMC3881224.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/9f/thnov04p0024.PMC3881225.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/1a/thnov04p0036.PMC3881226.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/85/thnov04p0047.PMC3881227.pdf
"Velikyan I. Synthesis, Characterization and Application of  68Ga-Labelled  Macromolecules; http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5876 [Doctorate thesis].",OADS,/arxiv_data1/oa_pdf/95/85/thnov04p0047.PMC3881227.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/23/thnov04p0081.PMC3881228.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/d0/thnov04p0090.PMC3881229.pdf
"ADC maps were constructed using ParaVision  5.1 software from Bruker Biospin (Ettlingen, Germ a- ny), while proton density images and T1 and T2 r e- laxation maps were calculated by a pixel- by-pixel  mono- exponential fitting of the data with  self-developed applications for Image -J (Rasband,  W.S., ImageJ, U. S. National Institutes of Health, B e- thesda, Maryland, USA, http://imagej.nih.gov/ij/,  1997 -2012).",OADS,/arxiv_data1/oa_pdf/23/d0/thnov04p0090.PMC3881229.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/08/79/thnov04p0106.PMC3881230.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:395-403 Targeting the Peroxisome Proliferator-Activated  Receptor-γ to Counter the Inflammatory Milieu in  Obesity Cesar Corzo, Patrick R. Griffin Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA Adipose tissue, which was once viewed as a simple organ for storage of triglycerides, is now considered an important endocrine  organ.",Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
Current standard of care includes pharmacologic intervention  and lifestyle modification such as nutritional consultation and Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.6.395 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
"Diabetes Metab J 2013;37:395-403 http://e-dmj.orgmodification of diet, rigorous weight control, and increased  regular exercise.",Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
397Modulating PPARG to control inflammation associated with diabetes Diabetes Metab J 2013;37:395-403 http://e-dmj.orgthe intracellular region.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
"Diabetes Metab J 2013;37:395-403 http://e-dmj.orgtheir ability to interfere with insulin signaling in adipocytes  and muscle cells, negatively altering downstream kinase-de - pendent signaling and GLUT4 translocation [30,31] and op - posing the action of insulin in order to limit nutrient storage.",Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
399Modulating PPARG to control inflammation associated with diabetes Diabetes Metab J 2013;37:395-403 http://e-dmj.orgfailure and the propensity for bone fractures.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
Diabetes Metab J 2013;37:395-403 http://e-dmj.orgCONCLUSIONS The PPAR subfamily of nuclear receptors plays major roles in  the energy homeostasis by promoting either the utilization or  the storage of the energy sources glucose and free fatty acids.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
401Modulating PPARG to control inflammation associated with diabetes Diabetes Metab J 2013;37:395-403 http://e-dmj.orgtors: insight into multiple cellular functions.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
"Diabetes Metab J 2013;37:395-403 http://e-dmj.orglin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor  necrosis factor-alpha, overexpressed in human fat cells from  insulin-resistant subjects.",Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
403Modulating PPARG to control inflammation associated with diabetes Diabetes Metab J 2013;37:395-403 http://e-dmj.orgclear receptor signaling and the role of sirtuins.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/57/40/dmj-37-395.PMC3881323.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:404-414 Resistin in Rodents and Humans Hyeong Kyu Park1, Rexford S. Ahima2 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea, 2Division of Endocrinology, Diabetes and Metabolism, and the Institute for Diabetes, Obesity and Metabolism, Department of Medicine, Perelman School of  Medicine at the University of Pennsylvania, Philadelphia, PA, USA Obesity is characterized by excess accumulation of lipids in adipose tissue and other organs, and chronic inflammation associat - ed with insulin resistance and an increased risk of type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"In rodents, re -Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.6.404 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
405Resistin in rodents and humans Diabetes Metab J 2013;37:404-414 http://e-dmj.orgsistin is primarily expressed in mature white adipocytes.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
Diabetes Metab J 2013;37:404-414 http://e-dmj.orgsource of resistin in humans [38-41].,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"407Resistin in rodents and humans Diabetes Metab J 2013;37:404-414 http://e-dmj.orgmation in humans [13,14,68].",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
Diabetes Metab J 2013;37:404-414 http://e-dmj.orgthe mean follow-up period of 12 months [100].,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"409Resistin in rodents and humans Diabetes Metab J 2013;37:404-414 http://e-dmj.orged rat hearts, suggesting human resistin has direct cardiac ac - tions [115].",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
Diabetes Metab J 2013;37:404-414 http://e-dmj.orgby synergism between peroxisome proliferator-activated re - ceptor gamma and CCAAT/enhancer-binding proteins.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
411Resistin in rodents and humans Diabetes Metab J 2013;37:404-414 http://e-dmj.orgsion during chronic injury and induction of proinflammatory  actions in hepatic stellate cells.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"Diabetes Metab J 2013;37:404-414 http://e-dmj.orgta H, Nishimiya T, Niiya T, Shimizu I, Nishida W , Hashiramo - to M, Kanatsuka A, Fujii Y , Ohashi J, Makino H. The G/G  genotype of a resistin single-nucleotide polymorphism at -420  increases type 2 diabetes mellitus susceptibility by inducing  promoter activity through specific binding of Sp1/3.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"413Resistin in rodents and humans Diabetes Metab J 2013;37:404-414 http://e-dmj.orgsenkuhn T, Parhofer KG, Goke B, Broedl UC.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
Diabetes Metab J 2013;37:404-414 http://e-dmj.orgpausal women with acute coronary syndrome undergoing  percutaneous coronary intervention.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/dmj-37-404.PMC3881324.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:415-422 Diabetogenic Effect of Statins: A Double-Edged Sword?,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
"However, in this post hoc  analysis, Review Others http://dx.doi.org/10.4093/dmj.2013.37.6.415 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
"Diabetes Metab J 2013;37:415-422 http://e-dmj.orgthe definition of new-onset diabetes included at least one glu - cose level of ≥2.0 mmol/L (36 mg/dL) above baseline, which  was a nonstandardized diagnostic criteria for diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
417Diabetogenic effect of statins Diabetes Metab J 2013;37:415-422 http://e-dmj.orgwith the risk of new-onset diabetes.,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
"Diabetes Metab J 2013;37:415-422 http://e-dmj.org(atorvastatin 80 mg/pravastatin 40 mg), the Aggrastat to Zo - cor (A to Z trial; simvastatin 40 mg, simvastatin 80 mg/place - bo, simvastatin 20 mg), Treating to New Target (TNT; atorvas - tatin 80 mg/atorvastatin 10 mg), Incremental Decrease in End  Points through Aggressive Lipid Lowering (IDEAL; atorvas - tatin 80 mg/simvastatin 20 mg or 40 mg), and the Study of the  Effectiveness of Additional Reductions in Cholesterol and Ho - mocysteine (simvastatin 80 mg/simvastatin 20 mg)—revealed  that the risk of new-onset diabetes over a weighted mean fol - low-up of 4.9 years increased by 12% (95% CI, 1.04 to 1.22) in  subjects in intensive-dose statin therapy group compared with  those in moderate-dose statin group.",Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
419Diabetogenic effect of statins Diabetes Metab J 2013;37:415-422 http://e-dmj.orgin insulin levels and a decrease in plasma adiponectin levels  and insulin sensitivity [22].,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
"Diabetes Metab J 2013;37:415-422 http://e-dmj.orgthe synthesis of coenzyme Q 10 (CoQ10), an essential factor  in the mitochondrial electron-transfer system, resulting in in - hibition of insulin secretion by reduced production of ATP  [35].",Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
421Diabetogenic effect of statins Diabetes Metab J 2013;37:415-422 http://e-dmj.orgported.,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
Available from: http://www.fda.gov/drugs/ drugsafety/ucm293101.htm (update 2012 Feb 28).,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
Diabetes Metab J 2013;37:415-422 http://e-dmj.orgdiabetes: the important questions.,Non-OADS,/arxiv_data1/oa_pdf/f5/d6/dmj-37-415.PMC3881325.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:423-428 Clinical Marker of Platelet Hyperreactivity in Diabetes  Mellitus Jin Hwa Kim, Hak Y eon Bae, Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
Their primary function is to stop hemorrhage resulting Review Clinical Care/Education http://dx.doi.org/10.4093/dmj.2013.37.6.423 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
Diabetes Metab J 2013;37:423-428 http://e-dmj.orgfrom tissue trauma and vascular injury.,Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
425Diagnosis of aberrant platelet action in diabetes Diabetes Metab J 2013;37:423-428 http://e-dmj.orgwhich suggest that reduced insulin sensitivity may account for  platelet hyperreactivity in this condition [19].,Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
"Diabetes Metab J 2013;37:423-428 http://e-dmj.org[10,15].",Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
"427Diagnosis of aberrant platelet action in diabetes Diabetes Metab J 2013;37:423-428 http://e-dmj.orgACKNOWLEDGMENTS This study was supported by research funds from Chosun  University, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
Diabetes Metab J 2013;37:423-428 http://e-dmj.orgtionship between mean platelet volume and fasting plasma  glucose differs with glucose tolerance status in a Korean gener - al population: gender differences.,Non-OADS,/arxiv_data1/oa_pdf/2a/51/dmj-37-423.PMC3881326.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in  Drug Naïve Type 2 Diabetic Patients Dong-Lim Kim Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea Corresponding author: Dong-Lim Kim Department of Internal Medicine, Konkuk University Medical Center,  Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu,  Seoul 143-729, Korea E-mail: dlkim@kuh.ac.krThere is an explosive growth of type 2 diabetes mellitus (T2DM)  in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
One study evaluated the efficacy and  safety of glyburide/metformin combination regimen as initial Editorial   http://dx.doi.org/10.4093/dmj.2013.37.6.429 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
430Kim DL Diabetes Metab J 2013;37:429-432 http://e-dmj.orgtherapy in drug-naïve T2DM patients over 2 years.,Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
431Metformin based dual-combination therapy  Diabetes Metab J 2013;37:429-432 http://e-dmj.orgapy but also its side effects and its preventative effect on com - plications.,Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
432Kim DL Diabetes Metab J 2013;37:429-432 http://e-dmj.org1283-93.,Non-OADS,/arxiv_data1/oa_pdf/6d/80/dmj-37-429.PMC3881327.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:433-449 Prevalence and Management of Dyslipidemia in Korea:  Korea National Health and Nutrition Examination  Survey during 1998 to 2010 Eun Roh1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Nan Hee Kim3, Jae Hyeon Kim4, Chul Sik Kim5, Kee-Ho Song6,   Jong Chul Won7, Dae Jung Kim8, Sung Hee Choi1, Soo Lim1, Bong-Yun Cha2,   on behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul,  2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul,  3Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, 4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang,  6Department of Internal Medicine, Konkuk University School of Medicine, Seoul,  7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  8Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea Background:  Dyslipidemia is a major risk factor of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"Keywords:  Dyslipidemia, Korea; Prevalence Corresponding authors:  Bong-Yun Cha  Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College  of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea E-mail: bycha@catholic.ac.kr Soo Lim Department of Internal Medicine, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro  173beon-gil, Bundang-gu, Seongnam 463-707, Korea E-mail: limsoo@snu.ac.kr Received: Aug. 26, 2013; Accepted: Sep. 30, 2013Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.6.433 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgINTRODUCTION Cardiovascular disease is one of main causes of death world - wide [1].,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
435Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgid-lowering drugs or total cholesterol of ≥240 mg/dL.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
437Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgdyslipidemia was higher in women than in men every year  (57.6% in men and 60.4% in women in 2010).,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"Diabetes Metab J 2013;37:433-449 http://e-dmj.orgglyceridemia, most frequent lipid abnormality in men, has not  changed significantly in men, while a significantly decreasing  tendency was found in women.",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
439Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgage groups than men.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgrates of awareness and treatment in diabetic subjects were much  higher than nondiabetic subjects in both sexes.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"441Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgtreatment, and control rates in Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgpertriglyceridemia and hypo-HDL-cholesterolemia in Korean  adults could be related with high-carbohydrate diet.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Available from: http://www.who.int/gho/publications/world_ health_statistics/2012/en/index.html (cited 2012 May 16).,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Available from: http://www.kostat.go.kr (updated 2012  Sep 13).,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"443Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgpusalo E, Tuomilehto J, Salonen JT.",Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.org27.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
445Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgAppendix 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgAppendix 2.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
447Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgAppendix 3.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
Diabetes Metab J 2013;37:433-449 http://e-dmj.orgAppendix 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
449Dyslipidemia in Korea Diabetes Metab J 2013;37:433-449 http://e-dmj.orgAppendix 5.,Non-OADS,/arxiv_data1/oa_pdf/b3/53/dmj-37-433.PMC3881328.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:450-457 Subclinical Hypothyroidism Is Independently  Associated with Microalbuminuria in a Cohort of  Prediabetic Egyptian Adults Mervat M. El-Eshmawy1, Hala A. Abd El-Hafez1, Walaa Othman El Shabrawy2, Ibrahim A. Abdel Aal2 Departments of 1Internal Medicine, 2Clinical Pathology, Specialized Medical Hospital, Mansoura University Faculty of Medicine, Mansoura, Egypt Background:  Recent evidence has suggested an association between subclinical hypothyroidism (SCH) and microalbuminuria  in patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
Around 5% to 10% of people with prediabetes become diabet -Original Article Pathophysiology http://dx.doi.org/10.4093/dmj.2013.37.6.450 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"451Prediabetes, subclinical hypothyroidism, microalbuminuria Diabetes Metab J 2013;37:450-457 http://e-dmj.orgic every year, with the same proportion converting back to  normoglycaemia, although the conversion rate varies with  population characteristics and prediabetes definitions [3,4].",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"Diabetes Metab J 2013;37:450-457 http://e-dmj.orgStatistical methods  Data entry and analysis were performed using SPSS statistical  package version 17 (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"453Prediabetes, subclinical hypothyroidism, microalbuminuria Diabetes Metab J 2013;37:450-457 http://e-dmj.orgdent of WC, fasting insulin, and HOMA-IR ( β=2.59; odds ra - tio, 4.62; 95% confidence interval, 1.45 to 14.73; P=0.01) (Ta -ble 4).",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"Diabetes Metab J 2013;37:450-457 http://e-dmj.orgDISCUSSION  The current study examined, for the first time, the relationship  between SCH and microalbuminuria in prediabetic subjects.",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"455Prediabetes, subclinical hypothyroidism, microalbuminuria Diabetes Metab J 2013;37:450-457 http://e-dmj.orgdependent of dyslipidemia and improved by levothyroxine  treatment [41].",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
Diabetes Metab J 2013;37:450-457 http://e-dmj.orgJAMA 2004;291:228-38.,Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"457Prediabetes, subclinical hypothyroidism, microalbuminuria Diabetes Metab J 2013;37:450-457 http://e-dmj.orghypothyroidism may be associated with elevated high-sensitive  c-reactive protein (low grade inflammation) and fasting hy - perinsulinemia.",Non-OADS,/arxiv_data1/oa_pdf/4d/ad/dmj-37-450.PMC3881329.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:458-464 Relative Skeletal Muscle Mass Is Associated with  Development of Metabolic Syndrome Byung Sam Park, Ji Sung Y oon Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Background:  Visceral adiposity is related to insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"Potential mechanisms contributing to reduced insulin sig - naling and action in skeletal muscle include adipose tissue ex - pansion and increased levels of inflammatory adipokines, in - creased renin-angiotensin-aldosterone system activity, decreased  muscle mitochondrial oxidative capacity, increased intramus - cular lipid accumulation, and increased levels of reactive oxy -Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.6.458 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
459Skeletal muscle in development of metabolic syndrome Diabetes Metab J 2013;37:458-464 http://e-dmj.orggen species [5].,Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"Diabetes Metab J 2013;37:458-464 http://e-dmj.orgously diagnosed hypertension; 3) elevated FPG (≥100 mg/dL)  or treatment of diabetes; 4) elevated TG (≥150 mg/dL), or spe - cific treatment for this lipid abnormality; and 5) reduced HDL- C (<40 mg/dL in males and <50 mg/dL in females).",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
461Skeletal muscle in development of metabolic syndrome Diabetes Metab J 2013;37:458-464 http://e-dmj.orgproportion in subjects with MS.,Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"Diabetes Metab J 2013;37:458-464 http://e-dmj.orgare indicative of relative muscle mass, reduced the risk of high  BP , dysglycemia, and high TG, in addition to reducing the de - velopment of MS.  MS and associated morbidities include dyslipidemia, hyper - tension, type 2 diabetes mellitus, and nonalcoholic steatohepa - titis, which are known as insulin resistance syndrome.",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"463Skeletal muscle in development of metabolic syndrome Diabetes Metab J 2013;37:458-464 http://e-dmj.orgdiabetes federation (IDF) criteria, were used for defining MS  because it has been reported that central obesity is less preva - lent in Koreans than Caucasians and the IDF criteria are infe - rior to the modified NCEP criteria in identifying high-risk pa - tients who lack central obesity [20].",Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
Diabetes Metab J 2013;37:458-464 http://e-dmj.org17.,Non-OADS,/arxiv_data1/oa_pdf/43/2e/dmj-37-458.PMC3881330.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:465-474 Glycemic Effectiveness of Metformin-Based   Dual-Combination Therapies with Sulphonylurea,  Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean  Type 2 Diabetic Patients  Y oung Ki Lee1,2, Sun Ok Song2,3, Kwang Joon Kim1, Y ongin Cho1, Y ounjeong Choi1, Yujung Yun1, Byung-Wan Lee1,   Eun-Seok Kang1, Bong Soo Cha1, Hyun Chul Lee1 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Y onsei University College of Medicine, Seoul,  2Department of Medicine, The Graduate School of Y onsei University, Seoul,  3Division of Endocrinology, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea Background:  This study compared the glycemic effectiveness of three metformin-based dual therapies according to baseline  hemoglobin A1c (HbA1c) to evaluate the appropriateness of the guideline enforced by the National Health Insurance Corpora - tion of Korea for initial medication of type 2 diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"However, optimal or recommended regimens regarding the se - lection of hypoglycemic agents to effectively and safely achieve Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2013.37.6.465 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
Diabetes Metab J 2013;37:465-474 http://e-dmj.orggood glycemic status have differed slightly between several  guidelines [4-6].,Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"467Response to metformin-based dual combinations Diabetes Metab J 2013;37:465-474 http://e-dmj.orgfunction and insulin sensitivity were determined by homeosta - sis model assessment (HOMA) of pancreatic β-cell function  (HOMA-β; [baseline insulin ( μIU/mL)×20]/[0.055551×fast - ing glucose (mg/dL)–3.5]) and HOMA of insulin resistance  (HOMA-IR; [0.055551×fasting glucose (mg/L)×baseline insu - lin (μIU/mL)]/22.5), respectively.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"Diabetes Metab J 2013;37:465-474 http://e-dmj.orgRESULTS Baseline characteristics of the study population Of the 116 subjects who were enrolled in this study, 17 subjects  failed to complete follow-up; 99 subjects were ultimately ana - lyzed and were classified into three groups: group I ( n=31,  metformin and either gliclazide-MR [ n=22 (71.0%), 60 (30 to 60) mg] or glimepiride n=9 [29.0%], 4 [2.5 to 4] mg); group II  (n=30, metformin and 15 mg pioglitazone), and group III  (n=38, metformin and 100 mg sitagliptin) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"469Response to metformin-based dual combinations Diabetes Metab J 2013;37:465-474 http://e-dmj.orgbaseline demographics, anthropometrics, or metabolic char - acteristics was observed among the three groups.",OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"Diabetes Metab J 2013;37:465-474 http://e-dmj.org The proportion of individuals who achieved HbA1c level  ≤7% at 24 weeks was 89.3%, 81.5%, and 84.8% in groups I, II,  and III, respectively, with no statistically significant difference  in the proportion among the groups ( P=0.649) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"471Response to metformin-based dual combinations Diabetes Metab J 2013;37:465-474 http://e-dmj.orgSecondary and other outcomes The subjects were also classified into three categories accord - ing to HbA1c level: category I ( n=43; 7.5%≤HbA1c<9.0%),  category II ( n=23; 9.0%≤HbA1c<11.0), and category III  (n=22; 11.0%≤HbA1c) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
Diabetes Metab J 2013;37:465-474 http://e-dmj.orgOHAs prescribed by analyzing the proportion of subjects  reaching a target HbA1c level ≤7% according to initial HbA1c.,Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"473Response to metformin-based dual combinations Diabetes Metab J 2013;37:465-474 http://e-dmj.orggreater reduction of HbA1c according to higher baseline HbA1c,  when two drugs are used simultaneously, the increased reduc - tion of HbA1c according to higher baseline HbA1c might  show a greater magnitude due to the additive effect.",Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
Diabetes Metab J 2013;37:465-474 http://e-dmj.orgthe European Association for the Study of Diabetes (EASD).,Non-OADS,/arxiv_data1/oa_pdf/ae/4c/dmj-37-465.PMC3881331.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:475-483 Pattern of Stress-Induced Hyperglycemia according to  Type of Diabetes: A Predator Stress Model Jin-Sun Chang, Y oung-Hye Y ou, Shin-Y oung Park, Ji-Won Kim, Hun-Sung Kim, Kun-Ho Y oon, Jae-Hyoung Cho Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Background:  We aimed to quantify stress-induced hyperglycemia and differentiate the glucose response between normal ani - mals and those with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"In addition, the pattern and level of hyperglycemia Original Article Others http://dx.doi.org/10.4093/dmj.2013.37.6.475 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
Diabetes Metab J 2013;37:475-483 http://e-dmj.orginduced by psychiatric stress are difficult to investigate because  psychiatric stress is difficult to objectively measure and quan - tify and to reproduce in humans due to ethical and method - ological considerations.,Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
477Patterns of stress-induced hyperglycemia Diabetes Metab J 2013;37:475-483 http://e-dmj.orgcose level (G peak; mg/dL) as the peak level of blood glucose dur - ing the stress-loading test.,Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
Diabetes Metab J 2013;37:475-483 http://e-dmj.orgnificant differences were recognized at P<0.05.,Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"479Patterns of stress-induced hyperglycemia Diabetes Metab J 2013;37:475-483 http://e-dmj.orgNonobese type 2 diabetes model After exposing the rats to the stressor, the blood glucose con - centration increased at a rate of 6.5±1.7 mg/dL/min during  the first 15 minutes, which was significantly higher than the  baseline rate (2.9±1.4 mg/dL/min, P<0.01).",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
Diabetes Metab J 2013;37:475-483 http://e-dmj.orgDISCUSSION It has been reported that stress plays a role in the etiology and  treatment of diabetes mellitus [3].,Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"481Patterns of stress-induced hyperglycemia Diabetes Metab J 2013;37:475-483 http://e-dmj.orgstress were significantly higher in all of the diabetes models  compared to the normal glucose states, and the increased glu - cose level induced by the 60-minute stress only returned to  baseline after 3 to 4 hours in the diabetes models.",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"Diabetes Metab J 2013;37:475-483 http://e-dmj.orgfered according to type of diabetes, which could be applied in  the actual treatment of patients with different types of diabe - tes.",Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
483Patterns of stress-induced hyperglycemia Diabetes Metab J 2013;37:475-483 http://e-dmj.orgBehav Neurosci 2001;115:443-54.,Non-OADS,/arxiv_data1/oa_pdf/f7/a7/dmj-37-475.PMC3881332.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/7a/dmj-37-484.PMC3881333.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:484-485 Predicting Mortality of Critically Ill Patients by Blood  Glucose Levels ( Diabetes Metab J  2013;37:385-90) Hyeong Kyu Park Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea  Corresponding author: Hyeong Kyu Park Department of Internal Medicine, Soonchunhyang University Hospital,  Soonchunhyang University College of Medicine, 59 Daesagwan-ro,   Y ongsan-gu, Seoul 140-743, Korea E-mail: hkpark@schmc.ac.krCritical illness is associated with a high risk for multiple organ  failure and mortality.",Non-OADS,/arxiv_data1/oa_pdf/1e/7a/dmj-37-484.PMC3881333.pdf
"In this study, the authors showed that patients (group 1, n=  110) with glucose levels less than 100 mg/dL upon ICU admis -Letter http://dx.doi.org/10.4093/dmj.2013.37.6.484 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/1e/7a/dmj-37-484.PMC3881333.pdf
"485Predicting mortality by blood glucose at admission Diabetes Metab J 2013;37:484-485 http://e-dmj.orgsion had higher mortality rate compared to those (group 2,  n=799) with glucose levels ranging between 100 and 199 mg/ dL, although there was no statistical difference.",Non-OADS,/arxiv_data1/oa_pdf/1e/7a/dmj-37-484.PMC3881333.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/5b/dmj-37-486.PMC3881334.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:486-487Erratum http://dx.doi.org/10.4093/dmj.2013.37.6.486 pISSN 2233-6079 · eISSN 2233-6087 Erratum: Figure Correction Intestinal and Hepatic Niemann-Pick C1-Like 1 Sung-Woo Park Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of  Medicine, Seoul, Korea Diabetes Metab J 2013;37:240-248. http://dx.doi.org/10.4093/dmj.2013.37.4.240  To the Editor: An error was found in the following published article: Park SW .",Non-OADS,/arxiv_data1/oa_pdf/ca/5b/dmj-37-486.PMC3881334.pdf
487 Erratum: figure correction Diabetes Metab J 2013;37:486-487 http://e-dmj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ca/5b/dmj-37-486.PMC3881334.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/d2/dmj-37-488.PMC3881335.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:488Erratum http://dx.doi.org/10.4093/dmj.2013.37.6.488 pISSN 2233-6079 · eISSN 2233-6087 Erratum: Author’s Name Correction  Diabetic Retinopathy and Endothelial  Dysfunction in Patients with Type 2 Diabetes  Mellitus Jae-Seung Yun1, Seung-Hyun Ko1, Ji-Hoon Kim2, Kun-Woong Moon2, Y ong-Moon Park3,4, Ki-Dong Y oo2,   Yu-Bae Ahn1 Divisions of 1Endocrinology and Metabolism, 2Cardiology, Department of Internal Medicine, 3Department of Preventive Medicine, St. Vincent’s  Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea   4Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA Diabetes Metab J 2013;37:262-269. http://dx.doi.org/10.4093/dmj.2013.37.4.262 One of the authors’ names was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/6e/d2/dmj-37-488.PMC3881335.pdf
"OncoImmunology 2013; 2:e26442; http://dx.doi.org/10.4161/onci.26442The IL-15-based superagonist ALT-803   promotes the antigen-independent conversion   of memory CD8+ T cells into innate-like   effector cells with antitumor activity hing C w ong*, e mily K Jeng, and Peter r r hode altor Bios cience Corporation; Miramar, FL usa Keywords:  adaptive immunity, immunotherapy, innate immunity, interferon γ ,  interleukin-15, memory CD8+ T cells, myeloma, NKG2D, tumor Abbreviations: IFN, interferon; IL, interleukin; IL-2R β, IL-2 receptor β ; Lm, Listeria monocytogenes; NK, natural killer;   OVA, ovalbumin; TAA, tumor-associated antigen; TCR, T-cell receptor aLT-803, an interleukin-15-based superagonist, induces memory CD8+ T  cells to proliferate, upregulate receptors  involved in innate immunity, secrete interferon γ and acquire the ability to kill malignant cells in the absence of antigenic  stimulation.",Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Nat Rev Cancer 2011; 11:805-12;  PMID:22020206 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Crit Rev Immunol 2012; 32:139-55; PMID:23216612 ; http://dx.doi.org/10.1615/ CritRevImmunol.v32.i2.30 3.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Blood 2012; 119:3073-83;  PMID:22251483 ;  http://dx.doi.org/10.1182/blood-2011-07-369736 4.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Immunity 2012; 37:549-62; PMID:22940097 ;  http://dx.doi.org/10.1016/j.immuni.2012.05.0295.,OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Cell Rep 2013; 3:701- 8; PMID:23523350 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Clin Exp  Immunol 2013;  Forthcoming;  PMID:23937663 ;  http://dx.doi.org/10.1111/cei.12186 7.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
Cancer Res 2013; 73:3075-86;  PMID:23644531 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-23578.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
J Immunol 2009; 183:3598-607; PMID:19710453 ; http://dx.doi.org/10.4049/ jimmunol.0901244 9.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/onci-2-e26442.PMC3881336.pdf
"1 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgImpact on an international scale: Growing our reach within the  allergy and asthma fields for the past 2 years Since the Allergy, Asthma & Immunology Research (AAIR)  launched its first issue in October of 20091 and thanks to the ex - ceptional quality of all contributors, it only took 18 months for  the AAIR to receive the honor of being listed on the SCIE which  occurred in June, 2011.2 Recently, in 2012, we were awarded our  highest impact factor (IF) of 2.65.",Non-OADS,/arxiv_data1/oa_pdf/4e/f1/aair-6-1.PMC3881393.pdf
"2014 January;6(1):1-2. http://dx.doi.org/10.4168/aair.2014.6.1.1 pISSN 2092-7355 • eISSN 2092-7363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/f1/aair-6-1.PMC3881393.pdf
"2014 January;6(1):1-2. http://dx.doi.org/10.4168/aair.2014.6.1.1Volume 6, Number 1, January 2014 2 http://e-aair.orgeditorial team, I look forward to the excellent and continued  support from all the members of the KAAACI and KAPARD.",Non-OADS,/arxiv_data1/oa_pdf/4e/f1/aair-6-1.PMC3881393.pdf
"13 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgUrticaria is a common skin disorder, affecting 15%-30% of the  population and leading to consultations at medical facilities.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13 pISSN 2092-7355 • eISSN 2092-7363 Chronic urticaria (CU) is a common allergic skin disease that requires long-term pharmacological treatment.,Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"Key Words:  Chronic urticaria; genetic association; leukotriene; mast cellThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13Volume 6, Number 1, January 2014 14 http://e-aair.org(AIAU).",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13AAIR  15 http://e-aair.orgcific for various autoantigens, such as TPO on the mast cell sur - face, which could activate mast cells.28 When mast cells are trig - gered, they release preformed mediators, and subsequently  leukotrienes, prostaglandins, cytokines, and chemokines, which  aggravate chronic inflammation.29,30 FcεRI is a tetramer consist - ing of a ligand-binding α chain, a signal-amplifying β chain, and  a signal-transducing γ chain dimer.31,32 Recent studies have  demonstrated their roles in aspects of molecular genetic me - chianism of CU.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13Volume 6, Number 1, January 2014 16 http://e-aair.orgmune systems and that plays an essential role in the regulation  of immune responses.55-57 Moreover, it has been shown to in - duce pro- and anti-inflammatory responses.55 The genetic vari - ants -1082A/G, -819C/T, and 592A/C in the promoter region of  the IL-10  gene have been described frequently in association  with cutaneous diseases, while their influence on IL-10 pro - duction is unclear.58-61 A genetic association of -819T >C in IL- 10 with AIU, including both AIAU and AICU, was identified in a  Korean population.62 The authors demonstrated a significantly  higher frequency of the major allele of IL-10  -819T >C in those  with AIU phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13AAIR  17 http://e-aair.orgWhen HLA class I and II alleles were evaluated in Korean pa - tients with AIU using a high-resolution technique, the frequen - cy of the HLA-DRB1*1302-DQB1*0609-DPB1*0201 haplotype  was significantly higher in the patient group.84 Although studies  using a high-resolution technique in a larger CU cohort, fol - lowed by in vitro  functional studies, are essential, these findings  suggest the potential involvement of HLA alleles in CU pheno - types.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13Volume 6, Number 1, January 2014 18 http://e-aair.orgPTPN22 to reduce antigen-receptor signaling, leading to com - promised central and peripheral tolerance.95 PTPN22 was re - ported to contribute to CU susceptibility in a Polish popula - tion.99 The prevalences of the PTPN22  promoter polymorphism  -1123G >C, and its haplotype construct including rs2488457C,  rs1310182T and 3811021T, showed significant associations with  CU.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13AAIR  19 http://e-aair.orgsiveness to other stimuli.,Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13Volume 6, Number 1, January 2014 20 http://e-aair.org57.",Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
2014 January;6(1):13-21. http://dx.doi.org/10.4168/aair.2014.6.1.13AAIR  21 http://e-aair.orgpirin-intolerant urticaria.,Non-OADS,/arxiv_data1/oa_pdf/06/40/aair-6-13.PMC3881394.pdf
"22 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION M. pneumoniae  accounts for 10%-40% of community-acquired  pneumonia in school-aged children and young adults.1-4 Al- though M. pneumoniae  pneumonia (MP) typically follows a be - nign course, it may develop into severe fulminant pneumonia  and pulmonary complications such as acute respiratory distress  syndrome, necrotizing pneumonia, or bronchiolitis obliterans in  rare cases.5 In Korea, the epidemic incidence of M. pneumoniae   infections, which formerly peaked at 4-7-year intervals in school- aged children, now occurs every 3-4 years at a high prevalence.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
2014 January;6(1):22-26. http://dx.doi.org/10.4168/aair.2014.6.1.22 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Mycoplasma pneumoniae (M. pneumoniae)  is one of the most common causes of community-acquired pneumonia in children.,Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"Key Words:  Children; methylprednisolone; Mycoplasma pneumoniae ; pneumoniaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"2014 January;6(1):22-26. http://dx.doi.org/10.4168/aair.2014.6.1.22AAIR  23 http://e-aair.orgMATERIALS AND METHODS We retrospectively reviewed the medical records of 12 previ - ously healthy children with refractory MP who were treated  with high doses of methylprednisolone therapy at Chungnam  National University Hospital (Daejeon, Korea) between Janu - ary 2011 and December 2011.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"2014 January;6(1):22-26. http://dx.doi.org/10.4168/aair.2014.6.1.22Volume 6, Number 1, January 2014 24 http://e-aair.orgtokine responses against the pathogens.9 For pathogenesis, M. pneumoniae  shows strong cytoadher - ence to the host respiratory epithelium.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"2014 January;6(1):22-26. http://dx.doi.org/10.4168/aair.2014.6.1.22AAIR  25 http://e-aair.orginfection, and infected children were older than 6 years.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"2014 January;6(1):22-26. http://dx.doi.org/10.4168/aair.2014.6.1.22Volume 6, Number 1, January 2014 26 http://e-aair.orgREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/e2/02/aair-6-22.PMC3881395.pdf
"27 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Allergic rhinitis (AR) has been shown to be a risk factor for the  development of asthma.1,2 Lower airway pathology of AR may  represent the link between these 2 diseases.3 Airway inflamma - tion, bronchial hyper-responsiveness (BHR), and bronchodila - tor response (BDR) are representative characteristics of asth - ma.",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Airway inflammation, bronchial hyper-responsiveness (BHR), and bronchodilator response (BDR) are representative characteristics of asth - ma.",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"Key Words:  Asthma; allergic rhinitis; bronchial hyper-responsiveness; bronchodilator effect; child; nitric oxideThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27Volume 6, Number 1, January 2014 28 http://e-aair.orgknowledge, there have been few studies evaluating BHR in AR  using IOS or to evaluate BDR in AR using IOS.15 The aim of this study was to evaluate BDR in the AR, asthma,  and control groups.",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27AAIR  29 http://e-aair.orgto the resonant frequency.,Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27Volume 6, Number 1, January 2014 30 http://e-aair.orgFEV1 and % change in FEF 25-75 were higher in the asthma group  than in the AR and control groups ( P<0.0001).",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27AAIR  31 http://e-aair.orged to have higher FeNO levels than the AR group without ( P=  0.08) (E-Table 2, Figure A).",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):27-32. http://dx.doi.org/10.4168/aair.2014.6.1.27Volume 6, Number 1, January 2014 32 http://e-aair.orgetro C, Marseglia GL.",Non-OADS,/arxiv_data1/oa_pdf/ef/cf/aair-6-27.PMC3881396.pdf
"2014 January;6(1):3-5. http://dx.doi.org/10.4168/aair.2014.6.1.3 pISSN 2092-7355 • eISSN 2092-7363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/e7/aair-6-3.PMC3881397.pdf
"2014 January;6(1):3-5. http://dx.doi.org/10.4168/aair.2014.6.1.3Volume 6, Number 1, January 2014 4 http://e-aair.orgpneumonia.23,24  Extrapulmonary manifestations are common in patients with  MP infections, with encephalitis being the most common ex - trapulmonary manifestation.",Non-OADS,/arxiv_data1/oa_pdf/fd/e7/aair-6-3.PMC3881397.pdf
2014 January;6(1):3-5. http://dx.doi.org/10.4168/aair.2014.6.1.3AAIR  5 http://e-aair.orgdren.,Non-OADS,/arxiv_data1/oa_pdf/fd/e7/aair-6-3.PMC3881397.pdf
"33 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Children are the major age group affected by cow’s milk pro - tein allergy (CMPA).1 The symptoms that suggest CMPA are ob - served in 5%-15% of infants; however, the incidence of CMPA is  approximately 2%-5% when specific diagnostic criteria are used.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Calprotectin is a cytosolic protein with immunomodulatory, antimicrobial, and antiproliferative actions.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"Key Words:  Milk hypersensitivity; milk protein; fecal calprotectinThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33Volume 6, Number 1, January 2014 34 http://e-aair.orgtectin is a calcium and zinc binding protein.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33AAIR  35 http://e-aair.orgwhose cow’s milk-specific IgE was found to be negative.,Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33Volume 6, Number 1, January 2014 36 http://e-aair.orgdemographic and general properties of the patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33AAIR  37 http://e-aair.orgP=0.03).,Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"2014 January;6(1):33-38. http://dx.doi.org/10.4168/aair.2014.6.1.33Volume 6, Number 1, January 2014 38 http://e-aair.orgRapacciuolo L, Polito G, Bisesti V , Manguso F , Vallone G, Sodano A,  Troncone R. Combined use of noninvasive tests is useful in the ini - tial diagnostic approach to a child with suspected inflammatory  bowel disease.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/aair-6-33.PMC3881398.pdf
"39 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Allergic diseases continue to increase in prevalence worldwide  and many environmental factors contribute to their develop - ment such as allergens and exposure to air pollution.1 Sensiti - zation to an allergen is a critical step in the induction of aller - gy.2,3 Allergic diseases induced by aeroallergens can show vari - ous clinical manifestations such as rhinoconjuctivitis, eosino - philic bronchitis, and asthma.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Sensitization to specific allergens may be important in the development of allergic airway inflammation and airway hyperresponsiveness  (AHR).,Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"Key Words:  Aeroallergen; airway eosinophilia; airway hyperresponsivenessThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39Volume 6, Number 1, January 2014 40 http://e-aair.orgallergen sensitization among the general population, among  patients with allergic diseases, or on the development of asth - ma according to sensitization to some allergens.8,12-14 Limited  studies have been conducted in regards to the risk of airway in - flammation and AHR according to the patterns of aeroallergen  sensitization.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39AAIR  41 http://e-aair.orgStatistical analysis All statistical analyses were performed using SPSS software  (ver.,OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39Volume 6, Number 1, January 2014 42 http://e-aair.orgAlternaria  (OR, 2.3; 95% CI, 1.2-4.7), and cat (OR, 2.7; 95% CI,  1.7-4.3; Table 4).",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39AAIR  43 http://e-aair.orgDISCUSSION In the present study, the development of sputum eosinophilia  or AHR was significantly associated with sensitization to peren - nial allergens such as house dust mite, Alternaria , dog, or cat.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39Volume 6, Number 1, January 2014 44 http://e-aair.organd eosinophilic airway inflammation unlike perennial aller - gens in the old adult population.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39AAIR  45 http://e-aair.orgskin test responses with a lower A/H ratio.,Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"2014 January;6(1):39-46. http://dx.doi.org/10.4168/aair.2014.6.1.39Volume 6, Number 1, January 2014 46 http://e-aair.organd bronchial responsiveness.",Non-OADS,/arxiv_data1/oa_pdf/95/0b/aair-6-39.PMC3881399.pdf
"47 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION An investigation of the main offending allergen is essential to  treat allergic rhinitis (AR).",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  This study evaluates offending allergens in patients with allergic rhinitis (AR) according to age that establish a minimal panel for skin  prick test (SPT) allergens required to identify if a patient is sensitized.,Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"Key Words:  Allergic rhinitis; aeroallergen; skin prick test; sensitizationThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47Volume 6, Number 1, January 2014 48 http://e-aair.orginhalant allergens in patients across Europe and the minimum  test battery of inhalant allergens needed for an epidemiological  study.1-3 Other studies similar to population-based epidemio - logic studies show that a limited number of allergens identified  the majority of sensitized subjects in patients-based studies.4 This study evaluates the annual distribution of offending al - lergens in AR patients over a 5 year period and documents the  most prevalent offending allergens based on age.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47AAIR  49 http://e-aair.orgwas as follow: group 0-6 years, n =268 (3.7%); 7-12 years, n =673  (9.3%); 13-19 years, n =660 (9.1%); 20-29 years, n =1,032 (14.3%);  30-39 years, n =735 (10.2%); 40-49 years, n =550 (7.6%); 50-59  years, n =622 (8.6%); 60-69 years, n =356 (4.8%); and over 70  years, n =136 (1.8%) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47Volume 6, Number 1, January 2014 50 http://e-aair.orgTable 1.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47AAIR  51 http://e-aair.orgwort), the detection rate reached the level of 90.0%; however,  the allergens in the minimum test panel differed slightly among  all age groups.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47Volume 6, Number 1, January 2014 52 http://e-aair.org≤6 N Left % Cumulative % Total 268 1 D.f.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47AAIR  53 http://e-aair.orging allergens.,OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"2014 January;6(1):47-54. http://dx.doi.org/10.4168/aair.2014.6.1.47Volume 6, Number 1, January 2014 54 http://e-aair.orgREFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/aair-6-47.PMC3881400.pdf
"55 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Eosinophils play an important role in the development of asth - ma and allergic disease as an effector cell.",Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Eosinophils function as an effector cell in the development of asthma and allergic disease.,Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"Key Words:  Asthma; epistasis; polymorphisms; CCR3; eotaxinThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55Volume 6, Number 1, January 2014 56 http://e-aair.org-2, and -3, are selectively bound by CCR3.",Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55AAIR  57 http://e-aair.orgα denotes the coefficient fitted by logistic regression ( α1=0.3601,  α2=0.3525, α3=0.4204, and α4=0.1867).",OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55Volume 6, Number 1, January 2014 58 http://e-aair.org174C>T and EOT2 +304C>A was the best model (accuracy =  0.536, CVC 9/10; Table 4).",OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55AAIR  59 http://e-aair.orgwere included in the high-risk group.,Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"2014 January;6(1):55-60. http://dx.doi.org/10.4168/aair.2014.6.1.55Volume 6, Number 1, January 2014 60 http://e-aair.orgIn: Braunwald E, Fauci AS, Kaper DL, Hauser SL, Longo DL, Jame - son JL, editors.",Non-OADS,/arxiv_data1/oa_pdf/5a/a9/aair-6-55.PMC3881401.pdf
"6 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION  The mast cell has long been known to be a key effector cell type  in IgE-mediated immediate hypersensitivity and allergic disor - ders,1,2 although recent studies have added their novel roles in  host defense against bacteria and bee and snake venoms, as  well as immunoregulatory roles.3 Mast cells are activated by  cross-linking of IgE-bound high-affinity IgE receptors (Fc εRI)  with multivalent antigen.4 Activated mast cells secrete preformed  proinflammatory mediators, such as histamine, serotonin, nu - cleotides, proteases, and tumor necrosis factor (TNF)- α, and  synthesize and secrete various cytokines, chemokines, and lip - id mediators, such as leukotrienes and prostaglandins.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6 pISSN 2092-7355 • eISSN 2092-7363 Factors that can induce the release of histamine from basophils have been studied for more than 30 years.,Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"Key Words:  Asthma; allergy; histamine-releasing factor; IgE; mast cell; basophilThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6AAIR  7 http://e-aair.orgHETEROGENEITY OF IgE MOLECULES Two papers published in 2001 showed the same effects of mo - nomeric IgE, i.e., survival promotion, as well as disparate results.",OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6Volume 6, Number 1, January 2014 8 http://e-aair.orgof allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6AAIR  9 http://e-aair.orgtified.,Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6Volume 6, Number 1, January 2014 10 http://e-aair.orgmation.46,47 Although it is unknown whether HRF can activate  mast cells and basophils under homeostatic conditions (or  physiological levels and the repertoire of IgE and IgG), HRF-me - diated mast cell activation should contribute to the amplifica - tion of allergic reactions when IgE, IgG, and HRF levels are high  enough at the allergic inflammatory site.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6AAIR  11 http://e-aair.org29.,Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"2014 January;6(1):6-12. http://dx.doi.org/10.4168/aair.2014.6.1.6Volume 6, Number 1, January 2014 12 http://e-aair.org62.",Non-OADS,/arxiv_data1/oa_pdf/c4/5c/aair-6-6.PMC3881402.pdf
"61 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Lysophosphatidylcholine (LPC) is a lipid mediator with pro- inflammatory and pro-atherogenic activities.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"2014 January;6(1):61-65. http://dx.doi.org/10.4168/aair.2014.6.1.61 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Asthma is a chronic inflammatory disease of the airways, and is associated with upregulation of phospholipase A 2 (PLA 2), the enzyme that  hydrolyzes phosphatidylcholine, producing lysophosphatidylcholine (LPC) and free fatty acids.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"Key Words:  Lysophosphatidylcholine; asthma; phospholipase A 2This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"2014 January;6(1):61-65. http://dx.doi.org/10.4168/aair.2014.6.1.61Volume 6, Number 1, January 2014 62 http://e-aair.orgmatics.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"2014 January;6(1):61-65. http://dx.doi.org/10.4168/aair.2014.6.1.61AAIR  63 http://e-aair.orgcytes further increased in the moderate-asthmatics, which now  included neutrophils.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"2014 January;6(1):61-65. http://dx.doi.org/10.4168/aair.2014.6.1.61Volume 6, Number 1, January 2014 64 http://e-aair.orgDISCUSSION The central new finding is that inherent levels of LPC16:0 and  LPC18:0, but not LPC18:1, were significantly elevated in lung  lining fluids of subjects with lung function impairment charac - teristic of moderate asthma.",Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
2014 January;6(1):61-65. http://dx.doi.org/10.4168/aair.2014.6.1.61AAIR  65 http://e-aair.org12.,Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
Available from: http://www.gin - asthma.org.,Non-OADS,/arxiv_data1/oa_pdf/42/48/aair-6-61.PMC3881403.pdf
"66 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Lysophosphatidylcholine (LPC) is a pro-inflammatory and  pro-atherogenic lipid mediator found at elevated levels in the  broncho-alveolar lavage fluids (BALF) from lungs with acute  and chronic inflammatory injury.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  In human subjects and animal models with acute and chronic lung injury, the bioactive lysophosphatidylcholine (LPC) is elevated in lung  lining fluids.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"Key Words:  Bronchial epithelium; phospholipase A 2; lysophosphatidylcholine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66AAIR  67 http://e-aair.orgphospholipase A 2 (PLA 2), which hydrolyzes native and oxidized  phosphatidylcholines at the sn-2 position, generating LPC fol - lowing release of a free fatty acid.15,16 PLA 2 is comprised of a su - perfamily of 15 distinct groups, each with numerous subtypes  that varies with tissues.15,16 Evidence indicates that pathological  lung conditions such as pneumonia,17 asthma,1,18,19 experimen - tal ALI,20,21 can upregulate several PLA 2 isotypes in lung tissues,  particularly airway epithelium and leukocytes.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66Volume 6, Number 1, January 2014 68 http://e-aair.orgwas 25 pg (2.5 ng/mL; 10 µL injection) based on a signal-to-noise  ratio of 10.",OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66AAIR  69 http://e-aair.orgspecies known to be biologically most active.,OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66Volume 6, Number 1, January 2014 70 http://e-aair.orgPLA 2 activity in the condition medium was attributed to upreg - ulation of PLA 2 mRNA.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66AAIR  71 http://e-aair.orga rapid decrease in resistance (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66Volume 6, Number 1, January 2014 72 http://e-aair.orgLPC12:0, LPC14:0, and LPC17:0 were ineffective.32 Further,  LPC16:0 and LPC18:0 are observed to be more potent than  LPC18:1 in stimulating eosinophil adhesion.33 Our results indi - cate that stimulated bronchial epithelial cells release these bio - active LPCs which can contribute to the promotion of an in - flammatory lung microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66AAIR  73 http://e-aair.orgrect surfactant protein A-phospholipase A2 protein interaction.,OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"2014 January;6(1):66-74. http://dx.doi.org/10.4168/aair.2014.6.1.66Volume 6, Number 1, January 2014 74 http://e-aair.orgduced gastric muscle contraction.",Non-OADS,/arxiv_data1/oa_pdf/f5/37/aair-6-66.PMC3881404.pdf
"75 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Bronchial asthma is defined as a chronic inflammatory disor - der of the airways which is characterized by persistent airway hy - perresponsiveness and intermittent reversible airway obstruc - tion caused by hypersensitivity to various stimulants.1 Clinically,  asthma is a complex disease caused by multiple genetic and en - vironmental factors and is diagnosed by airflow obstruction re - sponses to a bronchodilator.",Non-OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  To evaluate airway changes in ovalbumin-induced asthmatic mice in terms of postmortem micro-CT images and pathological findings.,Non-OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75Volume 6, Number 1, January 2014 76 http://e-aair.orgmulti-detector computed tomography (MDCT).",OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75AAIR  77 http://e-aair.orgimages, and the Lucion (Lucion 1.5; MeviSYS, Seoul, Korea)  program was used for 3-dimensional reconstruction.",OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75Volume 6, Number 1, January 2014 78 http://e-aair.orgto 0.14 mm (mean thickness, 0.119 ±0.01 mm) in the experimen - tal group and from 0.09 to 0.13 mm (mean thickness, 0.108 ± 0.013 mm) in the control group and the difference was statisti - cally significant ( P=0.0005) (Table 2) (Figs.",OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75AAIR  79 http://e-aair.org0.011 mm) in the experimental group and from 0.03 to 0.055  mm (mean thickness, 0.041 ±0.009 mm) in the control group,  and the difference was statistically significant ( P<0.0001) (Table  3) (Figs.",OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75Volume 6, Number 1, January 2014 80 http://e-aair.orgsimilar to histological examination, and the X-ray source and  detector are fixed while the samples rotate.",Non-OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75AAIR  81 http://e-aair.orgac movement and spatial resolution insufficient to analyze an - atomical structures.,OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"2014 January;6(1):75-82. http://dx.doi.org/10.4168/aair.2014.6.1.75Volume 6, Number 1, January 2014 82 http://e-aair.org4.",Non-OADS,/arxiv_data1/oa_pdf/3e/43/aair-6-75.PMC3881405.pdf
"83 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Asthma is a chronic inflammatory disease, characterized by  the infiltration of inflammatory cells (e.g., eosinophils) in the  airway or lung tissues, airway hypersensitivity, and remodeling.1  In recent decades, allergic diseases such as asthma have shown  a rapidly increasing trend.2-4 The hygiene hypothesis suggests  that a Westernized life style coupled with improved sanitation  has reduced microbial exposure, thereby curtailing Th1 immune  responses and exacerbating Th2 immune responses.5-7  Mycolic acid (MA), major components of the cell walls of My- cobacterium tuberculosis  and related species, is β-hydroxy- α-alkyl  branched fatty acids comprising about 60-90 carbon atoms.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Recognition of microbes is important to trigger the innate immune system.,Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"Key Words:  Mycolic acid; asthma; allergic inflammation; regulatory T cells; miceThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83Volume 6, Number 1, January 2014 84 http://e-aair.orgresponses.8 Recently, a negative correlation between a positive  tuberculin skin test and the development of allergic rhinitis was  reported.9 In addition, MA isolated from Mycobacteria  may mod - ulate experimental asthma by inducing alveolar macrophages  into foamy cell morphotype.10 This modulation prevents the on - set of allergic airway inflammation by inducing of regulatory T  cells (Tregs) which express markers, including Forkhead box p3  (Foxp3), neuropilin-1, and glucocorticoid-induced tumor ne - crosis factor receptor-related protein.10 Therefore, we postulat - ed that MA may serve as a potential therapeutic molecule for  allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83AAIR  85 http://e-aair.orgCD25 and Foxp3 expression according to the manufacturer’s  directions.,Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83Volume 6, Number 1, January 2014 86 http://e-aair.orgCell in BAL fluid ( ×105/mL) OVATotal cell Saline sMAVehicle sMA+Anti-CD25sMA+Isotype30 20 10 0** ****Cell in BAL fluid ( ×105/mL) OVAEosinophil Saline sMAVehicle sMA+Anti-CD25sMA+Isotype12 10 8 6 4 2 0* ** ***** Cell in BAL fluid ( ×105/mL) OVALymphocyte Saline sMAVehicle sMA+Anti-CD25sMA+Isotype1.0 0.8 0.6 0.4 0.2 0*** Cell in BAL fluid ( ×105/mL) OVANeutrophil Saline sMAVehicle sMA+Anti-CD25sMA+Isotype10.0 7.5 5.0 2.5 0*Cell in BAL fluid ( ×105/mL) OVAMacrophage Saline sMAVehicle sMA+Anti-CD25sMA+Isotype12.5 10.0 7.5 5.0 2.5 0* **** Fig.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83AAIR  87 http://e-aair.organd experimental animal models.14,15 MA is a novel cell wall  component derived from Mycobacterium tuberculosis  and the  role of MA in asthma development remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"2014 January;6(1):83-88. http://dx.doi.org/10.4168/aair.2014.6.1.83Volume 6, Number 1, January 2014 88 http://e-aair.orgma and allergy: a cross-sectional survey.",OADS,/arxiv_data1/oa_pdf/41/5e/aair-6-83.PMC3881406.pdf
"89 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Atopic dermatitis (AD) is a common chronic relapsing inflam - matory skin disease characterized by itching, dry skin, inflam - mation and exudation frequently associated with a personal or  familial history of allergic diseases.1 Hypersensitivity reaction to  environmental agents has been suggested as the pathogenetic  mechanism responsible for the development and maintenance  of chronic skin inflammation in patients with AD.2 However,  the pathogenetic mechanism of AD seems to be more complex  and associated with genetic abnormalities, environmental trig - gers, skin barrier dysfunction, and immunological abnormali - ties.2,3 The precise pathogenetic mechanism of AD is not com - pletely understood.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89 pISSN 2092-7355 • eISSN 2092-7363 The management of severe recalcitrant atopic dermatitis (AD) is a challenging issue for clinicians and patients.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"Key Words:  Dermatitis; atopic; immunoglobulin; treatmentThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89Volume 6, Number 1, January 2014 90 http://e-aair.orgreport, recalcitrant AD was defined when the clinical condition  of a patient was not effectively controlled by current standard  medical therapies (topical moisturizers, topical corticosteroids,  topical calcineurin inhibitors, and oral antihistamines) for more  than 2 months.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89AAIR  91 http://e-aair.orgRESULTS The analysis of protein concentrations in the autologous im - munoglobulin solutions from 3 patients with severe recalcitrant  AD showed that IgG was a major protein component with small  amounts of IgA, IgM, and IgE (Table 2).",OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89Volume 6, Number 1, January 2014 92 http://e-aair.orgverity of AD did not significantly improve in the patient during  the first 4 weeks after the initiation of AIGT; however, the clini - cal condition started to improve 5 weeks after the initiation of  AIGT.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89AAIR  93 http://e-aair.orgABT as the most frequently used complementary alternative  medicine for AD.10 ABT has been used for about 100 years in  many countries for the treatment of various chronic diseases.11  ABT is a treatment of repeatedly administering small amounts  of autologous blood (1-5 mL) by intramuscular injection im - mediately after the sampling of venous blood from a patient.9  Clinical efficacy of ABT has been demonstrated by randomized  placebo-controlled studies in patients with AD and chronic ur - ticaria.12,13 Autologous serum therapy (repeatedly administer - ing a small amount of serum separated from the clotted autolo - gous venous blood of patients by intramuscular injection) also  has been reported to be effective in patients with chronic urti - caria.14 The induction of an anti-idiotype immune response  (immune response to the antigen-binding portion of immuno - globulin) has been commonly suggested as the main mecha - nism for the development of immune tolerance in allergic dis - eases and autoimmune diseases.15,16 Based on these studies, we  hypothesized that repeated intramuscular injections of autolo - gous immunoglobulin might induce clinical improvements in  patients with AD by the stimulation of an active immune re - sponse to the antigen-binding-site of pathogenic antibodies.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"2014 January;6(1):89-94. http://dx.doi.org/10.4168/aair.2014.6.1.89Volume 6, Number 1, January 2014 94 http://e-aair.org8.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/aair-6-89.PMC3881407.pdf
"95 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Codeine is a methylated morphine derivative that is found  naturally in poppy seeds.1 Codeine has analgesic and antitus - sive activities, and has been widely prescribed in clinical set - tings.",Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
2014 January;6(1):95-97. http://dx.doi.org/10.4168/aair.2014.6.1.95 pISSN 2092-7355 • eISSN 2092-7363 Codeine is widely prescribed in clinical settings for the relief of pain and non-productive coughs.,Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
"Key Words:  Anaphylaxis; basophil degranulation test; codeineThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
"2014 January;6(1):95-97. http://dx.doi.org/10.4168/aair.2014.6.1.95Volume 6, Number 1, January 2014 96 http://e-aair.orgAfter stabilizing her asthma, we planned to perform in vivo   and in vitro  tests to confirm whether her systemic reactions  were caused by codeine and to evaluate the mechanism of the  codeine-induced anaphylaxis.",Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
"The CYP2D6  genotyping results revealed that the patient had the CYP2D6*1/   *10 allele, which indicated that she was an intermediate metab - olizer according to the expected enzyme activities reported on  the CYP2D6 allele web site (http://www.imm.ki.se/CYPalleles/ cyp2d6.htm).",Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
2014 January;6(1):95-97. http://dx.doi.org/10.4168/aair.2014.6.1.95AAIR  97 http://e-aair.orgtors to screen susceptible subjects.,Non-OADS,/arxiv_data1/oa_pdf/db/25/aair-6-95.PMC3881408.pdf
"98 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Idiopathic hypereosinophilic syndrome (IHES) is a group of  disorders characterized by the overproduction of eosinophils  resulting in inflammatory damage to multiple organs, includ - ing skin, heart, lung, gastrointestinal tract, and nervous system.1  Signs and symptoms associated with lung involvement are rel - atively common, occurring in approximately 40% of IHES pa - tients.2,3 However, despite frequent lung involvement, acute re - spiratory distress syndrome (ARDS) is rarely seen in conjunction  with IHES, with only a few cases described in the literature to  date.4,5 This is the first case report of IHES presented with ARDS  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
"2014 January;6(1):98-101. http://dx.doi.org/10.4168/aair.2014.6.1.98 pISSN 2092-7355 • eISSN 2092-7363 Although idiopathic hypereosinophilic syndrome(IHES) commonly involves the lung, it is rarely associated with acute respiratory distress syndrome  (ARDS).",Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
"Key Words:  Idiopathic hypereosinophilic syndrome; eosinophilia; acute respiratory distress syndrome; pulmonary thromboembolism This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
2014 January;6(1):98-101.  http://dx.doi.org/10.4168/aair.2014.6.1.98AAIR  99 http://e-aair.orgglass opacity in both lower lung zones was noticed in the initial  chest radiography (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
"2014 January;6(1):98-101.  http://dx.doi.org/10.4168/aair.2014.6.1.98Volume 6, Number 1, January 2014 100 http://e-aair.orgagnosis of IHES, which is still in use today.",Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
"2014 January;6(1):98-101.  http://dx.doi.org/10.4168/aair.2014.6.1.98AAIR  101 http://e-aair.orgmulticenter, retrospective analysis of clinical characteristics and re - sponse to therapy.",Non-OADS,/arxiv_data1/oa_pdf/a0/9a/aair-6-98.PMC3881409.pdf
Jung-Ho Lee (e-mail: ljhcivapt@ naver.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d6/d5/jpts-25-1359.PMC3881455.pdf
kubo11@gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f4/50/jpts-25-1363.PMC3881456.pdf
Kyung Yoon Kim (e-mail: red - bead7@daum.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/67/32/jpts-25-1367.PMC3881457.pdf
Kyoung Kim (e-mail: kykim257@ daegu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>,Non-OADS,/arxiv_data1/oa_pdf/38/89/jpts-25-1373.PMC3881458.pdf
Tomoyuki Asakura (e-mail:  asakuri@gunma-u.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cc/fe/jpts-25-1377.PMC3881459.pdf
Hohee Son (e-mail: sonhh@cup.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/01/f0/jpts-25-1383.PMC3881460.pdf
Min-Ho Hong (e-mail: rainysun00@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3c/b0/jpts-25-1387.PMC3881461.pdf
ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/97/97/jpts-25-1391.PMC3881462.pdf
Kwon-Young Kang (e-mail:  k2y1125@hotmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0f/a4/jpts-25-1393.PMC3881463.pdf
Su-kyoung Lee (e-mail: holeintwo@ naver.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/34/5f/jpts-25-1397.PMC3881464.pdf
Syamala Buragadda (e-mail:  sbadari@ksu.edu.sa) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/41/c4/jpts-25-1401.PMC3881465.pdf
Su-kyoung Lee (e-mail: holeintwo@ naver.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0f/94/jpts-25-1407.PMC3881466.pdf
ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fb/24/jpts-25-1411.PMC3881467.pdf
Chien-Hui Huang (e-mail: chien - huang@mail.tcu.edu.tw) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/df/21/jpts-25-1415.PMC3881468.pdf
Ji Won Park (e-mail: mylovept@ cu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4f/0c/jpts-25-1421.PMC3881469.pdf
Hwangbo Gak (e-mail: hbgak@ daegu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cb/35/jpts-25-1425.PMC3881470.pdf
ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e4/35/jpts-25-1429.PMC3881471.pdf
Jaemin Jung (e-mail: 6240394@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cc/6f/jpts-25-1433.PMC3881472.pdf
Hirokazu Haruna (e-mail: haruna@ hit.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/eb/e2/jpts-25-1437.PMC3881473.pdf
"Yun Bok Lee , (e-mail: caggg@ kyungnam.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/40/b1/jpts-25-1445.PMC3881474.pdf
Myoung Heo (e-mail: hmdong2@ hanmail.net) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1b/39/jpts-25-1451.PMC3881475.pdf
Ming Huo (e-mail: huoming8@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/> .Table 1.,Non-OADS,/arxiv_data1/oa_pdf/48/30/jpts-25-1455.PMC3881476.pdf
Ming Huo (e-mail: huoming8@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/ licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8f/b3/jpts-25-1459.PMC3881477.pdf
Ming Huo (e-mail: huoming8@ gmail.com) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/ licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/76/28/jpts-25-1463.PMC3881478.pdf
Sukhoon Yoon (e-mail: sxy134@ knsu.ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/ licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/41/ef/jpts-25-1467.PMC3881479.pdf
[Medline] 2) Statistics Korea: The elderly population for 2011. http://kosis.kr/abroad/abroad_01List.jsp (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/41/ef/jpts-25-1467.PMC3881479.pdf
http://www.cdc.gov/ncipc/factshhets/adultfalls.htm (Ac - cessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/41/ef/jpts-25-1467.PMC3881479.pdf
http://www.cdc.gov/ncipc/ wisqars (Accessed Apr.,OADS,/arxiv_data1/oa_pdf/41/ef/jpts-25-1467.PMC3881479.pdf
ac.kr) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/ licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/61/e2/jpts-25-1471.PMC3881480.pdf
Joo Soo Yoon (e-mail: orange1237@ hanmail.net)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cf/23/jpts-25-1475.PMC3881481.pdf
Syamala Buragadda (e- mail: sya - mala3110@yahoo.co.in) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9c/5e/jpts-25-1479.PMC3881482.pdf
ac.kr)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/56/71/jpts-25-1483.PMC3881483.pdf
Byoung-Jin	Jeon	(e-mail:	nomadot@ kangwon.ac.kr)©2013	The	Society	of	Physical	Therapy	Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives	(by-nc-nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5e/40/jpts-25-1485.PMC3881484.pdf
http://www.who.int	 (Accessed	 Apr.,Non-OADS,/arxiv_data1/oa_pdf/5e/40/jpts-25-1485.PMC3881484.pdf
hiromichi@gmail.com)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/96/47/jpts-25-1491.PMC3881485.pdf
lop@uol.com.br)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/55/9a/jpts-25-1497.PMC3881486.pdf
Claudia Santos Oliveira (e-mail:  csantos@uninove.br)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/jpts-25-1503.PMC3881487.pdf
ac.kr)©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/90/e6/jpts-25-1509.PMC3881488.pdf
4) Upper Back and Chest Pain Diagnosis Guide: http://www.physioadvisor.,Non-OADS,/arxiv_data1/oa_pdf/90/e6/jpts-25-1509.PMC3881488.pdf
"Masahiko Wakasa (e-mail: masa - loco@hs.akita-u.ac.jp, wakasa-1969@umin.ac.jp) ©2013 The Society of Physical Therapy Science This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/jpts-25-1511.PMC3881489.pdf
"The primers were designed based on wheat, barley, rice and corn phytocys-tatin sequences, which are available in the NCBI database(http://www.ncbi.nlm.nih.gov ).",OADS,/arxiv_data1/oa_pdf/70/c5/11105_2011_Article_384.PMC3881564.pdf
Computer Analysis of the Nucleotide and Amino Acid Sequences Sequence homology of the triticale phytocystatins was verified by database searches at NCBI ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/70/c5/11105_2011_Article_384.PMC3881564.pdf
The deduction of the amino acid sequen- ces and the calculation of the theoretical molecular weight and the isoelectric point (pI) were performed using the ExPASy Proteomics tools ( http://www.expasy.ch/tools/ ).,OADS,/arxiv_data1/oa_pdf/70/c5/11105_2011_Article_384.PMC3881564.pdf
The percentage identity of the a mino acid sequences was calculated using ClustalW software ( http://www.clustal.org/ ).,OADS,/arxiv_data1/oa_pdf/70/c5/11105_2011_Article_384.PMC3881564.pdf
EST Sequencing and Analysis Homology searches were conducted for all sequences using the GenBank database and the BLAST algorithms at the National Center for Biotechnology Information (NCBI) network service (http://www.ncbi.nlm.nih.gov/BLAST/ ).,OADS,/arxiv_data1/oa_pdf/86/c4/11105_2011_Article_361.PMC3881567.pdf
(http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/86/c4/11105_2011_Article_361.PMC3881567.pdf
Available from http://www.worldagroforestry.org/Sites/TreeDBS/aft/species PrinterFriendly.asp?Id=17953 .,OADS,/arxiv_data1/oa_pdf/16/84/11105_2009_Article_115.PMC3881568.pdf
